clstr_prot,SEQUENCE_prot,n_clusters_SAB mortality,n_clusters_SAB persistence,n_clusters_Growth rate (AUC),n_clusters_Cell death (AUC),n_st_SAB mortality,n_st_SAB persistence,n_st_Growth rate (AUC),n_st_Cell death (AUC),n_positions_SAB mortality,n_positions_SAB persistence,n_positions_Growth rate (AUC),n_positions_Cell death (AUC),nebraska_locus_tag,neb_mutant_id,neb_gene,neb_product,GENE,PRODUCT,MUTATION_SHORT,intersect,neb_c_phenotype,neb_c_signif_parameters,neb_g_phenotype,neb_g_signif_parameters
0,MNYRDKIQKFSIRKYTVGTFSTVIATLVFLGFNTSQAHAAETNQPASVVKQKQQSNNEQTENRESQVQNSQNSQNGQSLSATHENEQPNISQANLVDQKVAQSSTTNDEQPASQNVNTKKDSATAATTQPDKEQSKHKQNESQSANKNGNDNRAAHVENHEANVVTASDSSDNGNVQHDRNELQAFFDANYHDYRFIDRENADSGTFNYVKGIFDKINTLLGSNDPINNKDLQLAYKELEQAVALIRTMPQRQQTSRRSNRIQTRSVESRAAEPRSVSDYQNANSSYYVENANDGSGYPVGTYINASSKGAPYNLPTTPWNTLKASDSKEIALMTAKQTGDGYQWVIKFNKGHAPHQNMIFWFALPADQVPVGRTDFVTVNSDGTNVQWSHGAGAGANKPLQQMWEYGVNDPHRSHDFKIRNRSGQVIYDWPTVHIYSLEDLSRASDYFSEAGATPATKAFGRQNFEYINGQKPAESPGVPKVYTFIGQGDASYTISFKTQGPTVNKLYYAAGGRALEYNQLFMYSQLYVESTQDHQQRLNGLRQVVNRTYRIGTTKRVEVSQGNVQTKKVLESTNLNIDDFVDDPLSYVKTPSNKVLGFYSNNANTNAFRPGGAQQLNEYQLSQLFTDQKLQEAARTRNPIRLMIGFDYPDAYGNSETLVPVNLTVLPEIQHNIKFFKNDDTQNIAEKPFSKQAGHPVFYVYAGNQGNASVNLGGSVTSIQPLRINLTSNENFTDKDWQITGIPRTLHIENSTNRPNNARERNIELVGNLLPGDYFGTIRFGRKEQLFEIRVKPHTPTITTTAEQLRGTALQKVPVNISGIPLDPSALVYLVAPTNQTTNGGSEADQIPSGYTILATGTPDGVHNTITIRPQDYIVFIPPVGKQIRAVVYYNKVVASNMSNAVTILPDDIPPTINNPVGINAKYYRGDEVNFTMGVSDRHSGIKNTTITTLPNGWTSNLTKADKNNGSLSITGRVSMNQAFNSDITFKVSATDNVNNTTNDSQSKHVSIHVGKISEDAHPIVLGNTEKVVVVNPTAVSNDEKQSIITAFMNKNQNIRGYLASTDPVTVDNNGNVTLHYRDGSSTTLDATNVMTYEPVVKPEYQTVNAAKTATVTIAKGQSFSIGDIKQYFTLSNGQPIPSGTFTNITSDRTIPTAQEVSQMNAGTQLYHITATNAYHKDSEDFYISLKIIDVKQPEGDQRVYRTSTYDLTTDEISKVKQAFINANRDVITLAEGDISVTNTPNGANVSTITVNINKGRLTKSFASNLANMNFLRWVNFPQDYTVTWTNAKIANRPTDGGLSWSDDHKSLIYRYDATLGTQITTNDILTMLKATTTVPGLRNNITGNEKSQAEAGGRPNFRTTGYSQSNATTDGQRQFTLNGQVIQVLDIINPSNGYGGQPVTNSNTRANHSNSTVVNVNEPAANGAGAFTIDHVVKSNSTHNASDAVYKAQLYLTPYGPKQYVEHLNQNTGNTTDAINIYFVPSDLVNPTISVGNYTNHQVFSGETFTNTITANDNFGVQSVTVPNTSQITGTVDNNHQHVSATAPNVTSATNKTINLLATDTSGNTATTSFNVTVKPLRDKYRVGTSSTAANPVRIANISNNATVSQADQTTIINSLTFTETVPNRSYARASANEITSKTVSNVSRTGNNANVTVTVTYQDGTTSTVTVPVKHVIPEIVAHSHYTVQGQDFPAGNGSSASDYFKLSNGSDIADATITWVSGQAPNKDNTRIGEDITVTAHILIDGETTPITKTATYKVVRTVPKHVFETARGVLYPGVSDMYDAKQYVKPVNNSWSTNAQHMNFQFVGTYGPNKDVVGISTRLIRVTYDNRQTEDLTILSKVKPDPPRIDANSVTYKAGLTNQEIKVNNVLNNSSVKLFKADNTPLNVTNITHGSGFSSVVTVSDALPNGGIKAKSSISMNNVTYTTQDEHGQVVTVTRNESVDSNDSATVTVTPQLQATTEGAVFIKGGDGFDFGHVERFIQNPPHGATVAWHDSPDTWKNTVGNTHKTAVVTLPNGQGTRNVEVPVKVYPVANAKAPSRDVKGQNLTNGTDAMNYITFDPNTNTNGITAAWANRQQPNNQQAGVQHLNVDVTYPGISAAKRVPVTVNVYQFEFPQTTYTTTVGGTLASGTQASGYAHMQNATGLPTDGFTYKWNRDTTGTNDANWSAMNKPNVAKVVNAKYDVIYNGHTFATSLPAKFVVKDVQPAKPTVTETAAGAITIAPGANQTVNTHAGNVTTYADKLVIKRNGNVVTTFTRRNNTSPWVKEASAATVAGIAGTNNGITVAAGTFNPADTIQVVATQGSGETVSDEQRSDDFTVVAPQPNQATTKIWQNGHIDITPNNPSGHLINPTQAMDIAYTEKVGNGAEHSKTINVVRGQNNQWTIANKPDYVTLDAQTGKVTFNANTIKPNSSITITPKAGTGHSVSSNPSTLTAPAAHTVNTTEIVKDYGSNVTAAEINNAVQVANKRTATIKNGTAMPTNLAGGSTTTIPVTVTYNDGSTEEVQESIFTKADKRELITAKNHLDDPVSTEGKKPGTITQYNNAMHNAQQQINTAKTEAQQVINNERATPQQVSDALTKVRAAQTKIDQAKALLQNKEDNSQLVTSKNNLQSSVNQVPSTAGMTQQSIDNYNAKKREAETEITAAQRVIDNGDATAQQISDEKHRVDNALTALNQAKHDLTADTHALEQAVQQLNRTGTTTGKKPASITAYNNSIRALQSDLTSAKNSANAIIQKPIRTVQEVQSALTNVNRVNERLTQAINQLVPLADNSALKTAKTKLDEEINKSVTTDGMTQSSIQAYENAKRAGQTESTNAQNVINNGDATDQQIAAEKTKVEEKYNSLKQAIAGLTPDLAPLQTAKTQLQNDIDQPTSTTGMTSASIAAFNEKLSAARTKIQEIDRVLASHPDVATIRQNVTAANAAKSALDQARNGLTVDKAPLENAKNQLQHSIDTQTSTTGMTQDSINAYNAKLTAARNKIQQINQVLAGSPTVEQINTNTSTANQAKSDLDHARQALTPDKAPLQTAKTQLEQSINQPTDTTGMTTASLNAYNQKLQAARQKLTEINQVLNGNPTVQNINDKVTEANQAKDQLNTARQGLTLDRQPALTTLHGASNLNQAQQNNFTQQINAAQNHAALETIKSNITALNTAMTKLKDSVADNNTIKSDQNYTDATPANKQAYDNAVNAAKGVIGETTNPTMDVNTVNQKAASVKSTKDALDGQQNLQRAKTEATNAITHASDLNQAQKNALTQQVNSAQNVQAVNDIKQTTQSLNTAMTGLKRGVANHNQVVQSDNYVNADTNKKNDYNNAYNHANDIINGNAQHPVITPSDVNNALSNVTSKEHALNGEAKLNAAKQEANTALGHLNNLNNAQRQNLQSQINGAHQIDAVNTIKQNATNLNSAMGNLRQAVADKDQVKRTEDYADADTAKQNAYNSAVSSAETIINQTTNPTMSVDDVNRATSAVTSNKNALNGYEKLAQSKTDAARAIDALPHLNNAQKADVKSKINAASNIAGVNTVKQQGTDLNTAMGNLQGAINDEQTTLNSQNYQDATPSKKTAYTNAVQAAKDILNKSNGQNKTKDQVTEAMNQVNSAKNNLDGTRLLDQAKQTAKQQLNNMTHLTTAQKTNLTNQINSGTTVAGVQTVQSNANTLDQAMNTLRQSIANKDATKASEDYVDANNDKQTAYNNAVAAAETIINANSNPEMNPSTITQKAEQVNSSKTALNGDENLAAAKQNAKTYLNTLTSITDAQKNNLISQITSATRVSGVDTVKQNAQHLDQAMASLQNGINNESQVKSSEKYRDADTNKQQEYDNAITAAKAILNKSTGPNTAQNAVEAALQRVNNAKDALNGDAKLIAAQNAAKQHLGTLTHITTAQRNDLTNQISQATNLAGVESVKQNANSLDGAMGNLQTAINDKSGTLASQNFLDADEQKRNAYNQAVSAAETILNKQTGPNTAKTAVEQALNNVNNAKHALNGTQNLNNAKQAAITAINGASDLNQKQKDALKAQANGAQRVSNAQDVQHNATELNTAMGTLKHAIADKTNTLASSKYVNADSTKQNAYTTKVTNAEHIISGTPTVVTTPSEVTAAANQVNSAKQELNGDERLREAKQNANTAIDALTQLNTPQKAKLKEQVGQANRLEDVQTVQTNGQALNNAMKGLRDSIANETTVKTSQNYTDASPNNQSTYNSAVSNAKGIINQTNNPTMDTSAITQATTQVNNAKNGLNGAENLRNAQNTAKQNLNTLSHLTNNQKSAISSQIDRAGHVSEVTATKNAATELNTQMGNLEQAIHDQNTVKQSVKFTDADKAKRDAYTNAVSRAEAILNKTQGANTSKQDVEAAIQNVSSAKNALNGDQNVTNAKNAAKNALNNLTSINNAQKRDLTTKIDQATTVAGVEAVSNTSTQLNTAMANLQNGINDKTNTLASENYHDADSDKKTAYTQAVTNAENILNKNSGSNLDKTAVENALSQVANAKGALNGNHNLEQAKSNANTTINGLQHLTTAQKDKLKQQVQQAQNVAGVDTVKSSANTLNGAMGTLRNSIQDNTATKNGQNYLDATERNKTNYNNAVDSANGVINATSNPNMDANAINQIATQVTSTKNALDGTHNLTQAKQTATNAIDGATNLNKAQKDALKAQVTSAQRVANVTSIQQTANELNTAMGQLQHGIDDENATKQTQKYRDAEQSKKTAYDQAVAAAKAILNKQTGSNSDKAAVDRALQQVTSTKDALNGDAKLAEAKAAAKQNLGTLNHITNAQRTDLEGQINQATTVDGVNTVKTNANTLDGAMNSLQGSINDKDATLRNQNYLDADESKRNAYTQAVTAAEGILNKQTGGNTSKADVDNALNAVTRAKAALNGADNLRNAKTSATNTIDGLPNLTQLQKDNLKHQVEQAQNVAGVNGVKDKGNTLNTAMGALRTSIQNDNTTKTSQNYLDASDSNKNNYNTAVNNANGVINATNNPNMDANAINGMANQVNTTKAALNGAQNLAQAKTNATNTINNAHDLNQKQKDALKTQVNNAQRVSDANNVQHTATELNSAMTALKAAIADKERTKASGNYVNADQEKRQAYDSKVTNAENIISGTPNATLTVNDVNSAASQVNAAKTALNGDNNLRVAKEHANNTIDGLAQLNNAQKAKLKEQVQSATTLDGVQTVKNSSQTLNTAMKGLRDSIANEATIKAGQNYTDASPNNRNEYDSAVTAAKAIINQTSNPTMEPNTITQVTSQVTTKEQALNGARNLAQAKTTAKNNLNNLTSINNAQKDALTRSIDGATTVAGVNQETAKATELNNAMHSLQNGINDETQTKQTQKYLDAEPSKKSAYDQAVNAAKAILTKASGQNVDKAAVEQALQNVNSTKTALNGDAKLNEAKAAAKQTLGTLTHINNAQRTALDNEITQATNVEGVNTVKAKAQQLDGAMGQLETSIRDKDTTLQSQNYQDADDAKRTAYSQAVNAAATILNKTAGGNTPKADVERAMQAVTQANTALNGIQNLDRAKQAANTAITNASDLNTKQKEALKAQVTSAGRVSAANGVEHTATELNTAMTALKRAIADKAETKASGNYVNADANKRQAYDEKVTAAENIVSGTPTPTLTPADVTNAATQVTNAKTQLNGNHNLEVAKQNANTAIDGLTSLNGPQKAKLKEQVGQATTLPNVQTVRDNAQTLNTAMKGLRDSIANEATIKAGQNYTDASQNKQTDYNSAVTAAKAIIGQTTSPSMNAQEINQAKDQVTAKQQALNGQENLRTAQTNAKQHLNGLSDLTDAQKDAVKRQIEGATHVNEVTQAQNNADALNTAMTNLKNGIQDQNTIKQGVNFTDADEAKRNAYTNAVTQAEQILNKAQGPNTSKDGVETALENVQRAKNELNGNQNVANAKTTAKNALNNLTSINNAQKEALKSQIEGATTVAGVNQVSTTASELNTAMSNLQNGINDEAATKAAQKYTDADREKQTAYNDAVTAAKTLLDKTAGSNDNKAAVEQALQRVNTAKTALNGDERLNEAKNTAKQQVATMSHLTDAQKANLTSQIESGTTVAGVQGIQANAGTLDQAMNQLRQSIASKDATKSSEDYQDANADLQNAYNDAVTNAEGIISATNNPEMNPDTINQKASQVNSAKSALNGDEKLAAAKQTAKSDIGRLTDLNNAQRTAANAEVDQAPNLAAVTAAKNKATSLNTAMGNLKHALAEKDNTKRSVNYTDADQPKQQAYDTAVTQAEAITNANGSNANETQVQAALNQLNQAKNDLNGDNKVAQAKESAKRALASYSNLNNAQSTAATSQIDNATTVAGVTAAQNTANELNTAMGQLQNGINDQNTVKQQVNFTDADQGKKDAYTNAVTNAQGILDKAHGQNMTKAQVEATLNQVTTAKNALNGDANVRQAKSDAKANLGTLTHLNNAQKQDLTSQIEGATTVNGVNGVKTKAQDLDGAMQRLQSAIANKDQTKASENYIDADPTKKTAFDNAITQAESYLNKDHGANKDKQAVEQAIQSVTSTENALNGDANLQRAKTEAIQAIDNLTHLNTPQKTALKQQVNAAQRVSGVTDLKNSATSLNNAMDQLKQAIADHDTIVASGNYTNASPDKQGAYTDAYNAAKNIVNGSPNVITNAADVTAATQRVNNAETGLNGDTNLATAKQQAKDALRQMTHLSDAQKQSITGQIDSATQVTGVQSVKDNATNLDNAMNQIRNSIANKDDVKASQPYVDADRDKQNAYNTAVTNAENIINATSQPTLDPSAVTQAANQVSTNKTALNGAQNLANKKQETTANINQLSHLNNAQKQDLNTQVTNAPNISTVNQVKTKAEQLDQAMERLINGIQDKDQVKQSVNFTDADPEKQTAYNNAVTAAENIINQANGTNANQSQVEAALSTVTTTKQALNGDRKVTDAKNNANQTLSTLDNLNNAQKGAVTGNINQAHTVAEVTQAIQTAQELNTAMGNLKNSLNDKDTTLGSQNFADADPEKKNAYNEAVHNAENILNKSTGTNVPKDQVEAAMNQVNATKAALNGTQNLEKAKQHANTAIDGLSHLTNAQKEALKQLVQQSTTVAEAQGNEQKANNVDAAMDKLRQSIADNATTKQNQNYTDASQNKKDAYNNAVTTAQGIIDQTTSPTLDPTVINQAAGQVSTTKNALNGNENLEAAKQQASQSLGSLDNLNNAQKQTVTDQINGAHTVDEANQIKQNAQNLNTAMGNLKQAIADKDATKATVNFTDADQAKQQAYNTAVTNAENIISKANGGNATQAEVEQAIKQVNAAKQALNGNANVQHAKDEATALINSSNDLNQAQKDALKQQVQNATTVAGVNNVKQTAQELNNAMTQLKQGIADKEQTKADGNFVNADPDKQNAYNQAVAKAEALISATPDVVVTPSEITAALNKVTQAKNDLNGNTNLATAKQNVQHAIDQLPNLNQAQRDEYSKQITQATLVPNVNAIQQAATTLNDAMTQLKQGIANKAQIKGSENYHDADTDKQTAYDNAVTKAEELLKQTTNPTMDPNTIQQALTKVNDTNQALNGNQKLADAKQDAKTTLGTLDHLNDAQKQALTTQVEQAPDIATVNNVKQNAQNLNNAMTNLNNALQDKTETLNSINFTDADQAKKDAYTNAVSHAEGILSKANGSNASQTEVEQAMQRVNEAKQALNGNDNVQRAKDAAKQVITNANDLNQAQKDALKQQVDAAQTVANVNTIKQTAQDLNQAMTQLKQGIADKDQTKANGNFVNADTDKQNAYNNAVAHAEQIISGTPNANVDPQQVAQALQQVNQAKGDLNGNHNLQVAKDNANTAIDQLPNLNQPQKTALKDQVSHAELVTGVNAIKQNADALNNAMGTLKQQIQANSQVPQSVDFTQADQDKQQAYNNAANQAQQIANGIPTPVLTPDTVTQAVTTMNQAKDALNGDEKLAQAKQEALANLDTLRDLNQPQRDALRNQINQAQALATVEQTKQNAQNVNTAMSNLKQGIANKDTVKASENYHDADADKQTAYTNAVSQAEGIINQTTNPTLNPDEITRALTQVTDAKNGLNGEAKLATEKQNAKDAVSGMTHLNDAQKQALKGQIDQSPEIATVNQVKQTATSLDQAMDQLSQAINDKAQTLADGNYLNADPDKQNAYKQAVAKAEALLNKQSGTNEVQAQVESITNEVNAAKQALNGNDNLANAKQQAKQQLANLTHLNDAQKQSFESQITQAPLVTDVTTINQKAQTLDHAMELLRNSVADNQTTLASEDYHDATAQRQNDYNQAVTAANNIINQTTSPTMNPDDVNGATTQVNNTKVALDGDENLAAAKQQANNRLDQLDHLNNAQKQQLQSQITQSSDIAAVNGHKQTAESLNTAMGNLINAIADHQAVEQRGNFINADTDKQTAYNTAVNEAAAMINKQTGQNANQTEVEQAITKVQTTLQALNGDHNLQVAKTNATQAIDALTSLNDPQKTALKDQVTAATLVTAVHQIEQNANTLNQAMHGLRQSIQDNAATKANSKYINEDQPEQQNYDQAVQAANNIINEQTATLDNNAINQAATTVNTTKAALHGDVKLQNDKDHAKQTVSQLAHLNNAQKHMEDTLIDSETTRTAVKQDLTEVQALDQLMDALQQSIADKDATRASSAYVNAEPNKKQSYDEAVQNAESIIAGLNNPTINKGNVSSATQAVISSKNALDGVERLAQDKQTAGNSLNHLDQLTPAQQQALENQINNATTRGEVAQKLTEAQALNQAMEALRNSIQDQQQTEAGSKFINEDKPQKDAYQAAVQNAKDLINQTNNPTLDKAQVEQLTQAVNQAKDNLHGDQKLADDKQHAVTDLNQLNGLNNPQRQALESQINNAATRGEVAQKLAEAKALDQAMQALRNSIQDQQQTESGSKFINEDKPQKDAYQAAVQNAKDLINQTGNPTLDKSQVEQLTQAVTTAKDNLHGDQKLARDQQQAVTTVNALPNLNHAQQQALTDAINAAPTRTEVAQHVQTATELDHAMETLKNKVDQVNTDKAQPNYTEASTDKKEAVDQALQAAESITDPTNGSNANKDAVDQVLTKLQEKENELNGNERVAEAKTQAKQTIDQLTHLNADQIATAKQNIDQATKLQPIAELVDQATQLNQSMDQLQQAVNEHANVEQTVDYTQADSDKQNAYKQAIADAENVLKQNANKQQVDQALQNILNAKQALNGDERVALAKTNGKHDIDQLNALNNAQQDGFKGRIDQSNDLNQIQQIVDEAKALNRAMDQLSQEITDNEGRTKGSTNYVNADTQVKQVYDETVDKAKQALDKSTGQNLTAKQVIKLNDAVTAAKKALNGEERLNNRKAEALQRLDQLTHLNNAQRQLAIQQINNAETLNKASRAINRATKLDNAMGAVQQYIDEQHLGVISSTNYINADDNLKANYDNAIANAAHELDKVQGNAIAKAEAEQLKQNIIDAQNALNGDQNLANAKDKANAFVNSLNGLNQQQQDLAHKAINNADTVSDVTDIVNNQIDLNDAMETLKHLVDNEIPNAEQTVNYQNADDNAKTNFDDAKRLANTLLNSDNTNVNDINGAIQAVNDAIHNLNGDQRLQDAKDKAIQSINQALANKLKEIEASNATDQDKLIAKNKAEELANSIINNINKATSNQAVSQVQTAGNHAIEQVHANEIPKAKIDANKDVDKQVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMTKEEIEQAKAQLAQALQDIKDLVKAKEDAKQDVDKQVQALIDEIDQNPNLTDKEKQALKDRINQILQQGHNDINNALTKEEIEQAKAQLAQALQDIKDLVKAKEDAKNAIKALANAKRDQINSNPDLTPEQKAKALKEIDEAEKRALQNVENAQTIDQLNRGLNLGLDDIRNTHVWEVDEQPAVNEIFEATPEQILVNGELIVHRDDIITEQDILAHINLIDQLSAEVIDTPSTATISDSLTAKVEVTLLDGSKVIVNVPVKVVEKELSVVKQQAIESIENAAQQKINEINNSVTLTLEQKEAAIAEVNKLKQQAIDHVNNAPDVHSVEEIQQQEQAHIEQFNPEQFTIEQAKSNAIKSIEDAIQHMIDEIKARTDLTDKEKQEAIAKLNQLKEQAIQAIQRAQSIDEISEQLEQFKAQMKAANPTAKELAKRKQEAISRIKDFSNEKINSIRNSEIGTADEKQAAMNQINEIVLETIRDINNAHTLQQVEAALNNGIARISAVQIVTSDRAKQSSSTGNESNSHLTIGYGTANHPFNSSTIGHKKKLDEDDDIDPLHMRHFSNNFGNVIKNAIGVVGISGLLASFWFFIAKRRRKEDEEEELEIRDNNKDSIKETLDDTKHLPLLFAKRRRKEDEEDVTVEEKDSLNNGESLDKVKHTPFFLPKRRRKEDEEDVEVTNENTDEKVLKDNEHSPLLFAKRRKDKEEDVETTTSIESKDEDVPLLLAKKKNQKDNQSKDKKSASKNTSKKVAAKKKKKKAKKNKK,6,4,2,1,1,1,1,1,7,8,2,1,SAUSA300_1327,NE1,NA,cell surface protein,ebh|ebh_1,Extracellular matrix-binding protein ebh,L323S|E2602A|Y7469*|V7253fs|E10092Q|I8556T|V8219A,all,+,0,-,0
3,MASDFNIGILSTLEIDSSSSRKKINDTLKNIEANINSIKADLEVSDTKKSENNAIKSANNVIRNINSNGNLKKLNVELDVNLTKSRQNIQRALSTLSKDFKNKKIDVEVNAKANKNSIGQVKNSISKGASQPLEIKESPSSRSTSRDIKEQQSLMTGLANSYKNLDDLTRALNTSTFEGLRKTVKEIKNADNSLKSYQVTLERVNQEGKKLGSQRFDYTPSANGLKLNKTQLTDQTDKARKEENAAINKLLENEVSKYDRLLNKGKIDIKQHQTLLQTLRQITNEKSKANQFNRTDFNRVAKAAADEAKEYQYQNDMLRKKLALTSQIERIENRMAATIDKQQTNALKNQLNSLGNNRTPFGKEAAFHMNQIQDKVRQISAEAERATRTQLSFVDQFREAMTKSPVWMGATTLFFGAINGAKEMLDVITENDGKMITLAKVTGDDNALQQTFIDANNAASQFGQTLGSVLDVYAEFARQGVKGNELSQFSNAALIAANVGEIDAKQASEYLTSMSAQWETTGNQAMRQVDSLNEVSNKYATTVEKLAQGQAKAGSTAKSMGLTFDETNGIIGALTAKTKQSGDEIGNFMKATLPKLYSGKGKSTIEGLGISMKDENGQLKSAISLLEEVSQKTKNLEKDQKAAVINGLGGTYHYQRMQVLLDDLSKTDGLYKQIKESSESSAGSALQENAKYMESIEAKVNQAKTAFEQFALAVGETFAKSGMLDGIRMVTQLLTGLTHGITELGTTAPIFGMVGGAASLMSKNVRSGFEGARSSVANYITEVNKLAKVNNAAGQVVGLQKVQTGTASQLQFNKNGEYDKAASQAKAAEQATYQFSKAQKDVSASAMIASGAINKTTVATTASTVATRAATLAVNGLKLAFRGLLAATGVGLAITGVSFVLEKVVGSFNAASQAAEQYKQKQEQTKQAIASMSNGEINSLISSYDKLQQKMNSGSAFNTAEAEKYKEVTSQLANIFPDLVTGENRYGKEMAGNKEVMKQKIELIKQEMELERQKNAIKQKEEQDAYIKEQDSLAKKNRGQKWYQLGQTPELKLQEQARPTTVSDNSNINKINATIQKVKSQAQAEKALEQVDKQLAQSQTKNRQNEVQHLQKVRQALQDYITKTGQANQATRAAVLTAQQQFTNQIATMKKLGTTGQQVMNTISNSVAKTAKSGKAAQATFKSFETSLVKSSSFKSKMASYEASVKKFKNAANQSAKIAALKDVERDYSKVAKGIMQAAKAANMSKSQMKDLKKSLQQNIQAETGFRASVSKAGKVTIDQSKKIKQNTAETRRNSSAKLQNADASDQASEENKELADSMRAGIESSQLLGKAMGELQSQGTLSTETLIELTEKYGDEILAVAGDQEALSNFIMQKQNEETDNYNKNLKTKLENSSSYYKAVAGADSALSNYLMENYGIDTKNYKSLTEVKAKITDLYYNGSAEEQAKVVDAIAKAYHIDLSNYGSLNEKKEALENQLMKILGSKWKKYIGSVAKDMKSLGVDAGEVGADGFDDSKMFNPGALIGANNFQNVSNLSNISNVFNSLNGAFNEAKNEAAGVSRGLDDAASGLKDVGDSAGSAGSGLGKTAKGADKASDSLDGTNKELEKTKEKAEEAGVTVKQLYKQFTVTTYVADKLSMALDKINNKLEKQKLLTEKYATWSSSYRNSLKAENKLLDEKTAKIKKQIESMKEQIAQGKVIEYGLVGKDINVPYYEYTANNLDDGETGRISRYTGNSTQAKVWNFFKSKGLSDHAVAGIMGNMERESRFKPGAQEQGGTGIGLVQLSFGRANNLRNYAARRGKSWKDLNTQLDFIWKELNTTEVNALRGLKSATSVIGAANSFQRLYERAGVVAQGERNAAAKKYYRQFKGTNGSSGFLSGGVVAGTNGKPLTSDRNAYILDRQFGRYNGGGVHHGRDITSATINGSPIKAARSGIVTFKGWTGGGNTLSIFDGKNTYTYMHMKNPARVVKGQRVKAGQIVGNVGTTYDRRLGGFSTGPHLHVQANLGKTPSGTFMNTFNGAHRAVDPVKYGYTRVSGGGSLNLGSLTSGHSAMSGSISAAMAEDLNEAEQERLNKIEQAINAHNKAEEMKQKVDELRKTLMDKQLEEVQTAKEKSENLYNIQKSHVEEYDHWRTLQEARSAKLEYELNKIEFEKGRNTKEWRNKNKQLQASRQLEVNFEDSKIQYINKALKKNANKIFGKNTVNRDEFETMKRDAQQNIRDLKAGIQTASGEIATSMIDQILDEYEDRVGKVSAKIEKMGKQKEKLDLADNKQALKSSSLSRQQAKDSKSLASYINFYIKQLERQLKLTGKNHELQQKVKEQIKEMKVAYDDATLAAHQYITEAAEVDTERQLQLNANRLRDAQNELSKADYKAGFISQEYQIDLYRKNQEAKFKGYLKEKEALEQNKSELQDMYEIYKSVPTQAQKIKEALIETKNAIRDNNKGLYDLKYDMANSVINQIKDIYSKQLEVATKAYDDEYKAYEKMINKKLKLIDDEQTQESFNKDVRDRTEAMDKIRDEIAQRSGDDSLANQKKLKDLREQLKQQEEDYTMFINNKNRDDRRKALQDELNDKNEQIQEQKEDLNKAFQDLIGDTRRFNAIQESLMEGQIDKYKSLIADLTKYVNDNMKEIGRSTSEGILDGLAASFKGLSSLSKELQKQEKNNLNPVPNSKLKPTKVDEATIAAIKKVNGLSPTTILQGLDIKPVNLPKDVKPSKTVTNNNKTTAKALVNIENFNGTKAEADKLANNLATAMRKQGVL,1,2,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N431I,SAB mortality and SAB persistence,NA,NA,NA,NA
4,MTLNNHFAYTFEERPTPKLWLCKPDGTRIERIADFSKLGGTFKFTNVNTLHFDLPLQVFSEDTKQIERNKVVDLVKNKYLIDYRYNGYRDIFVIDDIKKSANDSDFITLNLDSRASELNKKAANEIELLGSTIPQMMNKILSIYAPLWKLGHVDGKIINVKRELTGSNTTVNALIDNICSLFDAVAIYNNINRTISFYHKDNVGTNRGLRVRENSYLKSFEDQFVSKDIVTRLYPFGQSGLTIQSVNPAGSSYIEDFSYFMSPFKRDNNRNVLQHSDYMSDELCHALLDYQEFYASKKDQAGELSKQYSAILKEHSQEDFRLNQLSATLQRLNERVELVKPKSEYIDLGTKVKNFKITVPKSSYYLIMIRNDGSFTRIKFNNKQYDIPSGEWLYIKLKTGKFNDATKFEKQLEYPLEILSANANLRVVYTRSSEGDYEEEDTKKIEEKYNLEKYKTLVKDQEKVVASIERRLKAFEDQRASVIRSMNAKNFLSEKLYKERELYVFESVWNEENHTDAQELYDDAVKQMKKQKKINRTITVDLVNFIQSLDHKDDWDKLNVGDKVIFQNKIFNTKIKAYITEMQLDFQTNQVKITISDIFDYKDLDMIIAEKLAQTTSTSSQVDFHKQQIREQTGRITDMTRLIEGEWDANKKRVMAGNETVDIGSHGVKVISKDNPNEFVIMVGGVIAMTRDNGETFKTGITPEGINAEMLIGKMIVGETLTFENESGTVKFDKDGLYVNSKNFHLVSNDGEENYFDKLKREMSENAKQQTDRMLEEYKKEVSQTISEATDVRNIVDNAADILQAAFADGVITDVEKRLISETLAQLEKENREFEDKINLALNHPYITEEDTIELNNSIVEYSSMYETLVISINESVSDKMITPQESEEINQNIINFREEIKDILSLVEEIIERTKNAQLQATLEEAKDYTTRVRDDIKDELNDLNKSFKSLNSTVEDSLKDNIFDAAELEAIKTVVLVTKSEYQDITNRYSSMSVNTDLKSESKSDLTKAYKTLDSSFNDFVKYIDEMTMDRVADETEKANYKKKYDTLQKNLSDYMKKYDNCILEISKKYSKDEADKVLGDFTAIATELKNDFQDVKDNWAEFKQTTLESFKDGIVTEAEKARLRVQLDMLDRESMDIEERYKSLLANQYTDTNIKNRLAASRSPYLSAHASLRQTIEQIITDGQVDESEKTLANKSLNTYNTTLTAYSKAIQEALNTLSQIISSDVASKKVEEFNGVITTISSDVDTIKKQRDGSVITYYYSGVPTLSNDPAKSWTTNDLKDLHIKDMYLDTKSGYAYTFTKSGTSYSWKPLTDQVIVSSLKQAKNAQDTADNKRRVFVTQPIPPYDQGDMWTQGSQGDIYVCGTSRTTGSFVSSDWVKASKYTDDTVAKQAAKDLENYKVKMTKDFKDLNDGVSTFKTEVIKDFKDGIVTEAEKTRLRVQLDILDRESQDIEERYNSIFNSQYADTQVKTSISNARSTYNNSLTNLRNTIQTIIEDGEVTSSEKTTANQTLTTYNNALTGYSTAIQEALSSMSKVIAQKEATSQVNQFNEVINNINTNITDIQKQVDGAIETFYYSGVPTLTNIPASDWKTTNKREAHLGDLYLDTATGIVYRFLKKGTTSPTYYWSAISDQIITDALNRAKTAQDTADGKRRVFVNTPVPPYDTGDMWTQGARGDIYVCQTPKAKGAIYSINDWVKASKYTDDTVANSAVQQLNEYKRTNNLDIADLKRKTSDFEKTVVNAFDDRVISISESSAIKGQLALLNHEKDRLARQYENIIGNSNLVGAEKTKLSTTYSNMNTKLSDLSTTINSAIVDNKIVDAESKSVTSKLELYKTSVNEYQLAFDNALNSIIREIASSQAKDRLDEWKRTEFSTDSDGIIERVAGAKFDSKWTDTWRSTVNPAISKVQSSLNDTNNKISNLKTGGVNLLQSYREETKAVIDPSITSTKKASFDKLWATPLYKPDYFRTYLQPNTEYTISYEIQIDNFNGAKTLTGRSFGMLLYDYTDTKVLSNFSVETLPETVDPKLVGKKFKATKTFTTPSSFKNNLNFLAYAGYYLANDGSRIYPSVTISNLKLETGNIVSDWTPAPEDTSTTLQDYNTRISSAETFIEKNKDKISQIATKTDVDTLLSKVATYETQYSVSSGNNYQVPLQEYNGSFFTDNYTYEVVAKNNSLSSNNVATAIFVSKGSNNGYELVELDNMSKTGANPKFVLDSKGRPSISTFSPQSATQDISVIYTKYLGSASTINTTKSLIEQTASSIELQVKKLTAETEYNNILLNSDFSSGWEGWINVDPQYSIVDKNTFGITLPDAITNKNKKYNTVKMTYNKNTNYPSVFSNFISVGKGQEVAIGEHLTLTCYAYIPSSSKGKLTGNIYIEFAGYYEKDQKSNPMIARHEILPKDFEYNKWFRMTASTAIPSTNSEGKKINYIRACLRYDGKNQSVNNSAIFYYALPQLERGSKPTEWSLSRLDVFSTEQLAAKIALNPESVDIIARNIDFNTDSMKIYNSNGTLNISGDTLTISNNNSSNEVIINPKGFTLKKDGVVKFKNGLDTSDYSVQAYEPQFSSWNNIKATDPAAKSKYNYIRHIEPGMNGYYTINTGVYNFAVQHKQLLEVNNTKNARVNRYTYLYNKRYLKIQMSASSQGKSKLYIIFKTKTGDTTLHQEIVSSTSLVYPDITIDLQAKLGYPPNNLPDFFELQAGIAYGENNSIDGFFRIRRMAMTDTPNAEV,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,L1286I,SAB persistence only,NA,NA,NA,NA
5,MNLFRQQKFSIRKFNVGIFSALIATVTFISTNPTTASAAEQNQPAQNQPAQPADANTQPNANAGAQANPTAQPAAPANQGQPAVQPANQGGQANPAGGAAQPNTQPAGQGNQADPNNAAQAQPGNQATPANQAGQGNNQATPNNNATPANQTQPANAPAAAQPAAPVAANAQTQDPNASNTGEGSINTTLTFDDPAISTDENRQDPTVTVTDKVNGYSLINNGKIGFVNSELRRSDMFDKNNPQNYQAKGNVAALGRVNANDSTDHGNFNGISKTVNVKPDSELIINFTTMQTNSKQGATNLVIKDAKKNTELATVNVAKTGTAHLFKVPTDADRLDLQFIPDNTAVADASRITINKDGYKYYSFIDNVGLFSGSHLYVKNRDLAPKATNNKEYTINTEIGNNGNFGASLKADQFKYEVTLPQGVTYVNNSLTTTFPNGNEDSTVLKNMTVNYDQNANKVTFTSQGVTTARGTHTKEVLFPDKSLKLSYKVNVANIDTPKNIDFNEKLTYRTASDVVINNAQPEVTLTADPFSVAVEMNKDALQQQVNSQVDNSHYTTASIAEYNKLKQQADTILNEDANHVKTANRASQADIDGLVTKLQAALIDNQAAIAELDTKAQEKVTAAQQSKKVTQDEVAALVTKINNDKNNAIAEINKQTTAQGVTTEKDNGIAVLEQDVITPTVKPQAKQDIIQAVTTRKQQIKKSNASLQDEKDVANDKIGKIETKAIKDIDAATTNAQVEAIKTKAINDINQTTPATTAKAAALEEFDEVVQAQIDQAPLNPDTTNEEVAEAIERINAAKVSGVKAIEATTTAQDLERVKNEEISKIENITDSTQTKMDAYNEVKQAATARKAQNATVSNATNEEVAEADAAVDAAQKQGLHDIQVVKSKQEVADTKSKVLDKINAIQTQAKVKPAADTEVENAYNTRKQEIQNSNASTTEEKQAAYTELDTKKQEARTNLDAANTNSDVTTAKDNSIAAINQVQAATTKKSDAKAEIAQKASERKTAIEAMNDSTTEEQQAAKDKVDQAVVTANADIDNAAANNDVDNAKTTNEATIAAITPDANVKPAAKQAIADKVQAQETAIDGNNGSTTEEKAAAKQQVQTEKTTADAAIDAAHTNAEVEAAKKAAIAKIEAIQPATTTKDNAKEAIATKANERKTAIAQTQDITAEEIAAANADVDNAVTQANSNIEAANSQNDVDQAKTTGENSIDQVTPTVNKKATARNEITAILNNKLQEIQATPDATDEEKQAADAEANTENGKANQAISAATTNAQVDEAKANAEAAINAVTPKVVKKQAAKDEIDQLQATQTNVINNDQNATTEEKEAAIQQLATAVTDAKNNITAATDDNGVDQAKDAGKNSIQSTQPATAVKSNAKNDVDQAVTTQNQAIDNTTGATTEEKNAAKDLVLKAKEKAYQDILNAQTTNDVTQIKDQAVADIQGITADTTIKDVAKDELATKANEQKALIAQTADATTEEKEQANQQVDAQLTQGNQNIENAQSIDDVNTAKDNAIQAIDPIQASTDVKTNARAELLTEMQNKITEILNNNETTNEEKGNDIGPVRAAYEEGLNNINAATTTGDVTTAKDTAVQKVQQLHANPVKKPAGKKELDQAAADKKTQIEQTPNASQQEINDAKQEVDTELNQAKTNVDQSSTNEYVDNAVKEGKAKINAVKTFSEYKKDALAKIEDAYNAKVNEADNSNASTSSEIAEAKQKLAELKQTADQNVNQATSKDDIEVQIHNDLDNINDYTIPTGKKESATTDLYAYADQKKNNISADTNATQDEKQQAIKQVDQNVQTALESINNGVDNGDVDDALTQGKAAIDAIQVDATVKPKANQAIEVKAEDTKESIDQSDQLTAEEKTEALAMIKQITDQAKQGITDATTTAEVEKAKAQGLEAFDNIQIDSTEKQKAIEELETALDQIEAGVNVNADATTEEKEAFTNALEDILSKATEDISDQTTNAEIATVKNSALEQLKAQRINPEVKKNALEAIREVVNKQIEIIKNADADASAKEIARTDLGRYFDRFADKLDKTQTNAEVAELQNVTIPAIEAIVPQNDPDANDTNNGIDNNDATANSNANATPENTGQPNVSETTANGKADASPTTPNNSDAATGETTATSATDDANDKPQANNNSSVDASTNSPTMDNDVTSKPEVESTNNGTTDKPVTETDNATPAESTTNNNSTTTATNENAPTGSTATAPTTASTEAASSADSKDNASVNDSKQNAEVNNSAESQSTNDKVAQPKSENKAKAEKDGSDSTNQSMVESTTETLPSADITEPNVPSNTSKDKEESTTNQTDAGQLKSETNVASNEADKSPSKADTEVSNKPSTSASSEAKEKMTSTNVSQKDDTATADTNDTQKSVGSAANNKATQNDGANASPATVSNGSNSANQDMLNVTNTDDHQAKTKSAQQGKVNKAKQQAKTLPDTGMSHNDDLPYAELALGAGMAFLIRRFTKKDQQTEE,1,2,0,0,1,2,0,0,1,2,0,0,SAUSA300_2109,NE472,fmtB,truncated FmtB protein,NA,hypothetical protein,I355T,SAB mortality and SAB persistence,+,1,+,0
7,MIMGNLRFQQEYFRIYKNNTESTTHRNAYWVKLAKNIEATKMMYALSTIVQQHASIRHFFDVTTDDNLTMILHEFLPFIEIKQVPSSSANYDLEAFFKQELSTYHFNDSPLFKFKLFQFADAAYILLDFHVSIFDDSQIDIFLDDLCNAYRGNTVINNTRQHAHLNRNDDKDNQDASHIALDSNYFRLENNSDIHIDSYLPIKHPFEQALYQTYLIDDMTSIDMASLAVSVYLANHIMSQQHDVTLGIHVPSHLPNDLHGNIVPLTLTIDAKDVCQRFTTDFNKSVLQNMSQLQCAKSSLSLETIFHCYHQMMSCCNDVIEDVHQIHDAHTSLADIEIFPHQHGFKIIYNSAAYDLLSIETLSDLVRNIYLQITKENGNKRTTVDELNLMTERDIQLYDDINLSLPEIDDAQTVVTLFEQQVEATPNYVAVQFDGVFITYQTLNARANDLAQRLRNQYGVEPNDRVAVIAEKSIEMIVAMIGVLKAGGAYVPIDPNYPSDRQEYILKDATPKVVITYQVVYENGKRDINHIDLNKIAWKNIDNLSKCNTLEDHAYVIYTSGTTGNPKGTLIPHRGIVRLVHQNHYVPLNEKTTILLSGTIAFDAATFEIYGALLNGGKLIVAKTEQLLNPIALEQLINENDVNTMWLTSSLFNQIASERIEVLVPLKYLLIGGEVLNAKWVDLLNQRPKHPQIINGYGPTENTTFTTTYNIPNKVPNRIPIGKPILGTHVYIMQGERRCGVGIPGELCTSGFGLAAGYLNQPELTADKFIKDSNINQLMYRSGDIVRLLPDGNIDYLYRKDKQVKIRGFRIELSEVEHALERIQGINKAVVIVQNHDQDQYIVAYYEAMHTLSHNKIKSQLRMTLPEYMIPVNFMHIEQIPITINGKLDKKALPIMDYVDTDAYVAPSTDTEHLLCQIFADILHVNQVGIHDNFFELGGHSLKATLVVNRIEASTGKRLQIGDLLQKPTVFELAQAIAKVQEQNYEVIPEAIVKDDYVLSSAQKRMYLLWKSNHKDTVYNIPFYGGYHQNLM,5,2,1,1,1,1,1,1,4,3,1,1,SAUSA300_0181,NE119,NA,non-ribosomal peptide synthetase,tycC,Tyrocidine synthase 3,Y1024fs|K1333E|R2308fs|L894P,all,-,5,-,0
9,MNLLKKNKYSIRKYKVGIFSTLIGTVLLLSNPNGAQALTTDNNVQSDTNQATPVNSQDKDVANNRGLANSAQNTPNQSATTNQATNQALVNHNNGSIVNQATPTSVQSSTPSAQNNNHTDGNTTATETVSNANNNDVVSNNTALNVPTKTNENGSGGHLTLKEIQEDVRHSSNKPELVAIAEPASNRPKKRSRRAAPADPNATPADPAAAAVGNGGAPVAITAPYTPTTDPNANNAGQNAPNEVLSFDDNGIRPSTNRSVPTVNVVNNLPGFTLINGGKVGVFSHAMVRTSMFDSGDNKNYQAQGNVIALGRIHGTDTNDHGDFNGIEKALTVNPNSELIFEFNTMTTKNGQGATNVIIKNADTNDTIAEKTVEGGPTLRLFKVPDNVRNLKIQFVPKNDAITDARGIYQLKDGYKYYSFVDSIGLHSGSHVFVERRTMDPTATNNKEFTVTTSLKNNGNSGASLDTNDFVYQVQLPEGVEYVNNSLTKDFPSNNSGVDVNDMNVTYDAANRVITIKSTGGGTANSPARLTPDKILDLRYKLRVNNVPTPRTVTFNETLTYKTYTQDFINSAAESHTVSTNPYTIDIIMNKDALQAEVDRRIQQADYTFASLDIFNGLKRRAQTILDENRNNVPLNKRVSQAYIDSLTNQMQHTLIRSVDAENAVNKKVDQMEDLVNQNDELTDEEKQAAIQVIEEHKNEIIGNIGDQTTDDGVTRIKDQGIQTLSGDTATPVVKPNAKKAIRDKATKQREIINATPDVTEDEIQDALNQLATDETDAIDNVTNATTNADVETAKNNGINTIGAVVPQVTHKKAARDAINQATATKRQQINSNREATQEEKNAALNELTQATNHALEQINQATTNADVDNAKGDGLNAINPIAPVTVVKQAARDAVSHDAQQHIAEINANPDATQEERQAAIDKVNAAVTAANTNILNANTNADVEQVKTNAIQGIQAITPATKVKTDAKNAIDKSAETQHNTIFNNNDATLEEQQAAQQLLDQAVATAKQNINAADTNQEVAQAKDQGTQNIVVIQPATQVKTDTRNVVNDKAREAITNINATTGATREEKQEAINRVNTLKNRALTDIGVTSTTAMVNSIRDDAVNQIGAVQPHVTKKQTATGVLNDLATAKKQEINQNTNATTEEKQVALNQVDQELATAINNINQADTNAEVDQAQQLGTKAINAIQPNIVKKPAALAQINQHYNAKLAEINATPDATNDEKNAAINTLNQDRQQAIESIKQANTNAEVDQAATVAENNIDAVQVDVVKKQAARDKITAEVAKRIEAVKQTPNATDEEKQAAVNQINQLKDQAINQINQNQTNDQVDTTTNQAVNAIDNVEAEVVIKPKAIADIEKAVKEKQQQIDNSLDSTDNEKEVASQALAKEKEKALAAIDQAQTNSQVNQAATNGVSAIKIIQPETKVKPAAREKINQKANELRAKINQDKEATAEERQVALDKINEFVNQAMTDITNNRTNQQVDDTTSQALDSIALVTPDHIVRAAARDAVKQQYEAKKREIEQAEHATDEEKQVALNQLANNEKRALQNIDQAIANNDVKRVETNGIATLKGVQPHIVIKPEAQQAIKASAENQVESIKDTPHATVDELDEANQLISDTLKQAQQEIENTNQDAAVTDVRNQTIKAIEQIKPKVRRKRAALDSIEENNKNQLDAIRNTLDTTQDERDVAIDTLNKIVNTIKNDIAQNKTNAEVDRTETDGNDNIKVILPKVQVKPAARQSVGVKAEAQNALIDQSDLSTEEERLAAKHLVEQALNQAIDQINHADKTAQVNQDSINAQNIISKIKPATTVKATALQQIQNIATNKINLIKANNEATDEEQNIAIAQVEKELIKAKQQIASAVTNADVAYLLHDEKNEIREIEPVINRKASAREQLTTLFNDKKQAIEANIQATVEERNSILAQLQNIYDTAIGQIDQDRSNAQVDKTASLNLQTIHDLDVHPIKKPDAEKTINDDLARVTALVQNYRKVSNRNKADALKAITALKLQMDEELKTARTNADVDAVLKRFNVALSDIEAVITEKENSLLRIDNIAQQTYAKFKAIATPEQLAKVKVLIDQYVADGNRMIDEDATLNDIKQHTQFIVDEILAIKLPAEATKVSPKEIQPAPKVCTPIKKEETHESRKVEKELPNTGSEGMDLPLKEFALITGAALLARRRTKNEKES,1,0,2,2,1,0,1,1,1,0,2,2,SAUSA300_1702,NE56,NA,cell wall surface anchor family protein,NA,hypothetical protein,A1394V|E1533K|V1394A,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
11,MSKRQKEFHDSLANEKTRVRLYKSGKNWVKSGIKEIEMFKIMGLPFISHSLVSQDNQSISKKITGYGLKTTAVIGGAFTVNMLHDQQAFAASDAPLTSELNTQSETVGNQNSTTIEASTSTTDSTSVTKNSSSEQTSNSDTVSSEKSENVTSTTNSTSNQQEKLTSTSESTSPKNTTSSSDTKSVTSISSTDQQTNTSTNQSTASNTTSQSTTPASANLNKTSTTSTSTAPIKLRTFSRLAMSTFASAATTSAVTANTITVNKDNLKQYMTTSGNATYDQSTGIVTLTQDAYSQKGAITLGTRIDSNKSFHFSGKVNLGNKYEGNGNGGDGIGFAFSPGVLGETGLNGAAVGIGGLSNAFGFKLDTYHNTSKPNAAAKANADPSNVAGGGAFGAFVTTDSYGVATTYTSSSAADNAAKLKVQPTNNTFQDFDINYNGDTKVMTVTYAGQTWTRNISDWIAKSGTTNFSLSMTASTGGATNLQQVQFGTFEYTESAVTQVRYVDVTTGKDIIPPKTYSGNVDQVVTIDNQQSALTAKGYNYTSVDSSYASTYNDTNKTVKMTNAGQSVTYYFTDVKAPTVTVGNQTIEVGKTMNPIVLTTTDNGTGTVTNTVTGLPSGLSYDSATNSIIGTPTKIGQSTVTVVSTDQANNKSTTTFTINVVDTTAPTVTPIGDQSSEVYSPISPIKIATQDNSGNAVTNTVTGLPSGLTFDSTNNTISGTPTNIGTSTITIVSTDASGNKTTTTFKYEVTRNSMSDSVSTSGSTQQSQSVSTSKADSQSASTSTSGSIVVSTSASTSKSTSVSLSDSVSASKSLSTSESNSVSSSTSTSLVNSQSVSSSMSGSVSKSTSLSDSISNSSSTEKSESLSTSTSDSLRTSTSLSDSVSMSTSGSLSKSQSLSTSTSDSASTSQSVSDSTSNSISTSESLSESASTSDSISISNSIANSQSASTSKSDSQSTSISLSTSDSKSMSTSESLSDSTSTSDSVSGSLSIATSQSVSTSSSDSMSTSEMISDSMSTSGSLAASDSKSMSVSSSMSTSQSGSTSESLSDSISTSDSDSKSLSLSTSQSGSTSTSTSTSSSVRTSESQSTSGSMSASQFDSTSISTSFSDSTSDSKSASTASSESISQSVSTSTSGSVSTSTSLSTSNSERTSTSMSDSTSLSTSESDSTSDSTSTSDSISEAISGSESTSISLSESNSTSDSESKSASAFLSESLSESTSESTSESLSGSTSDSTSLSDSNSESGSTSTSLSNSTSSSTSISTSISGSASTSAYKSDSVSTSLSTSTSTSLSDSTSLSTSLSDSASGSKSNSLSASMSTSDSISTRKSESLSTSTSLSVSTSESESGSTSSSESKSDSTSMSLSMSQSISGSTSVSTSESLSDSTSTSLSLSASMNQSGVDSNSASQSASTSTSTSTSESDSQSTSSYTSQSTSQSESTSTSTSLSDSTSMSRSTSQSGSTSTSASLSASESESDSQSISTSASDSTSESTSTSLSDSTSTSNSTSESTSKAISTSASASESDSSSTSLSDSTSASMQSSESDSQSTSASLSNSQSTSTSNRMSTITSESVSESTSESGSTSESTSESDSTSISDSESVSTSTSMSLSTSDSTSTSESLSTSMSGSQSISDSTSTSMSNSTSMSNSTSTSMSGSTSTSESNSMHPSDSMSMHHTHSTSTSRSSSEATTSTSESQSTLSATSEVTKHNGTPAQSEKRLPDTGDSIKQNGLLGGVMTLLVGLGLMKRKKKKDENDQDDSQA,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,S1502N,SAB persistence only,NA,NA,NA,NA
13,MGERIKGLSIGLDLDAANLNRSFAEIKRNFKTLNSDLKLTGNNFKYTEKSTDSYQQRIKELDGTIIGYKKNVDDLAKQYDKVSQEQGENSAEAQKLRQEYNKQANELNYLERELQKTSAEFEEFKKAQVEAQRMAESGWGKTSKIFESMGPKLTKMGDGLKSIGKGMMIGVTAPVLGIAAASGKAFAEVDKGLDTVTQATGATGGELKKLQNSFKDVYGNFPADAETVGGVLGEVNTRLGFTGKELESATESFLKFSHITGSEGVQAVQLITRAMGDAGIEADEYQSVLDMVAKAAQASGISVDTLADSITKYGAPMRAMGFEMKESIALFSQWEKSGVNTEIAFSGLKKAISNWGKAGKNPREEFKKTLAEIEKTPDIASATSLAIEAFGAKAGPDLADAIKGGRFSYQEFLKTIEDSQGTVNQTFKDSESGSERFKVAMNKLKLVGADVWTSIESAFAPVMEELIKKLSIAVDWFSNLSDGSKRSIVIFGGIAAAIGPVVFGLGAFISTIGNAVTVLAPLLAGIAKADGLISFLSTKVPILGTVFTALTGPIGIVLGVLAGLAVAFTIAYKKSETFRNFVNGAIESVKQTFSNFIQFIQPFIDSVKNIFKQAISAIVDFAKDIWSQINGFFNENGISIVQALQNICNFIKAIFEFIINFVIKPIMFAIWQVMQFIWPAVKALIVSTWENIKGVIQGALNIILGLIKFFSSLFTGDWRGVWDAIVMILKGVVQLIWNLIQLWFVGKILGVVRYFGGLLKGLIAGIWDVIKSIFSKSLSAIWNATKSIFGFLFNSVKSIFTNMKNWLSNTWSSIRTNTIGKAQSLFSGVKSKFTNLWNATKEIFSNLRNWMSNIWNSIKDNTVGIASRLWSKVRGIFTNMRDGLQSIISKIKSHIGGMVDAIKKGLNKLIDGLNWVGGKLGMDKIPKLHTGTEHTHTTTRLVKNGKIARDTFATVGDKGRGNGPNGFRNEMIEFPNGKRVITPNTDTTAYLPKGSKVYNGAQTYSMLNGTLPRFSLGTMWKDIKSGASSAFNWTKDQIGKGTKWLGDKVGDVLDFIEHPGKLLNYILEAFGIDFNSLTKGMGIAGDITKAAWSKIKKSATDWIKENLEAMGGGDLVGGILDPDKINYHYGRTAAYTAATGRPFHEGVDFPFVYQEVRTPMGGRLTRMPFMSGGYGNYVKITSGVIDMLFAHLKNFSKSPPSGTMVKPGDVVGLTGNTGFSTGPHLHFEIRRNGRHFDPEPYLRNAKKKGRLSIGGGDATSGSGATYASRVIRQAQSILGRRYKGKWIHDQMMRVAKRESNYQSNAVNNWDINAQRGDPSRGLFQIIGSTFRANAKRGYTNYNNPVHQGISAMQYIVRRYGWGGFKRAGDYAYATGGKVFDGWYNLGEDGHPEWIIPTDPARRNDAMKILHYAAAEVRGKKASKNKRPSQLSDLNGFDDPSLLLKMIEQQQ,1,2,0,0,1,1,0,0,1,4,0,0,SAUSA300_1930,NE46,NA,"phi77 ORF001-like protein, phage tail tape measure protein",NA,hypothetical protein,I1229M,SAB mortality and SAB persistence,-,1,-,0
14,MHNEKLIKGLYDYREEHDACGIGFYANMDNKRSHDIIDKSLEMLRRLDHRGGVGADGITGDGAGIMTEIPFAFFKQHVTDFDIPGEGEYAVGLFFSKERILGSEHEVVFKKYFEGEGLSILGYRNVPVNKDAIAKHVADTMPVIQQVFIDIRDIEDVEKRLFLARKQLEFYSTQCDLELYFTSLSRKTIVYKGWLRSDQIKKLYTDLSDDLYQSKLGLVHSRFSTNTFPSWKRAHPNRMLMHNGEINTIKGNVNWMRARQHKLIETLFGEDQHKVFQIVDEDGSDSAIVDNALEFLSLAMEPEKAAMLLIPEPWLYNEANDANVRAFYEFYSYLMEPWDGPTMISFCNGDKLGALTDRNGLRPGRYTITKDNFIVFSSEVGVVDVPESNVAFKGQLNPGKLLLVDFKQNKVIENNDLKGAIAGELPYKAWIDNHKVDFDFENIQYQDSQWKDETLFKLQRQFAYTKEEIHKYIQELVEGKKDPIGAMGYDAPIAVLNERPESLFNYFKQLFAQVTNPPIDAYREKIVTSELSYLGGEGNLLAPDETVLDRIQLKRPVLNESHLAAIDQEHFKLTYLSTVYEGDLEDALEALGREAVNAVKQGAQILVLDDSGLVDSNGFAMPMLLAISHVHQLLIKADLRMSTSLVAKSGETREVHHVACLLAYGANAIVPYLAQRTVEQLTLTEGLQGTVVDNVKTYTDVLSEGVIKVMAKMGISTVQSYQGAQIFEAIGLSHDVIDRYFTGTQSKLSGISIDQIDAENKARQQSDDNYLASGSTFQWRQQGQHHAFNPESIFLLQHACKENDYAQFKAYSEAVNKNRTDHIRHLLEFKACTPIDIDQVEPVSDIVKRFNTGAMSYGSISAEAHETLAQAMNQLGGKSNSGEGGEDAKRYEVQVDGSNKVSAIKQVASGRFGVTSDYLQHAKEIQIKVAQGAKPGEGGQLPGTKVYPWIAKTRGSTPGIGLISPPPHHDIYSIEDLAQLIHDLKNANKDADIAVKLVSKTGVGTIASGVAKAFADKIVISGYDGGTGASPKTSIQHAGVPWEIGLAETHQTLKLNDLRSRVKLETDGKLLTGKDVAYACALGAEEFGFATAPLVVLGCIMMRVCHKDTCPVGVATQNKDLRALYRGKAHHVVNFMHFIAQELREILASLGLKRVEDLVGRTDLLQRSSTLKANSKAASIDVEKLLCPFDGPNTKEIQQNHNLEHGFDLTNLYEVTKPYIAEGRRYTGSFTVNNEQRDVGVITGSEISKQYGEAGLPENTINVYTNGHAGQSLAAYAPKGLMIHHTGDANDYVGKGLSGGTVIVKAPFEERQNEIIAGNVSFYGATSGKAFINGSAGERFCIRNSGVDVVVEGIGDHGLEYMTGGHVINLGDVGKNFGQGMSGGIAYVIPSDVEAFVENNQLDTLSFTKIKHQEEKAFIKQMLEEHVSHTNSTRAIHVLKHFDRIEDVVVKVIPKDYQLMMQKIHLHKSLHDNEDEAMLAAFYDDSKTIDAKHKPAVVY,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0445,NE390,gltB,"glutamate synthase, large subunit",gltA,Glutamate synthase [NADPH] large chain,A595E,Growth rate and cell death,+,5,-,0
15,MHKLIIKYNKQLKMLNLRDGKTYTISEDERADITLKSLGEVIHLEQNNQGTWQANHTSINKVLVRKGDLDDITLQLYTEADYASFAYPSIQDTMTIGPNAYDDMVIQSLMNAIIIKDFQSIQESQYVRIVHDKNTDVYINYELQEQLTNKAYIGDHIYVEGIWLEVQADGLNVLSQNTVASSLIRLTQEMPHAQADDYNTYHRSPRIIHREPTDDIKIERPPQPIQKNNTVIWRSIIPPLVMIALTVVIFLVRPIGIYILMMIGMSTVTIVFGITTYFSEKKKYNKDVEKREKDYKAYLDNKSKEINKAIKAQRFSLNYHYPTVAEIKDIVETKAPRIYEKTSHHHDFLYYKLGIANVEKSFKLDYQEEEFNQRRDELFDDAKELYEFYTDVEQAPLINDLNHGPIAYIGARHLILEELEKMLIQLSTFHSYHDLEFLFVTREDEVETLKWARWLPHMTLRGQNIRGFVYNQRTRDQILTSIYSMIKERIQAVRERSRSNEQIIFTPQLVFVITDMSLIIDHVILEYVNQDLSEYGISLIFVEDVIESLPEHVDTIIDIKSRTEGELITKEKELVQLKFTPENIDNVDKEYIARRLANLIHVEHLKNAIPDSITFLEMYNVKEVDQLDVVNRWRQNETYKTMAVPLGVRGKDDILSLNLHEKAHGPHGLVAGTTGSGKSEIIQSYILSLAINFHPHEVAFLLIDYKGGGMANLFKDLVHLVGTITNLDGDEAMRALTSIKAELRKRQRLFGEHDVNHINQYHKLFKEGIATEPMPHLFIISDEFAELKSEQPDFMKELVSTARIGRSLGIHLILATQKPSGVVDDQIWSNSKFKLALKVQDRQDSNEILKTPDAADITLPGRAYLQVGNNEIYELFQSAWSGATYNIEGDKLEVEDKTIYMINDYGQLQAINKDLSGLEDEETKENQTELEAVIDHIESITTRLEIEEVKRPWLPPLPENVYQEDLVETDFRKLWSDDAKEVELTLGLKDVPEEQYQGPMVLQLKKAGHIALIGSPGYGRTTFLHNIIFDVARHHRPDQAHMYLFDFGTNGLMPVTDIPHVADYFTVDQEDKIAKAIRKIHDIISERKRLLSQERVVNIEQYNKETGNSIPNIFLIIDNYDTVKESPFMEEYEEMMSKVTREGLALGVYIILSGSRSSAIKSAIFTNIKTRVALYLFENNELTNIIGSYKKGVKDVKGRAAINDDNFTQFQIAQPFELAEGQTYNERIKNEVAQMKEFYVGDYPKHIPMMPDKVLMDDIQETYDLEKIIHEEHKLPLGLDFEDVELVGFDLSQTNIFTSVKPVDIDNGLTLLEKQLNIISNEYEIATLDTKGILKNTGYEDYLYCGDKKEIISFKNELVSFIKNVEPRKKWIVVISDFKEFINIASPNNDEIKTIFLDGPKNNVFPIIYGLYQETIGGFSSQIKLLKEIVSSAFVGISISEQELIKVRYKVNEKNLKNNEMYYIYNYEYKKIKLFE,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,essC,Type VII secretion system protein EssC,D1038G,SAB mortality and SAB persistence,NA,NA,NA,NA
18,MAMTEQQKFKVLADQIKISNQLDAEILNSGELTRIDVSNKNRTWEFHITLPQFLAHEDYLLFINAIEQEFKDIANVTCRFTVTNGTNQDEHAIKYFGHCIDQTALSPKVKGQLKQKKLIMSGKVLKVMVSNDIERNHFDKACNGSLIKAFRNCGFDIDKIIFETNDNDQEQNLASLEAHIQEEDEQSARLATEKLEKMKAEKAKQQDNNESAVDKCQIGKPIQIENIKPIESIIEEEFKVAIEGVIFDINLKELKSGRHIVEIKVTDYTDSLVLKMFTRKNKDDLEHFKALSVGKWVRAQGRIEEDTFIRDLVMMMSDIEEIKKATKKDKAEEKRVEFHLHTAMSQMDGIPNIGAYVKQAADWGHPAIAVTDHNVVQAFPDAHAAAEKHGIKMIYGMEGMLVDDGVPIAYKPQDVVLKDATYVVFDVETTGLSNQYDKIIELAAVKVHNGEIIDKFERFSNPHERLSETIINLTHITDDMLVDAPEIEEVLTEFKEWVGDAIFVAHNASFDMGFIDTGYERLGFGPSTNGVIDTLELSRTINTEYGKHGLNFLAKKYGVELTQHHRAIYDTEATAYIFIKMVQQMKELGVLNHNEINKKLSNEDAYKRARPSHVTLIVQNQQGLKNLFKIVSASLVKYFYRTPRIPHSLLDEYREGLLVGTACDEGELFTAVMQKDQSQVEKIAKYYDFIEIQPPALYQDLIDRELIRDTETLHEIYQRLIHAGDTAGIPVIATGNAHYLFEHDGIARKILIASQPGNPLNRSTLPEAHFRTTDEMLNEFHFLGEEKAHEIVVKNTNELADRIERVVPIKDELYTPRMEGANEEIRELSYANARKLYGEDLPQIVIDRLEKELKSIIGNGFAVIYLISQRLVKKSLDDGYLVGSRGSVGSSFVATMTEITEVNPLPPHYICPNCKTSEFFNDGSVGSGFDLPDKTCETCGAPLIKEGQDIPFETFLGFKGDKVPDIDLNFSGEYQPNAHNYTKVLFGEDKVFRAGTIGTVAEKTAFGYVKGYLNDQGIHKRGAEIDRLVKGCTGVKRTTGQHPGGIIVVPDYMDIYDFTPIQYPADDQNSAWMTTHFDFHSIHDNVLKLDILGHDDPTMIRMLQDLSGIDPKTIPVDDKEVMQIFSTPESLGVTEDEILCKTGTFGVPEFGTGFVRQMLEDTKPTTFSELVQISGLSHGTDVWLGNAQELIKTGICDLSSVIGCRDDIMVYLMYAGLEPSMAFKIMESVRKGKGLTEEMIETMKENEVPDWYLDSCLKIKYMFPKAHAAAYVLMAVRIAYFKVHHPLYYYASYFTIRASDFDLITMIKDKTSIRNTVKDMYSRYMDLGKKEKDVLTVLEIMNEMAHRGYRMQPISLEKSQAFEFIIEGDTLIPPFISVPGLGENVAKRIVEARDDGPFLSKEDLNKKAGLSQKIIEYLDELGSLPNLPDKAQLSIFDM,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1157,NA,NA,NA,polC,DNA polymerase III PolC-type,H647R,SAB mortality and SAB persistence,NA,NA,NA,NA
19,MLNRENKTAITRKGMVSNRLNKFSIRKYTVGTASILVGTTLIFGLGNQEAKAAESTNKELNEATTSASDNQSSDKVDMQQLNQEDNTKNDNQKEMVSSQGNETTSNGNKLIEKESVQSTTGNKVEVSTAKSDEQASPKSTNEDLNTKQTISNQEALQPDLQENKSVVNVQPTNEENKKVDAKTESTTLNVKSDAIKSNDETLVDNNSNSNNENNADIILPKSTAPKRLNTRMRIAAVQPSSTEAKNVNDLITSNTTLTVVDADKNNKIVPAQDYLSLKSQITVDDKVKSGDYFTIKYSDTVQVYGLNPEDIKNIGDIKDPNNGETIATAKHDTANNLITYTFTDYVDRFNSVQMGINYSIYMDADTIPVSKNDVEFNVTIGNTTTKTTANIQYPDYVVNEKNSIGSAFTETVSHVGNKENPGYYKQTIYVNPSENSLTNAKLKVQAYHSSYPNNIGQINKDVTDIKIYQVPKGYTLNKGYDVNTKELTDVTNQYLQKITYGDNNSAVIDFGNADSAYVVMVNTKFQYTNSESPTLVQMATLSSTGNKSVSTGNALGFTNNQSGGAGQEVYKIGNYVWEDTNKNGVQELGEKGVGNVTVTVFDNNTNTKVGEAVTKEDGSYLIPNLPNGDYRVEFSNLPKGYEVTPSKQGNNEELDSNGLSSVITVNGKDNLSADLGIYKPKYNLGDYVWEDTNKNGIQDQDEKGISGVTVTLKDENGNVLKTVTTDADGKYKFTDLDNGNYKVEFTTPEGYTPTTVTSGSDIEKDSNGLTTTGVINGADNMTLDSGFYKTPKYNLGNYVWEDTNKDGKQDSTEKGISGVTVTLKNENGEVLQTTKTDKDGKYKFTGLENGTYKVEFETPSGYTPTQVGSGTDEGIDSNGTSTTGVIKDKDNDTIDSGFYKPTYNLGDYVWEDTNKNGVQDKDEKGISGVTVTLKDENDKVLKTVTTDENGKYQFTDLNNGTYKVEFETPSGYTPTSVTSGNDTEKDSNGLTTTGVIKDADNMTLDSGFYKTPKYSLGDYVWYDSNKDGKQDSTEKGIKDVKVTLLNEKGEVIGTTKTDENGKYCFDNLDSGKYKVIFEKPAGLTQTGTNTTEDDKDADGGEVDVTITDHDDFTLDNGYYEEETSDSDSESDSDSESETDSESDSDSDSDSDSDSDAGKHTPVKPMSTTKDHHNKAKALPETGNENSGSNNATLFGGLFAALGSLLLFGRRKKQNK,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_0547,NE1289,sdrD,sdrD protein,sdrD,Serine-aspartate repeat-containing protein D,E1141D|ET1137DS|E1129D,SAB mortality and SAB persistence,NA,NA,NA,NA
20,MPELKRAGVKLTADGTAQYKADLKSATAALRQMAEESKRNVVALGNNASASKKYGLAIKDLGNTAKLAQAKLNVLQDRQKQLSESSRIFASEINKLENKMKTAKGDTTELSNALAELRSKESLNNAELHKLNATIARTETQMIKAKNAASQMIDEYRNAGGRFADVSEKLKTVGNKFDDAGNKATNLGKTMTTRVTTPIVAGFGYATKAYIDFDNQMNQMKVQLDDGSQSASQLKSQVEELGKSSQNMAKEYGVAGASIRNGMNELIKKGFTFNQVSGAMPSILKATVASGDNFNTVMNVSSNVLEQFGLKVDDTNQMLTNTDRVTSVLTFAANKTSAGFSDLGEAMQNVGPMAANNNQSLEDMASTLGILANRGIEGGEAGTYLMNALQNLATPTKEQSKGLKELGVSAFDANGKMRAFPDILSDIEKATAGMSDEQKNAALNTIFNTQAMKGINPLIQAGSKSIKDLSSSTKDASKYQDELAKKMGESASKNVDKMKESFKVLAETIGAKVLPHIIPLINKATELANKFGDLDGKTKDTIVKIAALAAAVGPLSLGFGGILRSIGGVVRGVGSLAQGFGKLTSSTAKITKGAGKATTGVSKIGSMAKKVGALAPLLSNPYGLAFGAIVGASAGVGYLIYKELHKDDENHKTAVNQTKGKYEDWYKTITSGAKDASGSQKQIQDATKKTGETYKEVTERLKKQNTDVQETMKKGWDGYDQRIGKTKILSFGITQETTKHIEGLKEKLKNLGLDKKDIDNAKQNYENYATMLGNTFTEFAKTAEKSKVVTRETASATIEATKNVTDEVVNSLNKEKEEKLNKLKQDQEYGILTQEQYQSETQKINDEYGKRVKALQDNQEKIRNIMANAAQEHRKLTSDEVASVTQAYLKLSESTGQAITDNTEAQKFFSENLQQMLTDSGLAALKHADIISSSTEDSIKKAKSTEEAMKILKKALEDYDNKDVKEKKIKAKDETSEEVKKASESVDKHNEKEVKEKELKAKDKTTEEANKANKSLDEYINKKVDEKVLKLKDETKEAKDKAKKAIEDYNNIKADIKKLKAKDEASEKTIKAKEKIIDYNKKQADKKY,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,Y1088fs,SAB mortality only,NA,NA,NA,NA
22,MSWFDKLFGEDNDSNDDLIHRKKKRRQESQNIDNDHDSLLPQNNDIYSRPRGKFRFPMSVAYENENVEQSADTISDEKEQYHRDYRKQSHDSRSQKRHRRRRNQTTEEQNYSEQRGNSKISQQSIKYKDHSHYHTNKPGTYVSAINGIEKETHKPKTHNMYSNNTNHRAKDSTPDYHKESFKTSEVPSAIFGTMKPKKLENGRIPVSKPSEKVESDKQKYDKYVAKTQTSQNKQLEQEKQNDSVVKQGTASKSSDENVSSTTKSMPNYSKVDNTIKIENIYASQIVEEIRRERERKVLQKRRFKKALQQKREEHKNEEQDAIQRAIDEMYAKQAERYVGDSSLNDDSDLTDNSTDASQLHTNGIENETVSNDENKQASIQNEDTNDTHVDESPYNYEEVSLNQVSTTKQLSDDEVTVSNVTSQHQSALQHNVEVNDKDELKNQSRLIADSEEDGTTNKEEYSGSQIDDAEFYELNDTEVDEDTTSNIEDNTNRNASEMHVDAPKTQEYAVTESQVNNIDKTVDNEIELAPRHKKDDQTNLSVNSLKTNDVNDNHVVEDSSMNEIEKNNAEITENVQNEAAESEQNVEEKTIENVNPKKQTEKVSTLSKRPFNVVMTPSDKKRMMDRKKHSKVNVPELKPVQSKQAVSERMPASQATPSSRSDSQESNTNAYKTNNMTSNNVENNQLIGHAETENDYQNAQQYSEQKPSVDSTQTEIFEESQDDNQLENEQVDQSTSSSVSEVSDITEESEETTHPNNTSGQQDNDDQQKDLQSSFSNKNEDTANENRPRTNQQDVATNQAVQTSKPMIRKGPNIKLPSVSLLEEPQVIESDEDWITDKKKELNDALFYFNVPAEVQDVTEGPSVTRFELSVEKGVKVSRITALQDDIKMALAAKDIRIEAPIPGTTRVGIEVPNQNPTTVNLRSIIESPSFKNAESKLTVAMGYRINNEPLLMDIAKTPHALIAGATGSGKSVCINSILMSLLYKNHPEELRLLLIDPKMVELAPYNGLPHLVAPVITDVKAATQSLKWAVEEMERRYKLFAHYHVRNITAFNKKAPYDERMPKIVIVIDELADLMMMAPQEVEQSIARIAQKARACGIHMLVATQRPSVNVITGLIKANIPTRIAFMVSSSVDSRTILDSGGAERLLGYGDMLYLGSGMNKPIRVQGTFVSDDEIDDVVDFIKQQREPDYLFEEKELLKKTQTQSQDELFDDVCAFMVNEGHISTSLIQRHFQIGYNRAARIIDQLEQLGYVSSANGSKPRDVYVTEADLNKE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1687,NE1481,-,FtsK/SpoIIIE family protein,NA,hypothetical protein,T455A,SAB mortality and SAB persistence,NA,NA,NA,NA
25,MAKKFNYKLPSMVALTLVGSAVTAHQVQAAETTQDQTTNKNVLDSNKVKATTEQAKAEVKNPTQNISGTQVYQDPAIVQPKTANNKTGNAQVSQKVDTAQVNGDTRANQSATTNNTQPVAKSTSTTAPKTNTNVTNAGYSLVDDEDDNSENQINPELIKSAAKPAALETQYKTAAPKAATTSAPKAKTEATPKVTTFSASAQPRSVAATPKTSLPKYKPQVNSSINDYIRKNNLKAPKIEEDYTSYFPKYAYRNGVGRPEGIVVHDTANDRSTINGEISYMKNNYQNAFVHAFVDGDRIIETAPTDYLSWGVGAVGNPRFINVEIVHTHDYASFARSMNNYADYAATQLQYYGLKPDSAEYDGNGTVWTHYAVSKYLGGTDHADPHGYLRSHNYSYDQLYDLINEKYLIKMGKVAPWGTQSTTTPTTPSKPTTPSKPSTGKLTVAANNGVAQIKPTNSGLYTTVYDKTGKATNEVQKTFAVSKTATLGNQKFYLVQDYNSGNKFGWVKEGDVVYNTAKSPVNVNQSYSIKPGTKLYTVPWGTSKQVAGSVSGSGNQTFKASKQQQIDKSIYLYGSVNGKSGWVSKAYLVDTAKPTPTPTPKPSTPTTNNKLTVSSLNGVAQINAKNNGLFTTVYDKTGKPTKEVQKTFAVTKEASLGGNKFYLVKDYNSPTLIGWVKQGDVIYNNAKSPVNVMQTYTVKPGTKLYSVPWGTYKQEAGAVSGTGNQTFKATKQQQIDKSIYLFGTVNGKSGWVSKAYLAVPAAPKKAVAQPKTAVKAYTVTKPQTTQTVSKIAQVKPNNTGIRASVYEKTAKNGAKYADRTFYVTKERAHGNETYVLLNNTSHNIPLGWFNVKDLNVQNLGKEVKTTQKYTVNKSNNGLSMVPWGTNNQVILTGNNIAQGTFNATKQVSVGKDVYLYGTINNRTGWVNAKDLTAPTAVKPTTSAAKDYNYTYVIKNGNGYYYVTPNSDTAKYSLKAFNEQPFAVVKEQVINGQTWYYGKLSNGKLAWIKSTDLAKELIKYNQTGMTLNQVAQIQAGLQYKPQVQRVPGKWTDANFNDVKHAMDTKRLAQDPALKYQFLRLDQPQNISIDKINQFLKGKGVLENQGAAFNKAAQMYGINEVYLISHALLETGNGTSQLAKGADVVNNKVVTNSNTKYHNVFGIAAYDNDPLREGIKYAKQAGWDTVSKAIVGGAKFIGNSYVKAGQNTLYKMRWNPAHPGTHQYATDVDWANINAKIIKGYYDKIGEVGKYFDIPQYK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0955,NE460,atl,autolysin,atl_2|atl_1|atl_3,Bifunctional autolysin,D144N,SAB mortality and SAB persistence,NA,NA,NA,NA
27,MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWECSCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDMSPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLEEIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRPMVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGRRGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKEMALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEIIREHPVLLNRAPTLHRLGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNILNPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVHASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTTLGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGITVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGELMQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEYFISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMIEPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARHGVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRIQEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQPVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLRKVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSAASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVESQTEVTE,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0528,NA,NA,NA,rpoC,DNA-directed RNA polymerase subunit beta',P1094R,Growth rate and cell death,NA,NA,NA,NA
29,MVYLKSIDAIGFKSFADQTNVQFDKGVTAIVGPNGSGKSNITDAIKWVLGEQSAKSLRGSKMEDIIFSGAEHRKAQNYAEVQLRLDNHSKKLSVDENEVIVTRRLYRSGESEYYINNDRARLKDIADLFLDSGLGKEAYSIISQGRVDEILNAKPIDRRQIIEESAGVLKYKKRKAESLNKLDQTEDNLTRVEDILYDLEGRVEPLKEEAAIAKEYKTLSHQMKHSDIVVTVHDIDQYTNDNRQLDQRLNDLQGQQANKEADKQRLSQQIQQYKGKRHQLDNDVESLNYQLVKATEAFEKYTGQLNVLEERKKNQSETNARYEEEQENLMELLENISNEISEAQDTYKSLKSKQKELNAVIRELEEQLYVSDEAHDEKLEEIKNEYYTLMSEQSDVNNDIRFLKHTIEENEAKKSRLDSRLVEVFEQLKDIQGQIKTTKKEYQQTNKELSAVDKEIKNIEKDLTDTKKAQNEYEEKLYQAYRYTEKMKTRIDSLATQEEEYTYFFNGVKHILKAKNKELKGIYGAVAEIIDVPSKLTQAIETALGASLQHVIVDSEKDGRQAIQFLKERNLGRATFLPLNVIQSRVVATDIKSIAKEANGFISIASEAVKVAPEYQNIIGNLLGNTIIVDHLKYANELARAIKYRTRIVTLEGDIVNPGGSMTGGGARKSKSILSQKDELTTMRHQLEDYLRQTESFEQQFKELKIKSDQLSELYFEKSQKHNTLKEQVHHFEMELDRLTTQETQIKNDHEEFEFEKNDGYTSDKSRQTLSEKETYLESIKASLKRLEDEIERYTKLSKEGKESVTKTQQTLHQKQSDLAVVKERIKTQQQTIDRLNNQNQQTKHQLKDVKEKIAFFNSDEVMGEQAFQNIKDQINGQQETRTRLSDELDKLKQQRIELNEQIDAQEAKLQVCHQDILAIENHYQDIKAEQSKLDVLIHHAIDHLNDEYQLTVERAKSEYTSDESIDALRKKVKLMKMSIDELGPVNLNAIEQFEELNERYTFLSEQRTDLRKAKETLEQIISEMDQEVTERFKETFHAIQGHFTAVFKQLFGGGDAELQLTEADYLTAGIDIVVQPPGKKLQHLSLLSGGERALTAIALLFAILKVRSAPFVILDEVEAALDEANVIRYAKYLNELSDETQFIVITHRKGTMEFADRLYGVTMQESGVTKLVSVNLNTIDDVLKEEQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1127,NE1342,smc,chromosome segregation protein SMC,smc,Chromosome partition protein Smc,L449F,SAB mortality only,NA,NA,NA,NA
30,MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETGEIVVEEGTLLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTTTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELTHKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDGRTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGLDVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD,1,2,1,1,1,2,1,1,1,2,1,1,SAUSA300_0527,NA,NA,NA,rpoB,DNA-directed RNA polymerase subunit beta,L309V,all,NA,NA,NA,NA
31,MTILTTLIKEDNHFQDLNQVFGQANTLVTGLSPSAKVTMIAEKYAQSNQQLLLITNNLYQADKLETDLLQFIDAEELYKYPVQDIMTEEFSTQSPQLMSERIRTLTALAQGKKGLFIVPLNGLKKWLTPVEMWQNHQMTLRVGEDIDVDQFLNKLVNMGYKRESVVSHIGEFSLRGGIIDIFPLIGEPIRIELFDTEIDSIRDFDVETQRSKDNVEEVDITTASDYIITEEVISHLKEELKTAYENTRPKIDKSVRNDLKETYESFKLFESTYFDHQILRRLVAFMYETPSTIIEYFQKDAIIAVDEFNRIKETEESLTVESDSFISNIIESGNGFIGQSFIKYDDFETLIEGYPVTYFSLFATTMPIKLNHIIKFSCKPVQQFYGQYDIMRSEFQRYVNQNYHIVVLVETETKVERMQAMLSEMHIPSITKLHRSMSSGQAVIIEGSLSEGFELPDMGLVVITERELFKSKQKKQRKRTKAISNAEKIKSYQDLNVGDYIVHVHHGVGRYLGVETLEVGQTHRDYIKLQYKGTDQLFVPVDQMDQVQKYVASEDKTPKLNKLGGSE,2,3,0,0,1,1,0,0,2,2,0,0,SAUSA300_0481,NE188,mfd,transcription-repair coupling factor,mfd_1|mfd|mfd_2,Transcription-repair-coupling factor,Ter568Wext*?|P675S|N714K,SAB mortality and SAB persistence,NA,NA,NA,NA
32,MTLHAYLGRAGTGKSTKMLTEIKQKMKADPLGDPIILIAPTQSTFQLEQAFVNDPELNGSLRTEVLHFERLSHRIFQEVGSYSEQKLSKAATEMMIYNIVQEQQKYLKLYQSQAKYYGFSEKLTEQIQDFKKYAVTPEHLEHFIADKNMQTRTKNKLEDIALIYREFEQRIQNEFITGEDSLQYFIDCMPKSEWLKRADIYIDGFHNFSTIEYLIIKGLIKYAKSVTIILTTDGNHDQFSLFRKPSEVLRHIEEIANELNISIERQYFNQLYRFNNQDLKHLEQEFDALQINRVACQGHINILESATMREEINEIARRIIVDIRDKQLRYQDIAILYRDESYAYLFDSILPLYNIPYNIDTKRSMTHHPVMEMIRSLIEVIQSNWQVNPMLRLLKTDVLTASYLKSAYLVDLLENFVLERGIYGKRWLDDELFNVEHFSKMGRKAHKLTEDERNTFEQVVKLKKDVIDKILHFEKQMSQAETVKDFATAFYESMEYFELPNQLMTERDELDLNGNHEKAEEIDQIWNGLIQILDDLVLVFGDEPMSMERFLEVFDIGLEQLEFVMIPQTLDQVSIGTMDLAKVDNKQHVYLVGMNDGTMPQPVTASSLITDEEKKYFEQQANVELSPTSDILQMDEAFVCYVAMTRAKGDVTFSYSLMGSSGDDKEISPFLNQIQSLFNQLEITNIPQYHEVNPLSLMQHAKQTKITLFEALRAWLYDEIVADSWLDAYQVIRDSDHLNQGLDYLMSALTFDNETVKLGETLSKDLYGKEINASVSRFEGYQQCPFKHYASHGLKLNERTKYELQNFDLGDIFHSVLKYISERINGDFKQLDLKKIRQLTNEALEEILPKVQFNLLNSSAYYRYLSRRIGAIVETTLSALKYQGTYSKFMPKHFETSFRRKPRTNDELIAQTLTTTQGIPINIRGQIDRIDTYTKNDTSFVNIIDYKSSEGSATLDLTKVYYGMQMQMMTYMDIVLQNTQRLGLTDIVKPGGLLYFHVHEPRIKFKSWSDIDEDKLEQDLIKKFKLSGLVNADQTVIDALDIRLEPKFTSDIVPVGLNKDGSLSKRGSQVADEATIYKFIQHNKENFIETASNIMDGHTEVAPLKYKQKLPCAFCSYQSVCHVDGMIDSKRYRTVDETINPIEAIQNININDEFGGEQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0869,NE1012,rexB,exonuclease RexB,addB,ATP-dependent helicase/deoxyribonuclease subunit B,T979K,SAB mortality and SAB persistence,NA,NA,NA,NA
34,MKQIKKLLVANRGEIAIRIFRAAAELDISTVAIYSNEDKSSLHRYKADESYLVGSDLGPAESYLNIERIIDVAKQANVDAIHPGYGFLSENEQFARRCAEEGIKFIGPHLEHLDMFGDKVKARTTAIKADLPVIPGTDGPIKSYELAKEFAEEAGFPLMIKATSGGGGKGMRIVREESELEDAFHRAKSEAEKSFGNSEVYIERYIDNPKHIEVQVIGDEHGNIVHLFERDCSVQRRHQKVVEVAPSVGLSPTLRQRICDAAIQLMENIKYVNAGTVEFLVSCDEFFFIEVNPRVQVEHTITEMVTGIDIVKTQILVAAGADLFGEEINMPQQKDITTLGYAIQCRITTEDPLNDFMPDTGTIIAYRSSGGFGVRLDAGDGFQGAEISPYYDSLLVKLSTHAISFKQAEEKMVRSLREMRIRGVKTNIPFLINVMKNKKFTSGDYTTKFIEETPELFDIQPSLDRGTKTLEYIGNVTINGFPNVEKRPKPDYELASIPTVSSSKIASFSGTKQLLDEVGPKGVAEWVKKQDDVLLTDTTFRDAHQSLLATRVRTKDMINIASKTADVFKDGFSLEMWGGATFDVAYNFLKENPWERLERLRKAIPNVLFQMLLRASNAVGYKNYPDNVIHKFVQESAKAGIDVFRIFDSLNWVDQMKVANEAVQEAGKISEGTICYTGDILNPERSNIYTLEYYVKLAKELEREGFHILAIKDMAGLLKPKAAYELIGELKAAVDLPIHLHTHDTSGNGLLTYKQAIDAGVDIIDTAVASMSGLTSQPSANSLYYALNGFPRHLRTDIEGMESLSHYWSTVRTYYSDFESDIKSPNTEIYQHEMPGGQYSNLSQQAKSLGLGERFDEVKDMYRRVNFLFGDIVKVTPSSKVVGDMALYMVQNDLDEQSVITDGYKLDFPESVVSFFKGEIGQPVNGFNKDLQAVILKGQEALTARPGEYLEPVDFEKVRELLEEEQQGPVTEQDIISYVLYPKVYEQYIQTRNQYGNLSLLDTPTFFFGMRNGETVEIEIDKGKRLIIKLETISEPDENGNRTIYYAMNGQARRIYIKDENVHTNANVKPKADKSNPSHIGAQMPGSVTEVKVSVGETVKANQPLLITEAMKMETTIQAPFDGVIKQVTVNNGDTIATGDLLIEIEKATD,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_1014,NE754,pyc,pyruvate carboxylase,pycA,Pyruvate carboxylase,C283G,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
35,MINKEQLDLLYKLKKEVEKSRNEALLHTINQVIKKVYLQQYTCSFVGHFSAGKSTLINLLIEQDILPSSPVPTTSNTAIVSVSDNHDIIANLPNQTYAKLSNYDEAREMNRQNVDVESVEINFQSAKFENGFTLQDTPGVDSNVASHQSITEQYMYTSNMIFYTVDYNHVQSELNFKFMKHINDVGIPVVFIINQIDKHQDDELSFSTFKSRVEKSIADWGIKLERTFYVSKFDHPENELEVLSSYLISLDQHRETIEDYTSRTVEYITEAQLDYIQSEIQEVLEDLGIEEAEFEQAFLNSQQHQAISEEAQLLNNPDELMAFLKNKRKNILENAYIMPHNMREMLRSYLESMSQDFNVGGFFNKKKKKLQIQQQRLLTATDALQEHVNQQIRQPMREDMSFVTRFINKKEASDKVLNQHYDVKPEMIEGLYQPQTSISNTYVLTFSDEVVKAIKKYVEQQSTPIFKEIIENVQADELPTEESDDLKEYQRYTELNELRQSLTTKNYRHYYIHLDESLDKLIGRQETTYQVATDNAQDNRDNQQLNQNTATTNMSIDIQKALDIISDVPLFKRTKQDIHETLTRIDNKLIKIGVFGTFSAGKSSLINALLGEHILVSSPNPTTAATTEISYGDESYITLKSQSQLLDEINAVVEYQDMSYSTIEDFINSDLEKLKSHLNKNQLAFIQAVEKHYKLYVNMLENGEKHAINQQELKKWSAEDEYATFVKTVHIALMHDWLKGKIIVDSLGLHSNNQRHTNETEQILTSSDLILYVSYFNHSFTDNDKAFIEHMKDMNQLNENQAFKMVINAADLAESQDDLEAVETYVSDALRQVHLQSDIFAVSSRNALQAEDKGIDQLKQSIQQFVDVESKSILEQQMIHQLQQMDRSYVEMITEFETNKADISRRQQRLTDYKDKQRLQHQLIDATLQHTDNEVEEQVYHLNARLKLQLLDDVKSVFNSQMTQNSDFNEEKKVSTRVYLDQIHQRLFLEQSLITERIKKYFNKQLTEQIAPIVQQLADLHVIINPQFNFESANIEQPLLHIDFNDMLNALPKQLTKRKILNPNGQRDIHESICQSTLGLLQPQMGLLRQQLELYVKQMAVEAESQFESFEANIQTQINDLLAFDLDTTLINQLKDKHQQLKTILY,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1333,NE582,NA,conserved hypothetical protein,der_2,GTPase Der,A106V,SAB mortality and SAB persistence,NA,NA,NA,NA
36,MINRDNKKAITKKGMISNRLNKFSIRKYTVGTASILVGTTLIFGLGNQEAKAAENTSTENAKQDDATTSDNKEVVSETENNSTTENNLTNPIKKETNTDSQQEAKEAPTTSSTQQQQNNATTSTETKPQNIEKENVQPSTDKTATEDTSVILEEKKAPNNTNNDVTTKPSTSEIQTTPTTPQESTKIENSQPQATPSKVDNKVTDATNPKEPVNVSKEELKNNPEKLKELVRNDSNTDRSTKPVAIAPTSVAPKRVNAKMRFAVAQPAAVASNNVNDLIKVTKQTIKVGDGKDDVVAAHDGEEIEYDSEFTIDNKVKAGDTMTINYDKNVIPSDLTDKNDPIDITDPSGEVIAKGTFDKATKQITYTFTDYVDKYEDIKSRLTLYSYIDKKTVPNETSLNLTFATAGKETNQNVTVDYQDPMVHGDSNIQSIFTKLDEDKQTIEQQIYVNPLKKTATNTKVDIAGSQVDDYGNIKLGNGSTIIDQNTEIKVYKVNPNQQLPQSNRIYDFSQYEDVTSQFDNKKTFGNNVATLDFGNIDSAYIIKVVSKYTPTSDGELDIAQGTSMRTTDNYGYYNYAGYSNFIVTSNDTGGGDGTVKPEEKLYKIGDYVWEDVDKDGVQGTDSKEKPMANVLVTLTYPDGTTKSVRTDANGHYEFGGLKDGETYTVKFETPAGYLPTKENGTTDGEKDSNGSSVTVKINGKDDMSLDTGFYKEPKYNLGDYVWEDTNKDGIQDANEPGIKDVKVTLKDSTGKVIGTTTTDASGKYKFTDLDNGNYTVEFETPAGYTPTVKNTTAEDKDSNGLTTTGVIKDADNMTLDSGFYKTPKYSLGDYVWYDSNKDGKQDTTEKGIKDVTVTLQNEKGEVIGTTKTDENGKYRFDNLDSGKYKVIFEKPAGLTQTGTNTTEDDKDADGGEVDVTITDHDDFTIDNGYFEEDTSDSDSDSDSDSESDSESESESESESERESDSDSDSDSDSDSDSESDSDSDTGKHTPVKPMSATKDHHNKAKALPETGSENNGSNNATLFGGLFAALGSLLLFGRRKKQNK,2,2,0,1,2,2,0,1,2,2,0,1,SAUSA300_0548,NE98,NA,sdrE protein,sdrE,Serine-aspartate repeat-containing protein E,E951D|T392fs,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
37,MIYSFINSLVWRKDGSISKHTKCYISDNVIPYDAFRNNFLDVLLIKMPQKNHPLNIWALHKLLKQCNLEKRDFLWTQYISINNEKVFEIINWLFSNYKKLDEETAEKYMIFLTWIFSATNNKLRDLGTKSLVKLFKTFPTKIIGLLKLFENNNDPYIVERLYASVLGATLRIDICEIHIEIANYIYEEIFDKEMVYPHILMRD,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_1750,NE703,NA,conserved hypothetical protein,NA,hypothetical protein,Ter204Yext*?|A346D,SAB mortality only,NA,NA,NA,NA
38,MKKKLDFLPNKLNKYSIRRFTVGTASILVGSTLLFGIGNEAHAAEEHQKSNTTENVADSNASEAPTKEEAPSNEATSEAPTKEEVPSNEATSEAPTKEEAPSNEATSEASTKEEAPAAEETDKATEEAPKTEETDKATKEEAPAVEETSKAATEEAPKAEETDKATEEAPKTEETSKAATEKAPKAEETKKV,1,0,1,0,1,0,1,0,1,0,1,0,NA,NA,NA,NA,pls,Surface protein,Ter193Eext*?,SAB mortality and growth rate,NA,NA,NA,NA
39,MVAYLNIHTAYDLLNSSLKIEDAVRLAVSENVDALAITDTNVLYGFPKFYDACIANNIKPIFGMTIYVTNGLNTVETVVLAKNNDGLKDLYQLSSEIKMNALEHVSFELLKRFSNNMIIIFKKVGDQHRDIVQVFETHNDTYMDHLSISIQGRKHVWIQNVCYQTRQDADTISALAAIRDNTKLDLIHDQEDFDAHFLTEKEINQLDINQEYLTQVDVIAQKCDAELKYHQSLLPQYETPNDESAKKYLWRVLVTQLKKLELNYDVYLERLKYEYKVITNMGFEDYFLIVSDLIHYAKTNDVMVGPGRGSSAGSLVSYLLGITTIDPIKFNLLFERFLNPERVTMPDIDIDFEDTRRERVIQYVQEKYGELHVSGIVTFGHLLARAVARDVGRIMGFDEVTLNEISSLIPHKLGITLDEAYQIDDFKKFVHRNHRHERWFSICKKLEGLPRHTSTHAAGIIINDHPLYEYAPLTKGDTGLLTQWTMTEAERIGLLKIDFLGLRNLSIIHQILTQVKKDLGINIDIEKIPFDDQKVFELLSQGDTTGIFQLESDGVRSVLKKLKPEHFEDIVAVTSLYRPGPMEEIPTYITRRHDPSKVQYLHPHLEPILKNTYGVIIYQEQIMQIASTFANFSYGEADILRRAMSKKNRAVLESERQHFIEGAKQNGYHEDISKQIFDLILKFADYGFPRAHAVSYSKIAYIMSFLKVHYPNYFYANILSNVIGSEKKTAQMIEEAKKQGITILPPNINESHWFYKPSQEGIYLSIGTIKGVGYQSVKVIVDERYQNGKFKDFFDFARRIPKRVKTRKLLEALILVGAFDAFGKTRSTLLQAIDQVLDGDLNIEQDGFLFDILTPKQMYEDKEELPDALISQYEKEYLGFYVSQHPVDKKFVAKQYLTIFKLSNAQNYKPILVQFDKVKQIRTKNGQNMAFVTLNDGIETLDGVIFPNQFKKYEELLSHNDLFIVSGKFDHRKQQRQLIINEIQTLATFEEQKLAFAKQIIIRNKSQIDMFEEMIKATKENANDVVLSFYDETIKQMTTLGYINQKDSMFNNFIQSFNPSDIRLI,4,3,1,1,1,1,1,1,2,2,1,1,SAUSA300_1649,NA,NA,NA,dnaE|dnaE_1,DNA polymerase III subunit alpha,D194G|I32V,all,NA,NA,NA,NA
42,MSQLLNDTLSAWLLIESLSPGEVNFTAEDILSAENFKNGAKQAQLQSFDEYFEIWNDERFIISEEKSEIGEIIFKFYRHCFRYNEINLKIQDIFDDYSDIHNPNGTHCYGYTFNIDKHGQVIVDSIHIPMIMSALKEIEKNKNANIEEKFNDSVEKFVQKVKEILADEPINEFKLKKMDIAYDEYFSVLNSKKDGLFAHYVAIEYVKDSDLPQPEFNSFFISDIEKARKSPNQTLIDYIEGVEESKRIEVDENKEMFDKFLHPSRLPDGRWPSQTEFRLSLMQQLAVNQITSGNERISSVNGPPGTGKTTLLKDIFAHLVVERGKELAKLNNPKDAFVKTKTHETDDKYVYLLKESIAKYKMVVASSNNGAVENISKDLPKIEEIIRNPEKCKFPKYEQNYANLAHELKDFAEIAEDLIGESAWGLFSGVFGKSTNINQVLSHMLKQDANDIGFAKLLQNENNRMSYNELMSEWQSHQRAFLEELRHVEMLKEESIRAYDVYKNCESYSKVEHELNSKKMNVKEKLNHLEIQISCDNKEIEDLDDRINYNTKQLETLNELIKSIRDSNKGFVNKLKAIFNSEEDERYKKHNAEKQQLLGQQIELEKCKKIKNEDLVSKLKEKEKLIKQLTKVQLQLDELNSQLQELEAYRIESKITIPEKDFWSDNNYDERQVTNLWTSDELQYRRAMLFLRAMILHKMILHKLLLIANNTTIYYAINDFKSRRKLIDANPDKVHNAWNVMHLIFPVVSTTFASFKSMYGGIPRDFIDYLFIDEAGQAIPQAAVGALFRSKKVVAVGDPIQIEPVVTLESHLIDNIRKNYNVPEYLVSKEASVQSVADNANQYGFWKSDATDSNQKTWIGIPLWVHRRCLKPMFTIANQIAYNNKMVLPSNITNVGKTGWYDVKGNSVQKQFVKEHGEKVLELLANDWFEAIKEGKNEPSSFVISPFSAVQKQVKRILKQQLPTRIDIERTKINQWVDKSIGTVHTFQGKEAQKVYFVIGTDNTQDGAVNWSCEKPNLLNVAVTRAKKEFYVIGDMQRIQSKPFYETIFKERNVK,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_0097,NE150,NA,conserved hypothetical protein,NA,hypothetical protein,M699_K703del,"SAB mortality, SAB persistence and cell death",-,0,-,0
44,MKNNLRYGIRKHKLGAASVFLGTMIVVGMGQDKEAAASEQKTTTVEENGNSATDNKTSETQTTATNVNHIEETQSYNATVTEQPSNATQVTTEEAPKAVQAPQTAQPANIETVKEEVVKEEAKPQVKETTQSQDNSGDQRQVDLTPKKATQNQVAETQVEVAQPRTASESKPRVTRSADVAEAKEASNAKVETGTDVTSKVTVEIGSIEGHNNTNKVEPHAGQRAVLKYKLKFENGLHQGDYFDFTLSNNVNTHGVSTARKVPEIKNGSVVMATGEVLEGGKIRYTFTNDIEDKVDVTAELEINLFIDPKTVQTNGNQTITSTLNEEQTSKELDVKYKDGIGNYYANLNGSIETFNKANNRFSHVAFIKPNNGKTTSVTVTGTLMKGSNQNGNQPKVRIFEYLGNNEDIAKSVYANTTDTSKFKEVTSNMSGNLNLQNNGSYSLNIENLDKTYVVHYDGEYLNGTDEVDFRTQMVGHPEQLYKYYYDRGYTLTWDNGLVLYSNKANGNGKNGLIIQNNKFEYKEDTIKETLTGQYDKNLVTTVEEEYDSSTLDIDYHTAIDGGGGYVDGYIETIEETDSSAIDIDYHTAVDSEAGHVGGYTESSEESNPIDFEESTHENSKHHADVVEYEEDTNPGGGQVTTESNLVEFDEESTKGIVTGAVSDHTTVEDTKEYTTESNLIELVDELPEEHGQAQGPVEEITENNHHISHSGLGTENGHGNYDVIEEIEENSHVDIKSELGYEGGQNSGNQSFEEDTEEDKPKYEQGGNIVDIDFDSVPQIHGQNKGNQSFEEDTEKDKPKYEHGGNIIDIDFDSVPHIHGFNKHTEIIEEDTNKDKPSYQFGGHNSVDFEEDTLPKVSGQNEGQQTIEEDTTPPIVPPTPPTPEVPSEPETPTPPTPEVPSEPETPTPPTPEVPSEPETPTPPTPEVPAEPGKPVPPAKEEPKKSSKPVEQGKVVTPVIEINEKVKAVAPTKKPQSKKSELPETGGEESTNKGMLFGGLFSILGLALLRRNKKNHKA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2441,NE186,fnbA,fibronectin binding protein A,fnbA,Fibronectin-binding protein A,L513P,SAB persistence only,-,3,+,0
45,MQELENQINEETSILKNLEIKLDRYDKTKLDLNDKESFISEIKSAVNIGDQCPICGNEIQDLGHHIDFDSIAKRQNEIKEIEANIHAIKSNIAVHNSEIKFVNEKISNINIKTQSDFSLEVLNKRLLENENALNNQRDLNKFIEQMKEEKDNLTLQIHNKQLRLNKNESELKLCRDLITEFETLSKYNNITNFEVDYKKYVQDVNQHQELSKEIEDKLMQLSQRKLIEQNNLNHYENQLETYNNDLELNEQSIEMEMSRLNLTDDNDIDEIIAWRGEQEELEQKRDTYKKRYHEFEMEIARLESLTKDKELLDSDKLKDEYELKKGKMNTLIDEYSAVHYQCQNNINKTQSIVSHINYLNQELKDQQEIFQLAEIVSGKNNKNLTLENFVLIYYLDQIIAQANLRLATMSDNRYQLIRREAVSHGLSGLEIDVFDLHSNKSRHISSLSGGETFQSSLALALGLSEIVQQQSGGISLESIFIDEGFGTLDQETLETALDTLLNLKSTGRMVGIISHVSELKNRIPLVLEVKSDQYQSSTRFKRN,2,2,0,0,1,2,0,0,2,3,0,0,SAUSA300_1243,NE1451,sbcC,exonuclease SbcC,sbcC|sbcC_2,Nuclease SbcCD subunit C,M1?|E792fs,SAB mortality and SAB persistence,NA,NA,NA,NA
46,MKKKNWIYALIVTLIIIIAIVSMIFFVQTKYGDQSEKGSQSVSNKNNKIHIAIVNEDQPTTYNGKKVELGQAFIKRLANEKNYKFETVTRNVAESGLKNGGYQVMIVIPENFSKLAMQLDAKTPSKISLQYKTAVGQKEEVAKNTEKVVSNVLNDFNKNLVEIYLTSIIDNLHNAQKNVGAIMTREHGVNSKFSNYLLNPINDFPELFTDTLVNSISANKDITKWFQTYNKSLLSANSDTFRVNTDYNVSTLIEKQNSLFDEHNTAMDKMLQDYKSQKDSVELDNYINALKQMDSQIDQQSSMQDTGKEEYKQTVKENLDKLREIIQSQESPFSKGMIEDYRKQLTESLQDELANNKDLQDALNSIKMNNAQFAENLEKQLHDDIVKEPDSDTTFIYNMSKQDFIAAGLNEDEANKYEAIVKEAKRYKNEYNLKKPLAEHINLTDYDNQVAQDTSSLINDGVKVQRTETIKSNDINQLTVATDPHFNFEGDIKINGKKYDIKDQSVQLDTSNKEYKVEVNGVAKLKKDAEKDFLKDKTMHLQLLFGQANRQDEPNDKKATSVVDVTLNHNLDGRLSKDALSQQLSALSRFDAHYKMYTDTKGREDKPFDNKRLIDMMVDQVINDMESFKDDKVAVLHQIDSMEENSDKLIDDILNNKKNTTKNKEDISKLIDQLENVKKTFAEEPQEPKIDKGKNDEFNTMSSNLDKEISRISEKSTQLLSDTQESKTIADSVSGQLNQLDNNVNKLHATGRALGVRANDLNRQMAKNDKDNELFAKEFKKVLQNSKDGDRQNQALKAFMSNPVQKKNLENVLANNGNTDVISPTLFVLLMYLLSMITAYIFYSYERAKGQMNFIKDDYSSKNNLWNNAITSGVIGATGLVEGLIVGLIAMNKFHVLAGYRAKFILMVILTMMVFVLINTYLLRQVKSIGMFLMIAALGLYFVAMNNLKAAGQGVTNKISPLSYIDNMFFNYLNAEHPIGLALVILTVLVIIGFVLNMFIKHFKKERLI,2,1,0,0,1,1,0,0,2,1,0,0,SAUSA300_0279,NE383,NA,putative membrane protein,esaA|esaA_2|esaA_1,Type VII secretion system accessory factor EsaA,Q792*|Ter40Qext*?|Q40*,SAB mortality and SAB persistence,NA,NA,NA,NA
48,MNMKKKEKHAIRKKSIGVASVLVGTLIGFGLLSSKEADASENSVTQSDSASNESKSNDSSSVSAAPKTDDTNVSDTKTSSNTNNGETSVAQNPAQQETTQSSSTNATTEETPVTGEATTTTTNQANTPATTQSSNTNAEELVNQTSNETTSNDTNTVSSVNSPQNSTNAENVSTTQDTSTEATPSNNESAPQSTDASNKDVVNQAVNTSAPRMRAFSLAAVAADAPAAGTDITNQLTNVTVGIDSGTTVYPHQAGYVKLNYGFSVPNSAVKGDTFKITVPKELNLNGVTSTAKVPPIMAGDQVLANGVIDSDGNVIYTFTDYVNTKDDVKATLTMPAYINPENVKKTGNVTLATGIGSTTANKTVLVDYEKYGKFYNLSIKGTIDQIDKTNNTYRQTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSIKVYKVDNAADLSESYFVNPENFEDVTNSVNITFPNPNQYKVEFNTPDDQITTPYIVVVNGHIDPNSKGDLALRSTLYGYNSNIIWRSMSWDNEVAFNNGSGSGDGIDKPVVPEQPDEPGEIEPIPEDSDSDPGSDSGSDSNSDSGSDSGSDSTSDSGSDSASDSDSASDSDSASDSDSASDSDSASDSDSDNDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSERESDSERETESDSDSD,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,clfA,Clumping factor A,E714_E718delinsDSD,SAB mortality and SAB persistence,NA,NA,NA,NA
50,MEKNFLARITAIISDFKRNMRTAQRMAKTDIPDEIKTEVTANIRDYQRELTRAKSMAQRWREHKVNIDADASKVKQVISFVKAELSNIRRKKVEIDGDASGLKRNVATSKAMLAGWRKHTVKLDFDTTGMTKMQVALTAGKRALDQYQSTMDGIASNIRTFGTIFAQQVKGLMIASIQALIPVIAGLVPAIMAVLNAVGVLGGGVIGLAGAFSVAGVGAVGFGAMAITALKMVKDGTLAVTKEVQNFRNASDQLKTTWQGIVKENQASIFNAMSAGIRGVTSAMSQLKPFLSEVSMLVEANAREFDNWVKHSETAKKAFEALNSIGGAIFGDLLNAAGRFGDGLVNIFTQLMPLFKFVSQGLQNLSIAFQNWANSVAGQNAIKAFIDYTTTNLPKIGQIFGNVFAGIGNLMIAFAQNSSNIFDWLVKLTSQFRAWSEQVGQSQGFKDFISYVQENGPTIMQLIGNIIKALVAFGTAMAPIASKLLDFITNLAGFIAKLFETHPAVAQIIGVMGILGGAFWALMAPVVAISSVLTNVFGLSLFSVVKKILEFVRTSSLVTGALEALTGVFGTISAPILAVIAVIGAFIGVLVYLWKTNENFRNTITEAWNGVKTAVSGAIQGVVGWLTELWGKIQSTLQPIMPILQVLGQIFMQVLGVLVIGIITNVMNIIQGLWTLITIAFQAIGTVISVAVQIIVGLFTALIQLLTGDFSGAWETIKTTITNVLDTIWQYMQSVWESIIGFLTGVMNRTLSMFGTSWSQIWSTITNFVSSIWNTVTSWFSRVASSVAEKMGQALNFIITKGSEWVSNIWNTVTSFASKVADGFKRVVSNVGDGMKNALDKIKSFFSDFLNAGAELIGKVAEGVANAAHKVVSAVGDAISSAWDSVTSFVSGHGGGSGLGKGLAVSQAKVMATSFGKTFTSELGSTLTDGFNDSLTPSVDGHMTNDVQHSMKENNRPIVNVTVRNEGDLNMIKSHIDDMDAKDGSFNLM,2,2,1,2,1,1,1,2,2,5,1,2,NA,NA,NA,NA,NA,hypothetical protein,D306E|T51R|K948Q|V585_G588del|L270fs|T158I|V622A,all,NA,NA,NA,NA
51,MNPEDIKNIGDIKDPNNGETIATAKHDTANNLITYTFTDYVDRFNSVQMGINYSIYMDADTIPVSKNDVEFNVTIGNTTTKTTANIQYPDYVVNEKNSIGSAFTETVSHVGNKENPGYYKQTIYVNPSENSLTNAKLKVQAYHSSYPNNIGQINKDVTDIKIYQVPKGYTLNKGYDVNTKELTDVTNQYLQKITYGDNNSAVIDFGNADSAYVVMVNTKFQYTNSESPTLVQMATLSSTGNKSVSTGNALGFTNNQSGGAGQEVYKIGNYVWEDTNKNGVQELGEKGVGNVTVTVFDNNTNTKVGEAVTKEDGSYLIPNLPNGDYRVEFSNLPKGYEVTPSKQGNNEELDSNGLSSVITVNGKDNLSADLGIYKPKYNLGDYVWEDTNKNGIQDQDEKGISGVTVTLKDENGNVLKTVTTDADGKYKFTDLDNGNYKVEFTTPEGYKPTTVTSGSDIEKDSNGLTTTGVINGADNMTLDSGFYKTPKYNLGNYVWEDTNKDGKQDSTEKGISGVTVTLKNENGEVLQTTKTDKDGKYQFTGLENGTYKVEFETPSGYTPTQVGSGTDEGIDSNGTSTTGVIKDKDNDTIDSGFYKPTYNLGDYVWEDTNKNGVQDKDEKGISGVTVTLKDENDKVLKTVTTDENGKYQFTDLNNGTYKVEFETPSGYTPTSVTSGNDTEKDSNGLTTTGVIKDADNMTLDSGFYKTPKYSLGDYVWYDSNKDGKQDSTEKGIKDVKVTLLNEKGEVIGTTKTDENGKYCFDNLDSGKYKVIFEKPAGLTQTGTNTTEDDKDADGGEVDVTITDHDDFTLDNGYYEEETSDSDSDSDSDSDSDRDSDSDSDSDSDSDSDSDSDSDSDSDSDSDRDSDSDSDSDSDSDSDSDSDSVSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDAGKHTPVKPMSTTKDHHNKAKALPETGNENSGSNNATLFGGLFAALGSLLLFGRRKKQNK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,sdrD_1,Serine-aspartate repeat-containing protein D,K447T,SAB persistence only,NA,NA,NA,NA
52,MIIKSLEIYGYGQFVQRKIEFNKNFTEIFGENEAGKSTIQAFIHSILFGFPTKKSKEPRLEPRLGNQYGGKLVLILDDGLEIEVERIKGSAQGDVKVYLPNGAVRDDAWLQKKLNYISKKTYQGIFSFDVLGLQDIHRNLNEKQLQDYLLQAGALGSTEFTSMREVINRKKDELYKKSGKNPIINQQIEQLKQLESQIREEEAKLETYHRLVDDRDKSSRRLENLKHNLNQLSKMHEEKQKEVALHDHSQEWKSLEQQLNIEPITFPEKGVDRYEKARAHKQSLERDIGLRNERLAQLKEEATQLEPVKQSDIDAFISLNQQENEIKNKEFELTAIEKDIANKQRDKDELQSNIGWSETHHDVDSSEAMKSYVSEQIKNKQEQAAYIKQLERSLEENKIEDNAVHSELDSVEEKIVPEETFEKKKEYSQQVIELNEKENLYSKLKERFEIEQQEKQKRQKLLRTTFILLTLVGIGLTAFSFISNNMLFGIIFAVLTLVFVIGIIMSKSKEVDYSEAITDEIEEIKAQLAILDENYDLDFDLDEQYRIRDHWQQALKNKDILEEKRQYIEGRLNDAKGRHDELQSTVENVKDELYLSSKISNDLIVDSISTMANIKALDQHISDLNQQRQQLVQELDTFYNHAEAVTKSQFVYFNKLSLFHDVQQWLKSAEDTNEKWRINAENTKLVTNELNHLNAQLEENNKEITALFDFINVGTEEDFYQHHEDYQTYTSNLSRFNDLTKYLENQNYSYELSSSLSEKTTAQLEEEDHLLATQVDEYNEQYLEMQAQVSDLSAQINHMETDTTLANLRHEYHSLKNQLNDIAKDWASLSYLQSLVDEHIKQIKDKRLPQVINEAVEILKHLTDGRYTMINYNEDSITVKHVNGQLYDPVELSQSTKELLYVALRISLIKVLKPYYPFPLIVDDAFVHFDKKRTEKMLNYLRSLSEHYQVLYFTCVKDNIVPSKEVITLNKIEEGGKR,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_1792,NE1173,-,hypothetical protein,NA,hypothetical protein,K913R,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
53,MSKWIEKNNEIMRRDELGQLSLSKDKEAIELYLEHIKSKTKQFSNQIARLRYLVEEDYYIDVFKDYSEETLLELLDYAYSFGFEFQSFMAASKFYDTYALKTRDKSQWLEDFEQHNVIVSLYLAGGDVDLAKRYIKAHTLQTVQTATPTYLNAGRKHRGELASCYLFTMDDTLNSINFIRSQVSQASKIAGGVAVNLTRLRGRGATLKGVKNVGKGIVPVAKLIEGEVSYADQLGQRAGAGAAYLNIFHSDVIELLNTKKVNADEDTRLATLSIGLIVPSLFFDLAKEDKDLYMFEPYSIQEEFGKDVILDDININDWYDKFVENENVIKHKINAREMLNLIAQIQLQSGYPYIMYKDNANKNHALNELGEIKMSNLCVTGDTELLTEKGYVKAKDLYESQEDLKVVIDNRTKNYDINNKGTDIVNAIPMQLTAKQAEIYEITTKQGFKIKSTEWHKYYRKINDSIEKVQLNQLEVGDKLLVQSGNGSYGDFHDPKLAFLMGLIAGDGTFGRDGSVKIYLYHEKQYLKETIEELVAYIIDKYRNKNEFLHHSANLHPKFVENKELQKLTISSVELYKILSRFGFNRETKLRFPNLLKNATKNTITAYLSGLYQMDACVNTNEKYKAMSIELTTISEELARDIQMQLLNLGVYSSIYQSEREISLLPDGNGGTKEYKVQNTYKISIQDRSSRDLFMKEVALKPKDIHKAMIFNLTLRPNSRKPKHDFTAEITEIKYIGKEDVYDTTQEDYHSLIFNGIVTGNCTEIFQYMHVSDIKDYNEQDELGQDIICNLASLNMVKSIEEKEIEESIRTGMRALTFVANNSRIEHLPTVHKANKNNRAVGLGVMSFHSMCAKNKIRYGSEESLDLLNVYCMMMDYYSLDESMKIAVERNDKFYGFDQTDYKAKDDKEFGEYFYKNNRVTKNVEPITPKIKEIFKGIYIPTKEDWQRLAREVDKNGLYNSYRLSIAPY,4,2,0,0,1,1,0,0,2,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,D540G|I12fs,SAB mortality and SAB persistence,NA,NA,NA,NA
55,MKKKLDFLPNKLNKYSIRRFTVGTASILVGSTLLFGIGNEAHAAEEHQKSNTTENVADSNASEAPTKEEAPSNEATSEAPTKEEVPSNEATSEAPTKEEAPSNEATSEAPTKEEAPSNEATSEASTKEEAPAAEETDKATEEAPKTEESYKASTEEAPAAEETNKAATEETPAVEDTNAKSNSNAQPSETERTQVVDTVAKDLYKKSEVTEAEKAEIEKVLPKDISNLSNEEIKKIALSEVLKETANKENAQPRATFRSVSSNARTTNVNYSATALRAAAQDTVTKKGTGNFTAHGDIIHKTYKEEFPNEGKLTAFNTNFNPDTGTKGALEYNDKIDFNKDFTITVPVANNNQGNTTGADGWGFMFTQGNGQDFLNQGGILRDKGMANASGFKIDTAYNNVNGKVDKLDADKTNNLSQIGAAKVGYGTFVKNGADGVTNQVGQNALNTKDKPVNKIIYADNTTNHLDGQFHGQRLNDVVLNYDAATSTITATYAGKTWKATTDDLGIDKSQKYNFLITSSHMQNRYSNGIMRTNLEGVTITTPQADLIDDVEVTKQPIPHKTIREFDPTLEPGSPDVIVQKGEDGEKTTTTPTKVDPDTGDVVERGEPTTEVTKNPVDEIVHFAPEEVPQGHKDEFDPNLPIDGTEEVPGKPGIKNPETGKVVTPPVDDVTKHGPKAGEPEVTKEEIPYETKRVLDPTMEPGSPDKVAQKGENGEKTTTTPTTINPLTGEKVGEGEPTTEVTKEPIDEIVNYAPEIIPHGTREEIDPNLPEGETKVIPGKDGLKDPETGEIIEEPQDEVIIHGAKDDSDSDADSDSDSDSDSDADSDSDADSDSDADSDSDADSDSDADSDSDADSDSDADSDSDSDSDSDADSDSDSDSDSDSDSDSDADSDSDADSDSDADSDSDADRDHNDKTDKPNNKELPDTGNDAQNNGTLFGSLFAALGGLFLVGRRRKNKNNEEK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,pls,Surface protein,SY149TN,SAB persistence only,NA,NA,NA,NA
56,MKRSTNQEKFLDTLIRLNTKIEELGKINILNNHIYSEYFFRDLLNIVYGYSLENHNKKQKNAPAFDLIDNTNKIIIQVTATCKKQKIEDTLKKEYLTNKMEEGYRLKFIFIGNQNNNIKNKNFSNPHNILFDSKKDIILTQDLCEEFLNLNINKQDHAIELLKKELSPLLFEDSLSYLKEEFINEKLEFNISNLASRYTANNDVDTINNKIIEGISITNNFKYTNISYLKELKGYIENDILDKMKSKYAKNIYLNFKKIFSNLEQSVNNYLELEEEFEEKKKYLSEIYELIDEINIDPYIFLTEHNECNIYKISENEKLELQTYMSKIEKVLLKYQTYLKETCKECLFYPYLLVQGEAGIGKSHLLAHLSKKLRDENHIIYLFLGQFFTKNEDPWHQILNDLEVTNSVDNFLRSISNKAKETKKRAFIIIDALNEGEGKRLWGNYFQSFINHIKKYSNIALIFSIRTPFEDVILPKNAIQDNNIVVFQHEGFSKEENYNPIVSFCDFYGLELPKLPILNPEFNNPLFLKLMCEYCVNKFKEFDQTISVAELFTNVLKTVNINLSKEDKFDFDKNINVVQKVIKGLVELMNDSEFNQLNYEESYTVVNNIAKEYVQKSNRFLEALIDENILIKNTGYKGEMIIYFSYERMGDYFLSEYLLEKYRNVDKRDLVTKLQSDEKVTRYFQKEDDLSYNRGLINELFIKLANEFNIELFEVFPQFKNNYNMIYSFINSLVWRKDGSISKHTKCYISDNVIPYDAFRNNFLDVLLIKMPQKNHPLNIWALHKLLKQCNLEKRDFIWTQYISINNEKVFEIINWLFSNYKKLDEETAEKYMIFLTWIFSATNNKLRDLGTKSLVKLFKTFPTKIIGLLKLFENNNDPYIVERLYASVLGATLRIDICEIHIEIANYIYEEIFDKEMVYPHILMRDYARQTIEYISLSKDISNINLEKIRIKSV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1750,NE703,NA,conserved hypothetical protein,NA,hypothetical protein,I798L,SAB mortality only,NA,NA,NA,NA
57,MSRLLNDFNQSLHKGFIDKHISHKGNYTPKLLVNNKNEKVLSTIIDELQKCETFYFSVAFITESGLASLKAQLLDLSNKGVKGKILTSNYLGFNSPKMYGELLKLKNVEVRLTDIAGFHAKGYIFEHKDYSSMVIGSSNLTSNALKVNYEHNVLLSTMKNGDLVDSVKSEFDLLWQKSTPLTEQWINSYKESFEYRSLEKLAEVEQTQMLLADKVKKSVEIVPNLMQAEALRSLKAIRDKAKDKALIISATGTGKTILCALDVREVNPNKFLFIVHNEGILNRAKEEFKKVLPIKNDSDFGLLTGKHRDVDAKYLFATIQTLSRDDNFKQFDENEFDYIVFDEAHRSAASTYQRVFNYFKPKFMLGMTATPERSDELSIFELFDYNIAYEIRLQAALESDILCPFHYFGVTDYVHQGIKEDDVTKLRYLTSDERVNYIIQKTDYYGYSGEILQGLIFVSSKKEAYDLADKLSSKGIKSVALTGDDSVNYRQIVIEKLKEGKINYIITVDLFNEGIDIPEVNQVVMLRPTESSIIFIQQLGRGLRKSSNKEYVTVIDFIGNYKTNYLIPIALSGDQSQNKDNYKKFLTNNDSINGVSTINFEEVAKKQIYNSLDAVSLNQNKLILKAYEEVENRLGHMPLLMDFIQQHSIDPSVIFSKFSNYYEILVRYKKIDTLLTENESKNLVFFSRQIAPGLKRIDSLVLEELLKNELTYDELKNKMLNEVKDITEDDIDTSLRILDFSFYNPGIEKIYGSPIIERNERMIRLSDAFTNALSNQTFNMFLEDLIELSKYNNEKYQKGKNGLILYNKYSREDFSKIFNWNKNGSSVIMGYMIKSQEMPIFITYDKHEDISDSTKYEDEFLSQDELKWFTKSNRTLESKEVQKILSHRAKGIKMYIFVQKKDDDGIYFYYLGTAGYIEGSEKQDKMPNGSNVVTMDLALDKAVRDDIYRYLTN,1,1,0,0,1,1,0,0,1,2,0,0,SAUSA300_2431,NE513,NA,putative helicase,uvrB_1,UvrABC system protein B,I664F,SAB mortality and SAB persistence,NA,NA,NA,NA
58,MKSNLRYGIRKHKLGAASVFLGTMIVVGMGQEKEAAASEQNNTTVEESGSSATESKASETQTTTNNVNTIDETQSYSATSTEQPSQSTQVTTEEAPKTVQAPKVETSRVDLPSEKVADKETTGTQVDIAQPSNVSEIKPRMKRSTDVTAVAEKEVVEETKATGTDVTNKVEVEEGSEIVGHKQDTNVVNPHNAERVTLKYKWKFGEGIKAGDYFDFTLSDNVETHGISTLRKVPEIKSTDGQVMATGEIIGERKVRYTFKEYVQEKKDLTAELSLNLFIDPTTVTQKGNQNVEVKLGETTVSKIFNIQYLGGVRDNWGVTANGRIDTLNKVDGKFSHFAYMKPNNQSLSSVTVTGQVTKGNKPGVNNPTVKVYKHIGSDDLAESVYAKLDDVSKFEDVTDNMSLDFDTNGGYSLNFNNLDQSKNYVIKYEGYYDSNASNLEFQTHLFGYYNYYYTSNLTWKNGVAFYSNNAQGDGKDKLKEPIIEHSTPIELEFKSEPPVEKHELTGTIEESNDSKPIDFEYHTAVEGAEGHAEGTIETEEDSIHVDFEESTHENSKHHADVVEYEEDTNPGGGQVTTESNLVEFDEDSTKGIVTGAVSDHTTIEDTKEYTTESNLIELVDELPEEHGQAQGPIEEITENNHHISHSGLGTENGHGNYGVIEEIEENSHVDIKSELGYEGGQNSGNQSFEEDTEEDKPKYEQDGNIVDIDFDSVPQIHGQNNGNQSFEEDTEKDKPKYEQGGNIIDIDFDSVPHIHGFNKHTEIIEEDTNKDKPNYQFGGHNSVDFEEDTLPQVSGHNEGQQTIEEDTTPPIVPPTPPTPEVPSEPETPTPPTPEVPSEPETPTPPTPEVPTEPGKPIPPAKEEPKKPSKPVEQGKVVTPVIEINEKVKAVVPTKKAQSKKSELPETGGEESTNNGMLFGGLFSILGLALLRRNKKNHKA,2,3,0,0,1,1,0,0,2,2,0,0,SAUSA300_2440,NE728,fnbB,fibronectin binding protein B,fnbB,Fibronectin-binding protein B,D703G|N775S|S775N,SAB mortality and SAB persistence,-,2,+,1
61,MAYQSEYALENEMMNQLEQLGYERVTIRDNKQLLDNFRTILNERHADKLEGNPLTDKEFQRLLTMIDGKSIFESARILRDKLPLRRDDESEIYLSFLDTKSWCKNKFQVTNQVSVEDTYKARYDVTILINGLPLVQVELKRRGIDINEAFNQVKRYRKQNYTGLFRYIQMFIISNGVETRYFSNNDSELLKSHMFYWSDKQNNRINTLQSFAESFMRPCQLAKMISRYMIINETDRILMAMRPYQVYAVEALIQQATETGNNGYVWHTTGSGKTLTSFKASQILSQQDDIKKVIFLVDRKDLDSQTEEEFNKFAKGAVDKTFNTSQLVRQLNDKSLPLIVTTIQKMAKAIQGNAHLLEQYKTNKVVFIIDECHRSQFGDMHRLVKQHFKNAQYFGFTGTPRFPENSSQDGRTTADIFGRCLHTYLIRDAIHDGNVLGFSVDYINTFKNKALKAEDNSMVEAIDTEEVWLADKRVELVTRHIINNHDKYTRNRQYSSIFTVQSIHALIKYYETFKRLNKKLEQPLTVAGIFTFKPNEDDRDGEVPYHSREKLEIMISDYNKKFETNFSTDTTNEYFNHISKNVKKGVKDSKIDILIVVNMFLTGFDSKVLNTLYVDKNLMYHDLIQAYSRTNRVEKESKPFGKIVNYRDLKKETDDALRVFSQTNDTDTILMRSYEEYKKEFIDAYRELKMIVPTPHMVDDIQDEEELKRFVEAYRLLAKIILRLKAFDEFEFTIDEIGMDEQENEDYKSKYLAVYDQVKRATAEKNKVSILNDIDFEIEMMRNDTINVNYIMNILRQIDLEDKAEQRRNQEQIRRILDHADDPTLRLKRDLIREFIDNVVPSLNKDDDIDQEYVNFESIKKEAEFKGFAEERSIDEQALKTISNDYQYSGVVNPHHLKKMIGDLPLKEKRKARKAIESFVAETTEKYGV,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0196,NE667,hsdR,"type I restriction-modification enzyme, R   subunit",hsdR,Type-1 restriction enzyme R protein,E870G,Growth rate and cell death,NA,NA,NA,NA
62,MNNKKTATNRKGMIPNRLNKFSIRKYSVGTASILVGTTLIFGLSGHEAKAAEHTNGELNQSKNETTAPSENKTTKKVDSRQLKDNTQTATADQPKVTMSDSATVKETSSNMQSPQNATANQSTTKTSNVTTNDKSSTTYSNETDKSNLTQAKDVSTTPKTTTIKPRTLNRMAVNTVAAPQQGTNVNDKVHFSNIDIAIDKGHVNQTTGKTEFWATSSDVLKLKANYTIDDSVKEGDTFTFKYGQYFRPGSVRLPSQTQNLYNAQGNIIAKGIYDSTTNTTTYTFTNYVDQYTNVRGSFEQVAFAKRKNATTDKTAYKMEVTLGNDTYSEEIIVDYGNKKAQPLISSTNYINNEDLSRNMTAYVNQPKNTYTKQTFVTNLTGYKFNPNAKNFKIYEVTDQNQFVDSFTPDTSKLKDVTDQFDVIYSNDNKTATVDLMKGQTSSNKQYIIQQVAYPDNSSTDNGKIDYTLDTDKTKYSWSNSYSNVNGSSTANGDQKKYNLGDYVWEDTNKDGKQDANEKGIKGVYVILKDSNGKELDRTTTDENGKYQFTGLSNGTYSVEFSTPAGYTPTTANVGTDDAVDSDGLTTTGVIKDADNMTLDSGFYKTPKYSLGDYVWYDSNKDGKQDSTEKGIKGVKVTLQNEKGEVIGTTETDENGKYRFDNLDSGKYKVIFEKPAGLTQTGTNTTEDDKDADGGEVDVTITDHDDFTLDNGYYEEETSDSDSDSDSDSDSDSDSDTDSDSDRDSDSDCESDSDIDSDSDSDSDSDAGKHTPAKPMSTVKDQHKTAKALPETGSENNNSNNGTFFGGLFAALGSLLLFGRRKKQNK,1,0,1,0,1,0,1,0,1,0,1,0,NA,NA,NA,NA,sdrC,Serine-aspartate repeat-containing protein C,R742S,SAB mortality and growth rate,NA,NA,NA,NA
63,MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNTIETPQLNTTANDTSDISANTNSANVDSTAKTMSTQTSNTTTTEPASTNETPQPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANNIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVAEPVVNAADAKGTNVNDKVTASDFKLEKTAFDPNQSGNTFMAANFKVTGQVKSGDYFTAKLPDSVTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFDNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTGEFKDKISYKYDNVASINFGDINKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPEPEPTPDPEPSPEPEPEPTPDPEPSPEPDPDSDSDSDSGSDSDSGSDSDSDSDSDSDSDSDSNSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSDSDSNSDSDSDSDSDSDSDSDSESESKSDREA,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,clfB,Clumping factor B,E681D,SAB mortality only,NA,NA,NA,NA
64,MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETFILHDGPPYANGNLHMGHALNKILKDFIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSTAEFREKCKEFALEQIELQKKDFRRLGVRGDFNDPYITLKPEYEAAQIRIFGEMADKGLIYKGKKPVYWSPSSESSLAEAEIEYHDKRSASIYVAFDVKDDKGVVDADAKFIIWTTTPWTIPSNVAITVHPELKYGQYNVNGEKYIIAEALSDAVAEALDWDKASIKLEKEYTGKELEYVVAQHPFLDRESLVINGDHVTTDAGTGCVHTAPGHGEDDYIVGQKYELPVISPIDDKGVFTEEGGQFEGMFYDKANKAVTDLLTEKGALLKLDFITHSYPHDWRTKKPVIFRATPQWFASISKVRQDILDAIENTNFKVNWGKTRIYNMVRDRGEWVISRQRVWGVPLPVFYAENGEIIMTKETVNHVADLFAEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKETDIMDVWFDSGSSHRGVLETRPELSFPADMYLEGSDQYRGWFNSSITTSVATRGVSPYKFLLSHGFVMDGEGKKMSKSLGNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNINDFNPDTDSIPESELLEVDRYLLNRLREFTASTINNYENFDYLNIYQEVQNFLNVELSNFYLDYGKDILYIEQRDSHIRRSMQTVLYQILVDMTKLLAPILVHTAEEVWSHTPHVKEESVHLADMPKVVEVDQALLDKWRTFMNLRDDVNRALETASNEKFIASEFLTSFDALHQLFIVSQVKVVDKLDDQATAYEHGDIVIEHADGEKCERCWNYSEDLGAVDELTHLCPRCQQVVKSLV,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1087,NA,NA,NA,ileS,Isoleucine--tRNA ligase,S816R,SAB persistence only,NA,NA,NA,NA
65,MNMKKKEKHAIRKKSIGVASVLVGTLIGFGLLSSKEADASENSVTQSDSASNESKSNDSSSVSAAPKTDDTNVSDTKTSSNTNNGETSVAQNPAQQETTQSSSTNATTEETPVTGEATTTTTNQANTPATTQSSNTNAEELVNQTSNETTSNDTNTVSSVNSPQNSTNAENVSTTQDTSTEATPSNNESAPQSTDASNKDVVNQAVNTSAPRMRAFSLAAVAADAPAAGTDITNQLTNVTVGIDSGTTVYPHQAGYVKLNYGFSVPNSAVKGDTFKITVPKELNLNGVTSTAKVPPIMAGDQVLANGVIDSDGNVIYTFTDYVNTKDDVKATLTMPAYINPENVKKTGNVTLATGIGSTTANKTVLVDYEKYGKFYNLSIKGTIDQIDKTNNTYRQTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSIKVYKVDNAADLSESYFVNPENFEDVTNSVNITFPNPNQYKVEFNTPDDQITTPYIVVVNGHIDPNSKGDLALRSTLYGYNSNIIWRSMSWDNEVAFNNGSGSGDGIDKPVVPEQPDEPGEIEPIPEDSDSDPGSDSGSDSNSDSGSDSGSDSTSDSGSDSASDSDSASDSDSASDSDSASDSDSASDSDSDNDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESESDSDSASDSDSGSDSDSSSDSDSESDSNSDSESGSNNNVVPPNSPKNGTNASNKNEAKDSKEPLPDTGSEDEANTSLIWGLLASIGSLLLFRRKKENKDKK,1,5,1,0,1,1,1,0,3,7,1,0,NA,NA,NA,NA,NA,hypothetical protein,E744D|E688D|E696A,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
67,MAANFKEQSKKHFDLNGQSYTYYDLKAVEEQGITKVSNLPYSIRVLLESLLRQEDDFVITDDHIKALSQFGKDGNEGEVPFKPSRVILQDFTGVPAVVDLASLRKAMDDVGGDITKINPEVPVDLVIDHSVQVDSYANPEALERNMKLEFERNYERYQFLNWATKAFDNYNAVPPATGIVHQVNLEYLASVVHVRDVDGEKTAFPDTLVGTDSHTTMINGIGVLGWGVGGIEAEAGMLGQPSYFPIPEVIGVRLVNSLPQGATATDLALRVTQELRKKGVVGKFVEFFGPGVQHLPLADRATIANMAPEYGATCGFFPVDDESLKYMKLTGRSDEHIALVKEYLKQNHMFFDVEKEDPNYTDVIELDLSTVEASLSGPKRPQDLIFLSDMKSSFENSVTAPAGNQGHGLDKSEFDKKAEINFKDGSKATMKTGDIAIAAITSCTNTSNPYVMLGAGLVAKKAVEKGLKVPEYVKTSLAPGSKVVTGYLRDAGLQPYLDDLGFNLVGYGCTTCIGNSGPLLPEIEKAIADEDLLVTSVLSGNRNFEGRIHPLVKANYLASPQLVVAYALAGTVDIDLQNEPIGKGNDGEDVYLKDIWPSIKEVSDTVDSVVTPELFIEEYNNVYNNNELWNDIDVTDQPLYDFDPNSTYIQNPSFFQGLSKEPGTIVPLNGLRVMGKFGDSVTTDHISPAGAIGKDTPAGKYLQDHQVPIREFNSYGSRRGNHEVMVRGTFANIRIKNQLAPGTEGGFTTYWPTNEVMPIFDAAMKYKEDGTGLVVLAGNDYGMGSSRDWAAKGTNLLGVKTVIAQSYERIHRSNLVMMGVLPLEFKKGESADSLGLDGTEEISVNIDENVQPHDYVKVTAKKQDGDLVEFDAMVRFDSLVEMDYYRHGGILQMVLRNKLAQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1246,NE861,acnA,aconitate hydratase,acnA,Aconitate hydratase A,D631E,SAB mortality and SAB persistence,NA,NA,NA,NA
68,MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNMIETPQLNTTANDTSDISANTNSANVDSTAKPMSTQTSNTTTTEPASTNETPQPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANNIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVAEPVVNAADAKGTNVNDKVTASDFKLEKTTFDPNQSGNTFMAANFTVTDKVKSGDYFTAKLPDSLTGNGDVDYSNSNNTMPIADIKSTNGDVVATATYNILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFNNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTNEFKDKITYKYQNVASINFGDITKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPSPEPEPEPTPDPEPSPDPEPEPTPDPEPSPDPEPEPTPDPEPSPDPDSDSDSDSDSDSNSDLDSDSGSDSDSDSDSDSDSDSDSDLDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHKTDDLPETGDKSENTNATLFGAMMALLGSLLLFRKRKQDHKEKA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2565,NE391,clfB,clumping factor B,NA,hypothetical protein,D807_S808del,SAB mortality and SAB persistence,-,0,+,0
69,MGMATYAVVDLETTGNQLDFDDIIQIGITFVRNNQIIDTYHSMIRTNLEIPPFIQALTSIEENMLQQAPYFNQVAQEIYDKIKDCIFVAHNVDFDLNFIKKAFKDCNIQYRPKKVIDTLEIFKIAFPTDKSYQLSELAEAHGITLANAHRADEDAATTAKLMILAFEKFEKLPLDTLKQLYYLSKQLKYDLYDIFFEMVRQYDAKPLDKSYEKFEQIIYRKQVDFKKPTTNYNGSLKSLYSKAVDQLGLTYRPQQLYLAETILDQLMHSEKAMIEASLGSGKSLAYLLAALMYNIETGKHVMISTNTKLLQSQLLEKDIPAMNEALNFKINALLIKSKSDYISLGLISQILKDDTSNYEVNILKMQLLIWITETPSGDIQELNLKGGQKMYFDQKIETYVPARHDVHYYNFIKRNAQNIQIGITNHAHLIHSDVENSIYQLFDDCIVDEAHRLPDYALNQVTNELSYADIKYQLGLIGKNENEKLLKAIDQLEKQRILEKLDIAPIDIFGLKASMNEIHELNEQLFSTIFTIINDSDVYDDDIHRFHNVFTFETKDILKDLHAIIDKLNKTLEIFNGISHKTVKSLRKQLLYLKDKFKNIEQSLKAGHTSFISIKNLSQKSTIRLYVKDYAVKVVLTKQVLEKFKSLIFISGTLKFNHSFEAFKQLFNKDVHFNTFEVNTSLQSAKNTSVFIPSDVAFYQYKNIDEYVASIVSYIIEYTTITSSKCLVLFTSYKMMHMVQDMLNELPEFEDYVVLTQQQNQNYKIVQQFNNFDKAILLGTSTFFEGFDFQANGIKCVMIAKLPFMNKHNAKYWLMDSEFTSTFKEYVLPDAVTRFRQGLGRLIRNENDRGIIVSFDDRLINSNYKNFFEQTLENYRQKKGDIQQFGKLLRQIQKKKK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1346,NE346,NA,putative DnaQ family exonuclease/DinG family helicase,dinG_1,3'-5' exonuclease DinG,V634D,SAB persistence only,-,0,-,0
70,MSYFNNVYTLKLDIKQQNPNPVIRIVQYDSAVFKIELYDNGRKIDIKDGERFTVSVEHEATGETHSGIAKYDGEQFVVYDLRKADMKNIGTYRARFASYKDRNRVSSLMFRYEVYEDYETVGDASELTMLQELFQEVEEVGRVTQRQGEYAEDRGDYANAAGDYANRAGDSQIMNWLPYVKTLAERNKLYPNPENGDTVYVIDENKVFRYDGIDALDWEAISGYDTSVIQDIYNTKEDKTVVAKLREDLNSLTIGARNLLTGTDFEKPMNLKYTSPTFTFTQNKSDSSMTLAPTDKYVSTSAVYFDLEKEALENNFFTLSFNVKVLSGSATLKFKVGDAAYSEPVTVKASSNYQRVVLTASTQDLKTNKTNLLLQTTSAIAIEKESFKAEIGNRATTWTPSYLDVKTKLDDYGTRIKGLEVEMNTNVVKKSVYEADKSKNEEKLSKIIQDANSLTSIVSKKVDKGQVKSMINQTAERIKIKASNIDFDGVVVFKNRNNKIDPNAFVRINGGELTAKGYYRRVWRDGKARNRVQVVQLTDGMLRISDPKGDLVDSTKDRDYRYDIDVNGKRVYSTVRSLYYSSDGVSTYRDGSGKAFNKEGKVVSSGTIEFFSHEYSRSRGLTLYSAGGAIGLQAANNAIHIDAAATLYNRSRQANVIIRPHENVRKGINDFKFGISADNTGRLVYGDESKRLGVGLRFSKSSKNKVITGIDSTGRASSDVRLEIGEVRANKILSRDGKETVYFNNAGSGNLTQSATLRAGGIKTNATNFYVGVRGELRVTNTRGANFGKGIGYMPVRASKFNSVSSRKYKTNIKDLEINSLDVLNSTDIKQYNLKSDLNDGIDKVKYGVILEDSHDALKEGDAIDVYTMTSILWDVVKKQQKEIEQLKKIISKVAIY,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,I890fs,SAB mortality only,NA,NA,NA,NA
71,MNKHHPKLRSFYSIRKSTLGVASVIVSTLFLITSQHQAQAAENTNTSDKISENQNNNATTTQPPKDTNQTQPATQPANTAKNYPAADESLKDAIKDPALENKEHDIGPREQVNFQLLDKNNETQYYHFFSIKDPADVYYTKKKAEVELDINTASTWKKFEVYENNQKLPVRLVSYSPVPEDHAYIRFPVSDGTQELKIVSSTQIDDGEETNYDYTKLVFAKPIYNDPSLVKSDTNDAVVTNDQSSSVASNQTNTNTSNQNTSTINNANNQPQATTNMSQPAQPKSSTNADQASSQPAHETNSNGNTNDKTNESSNQSDVNQQYPPADESLQDAIKNPAIIDKEHTADNWRPIDFQMKNDKGERQFYHYASTVEPATVIFTKTGPIIELGLKTASTWKKFEVYEGDKKLPVELVSYDSDKDYAYIRFPVSNGTREVKIVSSIEYGENIHEDYDYTLMVFAQPITNNPDDYVDEETYNLQKLLAPYHKAKTLERQVYELEKLQEKLPEKYKAEYKKKLDQTRVELADQVKSAVTEFENVTPTNDQLTDLQEAHFVVFESEENSESVMDGFVEHPFYTATLNGQKYVVMKTKDDSYWKDLIVEGKRVTTVSKDPKNNSRTLIFPYIPDKAVYNAIVKVVVANIGYEGQYHVRIINQDINTKDDDTSQNNTSEPLNVQTGQEGKVADTDVAENSSTATNPKDASDKADVIEPESDVVKDADNNIDKDVQHDVDHLSDMSDNNHFDKYDLKEMDTQIAKDTDRNVDKDADNSVGMSSNVDTDKDSNKNKDKVIQLNHIADKNNHTGKAAKLDVVKQNYNNTDKVTDKKTTEHLPSDIHKTVDKTVKTKEKAGTPSKENKLSQSKMLPKTGETTSSQSWWGLYALLGMLALFIPKFRKESK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1677,NE1075,NA,cell wall surface anchor family protein,isdH,Iron-regulated surface determinant protein H,Q270*,SAB persistence only,NA,NA,NA,NA
74,MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNTIETPQLNTTANDTSDISANTNSANVDSTAKPMSTQTSNTTTTEPASTNETPHPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANSIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVTEPVVNAADAKGTNVNGQVTASDFKLEKTTFDPNQSGNTFMAANFKVAGKVKSGDYFTAKLPDSVTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFNNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTDQFKDKISYKYDNVASINFGDINKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPEPEPKPDPEPSPDPEPEPTPDPEPSPDPEPEPTPDPEPTPDPEPSPDPEPSPDPDPEPSPDPDPDSDSDSDSDSGSDSDSDSESDSDSDSDLGSDSDSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSDSDSDSESDSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDPDPDSDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHKTDALPETGDKSENTNATLFGAMMALLGSLLLFRKRKQDHKEKA,0,1,1,1,0,1,1,1,0,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,D681E,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
75,MEMKPKYDPREVEAGRYEEWVKNGYFKPSEDKSKETYTIVIPPPNVTGKLHLGHAWDTTLQDIITRMKRMQGYDTLYLPGMDHAGIATQAKVEAKLNEQGITRYDLGREKFLEQAWDWKEEYASFIRAQWAKLGLGLDYSRERFTLDEGLSKAVKKVFVDLYNKGIIYRGERIINWDPKARTALSDIEVIHEDVQGAFYHFKYPYADGEGFIEIATTRPETMLGDTAIVVNPNDERYKDVIGKTVILPIVGRELPILADEYVDIDFGSGAMKVTPAHDPNDFEIGQRHQLENIIVMDENGKMNDKAGKYEGMDRFDCRKQLVKDLKEQDLVIKIEDHVHSVGHSERSGAVVEPYLSTQWFVRMEDLAKRSLDNQKTDDRIDFYPQRFEHTFNQWMENIRDWTISRQLWWGHQIPAWYHKETGEIYVGEEAPTDIENWQQDEDVLDTWFSSALWPFSTLGWPDLESEDFKRYYPTNALVTGYDIIFFWVARMIFQGLEFTDRRPFNDVLLHGLVRAEDGRKMSKSLGNGVDPMDVIDEYGADSLRYFLATGSSPGHDLRYSTEKVESVWNFINKIWNGARFSLMNIGEDFKVEDIDLSGNLSLADKWILTRLNETIATVTDLSDKYEFGEVGRALYNFIWDDFCDWYIEMSKIPMNSNDEEQKQVTRSVLSYTLDNIMRMLHPFMPFVTEKIWQSLPHEGDTIVKASWPEVRESLIFEESKQTMQQLVEIIKSVRQSRVEVNTPLSKEIPILIQAKDKEIETTLSQNKDYLIKFCNPSTLNISTDVEIPEKAMTSVVIAGKVVLPLEGLIDMDKEISRLEKELAKLQSELDRVDKKLSNENFVSKAPEKVINEEKRKKQDYQEKYDGVKARIEQLKA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1611,NA,NA,NA,valS,Valine--tRNA ligase,E828K,SAB persistence only,NA,NA,NA,NA
83,MNLKAPYAGLRDNLLLTKTGEVWAYYRVRSESISTANYDAKEESKKRMRYFLESIKGYQDFHFEMYDHDLDLRNKFKEISKDFDDEAFNVAEYYSKETIDVLEQELQMITHNSFVMGVKIRELADDAVTLKEILKSTLSDTAERIVSNFGFDVNLDDKILDKYKTFERDLADSFLGIGGERLTENELAYIIRKPFISNATHDVQEESSRRAITDIYNAVIDPTRLSVLEVENDNEKFYTTTVVVDDFPLDMEYTHLFEKAQNMPFPVECHVKAKIINNEKVKKKFDRAKINHKQQAKEKQDTGDSASEDVQDNLFVLNQMEREVTGSGVFIEWVFMFVIKSDDYRDCKRKAKRLMKRLKETQIYAVNPLADQLQLFYQCLHGNDLFINKYWLQRTTATGIAENLFGVSQSLGTKTGFYIGRIDKFIRSVSREEAVASSRDIILFSLLLAAKGIKGAVSDSPHVLITGQTGKGKSFLAKLLWIYTSFFKGQMLYWDPKSEFAEWFDRVTESKEMQEKYPLFINHLKTFKYVTLNYEDSTNYGCLDPIVFLDGIEANEMLKSVFDEIKSFENYHHIETAIYQAISDTVEERENGKKVGSLNVIEKLQNNEDEHVKNAGDLLFEKTQNNILKLVFSDGTNPALNIQEKATILQVKGLDMPKADDDTSSYSTSEKNGITLMLLIGKFLEKFGSRRDVQTTIFIDEGWAFTASRQGKKVGKRIKRTGRSENNSLVFITQSVKDKADDDGGNFGCHFAFDEKDEREDILKSLGLEYSKESPENMEMLKDLKKGQCIFSDFYGRVGKMVVHCPFEGMTEAFRTQEDSASSKAEEKFAM,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1483,NE698,NA,conserved hypothetical protein,NA,hypothetical protein,G809E,SAB mortality only,NA,NA,NA,NA
84,MDIDIDCEGSKRQRIISALKKHYGEDRVLNVCTYGTEGAKSAIKMAARGLNIPDTEAQYLGSFIKVERGQQWSIKDTLYGNLDKDRKPDTQFKNEMEKYPRLLETAMKLEGLVTRRGIHAGGVIIFNDEAYKNNAIMTASGGDVHVTQYNLSDSEYMGGVKFDLLSVENLDRIRATLELLSKDGLIDNTKSLRENFSDLLHPKNLDLESNEYFELASTGEINDLFQFQTEIGQTTLKRVQPETFEQFCAANSLMRLQSDGEEQPIDKYIRHKNDINEWYKEMREFGLNEEEIKIMEEHLLHDKGLNITQENSMGLSADNRISNFTILEQNKLRKAIAKPKGSALDQIKSLFYSKGKECGAREVFLDYVWNVQFAMQFSYSFSLLHTTAYSVIGIQNLELNRRFPRIYWQTACLNVDSDSISTDSKDIDYEKIANGIGKMKENGVTVKLPSINKSTLEFSPDVEHNAIVYGLKPVKNINNEIVDHIIANRPYHSLDDVLTKLYDTKLITNKHLISIVKSGMLDEFGERKKIMMDVVKYITDLKTNLTLANIKLLLEADILSERPEYELVLLRENIKNKVLRKVQTGKSKTKHKIFKVEDTELYDRLIGNEAIVNVVGSHYEVDEKEFKKIFDKKTKDLKEWLKTDKPIELANRYVLNEAWKKHALGNYSSWEMETLSFYYHKHELYNVNKETYDITDFKELPVDPVVTDVFKFKGREMPKYEIVNIAGTVIAKNAPKKSVTILATDGSVVTIKYHGNFSYYDKTSKLNGSVVEESWFKKGNKLIFSGFRRGGQFVSKKYKDTSTSSSTKLIESISKDGVLRYKLERDYL,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,dnaE2,Error-prone DNA polymerase,D826fs,SAB persistence only,NA,NA,NA,NA
85,MKWSNIFEKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNTIETPQLNTTANDTSDISANTNSANVDSTAKTMSTQTSNTTTTEPASTNETPQPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANNIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVAEPVVNAADAKGTNVNDKVTASDFKLEKTAFDPNQSGNTFMAANFKVTGQVKSGDYFTAKLPDSVTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFDNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTGEFKDKISYKYDNVASINFGDINKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPEPEPTPDPEPSPEPEPEPTPDPEPSPEPDPDSDSDSVSDSDTDSDSDSDSDSDSDSESDSESDSDSDSESDSDSESDSDSDSDSDSDSDSDSDSDSESDSDSESDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHQTDALPETGDKSENTNATLFDAMVALLGSLLLFRKRKQDHKEKA,2,1,0,0,1,1,0,0,3,2,0,0,NA,NA,NA,NA,NA,hypothetical protein|Clumping factor B,VSD599DSG|E647D|E697D,SAB mortality and SAB persistence,NA,NA,NA,NA
86,MLFGRLTERAQRVLAHAQEEAIRLNHSNIGTEHLLLGLMKEPEGIAAKVLESFNITEDKVIEEVEKLIGHGQDHVGTLHYTPRAKKVIELSMDEARKLHHNFVGTEHILLGLIRENEGVAARVFANLDLNITKARAQVVKALGNPEMSNKNAQASKSNNTPTLDSLARDLTVIAKDGTLDPVIGRDKEITRVIEVLSRRTKNNPVLIGEPGVGKTAIAEGLAQAIVNNEVPETLKDKRVMSLDTGTVVAGTKYRGEFEERLKKVMEEIQQAGNVILFIDELHTLVGAGGAEGAIDASNILKPALARGELQCIGATTLDEYRKNIEKDAALERRFQPVQVDEPSVVDTVAILKGLRDRYEAHHRINISDEAIEAAVKLSNRYVSDRFLPDKAIDLIDEASSKVRLKSHTTPNNLKEIEQEIEKVKNEKDAAVHAQEFENAANLRDKQTKLEKQYEEAKNEWKNAQNGMSTSLSEEDIAEVIAGWTGIPLTKINETESEKLLSLEDTLHERVIGQKDAVNSISKAVRRARAGLKDPKRPIGSFIFLGPTGVGKTELARALAESMFGDDDAMIRVDMSEFMEKHAVSRLVGAPPGYVGHDDGGQLTEKVRRKPYSVILFDEIEKAHPDVFNILLQVLDDGHLTDTKGRTVDFRNTIIIMTSNVGAQELQDQRFAGFGGSSDGQDYETIRKTMLKELKNSFRPEFLNRVDDIIVFHKLTKEELKEIVTMMVNKLTNRLSEQNINIIVTDKAKDKIAEEGYDPEYGARPLIRAIQKTIEDNLSELILDGNQIEGKKVTVDHDGKEFKYDIAEQTSETKTPSQA,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0510,NE699,clpC,endopeptidase,clpC,ATP-dependent Clp protease ATP-binding subunit ClpC,T244M,SAB mortality and SAB persistence,NA,NA,NA,NA
87,MAYFTINSIVGELDFPNSEIFYYQQQQFTFLVDTSMNVEIVANKKALSTVRNKKKELKDLDSHAWESDNETSTNVVDALESVDELESNLDQTKESMYKLSYVVRVSAKNLDELKQRCDEVKDFYDDLSIKLVRPFGDMLGLHNEFIPSSKRYINDYIQYVTSDFLAGLGFGATQMIGENSGIYVGYNLDTGRNIYLQPSLASQGIKGSVTNALASAFIGSLGGGKSFSNNMLVYYSVLFGGQATIVDPKAERGEWKETLPDIAHEINIVNLTSENDNKGLLDPYVILKLPKDSESLAIDILTFLTGISSRDSEKFPVLRKAIRSVTQSKQRGLLLVIDELRKEDTPISNSIADHIESFVDYDFAHLLFSDGSVTQSISLEKQLNIIQVADLVLPDSNSSFEEYTTMELLSAAMLIVISTFALDFIHSDRSIFKIVDLDEAWSFLQVAQGKALSMRLVRAGRAMNAGVYFVTQNADDLLDEKMKNNIGLKFAFRSTDLVEIKKTLEFFGVDKEDENNQKRLRELENGQCLVSDIYGRVGVMQFHPIFEELLHAFDTRPPVRNEVEE,1,1,0,0,1,1,0,0,2,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,A411V|A663V,SAB mortality and SAB persistence,NA,NA,NA,NA
89,MLIKGGVYLEELGAIKAIAFDKTGTLTKGVPVVTDFEVLNDQVEEKELFSIITALEYRSQHPLASAIMKKAEQDNIPYSNVQVEEFTSITGRGIKGIVNGTTYYIGSPKLFKELNVSDFSLGFENNVKILQNQGKTAMIIGTEKTILGVIAVADEVRETSKNVIQKLHQLGIKQTIMLTGDNQGTANAIGTHVGVSDIQSELMPQDKLDYIKKMQSEYDNVAMIGDGVNDAPALAASTVGIAMGGAGTDTAIETADIALMGDDLSKLPFAVRLSRKTLNIIKANITFAIGIKIIALLLVIPGWLTLWIAILSDMGATILVALNSLRLMRVKDK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,cadA_2,Cadmium-transporting ATPase,Q131*,SAB mortality only,NA,NA,NA,NA
90,MANTKKTTLDITGMTCAACSNRIEKKLNKLDDVNAQVNLTTEKATVEYNPDQHDVQEFINTIQHLGYGVAVETVELDITGMTCAACSSRIEKVLNKMDGVQNATVNLTTEQAKVDYYPEETDADKLVTRIQKLGYDASIKDNNRDQTSRKAEALQHKLIKLIISAVLSLPLLMLMFVHLFNMHIPALFTNPWFQFILATPVQFIIGWQFYVGAYKNLRNGGANMDVLVAVGTSAAYFYSIYEMVRWLNGSTTQPHLYFETSAVLITLILFGKYLEARAKSQTTNALGELLSLQAKEARILKDGNEVMIPLNEVHVGDTLIVKPGEKIPVDGKIIKGMTAIDESMLTGESIPVEKNVDDTVIGSTMNKNGTITMTATKVGGDTALANIIKVVEEAQSSKAPIQRLADIISGYFVPIVVGIALLTFIVWITLVTPGTFEPALVASISVLVIACPCALGLATPTSIMVGTGRAAENGILFKGGEFVERTHQIDTIVLDKTGTITNGCPVVTDYHGDDQTLQLLATAEKDSEHPLAEAIVNYAKEKQLTLTETTTFKAVPGHGIETTIDHHHILVGNRKLMADNDISLPKHISDDLTHYERDGKTAMLIAVNYSLTGIIAVADTVKDHAKDAIKQLHDMGIEVAMLTGDNKNTAQAIAKQVGIDTVIADILPEEKAAQITKLQQQGKKVAMVGDGVNDAPALVKADIGIAIGTGTEVAIEAADITILGGDLMLIPKAIYASKATIRNIRQNLFWAFGYNIAGIPIAALGLLAPWVAGAAMALSSVSVVTNALRLKKMRLEPRRKDA,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2494,NE561,NA,copper-translocating P-type ATPase,copA,Copper-exporting P-type ATPase,T562A,SAB mortality and SAB persistence,NA,NA,NA,NA
91,MIAKVIVDVASKSVDYKFDYIIPEQLESVIQPGVRVIVPFGPRTIQGYVMEVTAEPDAQLDVSKLKKIIEVKDIQPELTSELIALSEWMGSTHVIKRISMLEVMLPSAIKAKYKKAFKMKDDIELPSALLQKFDKHGYYYYKDAQKNNDIQLLMKLLKDDIVEEKTILTQNITKKTKRAVRVIEGYHPDEVLAKLEKVIKQYDLYAYLSEEQHKTIFLTDIEDMGFSKSSLDGLIKKGYVEKYDAVVERDPFKDRVFEQESKQQLTEDQYKAYEAIKAKIVSQEQETFLLHGVTGSGKTEVYLQTIEDVLSQGKQAMMLVPEIALTPQMVLRFKRRFGDDVAVLHSGLSNGERYDEWQKIRDGRARVSVGARSSVFAPFKNLGLIIIDEEHESTYKQEDYPRYHAREIAQWRSEYHHCPVILGSATPCLESYARAEKGVYHLLSLPNRVNQQALPEIDIVDMREELSEGNRSMFSKDLREAIQLRLDRQEQVVLFLNRRGYASFMLCRDCGYVPQCPNCDISLTYHKTTDLLKCHYCGYQETPPNQCPNCESEHIRQVGTGTQKVEELLQQEFEDARIIRMDVDTTSKKGAHEKLLTEFEKGNGDILLGTQMIAKGLDYPNITLVGVLNADTMLNLPDFRASERTYQLLTQVAGRAGRHEKAGQVIIQTYNPDHYSILDVQKNDYLTFYRQEMEYRKLGKYPPYYYLINFTISHKEMKKVMVASQHVHKILLQHLTEKALVLGPSPAALARINNEFRFQILVKYKSEPGLLQAIQFLDDYYHEKFIKEKLALKIDIDPQMMM,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1105,NA,NA,NA,priA,primosomal protein N',V762L,SAB mortality and growth rate,NA,NA,NA,NA
93,MAKQKLVMIGNGMAGIRTIEEILERANDLYDITVIGKEPYPNYNRIMLSNILQNKMTVEETIMNPYEWYEEHGIELITNDPVIEVDRANQSVTTANGIEVSYDKLIFATGSKAFIIPVPGSTLPSVIGWRTIDDTEQMMNIAKTKKKAIVIGGGLLGLECARGLLDQGMEVTVLHLAEWLMEMQLDRKAGNMLKADLEKQGMKFEMQANTTEILGEDDVEGVKLADGREIPADLVVMAVGIRPYTEVAKESGLDVNRGIVVNDVMQTSDSNVYAVGECAEHNGKVYGLVAPLYEQGKVLADHLTNKETNGYKGSTTFTSLKVSGCDLYSAGQIVENAEIKGIEIFNSVDNNYKKIFLKDGNVVGAVLYGDIDDGSRFYNMMKKGESTEDYTLVSLLTKGGEEASLSIADMADDETICGCNGVDKGTIVNAITENGFTTVEEVTAKTKAGNSCGKCKPQIAQILQHTLGDDFVAAKPAGICGCTDLTRDQIVTQIRAKGLKTSKEVRHVLNFKNKGGCPKCRPAINYYLNMVYPHDHEDERESRFANERYHANIQNDGTFSVIPQMRGGVTDADQLIRLGEVAKKYHVPLVKVTGSQRVGLYGVKKEELPNIWEDLGMRSASAYGKKTRSVKSCVGKEFCRFGTQYTTRLGIRLEKTFEYIDTPHKFKMGVSGCPRSCVESGVKDFGIISVENGFQIYIGGNGGTEVEKAEFLTTVETEDEVIKLCGALMQYYRETGIYAERTAPWLRRLGFENVKEVLLDPERQNELFERIMDAKKAVEAEPWEAITSNAQARRIFEVEKV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2346,NE857,nirB,"nitrite reductase [NAD(P)H], large subunit",nasD,Nitrite reductase [NAD(P)H],I115V,SAB mortality only,NA,NA,NA,NA
94,MLISNEWLKEYVTIDDSVSNLAERITRTGIEVDDLIDYTKDIKNLVVGFVKSKEKHPDADKLNVCQVDIGEDEPVQIVCGAPNVDAGQYVIVAKVGGRLPGGIKIKRAKLRGERSEGMICSLQEIGISSNYIPKSFESGIYVFSEAQVPGTDALQALYLDDQVMEFDLTPNRADALSMIGTAYEVAALYNTKMTKPETTSNELDLSANDELTVTIENEDKVPYYSARVVHDVTIEPSPIWMQARLIKAGIRPINNVVDISNYVLLEYGQPLHMFDQDAIGSQQIVVRQANEGEKMTTLDDTERELLTSDIVITNGQTPIALAGVMGGDFSEVKEQTSNIVIEGAIFDPVSIRHTSRRLNLRSESSSRFEKGIATEFVDEAVDRACYLLQTYANGKVLKDRVSSGELGAFITPIDITADKINRTIGFDLSQNDIVTIFNQLGFDTEINDDVITVLVPSRRKDITIKEDLIEEVARIYGYDDIPSTLPVFDKVTSGQLTDRQYKTRMVKEVLEGAGLDQAITYSLVSKEDATAFSMQQRQTIDLLMPMSEAHASLRQSLLPHLIEAASYNVARKNKDVKLFEIGNVFFANGEGELPDQVEYLSGILTGDYVVNQWQGKKETVDFYLAKGVVDRVSEKLNLEFSYRRADIDGLHPGRTAEILLENKVVGFIGELHPILAADNDLKRTYVFELNFDALMAVSVGYINYQPIPRFPGMSRDIALEVDQNIPAADLLSTIHAHGGNILKDTLVFDVYQGEHLEKGKKSIAIRLNYLDTEETLTDERVSKVQAEIEAALIEQGAVIR,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_1038,NA,NA,NA,pheT,Phenylalanine--tRNA ligase beta subunit,A549V|V549A,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
96,MKHKLDVTINELRLKSIRKIVKRINTWSDEVKSYSDDVLKQKTLEFKERIASGVDTLDTLLPEAYAVAREASWRVLGMYPKEVQLIGAIVLHEGNIAEMQTGEGKTLTATMPLYLNALSGKGTYLITTNDYLAKRDFEEMQPLYEWLGLTASLGFVDIVDYEYQKGEKRNIYEHDIIYTTNGRLGFDYLIDNLADSAEGKFLPQLNYGIIDEVDSIILDAAQTPLVISGAPRLQSNLFHIVKEFVDTLIEDVHFKMKKTKKEIWLLNQGIEAAQSYFNVEDLYSEQAMVLVRNINLALRAQYLFESNVDYFVYNGDIVLIDRITGRMLPGTKLQAGLHQAIEAKEGMEVSTDKSVMATITFQNLFKLFESFSGMTATGKLGESEFFDLYSKIVVQVPTDKAIQRIDEPDKVFRSVDEKNIAMIHDIVELHETGRPVLLITRTAEAAEYFSKVFFQMDIPNNLLIAQNVAKEAQMIAEAGQIGSMTVATSMAGRGTDIKLGEGVEALGGLAVIIHEHMENSRVDRQLRGRSGRQGDPGSSCIYISLDDYLVKRWSDSNLAENNQLYSLDAQRLSQSSLFNRKVKQIVVKAQRISEEQGVKAREMANEFEKSISIQRDLVYEERNRVLEIDDAENRDFKVLAKDVFEMFVNEEKVLTKSRVVEYIYQNLSFQFNKDVACVNFKDKQAVVTFLLEQFEKQIALNRKNMQSAYYYNIFVQKVFLKAIDSCWLEQVDYLQQLKANVNQRQNGQRNAIFEYHRVALDSFEVMTRNIKKEW,3,3,2,1,1,1,1,1,5,2,2,1,SAUSA300_2584,NE66,NA,"preprotein translocase, secA protein",secA1_1|secA1_2,Protein translocase subunit SecA 1,E773fs|A676V|E753fs|R773fs,all,NA,NA,NA,NA
97,MNLKQSIEEIINQPEYEPMSVSDFQDALGLSSADSFRDLIKVLVELEQSGLIERTKTDRYQKKHSYRGQSKLIKGTLSQNKKGFAFLRPEDEDMEDIFIPPTKINRALDGDTVIVEIHQSKGEHKGKIEGEVKSIEKHSVTQVVGTYSEARHFGFVIPDDKRIMQDIFIPKGQSLGAVDGHKVLVQITKYADGSDNPEGHISAILGHKNDPGVDILSIIYQHGIEIEFPDEVLQEAEAVPDHIENTEIKGRHDLRDELTITIDGADAKDLDDAISVKKLANGNTQLTVSIADVSYYVTEGSALDKEAYDRATSVYLVDRVISMIPHRLSNGICSLNPNVDRLTLSCRMEIDASGRVVKHEIFDSVIHSDYRMTYDAVNQIITEKDPNIREQYNEITPMLDLAQDLSNRLIQMRKRRGEIDFDISEAKVLVNEDGIPTDVQLRQRGEGERLIESFMLIANETVAEHFSKLDVPFIYRVHEQPKSDRLRQFFDFITNFGIMIKGTGEDIHPTTLQKVQEEVEGRPEQMVISTMMLRSMQQAHYDDVNLGHFGLSAEYYTHFTSPIRRYPDLTVHRLIRKYLIEKSMDNKEVKRWEDKLPELAEHTSKRERRAIEAERDTDELKKAEYMIQHIGDEFEGIVSSVANFGMFIELPNTIEGMVHIANMTDDYYRFEERQMALIGERQAKVFRIGDTVKVKVTHVDVDERLIDFQIVGMPLPKNDRSQRPARGKTIQAKTRGKSLDKSKSDDKGRKKKGKQRKGKNQRNNDKSGNSKHKPFYKDKSVKKKARRKKK,2,3,0,0,1,1,0,0,1,1,0,0,SAUSA300_0764,NE501,rnr,ribonuclease R,rnr,Ribonuclease R,S322P,SAB mortality and SAB persistence,NA,NA,NA,NA
98,MNMKKKEKHAIRKKSIGVASVLVGTLIGFGLLSSKEADASENSVTQSDSASNESKSNDSSSVSVAPKTDDTNVSDTKTSSNTNNGETSVAQNPAQQETTQSSSTNATTEETPVTGEATTTTTNQANTPATTQSSNTNAEELVNQTSNETTSNDTNTVSSVNSPQNSTNAENVSTTQDTSTEATPSNNESAPQSTDASNKDVVNQAVNTSAPRMRAFSLAAVAADAPAAGTDITNQLTNVTVGIDSGTTVYPHQAGYVKLNYGFSVPNSAVKGDTFKITVPKELNLNGVTSTAKVPPIMAGDQVLANGVIDSDGNVIYTFTDYVNTKDDVKATLTMPAYINPENVKKTGNVTLATGIGSTTANKTVLVDYEKYGKFYNLSIKGTIDQIDKTNNTYRQTIYVNPSGDNVIAPVLTGNLKPNTDSNALIDQQNTSIKVYKVDNAADLSESYFVNPENFEDVTNSVNITFPNPNQYKVEFNTPDDQITTPYIVVVNGHIDPNSKGDLALRSTLYGYNSNIIWRSMSWDNEVAFNNGSGSGDGIDKPVVPEQPDEPGEIEPIPEDSDSDPGSDSGSDSNSDSGSDSGSDSTSDSGSDSARDSDSDSDSDSVCDSESDSDSDSDSDSESDSDSDSDSDSDSDSDSDSDSDSASDSDSGSDSDSSSDSDSESDSNSDSESGSNNNVVPPNSPKNGTNASNKNEAKDSKEPLPDTGSEDEANTSLIWGLLASIGSLLLFRRKKENKDKK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,R595S,SAB mortality and SAB persistence,NA,NA,NA,NA
99,MPNFFDQFDGTPDAASAAAPRGVRNNNPLNIEAGNYTKSQAGFTGSDGRFAKFENMDQGFAAAENLLGTYHSKHGINTISGVINRWAPASDGNPVSAYASKVAKEIGVDPDQPIDLANPVVRARVASSMAKFENGVDVPRSTDISAQSKPKGNFFDQFDEAKPSADATPATPGVKRVYIGGTQDPKSPFSERIAGDGTGPGLIQQPTTDRFQRMAIDFNNEMAGAGQLTTSNIGAQSKNLISDKVQEGDDGNAYFVDPKTGKLTQADKAQHVILTDPADNQLKVYARTDETDEGRMSAAGRLLRVGTMTSVPTVAATEKAVGSALLTGGKAAATAVTEGQQVAQAAERVGVDLPRAVTSDTLGAQQAGKLAANVPLAGLPLRKASQTAIQQMDDVMTASRAGYGSGNPATAGAAIREGVTEAIKSGPIKQRVNALYDKVDNLVDPTAVGPMPNTQRLASAIEARRVNGALPQSAKVAELEEALSRKGMNYEGIKDLRSYFGEMLDGSKVIPDGLGQKEVKQIYGALSDDMRLIIARAGGPEGLAAYKQAEKAAAKWSQVREDLQRVLNLKSEEAIFSKVIDAASSRRSADLQLLGRVRGAVGPEKWNEVASALIEKLGRAPDGTFSPDRLLGPSGLGGLSEAGKKILFRSTGQMSHADAIDDIATIAKRWKSLNQFANPSGTGQSASWSAGTLGAFVDPVSTVSAFVGSAVLAKVLSTPASSRSMAAWSRAYERAVRQPTVASIEGFKQASKLFATNVGRDIGKPEIVGNFTKQLQGAVPAAADGEEN,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,V311A,SAB mortality only,NA,NA,NA,NA
100,MIGALQLKNKIDFSKDFNFKVRVANNHQSNTTGADGWGFLFSKGNAEEYLTNGGILGDKGLVNSGGFKIDTGYIYTSSMDKTEKQAGQGYRGYGAFVKNDSSGNSQMVGENIDKSKTNFLNYADNSTNTSDGKFHGQRLNDVILTYVASTGKMRAEYAGKTWETSITDLGLSKNQAYNFLITSSQRWGLNQGINANGWMRTDLKGSEFTFTPEAPKTITELEKKVEEIPFKKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKEEVPGKPGIKNPETGDVVRPPVDSVTKYGPVKGDSIVEKEEIPFKKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPINELTEYGPETITPGHRDEFDPKLPTGEKEEVPGKPGIKNPETGDVVRPPVDSVTKYGPVKGDSIVEKEEIPFKKERKFNPDLAPGTEKVTREGQKGEKTITTPTLKNPLTGEIISKGESKEEITKDPVNELTEFGGEKIPQGHKDIFDPNLPTDQTEKVPGKPGIKNPDTGKVIEEPVDDVIKHGPKTGTPETKTVEIPFETKREFNPKLQPGEERVKQEGQPGSKTITTPITVNPLTGEKVGEGQPTEEITKQPVDKIVEFGGEKPKDPKGPENPEKPSRPTHPSGPVNPNNPGLSKDRAKPNGPVHSMDKNDKVKKSKIAKESVANQEKKRAELPKTGLESTQKGLIFSSIIGIAGLMLLARRRKN,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,sasG_1,Surface protein G,E270V,SAB mortality only,NA,NA,NA,NA
102,MKALLLKTSVWLVLLFSAMGLWQVSSAAEQHTPMKAHAVTTIDKATTDKQQVPPTKEAAHHYGEEAATNVSASAQGTADDTNNKVTSNAPSNKPSTAVSTTVNETRDVDTQQASTQKPTRTATFKLSNAKTASLSPRMFATNVPQTTTHKILHTNDIHGGLAEEKGRVIGMAKLKTVKEQEKPDLMLDAGDAFQGLPLSNQSKGEEMAKAMNAVGYDAMAVGNHEFDFGYDQLKKLEGMLDFPMLSTNVYKDGKRAFKPSTIVTKNGICYGIIGVTTPETKTKTRPEGIKGVEFRDPLQSVTAEMMRIYKDVDTFVVISHLGIDPSTQETWRGDYLVKQLSQNPQLKKRITVIDGHSHTVLQNGQIYNNDALAQTGTALANIGKITFNYRNGEVSNIKPSLINVKDVENVTPNKALAEQINQADQTFRAQTAEVIIPNNTIDFKGERDDVRTRETNLGNAIADAMEAYGVKNFSKKTDFAVTNGGGIRASIAKGKVTRYDLISVLPFGNTIAQIDVKGSDVWTAFEHSLGAPTTQKDGKTVLTANGGLLHISDSIRVYYDMNKPSGKRINAIQILNKETGKFENIDLKRVYHVTMNDFTASGGDGYSMFGGPREEGISLDQVLASYLKTANLAKYDTTEPQRMLLGKPAVSEQPAKGQQSSKGSESGKDAQPIGKDKVMDPAKQPAPSKVVLLPAHRGTVSSGREGSDRALEGTAVSSKSGKQLASMSAPKGSTHEKQLPKTGTDQSSSPAAMFVLVAGIGLIATVRRRKAS,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0025,NE295,NA,5'-nucleotidase family protein,NA,hypothetical protein,G160R,SAB mortality only,NA,NA,NA,NA
103,MDIGKKHVIPKSQYRRKRREFFHNEDREENLNQHQDKQNIDNTTSKKADKQIHKDSIDKHERFKNSLSSHLEQRNRDVNENKAEESKSNQDSKSAYNRDHYLTDDVSKKQNSLDSVDQDTEKSKYYEQNSEATLSTKSTDKVESTEMRKLSSDKNKVGHEEQHVLSKPSEHDKETRIDSESSRTDSDSSMQTEKIKKDSSDGNKSSNLKSEVISDKSNTVPKLSESDDEVNNQKPLTLPEEQKLQRQQSQNEQTKTYTYGDSEQNDKSNHENDLSHHIPSISDDKDNVMRENHIVDDNPDNDINTPSLSKTDDDRKLDEKIHVEDKHKQNADSSETVGYQSQSTASHRSTEKRNISINDHDKLNGQKTNTKTSANNNQKKATSKLNKGRATNNNYSDILKKFWMMYWPKLVILMGIIILIVILNAIFNNVNKNDRMNDNNDADAQKYTTTMKNANNTVKSVVTVENETSKDSSLPKDKASQDEVGSGVVYKKSGDTLYIVTNAHVVGDKENQKITFSNNKSVVGKVLGKDKWSDLAVVKATSSDSSVKEIAIGDSNNLVLGEPILVVGNPLGVDFKGTVTEGIISGLNRNVPIDFDKDNKYDMLMKAFQIDASVNPGNSGGAVVNREGKLIGVVAAKISMPNVENMSFAIPVNEVQKIVKDLETKGKIDYPDVGVKMKNIASLNSFERQAVKLPGKVKNGVVVDQVDNNGLADQSGLKKGDVITELDGKLLEDDLRFRQIIFSHKDDLKSITAKIYRDGKEKEINIKLK,2,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0923,NE881,htrA,serine protease,NA,Serine protease HtrA-like protein,H171Y|Y171H,SAB mortality and SAB persistence,NA,NA,NA,NA
104,MTLTVDLKKQPYEVFDLTESDCLHLKNKNFIFGKNGRGKSTLTKMIENEYREGYNIFVFDGFNNIVVNEQLNAIILGENNKSIQNKIDDIDGKLLEITKKEKEINLKLKSLDENTDFVSEDVNKHELLKNKIYQEKIYDNKKKEIQTFLKQKAKFLKELTNPRVSKTNYNRDDLQREISSAKKLETEEVKKCEKILKTEDKEELDNYELLDFNFEKLHNQVLGIINYELNEIVSFEELNKPNKKEFAEKGLSLHNPGDKCLFCGNIVENERYFKLEKYFKVDEINDLRSKVNILIGELDNVKNSIKSLQKNDEIYFEHLREDLSLVEEKYKSVLLEERNYIDNLIGGLKEKCRTPYSNDIAMPNLIESQYITYIKEHNKIIEKHNLFSKNIKYEQEQAEKRLRYHYISVIIEEKKQYNENWKGYIIENTILQENYKKLEKSLKDLQDEIKKLEGNDEQNETDNLKSIKNNINKLSIERSRLLESVQSTEKWVNIINDKLKKIGKTNLKLCLEKNEDNVEHYVIHDDTNGTREITKLSTGEKNIISFLYFMESLVDIRNDFKKNKIIIFDDPMNSNDDTMQYIIIQELLNLYRGKNSKKFNPSKDYFICLTHNVHFYLNIQPYGEQRKQVIKNGKKVEENKYTKMNFYRIENKRIMKISNVKEDLNTHYDSLWIELKEMYELKLINSMLNSMRRILETIIKFNGYDQNKFYENDLVALKLFNVNSHSIDDLTADMIGNDVEELLRIFREMFKNNNIEDHFNKRWN,0,0,0,1,0,0,0,1,0,0,0,2,NA,NA,NA,NA,NA,hypothetical protein,N639T|L204I,Cell death only,NA,NA,NA,NA
106,MIKPKYKWKLTKPAEYISDELTSKLKLTPIVKKILESKSIIDEQAIESIISDTDINHNALQLSDMTKTIERIKRAIANDEKILVYGDYDADGVTATTILVITLQLLGAQVGWHIPNRFTEGYGPNELAFRNAHDEGITLIITVDNGIQGHNEIKMVQDLGVDVIVTDHHEIGSTLPEAYAIVHPMHPSFNYPFQQLCGAGVAYKLAQALIENVPDYFKALVAIGTIADLVSLTDENRSLVKQGLKVLNDQCPTSVKALLKEAGYNDNIDEETIGFIIGPRLNAVGRLDDASLACELLMTDVEEEAAFLAEQVEHFNRERKDIVATITEEAMAMAETKVKKGDLFLLLAKENWHEGVLGIVASKIVETFALPTLILNIDREQNHAKGSARSIDQVSMFEILSAHQELIAKFGGHHMAAGMTMDIENIESLAEGLNKWMKELSKTTSLDPVKQVDVLLTENDITIKNIRDMNRLRPFGTDFSRPIFEMDDLSVSSVKAIGQQKNHLKLTLGESNIAALFWQNGHLEPELQDEQPINILGSVQINEWNGNQSPQIIIQDIAMNEQQILDYRSKRKSLPFTENDENIVVLIHPKSDKVNANEYYYGEEIKQQTDKVVLRDLPTSMEDLSNSLQQLQFSQLYIVLQHNHSIYFDGIPNMDIFKKCYKALITKQETNIQKEGMLLCQHLSVKPDTLKFMLKVFLDLKFVTQEDGLIRINQQPDKRSIDSSKVYQLRQQRMDVEKQLLYQDFSEIKNWIKSQLS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1592,NE11,recJ,single-stranded-DNA-specific exonuclease RecJ,NA,hypothetical protein,N58D,SAB mortality and SAB persistence,NA,NA,NA,NA
109,MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNTIETPQLNTTANDTSDISANTNSANVDSTAKPMSTQTSNTTTTEPASTNETPHPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANSIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVTEPVVNAADAKGTNVNGQVTASDFKLEKTTFDPNQSGNTFMAANFKVAGKVKSGDYFTAKLPDSVTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFNNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTDQFKDKISYKYDNVASINFGDINKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPEPEPKPDPEPSPDPEPEPTPDPEPTPDPEPSPDPEPSPDPDPEPRPDSDPESDSVSDSDSVSESDSESESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDPDPDSDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHKTDALPETGDKSENTNATLFGAMMALLGSLLLFRKRKQDHKEKA,2,2,0,0,2,2,0,0,2,3,0,0,NA,NA,NA,NA,NA,hypothetical protein,R601S|E613D,SAB mortality and SAB persistence,NA,NA,NA,NA
111,MAKQKIKIKKNKIGAVLLVGLFGLLFFILVLRISYIMITGHSNGQDLVMKANEKYLVKNAQQPERGKIYDRNGKVLAEDVERYKLVAVIDKKASANSKKPRHVVDKKETAKKLSTVINMKPEEIEKRLSQKKAFQIEFGRKGTNLTYQDKLKIEKMNLPGISLLPETERFYPNGNFASHLIGRAQKNPDTGELKGALGVEKIFDSYLSGSKGSLRYIHDIWGYIAPNTKKEKQPKRGDDVHLTIDSNIQVFVEEALDGMVERYQPKDLFAVVMDAKTGEILAYSQRPTFNPETGKDFGKKWANDLYQNTYEPGSTFKSYGLAAAIQEGAFDPDKKYKSGHRDIMGSRISDWNRVGWGEIPMSLGFTYSSNTLMMHLQDLVGADKMKSWYERFGFGKSTKGMFDGEAPGQIGWSNELQQKTSSFGQSTTVTPVQMLQAQSAFFNDGNMLKPWFVNSVENPVSKRQFYKGQKQIAGKPITKDTAEKVEKQLDLVVNSKKSHAANYRIDGYEVEGKTGTAQVAAPNGGGYVKGPNPYFVSFMGDAPKKNPKVIVYAGMSLAQKNDLEAYELGVSKAFKPIMENTLKYLNVGKSKDDTPNAEYSKVPDVEGQDKQKAIDNVSAKSLEPVTIGSGTQIKAQSIKAGNKVLPHSKVLLLTDGDLTMPDMSGWTKEDVIAFENLTNIKVNLKGSGFVSHQSISKGQKLTEKDKIDVEFSSENVDSNSTNNSDSNSDDKKKSDSKTDKDKSD,4,2,2,1,1,1,1,1,2,2,1,1,SAUSA300_1075,NA,NA,NA,pbpB,Penicillin-binding protein 2B,P595S|A109T,all,NA,NA,NA,NA
112,MTTIKTSNLGFPRLGRKREWKKAIESYWAKKISKEELDQTLTDLHKENLLLQKYYHLDSIPVGDFSLYDHILDTSLLFNIIPERFQGRTIDDDLLFDIARGNKDHVASALIKWFNTNYHYIVPEWDNVEPKVSRNVLLDRFKYAQSLNVNAHPVIVGPITFVKLSKGGHQTFEEKVKTLLPLYKEVFESLIDAGAEYIQVDEPILVTDDSKSYENITREAYDYFEKAGVAKKLVIQTYFERAHLKFLSSLPVGGIGLDFVHDNGYNLKQIEAGDFDKSKTLYAGIIDGRNVWASDIEAKKVLIDKLLAHTNELVIQPSSSLLHVPVSLDDETLDTSVGEGLSFATEKLDELDALRRLFNQNDSVKYDKLKARYERFQNQSFKNLDYDFESVRTSRQSPFAQRIEQQQKRLNLPDLPTTTIGSFPQSREVRKYRADWKNKRITDEAYETFLKNEIARWIKIQEDIGLDVLVHGEFERNDMVEFFGEKLQGFLVTKFGWVQSYGSRAVKPPIIYGDVKWTAPLTVDETVYAQSLTDKPVKGMLTGPVTILNWSFERVDLPRKVVQDQIALAINEEVLALEAAGIKVIQVDEPALREGLPLRSEYHEQYLKDAVLSFKLATSSVRDETQIHTHMCYSQFGQIIHAIHDLDADVISIETSRSHGDLIKDFEDINYDLGIGLGVYDIHSPRIPTKEEITTAINRSLQQIDRSLFWVNPDCGLKTRKEEEVKDALTVLVNAVKAKRQE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0357,NE944,metE,5-methyltetrahydropteroyltriglutamate-- homocysteine S-methyltransferase,metE,5-methyltetrahydropteroyltriglutamate-- homocysteine methyltransferase,K211E,SAB mortality and SAB persistence,NA,NA,NA,NA
113,MNGVYHIMNNEYPYSADEVLHKAKSYLSADEYEYVLKSYHIAYEAHKGQFRKNGLPYIMHPIQVAGILTEMRLDGLTIVAGFLHDVIEDTPYTFEDVKEMFNEEVARIVDGVTKLKKVKYRSKEEQQAENHRKLFIAIAKDVRVILVKLADRLHNMRTLKAMPREKQIRISRETLEIYAPLAHRLGINTIKWELEDTALRYIDNVQYFRIVNLMKKKRSEREAYIETAIDRIRTEMDRMNIEGDINGRPKHIYSIYRKMMKQKKQFDQIFDLLAIRVIVNSINDCYAILGLVHTLWKPMPGRFKDYIAMPKQNLYQSLHTTVVGPNGDPLEIQIRTFDMHEIAEHGVAAHWAYKEGKKVSEKDQTYQNKLNWLKELAEADHTSSDAQEFMETLKYDLQSDKVYAFTPASDVIELPYGAVPIDFAYAIHSEVGNKMIGAKVNGKIVPIDYILQTGDIVEIRTSKHSYGPSRDWLKIVKSSSAKGKIKSFFKKQDRSSNIEKGRMMVEAEIKEQGFRVEDILTEKNIQVVNEKYNFANEDDLFAAVGFGGVTSLQIVNKLTERQRILDKQRALNEAQEVTKSLPIKDNIITDSGVYVEGLENVLIKLSKCCNPIPGDDIVGYITKGHGIKVHRTDCPNIKNETERLINVEWVKSKDATQKYQVDLEVTAYDRNGLLNEVLQAVSSTAGNLIKVSGRSDIDKNAIINISVMVKNVNDVYRVVEKIKQLGDVYTVTRVWN,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1590,NE1714,-,GTP pyrophosphokinase,relA,GTP pyrophosphokinase,L76P,SAB mortality and SAB persistence,NA,NA,NA,NA
114,MLFVALSMIVGVLWNSSKVLSTFLFILLLYITYRKNKIVYAPISLFLIIFSAWYLHYSQQAIFNYINYIERNSQFNERAQVIQIQRQGSDTYKGRLSLKNEIYPFFLTDKKNFDLKKIESRNCIVKGQFKVNDNKFVTLKLQSIVVQSCLESNRSNLIEKHKQFIMNRIYDSGIKFPDRIMTLITGDVKEVNEQFKERVKEIGIYHLLAVSGSQIAAIVFLIYQPLKRLNLPLFVIKGITIIVLALFAQYTNYAPSAVRAIIMTTLVLVITKQIKIKSIQLLAFAFIIMFILNPLVVYDIGFQFSFIISFFIMLLFPFLQQLSKLQSLFIITFIAQLASFIVAIPSFHQLQWVGFLSNLIFVPYYSIILFPLSILFFITSHFIVGLTPLNYLVDLSFNFHDWLLDLFTRIKQSHFSVPKFNDWIFIVFIISVYYIFWLLAKRKYILVTFWTIIILTLLITFPTNSHHKITMLNVGQGDSILYEGGKNQNVLIDTGGKVIDDTKQPSYSISKYHILPTLNERGINELEYLILTHPHNDHIGEVEYIISHIKIKHIVIYNKGYSSNTLMLLSKLSHKYNIKLMDVRQVSSFKLGDSSFLFFSQVQTPV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1547,NE129,NA,DNA internalization-related competence proteinComEC/Rec2,NA,hypothetical protein,Q214H,SAB mortality and SAB persistence,NA,NA,NA,NA
115,MNALLNHMNTEQSEAVKTTEGPLLIMAGAGSGKTRVLTHRIAYLLDEKDVSPYNVLAITFTNKAAREMKERVQKLVGDQAEVIWISTFHSMCVRILRRDADRIGIERNFTIIDPTDQKSVIKDVLKNENIDSKKFEPRMFIGAISNLKNELKTPADAQKEATDYHSQMVATVYSGYQRQLSRNEALDFDDLIMTTINLFERVPEVLEYYQNKFQYIHVDEYQDTNKAQYTLVKLLASKFKNLCVVGDSDQSIYGWRGADIQNILSFEKDYPEANTIFLEQNYRSTKTILNAANEVIKNNSERKPKGLWTANTNGEKIHYYEAMTERDEAEFVIREIMKHQRNGKKYQDMAILYRTNAQSRVLEETFMKSNMPYTMVGGQKFYDRKEIKDLLSYLRIIANSNDDISLQRIINVPKRGVGPSSVEKVQNYALQNNISMFDALGEADFIGLSKKVTQECLNFYELIQSLIKEQEFLEIHEIVDEVLQKSGYREMLERENTLESRSRLENIDEFMSVPKDYEENTPLEEQSLINFLTDLSLVADIDEADTENGVTLMTMHSAKGLEFPIVFIMGMEESLFPHIRAIKSEDDHEMQEERRICYVAITRAEEVLYITHATSRMLFGRPQSNMPSRFLKEIPESLLENHSSGKRQTIQPKAKPFAKRGFSQRTTSTKKQVLSSDWNVGDKVMHKAWGEGMVSNVNEKNGSIELDIIFKSQGPKRLLAQFAPIEKKED,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1886,NA,NA,NA,pcrA,ATP-dependent DNA helicase PcrA,I85M,SAB persistence only,NA,NA,NA,NA
116,MAKSCLHILTNNEYATTRCQDGIVLFWPIDGEIELQKFRKSKIIEDDIYIINHLDVFSIKNNKKTIMLYLSSYWFAELGFTFFNYHYTAKLIKSSYNLKCLLLKLTYRYLDNQPLNDADIRKLQDIIKIIAKEASMDKKIAQNQYRYAYYGDLRDELEYIYQNVNQRLTLKSVADKLFVSKSNLSSQFHLLMGMGFKKYIDTLKIGKSIEILLTTDSTISNISEHLGFSSSSTYSKMFKSYMDITPNEYRNLSKYNKCLMLKPEPLVGKMVQEVKEIILNYIEHYKNHLTDVIHIDEDKFETPKLFQTVIQINTYTEMKLVFLEGIFKTLLNKNSQVVFFIMPSILKSKNTMSEEEKFTIIKTIIESDLKIAFNINNIESTYFVEEAFMSVFRQISPNELSNHNNYEVHFVFDLSLMEIRTIYRMILKLHNIMLNVKLGLNITCLFEKPSVFKSLVSQIKRLKFDSLIIDNANLSSPYLMGESDELLLKNILHFKNLKQVINELDIEQEKLIFLNVENHKLLNNKERDLSNSAPLIYKTLSALYHNFDGFGLNIFDNHQAFNAMHLYDKNGFKTTLGLILEKFIEYVSKPKYENSYYSIFDIENYYCLVIYDWRVIESETIMSNFEDSQVYINFKNNVLNDKYLIVIETLDENSGNINHLISKELRDKYEWNPSLLSKIDNYLKPAIEIKEHNFSDNSLNINVTFNALYIIKIGKK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0653,NE872,-,AraC family transcriptional regulator,rhaR,HTH-type transcriptional activator RhaR,S380T,SAB mortality and SAB persistence,+,0,-,0
118,MSKFIEPSVEEIKLEKVYQDMGLSDQEYEKVCDILGRQPNFTETGIFSVMWSEHCSYKHSKPFLKQFPTSGDHVLMGPGEGAGVVDIGDNQAVVFKVESHNHPSAIEPYQGAATGVGGIIRDIVSIGARPINLLNSLRFGELDNKQNQRLLKGVVKGIGGYGNCIGIPTTAGEIEFDERYDGNPLVNAMCVGVINHDMIQKGTAKGVGNSVIYVGLKTGRDGIHGATFASEELTEESESKRPSVQIGDPFVGKKLMEATLEAITFDELVGIQDMGAAGLTSSSSEMAAKGGSGLHLRLEQVPTREPGISPYEMMLSETQERMLLVVEKGTEQKFLDLFDKHELDSAVIGEVTDTNRFVLTYDDEVYADIPVEPLADEAPVYILEGEEKDYNTSKNDYTHIDVKDTFFKLLKHPTIASKHYLYDQYDQQVGANTIIKPGLQASVVRVEGTNKAIASTIDGEARYVYNNPYEGGKMVVAEAYRNLIAVGATPLAMTDCLNYGSPEKKEIYQQLIDSTKGMAEACDILKTPVVSGNVSLYNETKGTSIFPTPVVGMVGLIENVNYLNDFEPQVGDKLYLIGDTKDDFGGSQLEKLIYGKVNHEFESLDLSSEVEKGESIKTAIREGLLSHVQTVGKGGLLITLAKLSAHYGLGLKSSIDITNAQLFSETQGRYVVSVKSGKTLNIDNAIEIGLLTDSDNFKVTTPYTEISENVSDIKQIWEGAIAQCLTTQD,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_0971,NE1464,purL,phosphoribosylformylglycinamidine synthase II,purL,Phosphoribosylformylglycinamidine synthase subunit PurL,Q272R|A720fs,all,NA,NA,NA,NA
119,MTENKGSSQPKKNGNNGGKSNSKKNRNVKRTIIKIIGFMIIAFFVVLLLGILLFAYYAWKAPAFTEAKLQDPIPAKIYDKNGELVKTLDNGQRHEHVNLKDVPKSMKDAVLATEDNRFYEHGALDYKRLFGAIGKNLTGGFGSEGASTLTQQVVKDAFLSQHKSIGRKAQEAYLSYRLEQEYSKDDIFQVYLNKIYYSDGVTGIKAAAKYYFNKDLKDLNLAEEAYLAGLPQFPNNYNIYDHPKAAEDRKNTVLYLMHYHKRITDKQWEDAKKIDLKANLVNRTAEERQNIDTNQDSEYNSYVNFVKSELMNNKAFKDENLGNVLQSGIKIYTNMDKDVQKTLQNDVDNGSFYKNKDQQVGATILDSKTGGLVAISGGRDFKDVVNRNQATDPHPTGSSLKPFLAYGPAIENMKWATNHAIQDESSYQVDGSTFRNYDVKSHGTVSIYDALRQSFNIPALKAWQSVKQNAGNDAPKKFAAKLGLNYEGDIGPSEVLGGSASEFSPTQLASAFAAIANGGTYNNAHSIQKVVTRDGETIEYDHTSHKAMSDYTAYMLAEMLKGTFKPYGSAYGHGVSGVNMGAKTGTGTYGAETYSQYNLPDNAAKDVWINGFTPQYTMSVWMGFSKVKQYGENSFVGHSQQEYPQFLYENVMSKISSRDGEDFKRPSSVSGSIPSINVSGSQDNNTTNRSAHGGSDTSANSSGTAQSNNNTRSQQSRNSGGLTGIFN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1341,NA,NA,NA,ponA,Penicillin-binding protein 1A/1B,F233V,SAB mortality only,NA,NA,NA,NA
120,MNKINDRDLTELSSYWVYQNIDIKKEFKVNGKRFKQVDSYNDDKNSNLNGAADIKIYELLDDKSKPTGQQTIIYQGTSNEAINPNNPLKSSGFGDDWLQNAKLMNNDNESTDYLKQTDQLSNQYKIKLEDADRLSNSDFLKKYRMESSNFKNKTIVADGGNSEGGAGAKYQGAKHPNEKVVATDSAMIPYAAWQKFARPRFDNMISFNSTNDLLTWLQDPFIKDMPGKRVNINDGVPRLDTLIDSHVGYKRKLNRKDNTYDTVPLIKIKSVKDTEIKNGKKVKKTINITLDMDGRIPINVWTGDSIARSGRGTLIKLNLENLDALSKLITGETSGMLAECVIFLNESFNISENENKNFADRKKQLSEGFKDKINLFQLEEMERTLISKINSLEEVADETIESISAVKHLLPDFALDALKERINELFKGIKSFIEKVYDSIDNEILEIFKNIDHDFRDGVSEEMMKHLKVVKQNIDQIKNQNDIYGRQIADIRSIMKQQDATILDGNFQINCSGENMVQGLVIPSNYLGRKMKILKDHIDDGIKKIADYVQGIYDEYASKIVDVIKYLINTIPKIRKNLRHAIEMLNVKKKEFLSLIPNVTCNYIKTKLEELDNTLGKWEPFLNDLKAVSPILDNHLDDIVKNMKPLIVQMIFEPSHYDDMFILNTQAHARLDQMAQQFEVVCNGLNENEGQAIQTMDQSASLIRSNLIQVKEQLEKLAVY,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1380,NA,NA,NA,NA,hypothetical protein,Q364R,Growth rate and cell death,NA,NA,NA,NA
121,MNKINDRDLTELSGYWVYQDINTNKEIKVNGNRFMQVDS,0,0,0,1,0,0,0,1,0,0,0,2,NA,NA,NA,NA,NA,hypothetical protein,N32K|Ter40Yext*?,Cell death only,NA,NA,NA,NA
122,MLNNPTLVVVTDRNDLDNQLYSTFVKSKGRSGKGLLRQTPKQAETRKELKSLLSVESGGIVFTTMQKFEPEQNETTMSALTERKNVIVMADEAHRTQYGFNAKYDDKGEGIKYGYAKYLRDALPNATFVGFTGTPVASTDKNTQMVFGNYIDVYDMTQAVADGSTVKIYYESRIIPLNLPQNLDLDEAYNDITEDQEEDVKQRLKSKWSRIEALAGAKPRVEALAKDIIQHFETRQQAMKGKGMIVTMSRRIAVDLYDEIIRLKPEWHSDDDDKGVIKVVMTGSSSDPTSFQRHIGPKKRRNLLEKRMKDMNDELQLVIVRDMWLTGFDVPSMHTMYIDKPMKGHNLMQAIARVNRVFKDKPGGLIVDYVGIAESLKEALKEYTESDQAQTAIDTDKAVELMLLKYDVIQDMLYNLDYSKFNSEKKSERYYAISDTMDYVIGLGEDERQRFIKTVTELGKAFALCATEPTAQELNDEIAFFKAVKAGLVKLLQPPKEGKTRKTPAEVEAEINQLVSQSVVTEDVIDVYQTLGLEQPDLSILSDDFLKDVEGLKQKNVAVELLNRLLKGQVKSLMKTNATVSKRFSEMLGNSINKYNSRSIETSKVIEELIQLAKDIKQEQQRGNELGLNSDEIAFYDALASHETAKEAMGDKELRAIAHELTKTVKENMGVDWSKRDSAKAKMRVAVRRLLKKYGYPPDLQKMAVEQVVEQAELMASNQ,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0035,NE1824,-,hypothetical protein,NA,hypothetical protein,R262H|H262R,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
123,MKSLILAEKPSVARDIADALQINQKRNGYFENNQYIVTWALGHLVTNATPEQYDKNLKEWRLEDLPIIPKYMKTVVIGKTSKQFKTVKALILDNKVKDIIIATDAGREGELVARLILDKVGNKKPIRRLWISSVTKKAIQQGFKNLKDGRQYNDLYYAALARSEADWIVGINATRALTTKYDAQLSLGRVQTPTIQLVNTRQQEINQFKPQQYFTLSLTVKGFDFQLESNQRYTNKETLEQMVNNLKNVDGKIKSVATKHKKSYPQSLYNLTDLQQDMYRRYKIGPKETLNTLQSLYERHKVVTYPRTDSNYLTTDMVDTMKERIQATMATTYKDQARPLMSKTFSSKMSIFNNQKVSDHHAIIPTEVRPVMSDLSNRELKLYDMIVERFLEALMPPHEYDAITVTLEVAGHTFVLKENVTTVLGFKSIRQGESITEMQQPFSEGDEVKISKTNIREHETTPPEYFNEGSLLKAMENPQNFIQLKDKKYAQTLKQTGGIGTVATRADIIDKLFNMNAIESRDGKIKVTSKGKQILELAPEELTSPLLTAQWEEKLLLIERGKYQAKTFINEMKDFTKDVVNGIKNSDRKYKHDNLTTTECPKCGKFMIKVKTKNGQMLVCQDPSCKTKKNVQRKTNARCPNCKKKLTLFGKGKEAVYRCVCGHSETQAHMDQRMKSKSSGKVSRKEMKKYMNKNEGLDNNPFKDALKNLNL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2208,NE152,topB,DNA topoisomerase III,topB,DNA topoisomerase 3,K602T,SAB persistence only,NA,NA,NA,NA
127,MKTMEEKKYNHIELNNEVTKRREDGFFSLEKDQEALVAYLEEVKDKTIFFDTEIERLRYLVDNDFYFNVFDIYSEADLIEITDYAKSIPFNFASYMSASKFFKDYALKTNDKSQYLEDYNQHVAIVALYLANGNKAQAKQFISAMVEQRYQPATPTFLNAGRARRGELVSCFLLEVDDSLNSINFIDSTAKQLSKIGGGVAINLSKLRARGEAIKGIKGVAKGVLPIAKSLEGGFSYADQLGQRPGAGAVYLNIFHYDVEEFLDTKKVNADEDLRLSTISTGLIVPSKFFDLAKEGKDFYMFAPHTVKEEYGVTLDDIDLEKYYDDMVANPNVEKKKKNAREMLNLIAQTQLQSGYPYLMFKDNANRVHPNSNIGQIKMSNLCTEIFQLQETSIINDYGIEDEIKRDISCNLGSLNIVNVMESGKFRDSVHSGMDALTVVSDVANIQNAPGVRKANSELHSVGLGVMNLHGYLAKNKIGYESEEAKDFANIFFMMMNFYSIERSMEIAKERGIKYQDFEKSDYANGKYFEFYTTQEFEPQFEKVHELFDGMAIPTSEDWKKLQQDVEQYGLYHAYRLAIAPTQSISYVQNATSSVMPIVDQIERRTYGNAETFYPMPFLSPQTMWYYKSAFNTDQMKLIDLIATIQTHIDQGISTILYVNSEISTRELARLYVYAHYKGLKSLYYTRNKLLSVEECTSCSI,2,1,0,1,1,1,0,1,2,1,0,1,SAUSA300_0716,NA,NA,NA,nrdE_2|nrdE,Ribonucleoside-diphosphate reductase subunit alpha,H545R|N71D,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
128,MATNTTDIHIDDFNPKDRSQRAKVFVRFSNFNELFQFIFNEYYDINFEHLPKPVVFIDDIHDIEISQTNYNLLNRCFEKLFEKNIGLAIAIKSTQQFETMKQLILTFLQGNQDYKTSKKLVKFMLVFCSNSMTAEEIHLCHLKIKNKNKEIKYSVTVDGFLETYSTVEQVYDVMQRLKFHYYFIDIENSKTATHLITKNQHYHQTDTHFEQYKKFILDSGISSTQFVYNNLSVSGFKYTNDGKNPIQLSDIVYHLIALLRYGGGISYQLLDDHSNYISLYNKYGSPLPLMHLYKMFRPFVNEDIEITNNYVLSRKDNNYHFLLFNKINDRYMSDVKQDFIFHNELPQDSLMIIKTLNHEHGSIQHLLPISDQLVYIEKEILDELDKTNYPKTELAVQEETGRTFELKLNHDEVKYICFKPS,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2326,NE1304,-,transcription regulatory protein,NA,hypothetical protein,W281fs,Growth rate and cell death,-,5,+,0
131,MNGDNQQILREIVLNPTIHGKELESIFGLSRRQLGYRIQKINLWLEQEGYPKLERTSQGNFIVSSEIMTLFKRDVSEQQMLNGNNVIFNIETRRYYLMLMLFSKENAMSLNHFSIDLQVSKNTVIHDINHVKEQLEDHGLSLKYSRKHGYEIVGDEFEVRRFFIKLIDQRLNHDITKSEVLKALNLTFEDIAYQKDKIKQVEQFLKSRFIDKSLSSLPYVLCVIRRRIQSGHVINPLNINYQYLRDTKEYQATEIMTQHEPDLPEAEKLYLTLHLLSTSVQWTDLQESDNISNLTMAIDQMIHHFEQITFINIEDKEKLSQQLLLHLTPAFYRIKYNLTDRDELINPLQGNYQSLFHMVKQSCQSLTEYFGKSLPDNEIAYLTMLFGGSLRRQDENFDGKIKAIIVCTQGTSVSQMMLYELRNLFPEIIFLDAISLRTFENYTLDYDIVFSPMFVLTHKKLFITKVALSENEQRKLRKEVMKYINKESADIDKEINKLMALIERTTTVNDITELRDGLEDFIANYNSISTINGSIVTQNKTLDLADLIPARYVKRIHHVENIDEAIAKASDVLVANHFIDIKYIHEMQQAFDDSYMVIMQNIAIPHAYSEKHVHKTAMSMLILQEPIYMSDGTAIHIIVPIAAVDKVTHLRALLQLRDVAQNNDAIKRIIQSRKNSDVNEILKNYSNKEARENGWDSN,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0238,NE20,NA,"transcriptional antiterminator, BglG family",NA,hypothetical protein,Q415K,SAB mortality and growth rate,NA,NA,NA,NA
135,MKKRIDYLSNKQNKYSIRRFTVGTTSVIVGATILFGIGNHQAQASEQSNDTTQSSKNNASADSEKNNTIETPQLNTTANDTSDISANTNSANVDSTAKTMSTQTSNTTTTEPASTNETPQPTAIKDQATAAKMQDQTVPQEANSQVDNKTTNDANNIATNSELKNPQTLDLPQSSPQTISNAQGTSKPSVRTRAVRSLAVAEPVVNAADAKGTNVNDKVTASDFKLEKTAFDPNQSGNTFMAANFKVTGQVKSGDYFTAKLPDSVTGNGDVDYSNSNNTMPIADIKSTNGDVVAKATYDILTKTYTFVFTDYVNDKENINGQFSLPLFTDRAKAPKSGTYDANINIADEMFDNKITYNYSSPIAGIDKPNGANISSQIIGVDTASGQNTYKQTVFVNPKQRVLGNTWVYIKGYQDKIEESSGKVSATDTKLRIFEVNDTSKLSDSYYADPNDSNLKEVTGEFKDKISYKYDNVASINFGDINKTYVVLVEGHYDNTGKNLKTQVIQENIDPATGKDYSIFGWNNENVVRYGGGSADGDSAVNPVDPTPGPPVDPEPEPEPTPDPEPSPEPEPEPTPDPEPSPEPDPDSDSDSDSDSDSDSDSESESDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHQTDALPETGDKSENTNATLFDAMVALLGSLLLFRKRKQDHKEKA,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,clfB,Clumping factor B,D595G,SAB persistence only,NA,NA,NA,NA
137,MLRGQEERKYSIRKYSIGVVSVLAATMFVVTSHEAQASEKIPTTNAAAQKETLNQPGEQGNAITSHQMQSGKQLDDMHKENGKSGTVTEGKDMLQSSKHQSTQNSKIIRTQNDNQVKQDSERQGSKQSHQNNATNKTERQNDQIQNTHHAERNGSQSTTSQSNDVDKSQPSIPAQKVIPNHDKAAPTSTTPPSNDKTAPKSTKEQDATTDKHPNQQDTHQPAHQIIDAKQDDNVHQSNQKPQVGDLSKHIDGQNSPEKPTDKNTDNKQLIKDALQAPKTRSTTNAAADAKKVRPLKANQVQPLNKYPVVFVHGFLGLVGDNAPALYPNYWGGNKYKVIEELRKQGYNVHQASVSAFGSNYDRAVELYYYIKGGRVDYGAAHAAKYGHERYGKTYKGIMPNWEPGKKVHLVGHSMGGQTIRLMEEFLRNGNKEEIAYHKAHGGEISPLFTGGHNNMVASITTLATPHNGSQAADKFGNTEAVRKIMFALNRFMGNKYSNIDLGLTQWGFKQLPNESYIDYIKRVSKSKIWTSDDNAAYDLTLNGSAKLNNMTSMNPNITYTTYTGVSSHTGPLGYENPDLGTFFLMDTTSRIIGHDAREEWRKNDGVVPVISSLHPSNQPFVNVTNDEPATRRGIWQVKPIIQGWDHVDFIGVDFLDFKRKGAELANFYTGIINDLLRVEATESKGTQLKAS,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_0320,NE1775,-,triacylglycerol lipase,lip2,Lipase 2,H129Y,all,NA,NA,NA,NA
139,MAKVNLIESPYSLLQLKGIGPKKIEVLQQLNIHTVEDLVLYLPTRYEDNTVIDLNQAEDQSNVTIEGQVYTAPVVAFFGRNKSKLTVHLMVNNIAVKCIFFNQPYLKKKIELNQTITVKGKWNRVKQEITGNRVFFNSQGTQTQENADVQLEPVYRIKEGIKQKQIRDQIRQALNDVTIHEWLTDELREKYKLETLDFTLNTLHHPKSKEDLLRARRTYAFTELFLFELRMQWLNRLEKSSDEAIEIDYDIDQVKSFIDRLPFELTEAQKSSVNEIFRDLKAPIRMHRLLQGDVGSGKTVVAAICMYALKTAGYQSALMAPTEILAEQHAESLMALFGDSMNVALLTGSVKGKKRKILLEQLENGTIDCLIGTHALIQDDVIFHNVGLVITDEQHRFGVNQRQLLREKGAMTNVLFMTATPIPRTLAISVFGEMDVSSIKQLPKGRKPIITTWAKHEQYDKVLMQMTSELKKGRQAYVICPLIESSEHLEDVQNVVALYESLQQYYGVSRVGLLHGKLSADEKDEVMQKFSNHEINVLVSTTVVEVGVNVPNATFMMIYDADRFGLSTLHQLRGRVGRSDQQSYCVLIASPKTETGIERMTIMTQTTDGFELSERDLEMRGPGDFFGVKQSGLPDFLVANLVEDYRMLEVARDEAAELIQSGVFFENTYQHLRHFVEENLLHRSFD,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1120,NE1344,recG,ATP-dependent DNA helicase RecG,recG,ATP-dependent DNA helicase RecG,A320V,SAB mortality and SAB persistence,NA,NA,NA,NA
140,MKFKSLITTTLALGVLASTGANFNNNEASAAAKPLDKSSSSLHHGYSKVHVPYAITVNGTSQNILSSLTFNKNQNISYKDLEDRVKSVLKSDRGISDIDLRLSKQAKYTVYFKNGTKKVIDLKAGIYTADLINTSEIKAININVDTKKQVEDKKKDKANYQVPYTITVNGTSQNILSSLTFNKNQNISYKDLEDKVKSVLESNRGITDVDLRLSKQAKYTVNFKNGTKKVIDLKSGIYTANLINSSDIKSININVDTKKHIENKAKRNYQVPYSINLNGTSTNILSNLSFSNKPWTNYKNLTSQIKSVLKHDRGISEQDLKYAKKAYYTVYFKNGGKRILQLNSKNYTANLVHAKDVKRIEITVKTGTKAKADRYVPYTIAVNGTSTPILSDLKFTGDPRVGYKDISKKVKSVLKHDRGIGERELKYAKKATYTVHFKNGTKKVININSNISQLNLLYVQDIKKIDIDVKTGTKAKADSYVPYTIAVNGTSTPILSKLKISNKQLISYKYLNDKVKSVLKSERGISDLDLKFAKQAKYTVYFKNGKKQVVNLKSDIFTPNLFSAKDIKKIDIDVKQYTKSKKNK,4,3,2,1,1,1,1,1,6,5,1,1,NA,NA,NA,NA,NA,65 kDa membrane protein|Protein map,N583fs|N67S|I583fs|I462fs|I527fs|I242fs|I176L,all,NA,NA,NA,NA
141,MRKKLFGQLQRIGKALMLPVAILPAAGLLLAIGTAMQGEALQHYLPFIQNGGVQTVAKLMTGAGGIIFDNLPMIFALGVAIGLAGGDGVAAIAAFVGYIIMNKTMGDFLQVTPKNIGDPASGYASILGIPTLQTGVFGGIIIGALAAWCYNKFYNINLPSYLGFFAGKRFVPIMMATTSFILAFPMALIWPTIQTGLNAFSTGLLDSNTGVAVFLFGFIKRLLIPFGLHHIFHAPFWFEFGSWKNAAGEIIHGDQRIFIEQIREGAHLTAGKFMQGEFPVMMFGLPAAALAIYHTAKPENKKVVAGLMGSAALTSFLTGITEPLEFSFLFVAPLLFFIHAVLDGLSFLTLYLLDLQLGYTFSGGFIDYFLLGILPNKTQWWLVIPVGLVYAVIYYFVFRFLIVKLKYKTPGREDKQSQAATASATELPYAVLEAMGGKANIKHLDACITRLRVEVNDKSKVDVPGLKDLGASGVLEVGNNMQAIFGPKSDQIKHEMQQIMNGQVVENPTTMEDDKDETVVVAEDKSATSELSHIVHAPLTGEVTPLSEAPDQVFSEKMMGDGIAIKPSQGEVRAPFNGKVQMIFPTKHAIGLVSDSGLELLIHIGLDTVKLNGEGFTLHVEEGQEVKQGDLLINFDLDYIRNHAKSDITPIIVTQGNITNLDFKQGEHGNISFGDQLFEAK,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_0191,NE172,ptsG,"PTS system, glucose-specific IIBC component domain protein",ptsG_1,PTS system glucose-specific EIICBA component,Q356H,all,-,3,-,1
144,MTQKQKKFLHYSWITLLCVGVILLLLGTLGNAVQATGLVDETIDTSNEYSKYGLNQYQLDYYVDNSWGWLPWNWSDGIGQSVMYGLYAITNFIWTISLYLSNATGYLVKEAYALDFISQTSQAIGENMQTIAGITPNGFSSSGFYVGFLLLFILIVGIYVAYTGLVKRETTKVIRAVLNFVVVFILSASFIAYAPDYIAKINDFSKDVSTASLNIGTKIVLPNTDSQGKDSVDMIRDSLFSVQVKQPWLLLQYGSTDVEALGEERVESLLSTSPDTNNGEDRENVVIEEIEDHDNTYLTLPKTISRLGTVFFLFVFNIGISIFVFLLTGIMIFSQVLFIIFAMFLPISFLLSMLPSFDGMGRHAITKLFNVIMTRAGITLIITVAFSISTMLYSLSASSPFFMIMFLQIVTFAGIYFKLGDLMSLFSLQSNDSQNMGRQVFRRPRQMMNRQTRRFQRSMSKIFRGKAGSTKQKTMTTKQNQTNKANHTRQNERTTPKKETALSNVKKQQGGIGQRLGEKTAHVLDTKNRLVNKRKQAKQQIQATPTHVKYALHQGKENVTHNVTDFKQSMADTKAQRKQQRMNQQEQKRKNIAQKRLELDKAKEKRRKENPSSPVQNNQQHVRKRQQTVTPVLSQNTKRENHQRPLKKEQKQKTPPKQFNQRKLNKRTDKRGQQT,1,1,1,1,1,1,1,1,1,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,S430N,all,NA,NA,NA,NA
147,MGKIKELQTSLANKIAAGEVVERPSSVVKELLENAIDAGATEISIEVEESGVQSIRVVDNGSGIEAEDLGLVFHRHATSKLDQDEDLFHIRTLGFRGEALASISSVAKVTLKTCTDNANGNEIYVENGEILNHKPAKAKKGTDILVESLFYNTPARLKYIKSLYTELGKITDIVNRMAMSHPDIRIALISDGKTMLSTNGSGRTNEVMAEIYGMKVARDLVHISGDTSDYHIEGFVAKPEHSRSNKHYISIFINGRYIKNFMLNKAILEGYHTLLTIGRFPICYINIEMDPILVDVNVHPTKLEVRLSKEEQLYQLIVSKIQEAFKDRILIPKNNLDYVPKKNKVLHSFEQQKIEFEQRQNTENNQEKTFSSEESNSKPFMEENQNDEIVIKEDSYNPFVTKTSESLIADDESSGYNNTREKDEDYFKKQQEILQEMDQTFDSNDDTTVQNYENKASDDYYDVNDIKGTKSKDPKRRIPYMEIVGQVHGTYIIAQNEFGMYMIDQHAAQERIKYEYFRDKIGEVTNEVQDLLIPLTFHFSKDEQLVIDQYKNELQQVGIMLEHFGGHDYIVSSYPVWFPKDEVEEIIKDMIELILEEKKVDIKKLREDVAIMMSCKKSIKANHYLQKHEMSDLIDQLREAEDPFTCPHGRPIIINFSKYELEKLFKRVM,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1189,NE80,mutL,DNA mismatch repair protein mutL,mutL,DNA mismatch repair protein MutL,G270A,SAB mortality only,NA,NA,NA,NA
148,MTTHGKTVAVPAIPKLFDYIHKRYAKLSLEDLINPAIELAIEGHAANWATEKYSRQQHARLTKYYETAQVFTHENQYWREGDWIVQAELGKTFQILREQGFNAFYKGDIAKQLVNVVKACGGTITLEDLAKYDIQIKAPISATFKDYDIYSMGPSSSGGITVIQILKLLEHVDLPSMGPRSVDYLHHLIQAMHLAYSDRAQYLADDNFHEVPVQSLIDDDYLKARSTLIDSNKANIDIEHGVVSDCISHTDVEENHTETTHFCVIDKEGNIASFTTSIGMIYGSGITIPGYGVLLNTTMDGFDVVDGGINEIAPYKRPLSNMAPTIVMHHGKPILTVGAPGAISIIASVAQTLINVLVFGMDIQQAIDEPRIYSSHPNRIEWEPQFSQSTILALIARGHAMEHKPEAYIGDVHGLQVDLNTRDASGGADDTREGTVIGGDVLSIRKQPLPSPKIYDNDTHRVYFNDMQLPLYAEQVRWMHDKYWVDESVIRIIFPEVSVHIEDLRSYEIAGKNYIDIAWLARKKGYQVTLKDDSLYLTDETYHSVKANTNAYYRYDRDSITR,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0204,NE254,ggt,gamma-glutamyltranspeptidase,NA,hypothetical protein,A87P,SAB persistence only,NA,NA,NA,NA
149,MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE,1,2,2,1,1,1,1,1,2,1,1,1,SAUSA300_0032,NE1868,mecA,penicillin-binding protein 2',mecA_1|mecA_2,PBP2a family beta-lactam-resistant peptidoglycan transpeptidase MecA,K239E|I11L|E239K,all,NA,NA,NA,NA
150,MKLRLLWHIVRRQFITQRLVIIPFILAVSVLFMIEYTLVSIGLNSYIKQKNDFLVPFIIIANFFMALLTFIFIFYANHFMMSQRRKEFSIFMTLGMTKKSMRLIVVMETILQFMIISVISIAGGYLLGAIFFLFIQKIMGSEVATLRYYPFDTVAMFITLIIIAVLMGMLLIFNLFSINFQRPITYQHRSDSSVISRWLRYVLIVIGSAALYLGYFIALQQDTTFGAFFKIWIVIGLVIIGTYAFFVGISEIIISILQQVSKVYYHPRYFLW,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2556,NE1105,-,ABC transporter protein,NA,hypothetical protein,L271fs,SAB mortality and SAB persistence,NA,NA,NA,NA
151,MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEIDVTINKDGSISIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGASVVNALSEWLEVEIHRDGNIYHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKASTSFNFDVLSERLQESAFLLKNLKITLNDLRSGKERQEHYHYEEGIKEFVSYVNEGKEVLHDVATFSGEANGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKIAMTRVFNDYARRINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQTKSKLGTSEARSAVDSVVADKLPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQSKNTEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTIGAGVGTDFKIEDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLYKLEKGKGKTKRVEYAWTDEELNKLQKELGKGFTLQRYKGLGEMNSEQLWETTMNPETRTLIRVQVEDEVRSSKRVTTLMGDKVQPRREWIEKHVEFGMQEDQSILDNSEVQVLENDQFDEEEI,2,2,0,0,2,1,0,0,2,2,0,0,SAUSA300_1250,NA,NA,NA,parE,DNA topoisomerase 4 subunit B,S585P|S451P,SAB mortality and SAB persistence,NA,NA,NA,NA
152,MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESRGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTIAVPLKKRRSSKAY,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1113,NE217,pknB,protein kinase,prkC_1,Serine/threonine-protein kinase PrkC,R296fs,SAB mortality only,NA,NA,NA,NA
153,MKKQIISLGALAVASSLFTWDNKADAIVTKDYSKESRVNENSKYDTPIPDWYLGSILNRLGDQIYYAKELTNKYEYGEKEYKQAIDKLMTRVLGEDHYLLEKKKAQYEAYKKWFEKHKSENPHSSLKKIKFDDFDLYRLTKKEYNELHQSLKEAVDEFNSEVKNIQSKQKDLLPYDEATENRVTNGIYDFVCEIDTLYAAYFNHSQYGHNAKELRAKLDIILGDAKDPVRITNERIRKEMMDDLNSIIDDFFMDTNMNRPLNITKFNPNIHDYTNKPENRDNFDKLVKETREAVANADESWKTRTVKNYGESETKSPVVKEEKKVEEPQLPKVGNQQEDKITVGTTEEAPLPIAQPLVKIPQGTIQGEIVKGPEYLTMENKTLQGEIVQGPDFPTMEQNRPSLSDNYTQPTTPNPILKGIEGNSTKLEIKPQGTESTLKGTQGESSDIEVKPQATETTEASHYPARPQFNKTPKYVKYRDAGTGIREYNDGTFGYEARPRFNKPSETNAYNVTTNQDGTVSYGARPTQNKPSETNAYNVTTHANGQVSYGARPTYKKPSETNAYNVTTNQDGTVSYGARPTQNKPRQTNA,0,1,0,1,0,1,0,1,0,1,0,1,NA,NA,NA,NA,NA,Staphylocoagulase,Ter591Yext*?,SAB persistence and cell death,NA,NA,NA,NA
154,MFNEKDQLAVDTLRALSIDTIEKANSGHPGLPMGAAPMAYTLWTRHLNFNPQSKDYFNRDRFVLSAGHGSALLYSLLHVSGSLELEELKQFRQWGSKTPGHPEYRHTDGVEVTTGPLGQGFAMSVGLALAEDHLAGKFNKEGYNVVDHYTYVLASDGDLMEGISHEAASFAGHNKLSKLVVLYDSNDISLDGELNKAFSENTKARFEAYGWNYLLVKDGNDLEEIDKAITTAKSQEGPTIIEVKTTIGFGSPNKAGTNGVHGAPLGEVERKLTFENYGLDPEKRFNVSEEVYEIFQNTMLKRANEDESQWNSLLEKYAETYPELAEEFKLAISGKLPKNYKDELPRFELGHNGASRADSGTVIQAISKTVPSFFGGSADLAGSNKSNVNDATDYSSETPEGKNVWFGVREFAMGAAVNGMAAHGGLHPYGATFFVFSDYLKPALRLSSIMGLNATFIFTHDSIAVGEDGPTHEPIEQLAGLRAIPNMNVIRPADGNETRVAWEVALESESTPTSLVLTRQNLPVLDVPEDVVEEGVRKGAYTVYGSEETPEFLLLASGSEVSLAVEAAKDLEKQGKSVRVVSMPNWNAFEQQSEEYKESVIPSSVTKRVAIEMASPLGWHKYVGTAGKVIAIDGFGASAPGDLVVEKYGFTKENILNQVMSL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1239,NA,NA,NA,tkt,Transketolase,F295S,SAB persistence only,NA,NA,NA,NA
159,MKWFKLILDVTIFILIAILLFVYTYKENEEILPDTKYPIAVTDWNKKYSKNEIYKRIDQFAKNENVAIYKSTSNYTNKNVDKDIYVFNKSKAATITPFNAKYNIHYLSDDEVLKKISKGVIL,2,2,0,0,1,1,0,0,4,4,0,0,SAUSA300_0934,NE345,NA,"membrane protein""",NA,hypothetical protein,I116fs|I233L|N223I|C231W,SAB mortality and SAB persistence,NA,NA,NA,NA
160,MRVTELLTKDTIAMDLMANDKNGVIDELVNQLDKAGKLSDVASFKEAIHNRESQSTTGIGEGIAIPHAKVAAVKSPAIAFGKSKAGVDYQSLDMQPAHLFFMIAAPEGGAQTHLDALAKLSGILMDENVREKLLHASSPGEVLAIIDEADDEVTKEEEAEAEAQQVATAEQSSKQSNEPYVLAVTACPTGIAHTYMARDALKKQADKMGIKIKVETNGSSGIKNHLTEQDIENATGIIVAADVHVETDRFDGKNVVEVPVADGIKRPEELINKALDTSRKPFVARDGQRKGNSNDSQEKLSPGKAFYKHLMNGVSNMLPLVISGGILMAIVFLFGANSFNPKSSEYNAFAEQLWNIGSKSAFALIIPILSGFIARSIADKPGFASGLVGGMLAISGGSGFIGGIIAGFLAGYLTQGVKAMTRKLPQALEGLKPTLIYPLLTVTATGLLMIYAFNPPASWLNHLLLDGLNNLSGSNIVLLGLVIGAMMAIDMGGPFNKAAYVFATGALIEGNAAPITAAMIGGMIPPLAIATAMLIFRRKFTKEQRGSIIPNYVMGMSFITEGAIPFAAADPLRVIPSMMIGSGIGGAIALGLGSRITAPHGGIIVIVGTDGAHLLQTLIALLVGTLVSALIYGLIKPKLTETEIEASKSMDE,1,2,0,0,1,1,0,0,1,2,0,0,SAUSA300_0685,NE768,fruA,fructose specific permease,fruA,PTS system fructose-specific EIIABC component,G140E,SAB mortality and SAB persistence,NA,NA,NA,NA
161,MLSYRQIEILYLLIHEQTFIPINTIANQLGVSPRTIQYDIAYIEQYAETYHYQVSRNKAAGIKVTTAHATLLNELEHNLTNQIHFSKDERLTHIALKLFETTDPVSTKQLAQDVNVSRRTIADDIKMIQAQLDQYHLKLNYVHNKGFNIIGEEDHYRKAYAHFIHQYMKQAAPFIEADIFNLESIALVRRAIIKTLNSENYHLVQSAIDGLIYHILIAIQRLNENFSFDIPINEIDKWRHTNQYAIASKMIENLERSCNVTFPESEIIFITLHLLGSKMTEHTASSITFEYHDLSQNIHELITCVSQELGIDMSKDNKLHTSLITHIKPAIHRIKYDMLQPNPLRQEVMRRYPQIIEAVSKHISPIEQDAAIRFNEDELTYITIHFASSIERVATHKQSMIKVVLLCGSGIGTSQLLKSKLNHLYPEFHIWDAYSIYQLEESRLLQDNIDYVISTVPCEISAVPVIHVDPFINQQSRQKLNQIINDSREQRVMKMATDGKSLADLLPEHRIIINKQPLSIESAIAVAVQPLINDGIVYSNYTAAILKQFEQFGSYMVISPHIALIHAGTDYVQNGVGFALTYFTEGIIFGSKANDPVHLVITLATDHPNAHLKALGQLSECLSNDLYRQDFLDGNIFKIKQHIALTMTKEA,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_0333,NE695,NA,"transcriptional antiterminator, BglG family",NA,hypothetical protein,L182S,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
163,MTKLKRLATKEDEIVDVKIPISNEELKDRAKQYDLLTPKRFATRYNKMLFLPTSFKWNGSEYPIQYNYCINPFCCNFGKEQHKFKDVKGKPSRYKMTGSSKDKGHKGMYCNDNPIGRGVSQNCTVTPLSNWSVVEEIKRLIEINSIQDVEPDYQFHKEGCSEEESTPFNEPKQFYKRGKSRGKSQRYQCKACKKFTNVLPKREETTTYHQQKNTILPMFAKMVVGRVSVSRTCDILGIGVGTYYHKLEWLYRRCLEFLERYETQPLQTKKFNEMWLNTDKMHYYLNNVRKKGQGSKKYTGFEDLNMQTYIVVSAEVLSRYVFRSDVAYDWNISMDELNEDTRKFKEDHLNTFSRKNDRLDWSYYPQEPSANDSENRNAYLHELGKITNRSRFVDGLNVDAPYTTTAHYWLIKQMVNADEWRMISDDDFSIRNAFYRVFTKELRLSDAHHFICQVNKTKSRKQCLKEFGQAKAELLDWGDIRGFKTKFLRTLASHYLTELLTSHQFHEEAISKDGERYRKYADNPIKHPLATKDKGFYSVDCRTDLSALEPNEIAKMLLNVNDHSTNSFIQQIRRYISSLERPLTTARGDKKSYIYANFNPKYAQFAITILRTYYNFCRPFKSADKKVLTPAQRLGITDKQFDWKDIIYFK,0,0,1,1,0,0,1,1,0,0,1,1,NA,NA,NA,NA,NA,hypothetical protein,R177K,Growth rate and cell death,NA,NA,NA,NA
168,MKKFKLFLDFSTLLLISGLLFLFFFKENEEIIPESSNILTISNWDKSNSKSKVLDVIESGAKNQNIQIIKSVKDFDNKKVFFVFNSKRNNSDFIRNKTSLLTPSDLLNREIKGKYYIIGEHFNVEELTSELKKAGLTSEVEYINRNILFFELVIDNDLLVPFIFLGVLYLLYFLYDRGYNLKFYAIQKLHGFSTTRIIFHNIHIKIIYWLVLTTIFFIANILIIHIANLELDFLMFIRRFIVLLFVFACITTLLWLISYSLLLKLSIPLTLKGKKGYKFSIFMGTFTKCIMVLILSFLLAQNLNAYTKLKNIYDSEKIWQKLDNYYTLEISPNIRNSEEKQILETNIYNLIKKSEQLGGLLLKNNNIANPDKNNYIPENGNVFFINNNFLNFYKNINHDFKMIVNHSDKINVFIPPRLQYQKSEIQKNHQGWIDFQKQQNKKVDVQVLSKNVSVFSFDRTTNLKFGYLDSPIVMLLTPDDLTGDFYLAAVSQGGYLFKDLDTLKQLLKDNHLEEEISGITNYKDSVLNELNETKTKMIITIVTIIINVFILLIATVFETIQYFSWNKKQLLLRKIHGYSLFSSNVRYLTISILLSIMLAYTTHILFGSKILLFIIMSIAIIQHLLQIAYIKYLEKYFKDLMREI,0,1,1,1,0,1,1,1,0,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,V80E,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
169,MVTALSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEALAGYANQIEVVIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVSGGLHGVGSSVVNALSQDLEVYVHRNETIYHQAYKKGVPQFDLKEVGTTDKTGTVIRFKADGEIFTETTVYNYEILQQRIRELAFLNKGIQITLRDERDEENVREDSYHYEGGIKSYVELLNENKEPIHDEPIYIHQSKDDIEVEIAIQYNSGYATNLLTYANNIHTYEGGTHEDGFKRALTRVLNSYGLSSKIMKEEKDRLSGEDTREGMTAIISIKHGDPQFEGQTKTKLGNSEVRQVVDKLFSEHFERFLYENPQVARTVVEKGIMAARARVAAKKAREVTRRKSALDVASLPGKLADCSSKSPEECEIFLVEGDSAGGSTKSGRDSRTQAILPLRGKILNVEKARLDRILNNNEIRQMITAFGTGIGGDFDLAKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIAQPPLYKLTQGKQKYYVYNDRELDKLKSELNPTPKWSIARYKGLGEMNADQLWETTMNPEHRALLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0005,NA,NA,NA,gyrB,DNA gyrase subunit B,I194T,SAB mortality and SAB persistence,NA,NA,NA,NA
170,MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTDQSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNKDEEAVAAKNPESEEYKVNEKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAIGAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGMFIIGIIAILIGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIETMFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQNLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNMDTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAILVTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGINDAFIVATIFSIIALILCLFLQSNKKQKLQLKS,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2298,NE781,-,"multidrug resistance protein B, drug resistance transporter",mdtD,Putative multidrug resistance protein MdtD,Q627fs,SAB mortality only,-,2,-,0
171,MILLQLNHISKSFDGEDIFTDVDFEVKTGERIGIVGRNGAGKSTLMKIIAGVENYDSGNVSKIKNLKLGYLTQQMTLNSNATVFEEMSKPFEHIKRMESLIKEETDWLSKHANDYDSDTYKTHMSRYESLSNQFEQLEGYQYESKIKTVLYGLNFSEEDFNKPINDFSGGQKTRLSLAQMLLNEPDLLLLDEPTNHLDLETTKWLEDYLRYFKGAIVIISHDRYFLDKIVTQIYDVALGDVKRYVGDYEEFIQQRDLYYQKRMQEYESQQAEIKRLETFVEKNITRASTSGMAKSRRKILEKMERIDKPMLDAKSANIQFGFDRNTGNDVMHVKNLEIGYQTAITKPMSIEVSKGDHIAIIGPNGIGKSTLIKTIANQQKALNGDITFGANLQIGYYDQKQAEFKSSKTILDYVWDQYPLMNEKDIRAVLGRFLFVQDDVKKIINDLSGGEKARLLLALLMLQRDNVLILDEPTNHLDIDSKEMLEQALQHFEGTILFVSHDRYFINQLANKVFDLTIDGGKMYLGDYQYYIEKVEEAEALKAHQEEQSVNVQAHKKSMEQSSYHNQKEQRREQRKLERQISECENEIETLETTILQIDEQLTQPEVYNNPQKANELAIQKQDSEQKLEHAMSKWEELQQKL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2000,NE790,vga,ABC transporter ATP-binding protein,yheS,putative ABC transporter ATP-binding protein YheS,D247N,SAB mortality and SAB persistence,NA,NA,NA,NA
174,MGLPNPKNRKPTASEVVEWALYIAKNKIAIDVPGSGMGAQCWDLPNYLLDKYWGFRTWGNADAMAQKSNYRGRDFKIIRNTKDFVPQPGDWGVWTGGWAGHVNIVVGPCTKDYWYGVDQNWYTNNATGSPPYKIKHSYHDGPGGGVKYFVRPPYHPEKSTPAPKPEDDSDNNEKNNKKVPIWKDVTTIKYTISSQEVNYPEYIYHFIVEGNRRLEKPKGIMIRNAQTMSSVENLYNSRKKYKQDVEYPHFYVDRHNIWAPRRAVFEVPNEPDYIVIDVCEDYSASKNEFIFNEIHAMVVAVDMMIKYEIPLSIENLKVDDSIWRSMLEHVNWNMIDNGVPPKDKYEALEKALFNIFKNREKLLNSITKPTVTKSRIKVMVDNKNADIANVRDSSPTANNGSASKQPQIITETSPYTFKQALDKQMARGNPKKSNAWGWANATRAQTSSAMNVKRIWESNTQCYQMLNLGKYQGVSVSALNKILKGKGTLNNQGKAFAEACKKHSINEIYLIAHAFLESGYGTSNFANGKDGVYNYFGIGAYDNNPNYAMTFAKNKGWTSPAKAIMGGASFVRKDYINKGQNTLYRIRWNPKNPATHQYATAIEWCQHQASTIAKLYKQIGLKGIYFTRDKYK,1,1,0,1,1,1,0,1,8,7,0,8,NA,NA,NA,NA,NA,hypothetical protein,NPN544DPD|Y541F|NGKDGV527SGRYGA|V474I|NA434HT|A426S|K423R|N8T,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
175,MAYGLITSLHSMTGRKIVAQHEYNYRLLDEGMSKLEKMFIYHQKEEIYAHSAKQIKYLNDSVEDYLTYLNGRFSNMILGHNGDGINEVKDARIDNTGYGHKTLQDRLYHDYSTLDAFTKKVEKAVDEHYKEYRATEYRFEPKEQEPEFITDLSPYTNAVMQSFWIDPRTKIIYMTQARPGNHYMLSRLKPNGQFIDRLLVKNGGHGTHNAYRYIDGELWIYSAVLDSNKNNKFVRFQYRTGEITYGNEMQDVMPNIFNDRYTSAIYNPIENLMIFRREYKASERQAKNSLNFIEVRSADDIDKGIDKVLYQMDIPMEYTSDTQPMQGITYDAGILYWYTGDSNTANPNYLQGFDIKTKELLFKRRIDIGGVNNNFKGDFQEAEGLDMYYDLETGRKALLIGVTIGPGNNRHHSIYSIGQRGVNQFLKNIAPQVSMTDSGGRVKPLPIQNPAYLSDITEVGHYYIYTQDTQNALDFPLPKAFRDAGWFFDVLPGHYNGALRQVLTRNSTGRNMLKFERVIDIFNKKNNGAWNFCPQNAGYWEHIPKNITKLSDLKIVGLDFYITTEESKRFTDFPKDFKGIAGWILEVKSNTPGNTTQVLRRNNFPSAHQFLVRNFGTGGVGKWSLFEGKVVE,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,R72C,SAB mortality and SAB persistence,NA,NA,NA,NA
176,MDKLGEIYRFHAHAFRHSVGTRMINNGVPQHIVQKFLGHESPEMTSRYAHIFDETLKNEFTKFQEKLVTNNGDVLNLDDDSEVDDVELQWFKKNINAQVLPNGYCRLPVIAGGCPHANACLDCTHFCTSKQFLPQHEEQLERTEELLTIAKDKQWQRQIETNSRVKERLEQIIGSLTG,0,1,0,0,0,1,0,0,0,3,0,0,NA,NA,NA,NA,xerC_5|xerC_1|xerC_4|xerC_3|xerC_2|xerC_8,Tyrosine recombinase XerC,I110V|I562V|T600A,SAB persistence only,NA,NA,NA,NA
178,MSDRFIKFNDEQLDAKQVMMLQDLARLLLKNEQTQVKIQKFPYYNPVQNVLITSWFWSHRPSHIEMAGLKTDVMLAAYGYHMMDVQIVNEVVQDKTFKHPKFYQQLFKLLEDMRVLNSIKVERPSTAKLIDLRLDTRVSYTESQIKVYRTKTQYTDLLFLYLEHAFLSQDFFDIPSIHSDLDDILVNMFLYLPNFFQNQNSEDNMYLAQRIMYQVDDILKEDMLNEYYYLPKTLYNTLASPEFDDLKRTDASQVYGQDDTSEDDDNESEKADSKSADSESKGGAYLEMELHEGQNSETLGNDEAREGDATDDMTDMMTKKGKGSNDTLNREEGDAVGQSQAFQLDGVNKNVEIKWQIPEIEPQYVLEYQESKQDVQYEIKDLIQIIKKTIEREQRDARFNLTKGRLQKDLINWFIDDQYKLFYKKQDLSKSFDATFTLLIDASASMHDKMAETKKGVVLFHETLKALNIKHEILSFSEDAFDSDEHAQPNIINEIINYDYSTFEKDGPRIMALEPQDDNRDGVAIRVASERLMRRNQHQRFLIVFSDGEPSAFNYSQDGIIDTYEAVEMSRKFGIEVFNVFLSQDPITEDVEQTIHNIYGQYAIFVEGVAHLAGLLSPLLLILLVKCF,0,2,0,0,0,2,0,0,0,3,0,0,SAUSA300_1301,NE143,NA,conserved hypothetical protein,NA,hypothetical protein,A613P|L615H|Q618P,SAB persistence only,NA,NA,NA,NA
179,MAKYRGKPFQLYVKLSCSTMMATSIILTNILPYDAQAVSEKDTEISKELLSKQDLLDKVDKANRQIEQLKQLSASSKAHYKAQLNEAKTASQIDEIIKRANELDSKDNKGSQIEMNGQSDIDSKLDQLLKDLNEVSSKVDRGQQSGEDDLNAMKNDMSQTATTKHGEKDDKNDEAMVNKALEDLDHLSQQIHKSEDSAVSTTDNNHEVAKTPNNDGSGHVVLNKFLSNEENQSHSNRLTDKLQGSDKINHAMIEKLAKSNASTQHYTYHKLNTLQSLDQRIANTQLPKNQKSDLMSEVNKTKERIKSQRNIILEELARTDDKKHATQRILESIFNKDEADKILKDIRVDGKTDQQIADQITRHIDQLSLTTSDDLLTSLIDQSQDKSLLISQILQTKLGKAEADKLAEDWTNKGLSNRQIVDQLKKHFASTGDTSSDDILKAILNNAKDKKQAIETILATRIERQKAKLLADLITKIETDQNKIFNLVKSALNGKADDLLNLQKRLNQTKKDIDYVLSPIVNRPSLLDRLNKNGKTTDLNKLANLMNQGSNLLDSIPDIPTPKPEKTLTLGKGNGLLSGLLNADGNVSLPKAGETIKEHWLPISVIVGAMGVLMIWLSRRNKLKNKA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2581,NE800,-,putative surface anchored protein,NA,hypothetical protein,E408K,SAB mortality and SAB persistence,NA,NA,NA,NA
182,MEAYKIEHLNKSYADKTIFDNLDLSISEGEKIGLVGINGTGKSTLLKVIGGIDDDFTANVMHPNQYRIRYSSQKQDLNEDMTVFDAVLSSDTTTLRIIKQYEQAVQAYADDQSDKLFKRMMDAQDAMDQHDAWDYNAEIKTILSKLGIHDTTKYIKELSGGQQKRVVLAKTLIEQPDLLLLDEPTNHLDFESISWLINYVKQYPHTVLFVTHDRYFLNEVSTRIIELNRGKLASYPGNYESYIEMRAEREVTLQKQQQKQRALYKEVLAWMRAGAKARTTKQQARINRFNDLENEVNQQYKDDKGELNLAYSRLGKQVFELEDLSKAINDKVLFEHLTEIIQKGERIGVVGPNGAGKTTLLNILSGEDQQFEGKLKTGQTVKVAYFKQTDETLDRDIRMIDYLREENEIAKEKDGTSVSITQLLERFLFPSATHGKKVYKLSGGEQKRLYLLRLLVHQPNVLLLDEPTNDLDTETLTILEDYIHTFGGTVITVSHDRYFLNKVAQSYWFIHDGQMEKIIGTFEDYESYKKSLDKNKSTLKQQSKSSTTVRKKNGLSYKEKLEYEQLMKRIEQAEVRMEEIDVLMIEASADYGKIKELNEEKEQLEIQYDLDITRWSELEEIKEQQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0704,NE770,-,ABC transporter ATP-binding protein,ettA,Energy-dependent translational throttle protein EttA,V267E,SAB mortality and SAB persistence,NA,NA,NA,NA
183,MGLPNPKTRKPTASEVVEWAKSNIGKRINIDNYRGSQCWDTPNFIFKRYWGFVTWGNAKDMANYRYPKGFRFYRYSSGFVPEPGDIAVWHPGNGIGSDGHTAIVVGPSNKSYFYSVDQNWVNSNSWTGSPGRLVRHPYVSVTGFVRPPYSKDTSKPSSTDTSSASKANDSTITGEAKKPQFKEVKTIKYTAYSNVLDKEEHFIDHIVVMGDERSDIQGLYIKESMHMRSVDELYTQRNKFISDYEIPHLYVDREATWLARPTNFDDPRHPNWLVIEVCGGQTDSKRQFLLNQIQALIRGVWLLSGIDKNLSETTLKVDPNIWRSMKDLINYDLIKQGIPDNAKYEQVKKKMLETYIKRDILTRENIKEVTTKTTIRISDKTSVDSASTRGPTPSDEKPSIVTEISPFTFQQALDRQMSRGNPKKSHTWGWANATRAQTSSAMNVKRIWESNTQCYQMLNLGKYQGISVSALNKILKGKGTLDGQGKAFAEACKKNNINEIYLIAHAFLESGYGTSNFASGRYGAYNYFGIGAFDNDPDYAMTFAKNKGWTSPAKAIMGGASFVRKDYINKGQNTLYRIRWNPKNPATHQYATAIEWCQHQASTIAKLYKQIGLKGIYFTRDKYK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,I404T,SAB mortality and SAB persistence,NA,NA,NA,NA
185,MPKNKILIYLLSTTLVLPTLVSPTAYADTPQKDTTAKTTSHDSKKSTDDETSKDTTSKDIDKADNNNTSNQDNNDKKVKTIDDSTSDSNNIIDFIYKNLPQTNINQLLTKNKYDDNYSLTTLIQNLFNLNSDISDYEQPRNGEKSTNDSNKNSDNSIKNDTDTQSSKQDKADNQKAPKSNNTKPSTSNKQPNSPKPTQPNQSNSQPASDDKVNQKSSSKDNQSMSDSALDSILDQYSEDAKKTQKDYASQSKKDKNEKSNTKNPQLPTQDELKHKSKPAQSFNNDVNQKDTRATSLFETDPSISNNDDSGQFNVVDSKDTRQFVKSIAKDAHRIGQDNDIYASVMIAQAILESDSGRSALAKSPNHNLFGIKGAFEGNSVPFNTLEADGNQLYSINAGFRKYPSTKESLKDYSDLIKNGIDGNRTIYKPTWKSEADSYKDATSHLSKTYATDPNYAKKLNSIIKHYQLTQFDDERMPDLDKYERSIKDYDDSSDEFKPFREVSDNMPYPHGQCTWYVYNRMKQFGTSISGDLGDAHNWNNRAQYRDYQVSHTPKRHAAVVFEAGQFGADQHYGHVAFVEKVNSDGSIVISESNVKGLGIISHRTINAAAAEELSYITGK,1,2,1,1,1,1,1,1,2,1,1,1,SAUSA300_2579,NE1353,NA,N-acetylmuramoyl-L-alanine amidase domainprotein,NA,N-acetylmuramoyl-L-alanine amidase domain-containing protein,V286G|V63G,all,NA,NA,NA,NA
189,MEFLSLVIVVLAAFLTPIIVNRLNINFLPVVVAEILMGIVIGNSFLNIVERDSILNILSTLGFIFLMFLSGLEIDFKAFKKDKRARQGQNDDESSIPGHLNLALTVFAFIMIISILLAYVFKWLGLVDDVLLMVIIISTISLGVVVPTLKEMNIMRTTIGQFILLVAVLADLVTMILLTVYGAINGQGGSTIWLIGILVVFTAISYILGVQFKRMSFLQKLMDGTTQIGIRAVFALIILLVALAEGVGAENILGAFLAGVVVSLLNPDEEMVEKLDSFGYGFFIPIFFIMVGVDLNIPSLIKEPKLLIIIPILIVAFIISKLIPVMFIRRWFDMKTTIASAFLLTSTLSLVIAAAKISERLNAISAETSGILILSAVITCVFVPIIFKKLFPVPDEFNRKIEVSLIGKNQLTIPIAQNLTSQLYDVTLYYRKDLSDRRQLSDDITMIEIADYEQDVLERLGLFDRDIVVCATNDDDINRKVAKLAKAHQVERVICRLESTTDDTELVDSGIEIFSSYLSNKILLKGLIETPNMLNLLSNVETSLYEIQMLNYKYENIQLRNFPFGGDIIFVCIIRNNESIVPHGDTQLRYGDRLIVTGAKEYVDELKQELEFYF,1,2,1,1,1,1,1,1,1,1,2,1,SAUSA300_0911,NE308,NA,"transporter, monovalent cation:proton antiporter-2 (CPA2) family protein",kefB,Glutathione-regulated potassium-efflux system protein KefB,C572R,all,NA,NA,NA,NA
190,MSKIIGIDLGTTNSCVTVLEGDEPKVIQNPEGSRTTPSVVAFKNGETQVGEVAKRQAITNPNTVQSIKRHMGTDYKVDIEGKSYTPQEISAMILQNLKNTAESYLGEKVDKAVITVPAYFNDAERQATKDAGKIAGLEVERIINEPTAAALAYGLDKTDKDEKVLVFDLGGGTFDVSILELGDGVFEVLSTAGDNKLGGDDFDQVIIDYLVAEFKKENGVDLSQDKMALQRLKDAAEKAKKDLSGVSQTQISLPFISAGENGPLHLEVNLTRSKFEELSDSLIRRTMEPTRQAMKDAGLTNSDIDEVILVGGSTRIPAVQEAVKKEIGKEPNKGVNPDEVVAMGAAIQGGVITGDVKDVVLLDVTPLSLGIEILGGRMNTLIERNTTIPTSKSQIYSTAVDNQPSVDVHVLQGERPMAADNKTLGRFQLTDIPPAERGKPQIEVTFDIDKNGIVNVTAKDLGTNKEQRITIQSSSSLSDEEIDRMVKDAEVNAEADKKRREEVDLRNEADSLVFQVEKTLTDLGENIGEEDKKSAEEKKDALKTALEGQDIEDIKSKKEELEKVIQELSAKVYEQAAQQQQQAQGANGGQNNDSTVEDAEFKEVKDDDKK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1540,NA,NA,NA,dnaK,Chaperone protein DnaK,I5V,SAB mortality only,NA,NA,NA,NA
192,MLSNLLILPMLLPFLCALILVFLKNNDRISKYLYLGTMTITTIISLMLLIYVQRHRPITLDFGGWSAPFGIQFLGDSLSLIMVTTASFVITLIMAYGFGRGEHKANRYHLPSFILFLSVGVIGSFLTSDLFNLYVMFEIMLLASFVLITLGQSVEQLRAAIIYVVLNIIGSWLFLLGIGLLYKTVGTLNFSHIAMRLNDMGDNRTVTMISLIFLVAFSAKAALVLFMWLPKAYAVLNTELAALFAALMTKVGAYALIRFFTLLFDQHNDLIHPLLATMAAITMVIGAIGVIAYKDIKKIAAYQVIISIGFIILGLGTNTFAGINGAIFYLVNDIVVKTLLFFIIGSLVYITGYRQYQYLNGLAKKEPLFGVAFIIMIFAIGGVPPFSGFPGKVLIFQGALQNGNYIGLALMIITSLIAMYSLFRILFYMYFGDKDGEEVNFKKIPLYRKRILSILVVVVIAIGIAAPVVLNVTSDATELNTSDQLYQKLVNPHLKGED,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0613,NE1139,-,putative monovalent cation/H+ antiporter subunit D,mnhD1_2,Na(+)/H(+) antiporter subunit D1,L256*,SAB mortality and SAB persistence,NA,NA,NA,NA
193,MKWLKQLQSLHTKLVIVYVLLIIIGMQIIGLYFTNNLEKELLDNFKKNITQYAKQLEISIEKVYDEKGSVNAQKDIQNLLSEYANRQEIGEIRFIDKDQIIIATTKQSNRSLINQKANDSSVQKALSLGQSNDHLILKDYGGGKDRVWVYNIPVKVDKKVIGNIYIESKINDVYNQLNNINQIFIVGTAISLLITVILGFFIARTITKPITDMRNQTVEMSKGNYTQRVKIYGNDEIGKLALAFNNLSKRVQEAQANTESEKRRLDSVITHMSDGIIATDRRGRIRIVNDMALKMLGMAKEDIIGYYMLSVLSLEDEFKLEEIQENNDSFLLDLNEEEGLIARVNFSTIVQETGFVTGYIAVLHDVTEQQQVERERREFVANVSHELRTPLTSMNSYIEALEEGAWKDEELAPQFLSVTREETERMIRLVNDLLQLSKMDNESDQINKEIIDFNMFINKIINRHEMSTKDTTFIRDIPKKTIFTEFDPDKMTQVFDNVITNAMKYSRGDKRVEFHVKQNPLYNRMTIRIKDNGIGIPINKVDKIFDRFYRVDKARTRKMGGTGLGLAISKEIVEAHNGRIWANSVEGQGTSIFITLPCEVIEDGDWDE,2,2,0,0,1,1,0,0,2,1,0,0,SAUSA300_0021,NA,NA,NA,walK,Sensor protein kinase WalK,K239E|S358G,SAB mortality and SAB persistence,NA,NA,NA,NA
195,MAHLSVKLRLLILALIDSLIVTFSVFVSYYILEPYFKTYSVKLLILAAISLFISHHISAFIFNMYHRAWEYASVSELILIVKAVTTSIVITMVFVTIVTGNRPFFRLYLITWMMHLILIGGSRLFWRIYRKYLGGKSFNKKPTLVVGAGQAGSMLIRQMLKSDEMKLEPVLAVDDDEHKRNITITEGVKVQGKIADIPELVRKYKIKKIIIAIPTIGQERLKEINNICHMDGVELLKMPNIEDVMSGELEVNQLKKVEVEDLLGRDPVELDMDMISNELTNKTILVTGAGGSIGSEICRQVCNFYPERIILLGHGENSIYLINRELRNRFGKNVDIVPIIVDVQNRARMFEIMEMYKPYAVYHAAAHKHVPLMEDNPEEAVRNNILGTKNTAEAAKNAEVKKFVMISTDKAVNPPNVMGASKRIAEMIIQSLNDETHRTNFVAVRFGNVLGSRGSVIPLFKSQIEEGGPVTVTHPEMTRYFMTIPEASRLVLQAGALAEGGEVFVLDMGEPVKIVDLARNLIKLSGKKEDDIRITFTGIRPGEKMYEELMNKDEIHPEQVFEKIYRGKVQHMKCNEVEAIIQDIVNDFSKEKIINYANGKKGDNYVR,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,pglF,UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase,V341A,SAB mortality only,NA,NA,NA,NA
196,MDNEQRLKRRENIRNFSIIAHIDHGKSTLADRILENTKSVETRDMQDQLLDSMDLERERGITIKLNAVRLKYEAKDGNTYTFHLIDTPGHVDFTYEVSRSLAACEGAILVVGAAQGIEAQTLANVYLALDNELELLPVINKIDLPAAEPERVKQEIEDMIGLDQDDVVLASAKSNIGIEEILEKIVEVVPAPDGDPEAPLKALIFDSEYDPYRGVISSIRIVDGVVKAGDKIRMMATGKEFEVTEVGINTPKQLPVDELTVGDVGYIIASIKNVDDSRVGDTITLASRPASEPLQGYKKMNPMVYCGLFPIDNKNYNDLREALEKLQLNDASLEFEPESSQALGFGYRTGFLGMLHMEIIQERIEREFGIELIATAPSVIYQCVLRDGSEVTVDNPAQMPDRDKIDKIFEPYVRATMMVPNDYVGAVMELCQRKRGQFINMDYLDDIRVNIVYELPLAEVVFDFFDQLKSNTKGYASFDYEFIENKESNLVKMDILLNGDKVDALSFIVHRDFAYERGKALVEKLKTLIPRQQFEVPVQAAIGQKIVARTNIKSMGKNVLAKCYGGDISRKRKLLEKQKAGKAKMKAVGNVEIPQDAFLAVLKMDDE,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_1544,NE865,lepA,GTP-binding protein LepA,lepA,Elongation factor 4,G112D,SAB mortality and cell death,NA,NA,NA,NA
202,MTNIFEKIVNDLNLEQKDVVESEDNLYVNACPGSGKTRVLTRKIAYQAIKHDGSLKRIIAITYTNRAAEEIKERLSLLSIDDDINIWVGTIHQFCLEFIIYPFKMNLSRVSKGFTIIDDYTQRAYVSQINNMLNLNLKTYELNKIDLSLSHDFKINEVQYTQVSEMYHTMLEKNKEIDFDMILLVAYKILTVNSNVARNIASNIRAIYVDEFQDTRELQYNVIAKLLQNNPQIQSMFVGDIDQAIYGSLDGIAKSVEELEMLTSHTFQSKTLHGCYRSNQRLVDFYSNFQSCPYEIESRGNNKNDRGFISYDCKVTKEDLPNIIKNIIKEKIESGIHEKDICVLAPQHYPLFSLGEYLKKELPYCNFDAINISPIKVNNHSLFFKLAILYFTESGEKVRRRKLIANDILIILKNEFGIEVKDYFIDLDLLQLINSVKRMYSGDDNGVDLYKFVTKHIFVNLNIDEKNYPSIFKHYLFFINEVEDRIKNNSLSSSVSSFKKMFKSRDGITLTTAHKVKGNEYDTVIAINLLNGKIPHWNEIFNVSDKGISSARKLLYVICSRAKNNLFLFSEVGYFTSKGDLLYPTQLLDKIEFDYNI,3,2,0,0,1,1,0,0,2,1,0,0,NA,NA,NA,NA,rep|rep_1,ATP-dependent DNA helicase Rep,K402N|I174fs,SAB mortality and SAB persistence,NA,NA,NA,NA
203,MNQTILNRVKTRVMYQLVSSLIYENIVVYKASYQDGVGYFTIEGNDSEYRFTAEKTHSFDRIRITSPIERVVGDEADTTTDYTQLLREVVFTFPKNDEKLEQFIVELLQTELKDTQSMQYRESNPPATPETFNDYEFYAMEGHQYHPSYKSRLGFTLSDNLKFGPDFVPNVKLQWLAIDKDKVETTVSRNVVVNEMLRQQVGDKTYEHFVQQIEASGKHVNDVEMIPVHPWQFEHVIQVDLAEERLNGTVLWLGESDELYHPQQSIRTMSPIDTTKYYLKVPISLTNTSTKRVLAPHTIENAAQITDWLKQIQQQDTYLKDELKTAFLGEVLGQSYLNTQLSPYKQTQVYGALGVIWRENIYHMLIDEEDAIPFNALYASDKDGVPFIENWIKQYGSEAWTKQFLAVAIRPMIHMLYYHGIAFESHAQNMMLIHENGWPTRIALKDFHDGVRFKREHLSEAASHLTLKPMPEAHKKVNSNSFIETDDERLVRDFLHDAFFFINIAEIILFIEKQYGIDEKLQWKWVKGIIEAYQEAFPELNNYQHFDLFEPTIQVEKLTTRRLLSDSELRIHHVTNPLGVGGITDATTISET,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0123,NE214,NA,"siderophore biosynthesis protein, IucC family""",sbnF,2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2- aminoethylcarbamoyl)-2-hydroxypropanoate synthase,L285I,SAB mortality and SAB persistence,NA,NA,NA,NA
204,MYYSYGNYEAFARPKKPENVENKSAYLIGSGLASLAAACFLIRDGQMEGSKIHILEELPKAGGSLDGENMPLKGYVVRGGREMENHFECLWDLFRSIPSLEIDHASVLDEFYWLNKEDPNYSRCRVIEKQGQRLVTDGDFTLTKTAIKEILDLCLTNEEDLDDVKITDVFSDDFFNSNFWIYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVQFEYDVKVKDIKVDVTTSQKIAREILIDRNGNAESIKLTINDLVFVTNGSITESSTYGDNDTPAPPTDELGGSWTLWKNLARQSPEFGNPDKFCQNIPKKSWFVSATSTTNNKDIIDTIESICKRDPLAGKTVTGGIITINDSAWQISFTINRQQQFKDQPKNEISTWIYALYSDVNGDYIKKPITECSGNEICQEWLYHLGVPTDKIEDLAKHASNTIPVYMPYITSYFMTRAIGDRPLVVPHQSQNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLNIDRGIPEVINSTFDLRVLMDAVYELNDHQDLREITKDSKMQKLALAGFLKKIKGTYIESLLKEHKLL,1,2,1,1,1,1,1,1,1,2,1,1,SAUSA300_0108,NE757,NA,"antigen, 67 kDa",NA,Oleate hydratase,S343fs,all,NA,NA,NA,NA
205,MKKIISIAIIVLALVLSGCGVPTKSEVAQKSSKVEVKGERPTIHFLGQASYENDMNIVKDQLENAGFNVKMNIQPDYGSYRTQRQAGNYDIQIDDWMTVFGDPNYAMTALFSSTGSNSLLKDKHVDQLLNKASTQNEADVKQTYKQIEDEVVFDKGYMAPLYGSKKNLVYDNKVLDKNSVGLPNSRALIWQQFDYNNSRERDTRPLVMTQQDGEIPTLDPIRSIAPSVYSINMNMYTRLLLLDENDHLTTKGSLSRDYAVNKDNKAFYFLLRDDDYFAKVVNGQARNTGERVSAEDVKFSLDRARDKKSVPNNNTYNMHKHINDIKILKDEDIDQLRKEKDKDDNSIYDKLIKAYNVKSLTTDGQKVNNKDGIYQIVKITTDQSMPREVNYLTHSSAGILSKKFVNQVNQEYPKGYGDSSTIPANSDGKNALYASGAYIMTQKNAYQATFQRNPGFNETEKGSYGPAKIKNITLKFNGDPNNALSELRNHSIDMLADVNQKHFDLIKSDKNLSIIRKNGRKSVFLMLNIKKGIFKTHPNLRQAVVNAIDQDQFIKFYRGDKFKIASPITPLVDTGNEQRQDLEKVEKAINQ,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0203,NE215,NA,putative lipoprotein,NA,hypothetical protein,G163R,SAB persistence only,+,1,+,0
207,MSKTQHEVNQNIDPLKMAESLEPEQLNEKTLNDMRSGSEVLVEALLKENVDYLFGYPGGAVLPLYDTFYDGKIKHILARHEQGAVHAAEGYARVSGKTGVVVVTSGPGATNVMTGITDAHCDSLPLVVFTGQVATPGIGKDAFQEADILSMTSPITKQNYQVKRVEDIPKIVHEAFHVANSGRKGPVVIDFPKDMGVLATNVDLCDEINIPGYEVVTEPENKDIDTFISLLKEAKKPVVLAGAGINQSKSNQLLTQFVNKHQIPTVTTLLGLGAVPYEDTLFLGMGGMHGSYASNMALTECDLLINLGSRFDDRLASKPDAFAPNAKIVHVDIDPSEINKVIHVDLGIIADCKRFLECLNDKNVETIEHSDWVKHCQNNKQKHPFKLGEEDQVFCKPQQTIEYIGKITNGEAIVTTDVGQHQMWAAQFYPFKNHGQWVTSGGLGTMGFGIPSSIGAKLANPDKTVVCFVGDGGFQMTNQEMALLPEYGLDVKIVLINNGTLGMVKQWQDKFFNQRFSHSVFNGQPDFMKMAEAYGVKGFLIDKPEQLEEQLDAAFAYQGPALIEVRISPTEAVTPMVPSGKSNHEMEGL,1,3,1,1,1,1,1,1,1,2,1,1,SAUSA300_2007,NE1166,ilvB,acetolactate synthase large subunit,ilvB,Acetolactate synthase large subunit,T574I,all,NA,NA,NA,NA
208,MSKRTTYCGLVTEAFLGQEITLKGWVNNRRDLGGLIFVDLRDREGIVQVVFNPAFSEEALKIAETVRSEYVVEVQGTVTKRDPETVNPKIKTGQVEVQVTNIKVINKSETPPFSINEENVNVDENIRLKYRYLDLRRQELAQTFKMRHQITRSIRQYLDDEGFFDIETPVLTKSTPEGARDYLVPSRVHDGEFYALPQSPQLFKQLLMISGFDKYYQIVKCFRDEDLRADRQPEFTQVDIEMSFVDQEDVMQMGEEMLKKVVKEVKGVEINGAFPRMTYKEAMRRYGSDKPDTRFEMELIDVSQLGRDMDFKVFKDTVENDGEIKAIVAKGAAEQYTRKDMDALTEFVNIYGAKGLAWVKVVEDGLTGPIGRFFETENVETLLTLTGAEAGDLVMFVADKPNVVAQSLGALRVKLAKELGLIDETKLNFLWVTDWPLLEYDEDAKRYVAAHHPFTSPKEADIAKLGTAPEEAEANAYDIVLNGYELGGGSIRIHDGELQEKMFEVLGFTKEQAQEQFGFLLDAFKYGAPPHGGIALGLDRLVMLLTNRTNLRDTIAFPKTASATCLLTNAPGEVSDKQLEELSLRIRH,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1586,NA,NA,NA,aspS,Aspartate--tRNA ligase,D495A,SAB mortality and growth rate,NA,NA,NA,NA
209,MKPQLSWKVSGQQGEGIESTGEIFATAMNRKGYYLYGYRHFSSRIKGGHTNNKIRVSTTPVHAISDDLDILIAFDQETIDVNHHEMREDSIILADAKAKPVKPEGCHAQLIELPFTATAKELGTALMKNMVAIGATSALMNLNTNTFEELITNMFSKKGDKVVEVNIQALNEGYQLMQSRLPEIYGDFELESTDALPHLYMIGNDAIGLGAIAAGSQFMAAYPITPASEVMEYMIANISKVNGAVIQTEDEIAAVTMAIGANYGGVRAFTASAGPGLSLMMEAIGLSGMTETPLVIINTQRGGPSTGLPTKQEQSDLMQMIYGTHGDIPKIVVAPTDAEDAFYLTMEAFNLAEQYQCPVIVLSDLQLSLGKQTVEKLDYNRIEIKRGEIIQSDIEREEDDKGYFKRYALTSDGVSPRPIPGVKGGIHHITGVEHNEEGKPSESASNRQQQMEKRMRKIEQLLIESPVEANLQHEDADILYIGFISTKGAIQEGSNRLNQQGIKVNTIQIRQLHPFPTSVIQDAVNKAKKVVVVEHNYQGQLASIIKMNVNIHDKIENYTKYDGTPFLPHEIEEKGKIIATEIKEMV,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_1182,NE885,-,"pyruvate ferredoxin oxidoreductase, alpha subunit",korA,2-oxoglutarate oxidoreductase subunit KorA,S10G,all,NA,NA,NA,NA
211,MAKLLIMSIVSFCFIFLLLLFFKYILKRNFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKFNNVNNQAPTVESKSHDLNHNINTTKPIQEFATDIHKFNWDSIDNICTVIWIVLVIILSFKFLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYIILIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKEANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYPFDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSLKISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGWFVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ,3,2,0,1,1,1,0,1,3,6,0,2,NA,NA,NA,NA,blaR1|blaR1_2,beta-lactam sensor/signal transducer BlaR1|Regulatory protein BlaR1,K23R|I158fs|K276N,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
213,MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPINFSFFKFNNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFKFLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYIILIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFHIFSIAMSYNPLIQIVKRKMIHDNEVEADRFVLNNINKYEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKEANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYPFDSWNKDQDLNTAIQNSVNWYFERISNQLSKNYTSDQLKQLNYGNKNLGSYKAYWLEDSLKISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGWFVGYVITNHDKYYFSTHLSDEKASGENAKLINEKILKEMGVLNGQ,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,blaR1-2,beta-lactam sensor/signal transducer BlaR1,N54K,SAB persistence only,NA,NA,NA,NA
217,MTKKDVIKLLEQIATYMELKGENTFKISAYRKAAQSLELDERPLDEISDVTELKGIGKGVAEVINDYRETGESQYLQQLQEEVPEGLIPLLKIQGLGSKKIAKLYKELNIVDKASLQVACENGKVSELSGFAKKTEQNILEAVKQLGAKKDRYPIDQMRRLNQEIIDYIDTLNYIDQYSSAGSFRRFKEMSKDLDFIISTDNPKAVQQQLLNIPNKVKEVAVGNTKVSLELAYDDETIGVDFRLIEPSAFYHTLQHFTGSKEHNIRIRQLAKARDEKVSEYGIEQADGTLIQYDSEAKIYEHFNVNFIPPAMREDGSEFDKDLSNIITIDDINGDIHMHTTYSDGAFSIRDMVEANIAKGYKFMVITDHSQSLRVANGLQVERLLRQNEEIKALDKEYSEIDIYSGTEMDILPDGSLDYDDEILAQLDYVIGAIHQSFNQSEEQIMERLANACRNPYVRHIAHPTGRIIGRRDGYKPNIEQLMALAEETNTVLEINANPHRLDLSADIVRKYPNVKLTINTDAHHTNHLDFMNYGVATAQKGFVTKDRVINALSREAFKDFIENNTKLKK,1,2,0,0,1,1,0,0,1,2,0,0,SAUSA300_1042,NE947,-,hypothetical protein,polX,DNA polymerase/3'-5' exonuclease PolX,D5fs|D17fs,SAB mortality and SAB persistence,NA,NA,NA,NA
218,MKINIYKSIYNFQETNTIFLEILESLNDDNYELLNDKELVSDSNELKLISKVYIRKKDKKLLDWQLLIKNVYLDTEEDDNLFSESGHHFDAILFLKEDTTLQNNVYIIPFGQAYHDINNLIDYDFGIDFAERAIKNEDIVNKNVNFFQQNRLKEIVNYRRNSVDYVRPSESYISVQGHPQNPQIFGKTMTCGTSISLRVPNRKQQFIDKISVIIKEINAIINLPQKISEFPRIVTLKDLNKIEVLDTLLLKKLSNSSTTENISIDISRFLELSNMILLLDDMLDVNIYINSFKNNTLETFDATDPEVDYITEIGDYLLKYDVNSINDVRIEVIDNLGHSNNMLLKTILHAEVEMEDGKKYLLQNGKWGYFNREFFDLLNDHLNEIEIRYNTLTPTGLVFKEGEEGYIKEIVGRLPEEYLMLHKKFIKPINKNFIVKGNGIELADLYNIKNKELFTIKRGINTSLSLYSLEQNIIAINALKYPESYNFEELIEAIPDNSENIFNDIQRSTNFSIVWILPISSIDNMPIKDMVHTSNVINKNFQLTNLGSVLLKNKLVEWSLYLKDQRINPIIYMETPTEDRN,0,1,0,0,0,1,0,0,0,2,0,0,SAUSA300_0081,NE349,NA,conserved hypothetical protein,NA,hypothetical protein,I22N|I18N,SAB persistence only,NA,NA,NA,NA
220,MAKIKANEALVKALQAWDIDHLYGIPGDSIDAVVDSLRTVRDQFKFYHVRHEEVASLAAAGYTKLTGKIGVALSIGGPGLIHLLNGMYDAKMDNVPQLILSGQTNSTALGTKAFQETNLQKLCEDVAVYNHQIEKGDNVFEIVNEAIRTAYEQKGVAVVICPNDLLTEKIKDTTNKPVDTSRPTVVSPKYKDIKKAVKLINKSKKPVMLIGVGAKHAKDELREFIEMAKIPVIHSLPAKTILPDDHPYSIGNLGKIGTKTSYQTMQEADLLIMVGTNYPYVDYLPKKNIKAIQIDTNPKNIGHRFNINVGIVGDSKIALHQLTENIKHVAERPFLNKTLERKAVWDKWMEQDKNNNSKPLRPERLMASINKFIKDDAVISADVGTATVWSTRYLNLGVNNKFIISSWLGTMGCGLPGAIASKIAYPNRQAIAIAGDGAFQMVMQDFATAVQYDLPLTVFVLNNKQLAFIKYEQQAAGELEYAVDFSDMDHAKFAEAAGGKGYTIKSASEVDAIVEEALAQDVPTIVDVYVDPNAAPLPGKIVNEEALGYGKWAFRSITEDKHLDLDQIPPISVAAKRFL,2,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_2477,NE564,cidC,pyruvate oxidase,ydaP,Putative thiamine pyrophosphate-containing protein YdaP,D125E,all,-,0,+,1
221,MIKRYLQFVKPYKYRIFATIIVGIIKFGIPMLIPLLIKYAIDGVINNHALTTDEKVHHLTIAIGIALFIFVIVRPPIEFIRQYLAQWTSNKILYDIRKKLYNHLQALSARFYANNQVGQVISRVINDVEQTKDFILTGLMNIWLDCITIIIALSIMFFLDVKLTLAALFIFPFYILTVYVFFGRLRKLTRERSQALAEVQGFLHERVQGISVVKSFAIEDNEAKNFDKKNTNFLTRALKHTRWNAYSFAAINTVTDIGPIIVIGVGAYLAISGSITVGTLAAFVGYLELLFGPLRRLVASFTTLTQSFASMDRVFQLIDEDYDIKNGVGAQPIEIKQGRIDIDHVSFQYNDNEAPILKDINLSIEKGETVAFVGMSGGGKSTLINLIPRFYDVTSGQILIDGHNIKDFLTGSLRNQIGLVQQDNILFSDTVKENILLGRPTATDEEVVEAAKMANAHDFIMNLPQGYDTEVGERGVKLSGGQKQRLSIARIFLNNPPILILDEATSALDLESESIIQEALDVLSKDRTTLIVAHRLSTITHADKIVVIENGHIVETGTHRELIAKQGAYEHLYSIQNL,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_1847,NE370,NA,conserved hypothetical protein,NA,Putative multidrug export ATP-binding/permease protein,H552Y,"SAB mortality, growth rate and cell death",+,2,-,0
222,MFRITFKILNWVSPYKTRMVLGFIMSFLNAIFIALPIFLASQIFNNVVSNKSIYGKDIFNVVIIMIILVLGRFITAYLKSKNQESIAYEMSANERLNIGNKLKNVPLGYFNTHHSNELTTIVTTDLTFLENFAMKMVDIVINGYILISVLILSLLVVSWQVALLACIGVLLSFLAIQLLENKSKKNAPTYHYAQNQLIEKVVEVIRGIQVIKSFAKENTSLKSFNQAVNESKRINTKIEMQYIPFNLLHLLSLKVVSIMIVLVACLLYMNHSIDLPTLIMISIFSFVIFDSVENINSAAHVLEMIDMTIDDIEKIKNAPELDENGKNLTIKNENIAFQNVNFSYDDKQVIKNVNFEIPTQTSTAIIGPSGSGKSTLCHLLLRFYDIDDGNIRIDGVDIKDMTLSTLMSKISAVFQKVYLFNDTIENNILFGNPGATKEEIIRAAKQACCHDFIMSLPEGYQTMLNEKGSNLSGGEKQRISIARAILKDAPIIILDEATASIDPENEQLIQTAINELSKGKTVITIAHKLETIKNADQIIVLNEGEIIQKGSHDELIRKPGMYQDFIRIKSKSAGWKL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2374,NE139,NA,"ABC transporter, ATP-binding/permease protein",msbA|msbA_2,Lipid A export ATP-binding/permease protein MsbA,S183R,SAB persistence only,NA,NA,NA,NA
223,MKRENPLFFLFKKLSWPVGLIVAAITISSLGSLSGLLVPLFTGRIVDKFSVSHINWNLIALFGGIFVINTLLSGLGLYLLSKIGEKIIYAIRSVLWEHIIQLKMPFFDKNESGQLMSRLTDDTKVINEFISQKLPNLLPSIVTLVGSLIMLFILDWKMTLLTFITIPIFVLIMIPLGRIMQKISTSTQSEIANFSGLLGRVLTEMRLVKISNTERLELDNAHKNLNEIYKLGLKQAKIAAVVQPISGIVMLLTIAIILGFGALEIATGAITAGTLIAMIFYVIQLSMPLINLSTLVTDYKKAVGASSRIYEIMQEPIEPTEALEDSENVLIDDGVLSFEHVDFKYDVKKILDDVSFQIPQGQVSAFVGPSGSGKSTIFNLIERMYEIESGDIKYGLESVYDIPLSKWRRKIGYVMQSNSMMSGTIRDNILYGINRHVSDEELINYAKLANCHDFIMQFDEGYDTLVGERGLKLSGGQRQRIDIARSFVKNPDILLLDEATANLDSESELKIQEALETLMEGRTTIVIAHRLSTIKKAGQIIFLDKGQVTGKGTHSELMASHAKYKNFVVSQKLTD,2,2,1,2,1,1,1,1,2,2,1,2,SAUSA300_0630,NE1509,-,ABC transporter ATP-binding protein,bmrA,Multidrug resistance ABC transporter ATP-binding/permease protein BmrA,T70A|M456R,all,NA,NA,NA,NA
228,MSFKMTQNQYTSLYGPTVGDSIRLGDTNLFAQIEKDYAVYGEEATFGGGKSIRDGMAQNPRVTRDDVNVADLVISNAVIIDYDKVVKADIGIKNGYIFAIGNAGNPDIMDNVDIIIGSTTDIIAAEGKIVTAGGIDTHVHFINPEQAEVALESGITTHIGGGTGASEGSKATTVTPGPWHIHRMLEAAEGLPINVGFTGKGQATNPTALIEQINAGAIGLKVHEDWGATPSALSHALDVADEFDVQIALHADTLNEAGFMEDTMAAVKDRVLHMYHTEGAGGGHAPDLIKSAAFSNILPSSTNPTLPYTHNTVDEHLDMVMITHHLNAAIPEDIAFADSRIRKETIAAEDVLQDMGVFSMISSDSQAMGRVGEVITRTWQVAHRMKEQRGPLDGDFEHNDNNRIKRYIAKYTINPAITHGISEYVGSIEPGKLADIVLWDPIFFGVKPELVVKGGLINSAVNGDANGSIPTSEPMKYRKMYGQYGGNLTSTSMTFVSKTAYENGINRALNLKRMVRPVKNIRQLSKADMKNNSATPKLDVDPQTYEVYVDGEKITSNAATELPLTQRYFLF,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_2240,NE410,ureC,"urease, alpha subunit",ureC,Urease subunit alpha,P448L,SAB mortality and cell death,NA,NA,NA,NA
230,MTEPIISFKDFSFQYHSQATPTLQNINVDIYPGEKVLVVGASGSGKSTFANCINGLIPFKTKGNVTGELHINNQDATVSCLHKRSNVVGTVLQDTDGQFIGLTAAEDMAFLLENNCVEQDDMKKNVSYWAEKVDMIEHLNHRPQDLSGGQKQRVSLGGILIHRTPILILDEPLANLDPATGHETLRLLNNIHEETKSTMIIVEHRLEESLDDTFDRVLLFKDGKIIANTTPSDLLKSSKLKEAGIREPLYCTALKYAEVDVESIDNLANLREVCMSEHVKFKVKKWIDKTSSNDDNKYKSEPLLELNEVCVQYSDYSNSVLNNVQLNVYRREMLSIVGHNGAGKSTLAKAICGFLDITGNIQFCNKGFNQLSISERSEFIGYVMQNPNHMISEKMIYDEVALGLRARGMKESDIKIRVENVLKICGLYAFRNWPIAALSYGQKKRVTIASVLVLNPEIIILDEPTAGQDFYHYNEIMSFLIELNRQGKTIIMITHDMHLLSEYSSRTVVLSKGQVVADTTPVLVLNDKKICEIASLRQTSLFEMAEYIGISEPQKLIQLFINHDRKVRRQ,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2617,NE1186,-,putative cobalt ABC transporter ATP-binding protein,ykoD_1,Putative HMP/thiamine import ATP-binding protein YkoD,V311fs,SAB mortality and growth rate,NA,NA,NA,NA
232,MSNKNKSYDYVIIGGGSAGSVLGNRLSEDKDKEVLVLEAGRSDYFWDLFIQMPAALMFPSGNKFYDWIYSTDEEPHMGGRKVAHARGKVLGGSSSINGMIYQRGNPMDYEGWAEPEGMETWDFAHCLPYFKKLEKTYGAAPYDKFRGHDGPIKLKRGPATNPLFQSFFDAGVEAGYHKTPDVNGFRQEGFGPFDSQVHRGRRMSASRAYLHPAMKRKNLTVETRAFVTEIHYEGRRATGVTYKKNGKLHTIDANEVILSGGAFNTPQLLQLSGIGDSEFLKSKGIEPRVHLPGVGENFEDHLEVYIQHKCKEPVSLQPSLDIKRMPFIGLQWIFTRTGAAASNHFEGGGFVRSNNEVDYPNLMFHFLPIAVRYDGQKAAVAHGYQVHVGPMYSNSRGSLKIKSKDPFEKPSIRFNYLSTEEDKKEWVEAIRVARNILSQKAMDPFNGGEISPGPEVQTDEEILDWVRRDGETALHPSCSAKMGPASDPMTVVDPLTMKVHGMENLRVVDASAMPRTTNGNIHAPVLMLAEKAADIIRGRKPLEPQYIDYYKHGVHDENEGAIEVKPYAK,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_2545,NE368,NA,choline dehydrogenase,betA,Oxygen-dependent choline dehydrogenase,T490A|T566fs,SAB mortality and SAB persistence,NA,NA,NA,NA
233,MKVEVYKGAQGKHNLKDYEETYNTFDWKDVEQAFSWSETGKMNMAYECIDRHVDQGLGDKIALNYKDEHRKESYTYKDMQRLSNKAANVLSEHAEVDKGDRVFIFMSRTPELYFALLGVLKIGAIVGPLFEAFMEKAVADRLENSEAKVLITNKALLPRVPVDKLPNLKKIVVVDEDVEDNYIDFISLMETASDEFDIEWLKSDDGLILHYTSGSTGQPKGVLHVQQAMLVHYISGKYVLDLQEDDVYWCTADPGWVTGTSYGIFAPWLNGATNCIAGGRFSPEQWYSMIEDFKVTIWYTAPTALRMLMSAGDDIVEKYDLSSLRSILSVGEPLNPEVIKWAKKVYGLTVLDTWWMTETGGHMIVNYPTMDVKLGSMSKPLPGIQAAIIDDAGNELPPNRMGNLAIKKGWPSMMYRIWKNPEKYKSYFIGDWYVSGDSAYKDEDGYFWFQGRVDDVIMTAGERVGPFEVESKLVEHEAVAEAGIIGKPDPVRGEIIKAFVALRKGYEPTDELKEEIRIFVKEGLSAHAAPREIEFKDKLPKTRSGKIMRRVLKAWELNLDAGDLSTME,1,1,0,0,1,1,0,0,2,1,0,0,SAUSA300_1679,NE385,acsA,acetyl-coenzyme A synthetase,acsA_2,Acetyl-coenzyme A synthetase,S525W|G378S|S378G,SAB mortality and SAB persistence,+,1,+,0
234,MDMFAALLQIKNYKLFVANMFLLGMGIAVTVPYLVLFATKDLGMTTNQYGLLLASAAISQFTVNSIIARFSDTHHFNRKIIIILALLMGALGFSIYFFVDTIWLFILLYAIFQGLFAPAMSQLYASARESINVSSSKDRAQFANTVLRSMFSLGFLFGPFIGAQLIGLKGYAGLFGGTISIILFTLVLQVFFYKDLNIKHPISTQQHVEKIAPNMFKDKTLLLPFIAFILLHIGQWMYTMNMPLFVTDYLKENEQHVGYLASLCAGLEVPFMIILGVLSSRLQTRTLLIYGAIFGGLFYFSIGVFKNFYMMLAGQVFLAIFLAVLLGIGISYFQDILPDFPGYASTLFSNAMVIGQLGGNLLGGAMSHWVGLENVFFVSAASIMLGMILIFFTKNQKNYKRGCDINMTIILWLLIIAAFMLAFVGLIKPIIPSVLVLWVGFLIYQFGFHNQHLSWVFYVSMALLTILILCADFLANKYFVNRFGGSKFGEYAALIGVVIGCFVLPPFGIIIIPFILVFIVELIQGYSFERAVKVSIGSIVAFLTSSIAQAIIMFIMIVWFFIDALLIN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0659,NE979,NA,sugar efflux transporter,NA,hypothetical protein,S121P,SAB persistence only,NA,NA,NA,NA
236,MKCIDKTWVSYYKELADKLTDYQNKRYELIEIVKEVYKKTGIKFPTLASDNVLMDIDPFTIFALFNKNSMRETNKVKILTELASELNIKSKIPLVFDSIPTVNNLNSTYYNFKDYGKDNDIETLWTLFTAALNFANYPSEDNKLKFIHSFDKNITKTGNGNSKITSGLYWIAPETFANFDSRSIWYIFDTYKLPKELINEQLKPKEKLTGRHYLELINMLKQVLKCQEVEINDFIDLSYESWHYSEMINEANRNKFDSNIKEIVVSENDNIIQNRSRTTKVIPYGKQEFLDEVFIDESDYDRLVQLLRRKRNVILQGPPGVGKTFLAKRLAYSLIGSKCKERIKLIQFHQSYSYEDFIMGYRPTSSGFELTTGTFYDFCKKADKDRDNEYFLIIDEINRGNLSKIFGELFMLIESDKRDEELILLYSGERFSVPRNIYIVGMMNTADRSLAILDYALRRRFAFYNMQPAFHTTKFKKLLKAINNTELESVINCIEGLNKEIVQDDMLGNGFVIGHSYFSNIECIDKDELSNIIEFEIIPMLEEYWFDEPSKINVWSEKLRNSINND,2,2,2,1,1,1,1,1,4,2,2,1,NA,NA,NA,NA,NA,hypothetical protein,S107A|Ter541Lext*?|NT538IP|Q536E,all,NA,NA,NA,NA
238,MTKTKQAIHIDNIYWERVQLYIEGHSEGVDLTSGQFVLRNLTETKTLEANEMKIDGNTFLCRFNVAILDDGYYLPMDKYLFVYHDQLEYIGQLNPNIIDQAYAALNEEQIEEYNELTTQNGKANYVLANEAKVFRKGGVSQHTVYTITPEIASDVNEFVFDIDITLPQEKSGVIATSAHWLHKQGHKASFESRSFLL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0247,NE362,NA,putative teichoic acid biosynthesis protein B,NA,hypothetical protein,F8fs,SAB mortality and SAB persistence,NA,NA,NA,NA
239,MVLYIILAIIVIILIAVGVLFYLRSNKRQIIEKAIERKNEIETLPFDQNLAQLSKLNLKGETKTKYDAMKKDNVESTNKYLAPVEEKIHNAEALLDKFSFNASQSEIDDANELMDSYEQSYQQQLEDVNEIIALYKDNDELYDKCKVDYREMKRDVLANRHQFGEAASLLETEIEKFEPRLEQYEVLKADGNYVQAHNHIAALNEQMKQLRSYMEEIPELIRETQKELPSQFQDLKYGCRDLKVEGYDLDHVKVDSTLQSLKTELSFVEPLISRLELEEANDKLANINDKLDDMYDLIEHEVKAKNDVEETKDIITDNLFKAKDMNYTLQTEIEYVRENYYINESDAQSVRQFENEIQSLISVYDDILKEMSKSAVRYSEVQDNLQYLEDHVTVINDKQEKLQNHLIQLREDEAEAEDNLLRVQSKKEEVYRRLLASNLTSVPERFIIMKNEIDHEVRDVNEQFSERPIHVKQLKDKVSKIVIQMNTFEDEANDVLVNAVYAEKLIQYGNRYRKDYSNVDKSLNEAERLFKNNRYKRAIEIAEQALESVEPGVTKHIEEEVIKQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1664,NA,NA,NA,ezrA,Septation ring formation regulator EzrA,S230G,SAB mortality and SAB persistence,NA,NA,NA,NA
240,MRSDMIKKGDHQAPARSLLHATGALKSPTDMNKPFVAICNSYIDIVPGHVHLRELADIAKEAIREAGAIPFEFNTIGVDDGIAMGHIGMRYSLPSREIIADAAETVINAHWFDGVFYIPNCDKITPGMILAAMRTNVPAIFCSGGPMKAGLSAHGKALTLSSMFEAVGAFKEGSISKEEFLDMEQNACPTCGSCAGMFTANSMNCLMEVLGLTLPYNGTALAVSDQRREMIRQAAFKLVENIKNDLKPRDIVTREAIDDAFALDMAMGGSTNTVLHTLAIANEAGIDYDLERINAIAKRTPYLSKIAPSSSYSMHDVHEAGGVPAIINELMKKDGTLHPDRITVTGKTLRENNEGKEIKNFDVIHPLDAPYDAQGGLSILFGNIAPKGAVIKVGGVDPSIKTFTGKAICFNSHDEAVEAIDNRTVRAGHVVVIRYEGPKGGPGMPEMLAPTSSIVGRGLGKDVALITDGRFSGATRGIAVGHISPEAASGGPIALIEDGDEITIDLTNRTLNVNQPEDVLARRRESLTPFKAKVKTGYLARYTALVTSANTGGVMQVPENLI,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2006,NE718,ilvD,dihydroxy-acid dehydratase,ilvD,Dihydroxy-acid dehydratase,D289N,SAB mortality and growth rate,NA,NA,NA,NA
243,MNQHLLGNPKLTVTHVNEVKAGINHIVVDSVQYGNQEMIMEKDVTVEMRDGEKLYINIFRPNKDGKFPVVMSADTYGKDNKPKITNMGALWPTLGAIPTSSFTPEESPDPGFWVPNDYVVVKVALRGSDKSKGVLSPWSKREAEDYYEVIEWAANQSWSNGNIGTNGVSYLAVTQWWVASLNPPHLKAMIPWEGLNDMYREVAFHGGITDTGFYRFWTQGIFARWTDNPNIEDLIQAQQEHPLFDDFWKQRQVPLSQIKTPLLTCASWSTQGLHNRGSFEGFKHAASEEKWLYVHGRKEWESYYARENLERQKSFFDFYLKEENNDWKDTPHVIYEVRDQFYKGEFKSASAFPLPNTEYTPLYLNAENHTLNHAKISSAHVAQYDSEDKRQDVSFKYTFDKDTELVGNMNLKLWVSTTDSDDMDLFAGIKKLDRRGNEVNFPDFNHIENGQVATGWLRVSHRELDQEKSTIAQPWHKHETELKLSQDEIVPVEIELLPSGTLFKQGETLEVVVKGSEIVIGNSTPGMKTRYEHEETVNKGMHMIYTGSKYDSQLIIPIVN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2531,NE380,NA,"hydrolase, CocE/NonD family",cocE,Cocaine esterase,M541I,SAB persistence only,NA,NA,NA,NA
245,MEIILFLTMMVMIAYVFSGYLYRVALMQSSRVDLIFTRFENMCFKIIGTDLEHMSAKTYVKHFLAFNGFIGVITFVLLIVQQWLFLNPNHNLNQSIDLAFNTAISFLTNSNLQHYNGESGVTYLTQMIVMTYLMFTSSASGYAVCIAMLRRLTGLTNIIGNFYQDIVRFIVRVLLPLSCLISILLMTQGVPQTLHANLMIRTLSGHIQHIAFGPIASLESIKHLGTNGGGFLAGNSATPFENPNILSNFIEMGSMMLLPMSMLFLFGRMLSRHGKRVHRHALILFVAMFFIFIAILTLTMWSEYRGNPILANLGIHGSNMEGKEVRFGAGLSALFTVITTAFTTGSVNNMHDSLTSLGGLGPMVLMMLNVVFGGEGVGLMNLLIYVLLTVFICSLMVGKTPEYLNMPIGAREMKCIVLVFLIHPILILVFSALTFMIPGASESITNPSFHGISQAMYEMTSAAANNGSGFEGLKDDTTFWNISTGIIMLLSRYIPIILQLMIASSLVNKKSYHQDKYTIAIDKPYFGVSLIIFIVLLSGLTFIPVLLLGPIGEFLTLK,2,1,0,0,2,1,0,0,2,1,0,0,SAUSA300_2034,NE91,kdpA,"K+-transporting ATPase, A subunit",kdpA,Potassium-transporting ATPase potassium-binding subunit,S318P|V430F,SAB mortality and SAB persistence,NA,NA,NA,NA
247,MKTRLKFQVDKDLLLAIVVGVCGSLVALAMFFLSGYMVTQSALGAPLYALMILVVTVKLFGFLRAITRYVERLISHKATFTMLRDIRVQFFGKLVNVIPNVYRKLSSSDLISRMISRVEALQNIYLRVYYPPVVIGLTALVTVIVLAFISIGHALLIMVSMLFTLLIVSWLSSKKARTLKKHAANEQARFLNHFYDYKAGMDELRQFNQINHYRDNLMDKLNHFDKLQLKEQRFLTIYDFILNIIAMLSIFGSLVLGLIQINEGQLNIIYMTSIVLMILTLFEQAVPMTNVAYYKADTDQALHDINEVISVPSTNGKNRLNDKYDATNIYEVKDASFKYWNQQTYVLSDINFNVNRGEKIAIVGPSGSGKSTLLQIMAGLYQLDSGSIRFENMDMFKIDDKDKFESLNVLLQSQQLFDGTIRQNLFTDEKDEAVQAIFKQLDLEHLALERQIDLDGHTLSGGEIQRLAIARMLLKDTASTWILDEPTTALDKQNSLKVMDLIEAHAETLIVATHDLTLLSRFETIIVMINGKIVEKGNYQQLLANQGALWNMVQYNA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0671,NE364,NA,"ABC transporter, ATP-binding protein, MsbA family",NA,Putative multidrug export ATP-binding/permease protein,Q206R,SAB persistence only,NA,NA,NA,NA
249,MIKQINVSNMQKFESQLMKAQSEGYTHVVPYANEIMIYQSMLDAVQLYPKSIVVDYTVDGQYKNDCHYFGQSSINIADWAQNNNYYPNLIYAIQQTLDLIHYYSVETIFDLALLTLLKGDLSIDGHVVFDFKAPIATSASIWETIKTIEDFDMMSQFYLNKMAYIDHHPIPFRNLFIEDSEQLNSPDNWLYSTKFMLPKWLYKIAKQRADNKQLQNFGLYTKQPNVLKDHIVFIGDHHQYIGNSKYLFTYFVKHNPMTACYFVTDDRRGPHFISPKSEKADELINSARVVIVENDIPETLQPNGTLIQLHQGTPIMQLFLDSKEPIKNIETPFYRAKRYNRWLQFDYVIHSADDISHFYQTAFPSHQANVLAYGNPKHQYLLQKSNESTTQQQYKKSFKINDQKPVLLYAPIGLVSAQQLPLSDALFKAYHVVVQGVDEAILPEEALVAPKYLSAQDLILMSDVVITDYSNIIFDAMAIDKTVALYTPNHSQYIESQGVNEDIWRHLSKIWYTDRQLLINNLISQAIPVIKYPQIQHKEQPLESISQLILSKMTSNQ,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2314,NE1350,NA,conserved hypothetical protein,NA,hypothetical protein,A449S,SAB persistence only,NA,NA,NA,NA
251,MMKFHHRLMLLISSILIISFVTLGIIIHASITYVLSEKHEQALATDARSYIYLVQDNEIDKVKKIVKQQNIDLLITKHDKKVFSSGKLKAIPNSDSYIQKRDVFIFNKKVNGYHVWIKGYNNDITEMHWTLWKYLILTCLVVLICLYFASRSFKRTLIRPIQEVTYATQLLANGYYHIRVPESNVVETKALFVSTNDLARRLQKLNNEQKIQSNRLKTTIENIPSAILMIDRNGKIVVANKAYYEQFNISHNIEQVGYHGYVNTEIEQLILESFKVEKPIYEQLEVAINQVHAKYFDISCVPILTRSQKSLQGILVVMHDITNLKQLENLRREFVANVSHELKTPITSIKGFAETLIDGAKNDAESLDMFLNIILKESNRIESLVTDLLDLSHIEQHTELDTDYMNLSDLTRRIIDNMMTQANQKNISVHTDIEKDVIVKAQESKIAQVITNLLTNAINYSYEDGDINVRVYRDDFRVIFEVQDFGIGIKLEDQQRIFERFYRVDKARSRDSGGTGLGLSITKHIVEAHQGNIEVNSQVGKGSTFKVILKDYKE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1638,NE618,phoR,sensory box histidine kinase PhoR,sasA,Adaptive-response sensory-kinase SasA,V429I,SAB mortality and SAB persistence,NA,NA,NA,NA
252,MISNKYVDEYINLWKQGKIILNKERIDLFNYLQKHIYSRDDVYFDEHKIDDCIKFIEKWYFPTLPFQRFIIANIFLIDKNTDEAFFTEFAIFMGRGGGKNGLISAISDFLSTPLHGVKEYHISIVANSEDQAKTSFDEIRTVLMDNKRNKTGKTPKAPYEVSKAKIINRATKSVIRYNTSNTKTKDGGREGCVIFDEIHYFFGPEMVNVKRGGLGKKKNRRTFYISTDGFVREGYIDAMKHKIASVLSGKVKNSRLFAFYCKLDDPKEVDDRQTWEKANPMLHKPLSEYAKTLLSTIEEEYNDLPFNRSNT,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1941,NE708,NA,"phi77 ORF003-like protein, phage terminase,large subunit",NA,hypothetical protein,H47Q,SAB persistence only,NA,NA,NA,NA
253,MSESKEMVRGTFLITISILITKVLGVLFIIPFNYLIGGQENMAPFTYAYAPYNIAIAVATAGVPLAASKYVAKYNAIGAYKVSQKFYKSSFIVMSITGVLGFLVLYFLAPYISELTLARNIHDKNGWSVDDITWIIRIISMVVIFIPVLATWRGIFQGYKSMGPTAVSEVTEQIARVIFILIGSYLVLNVFDGSILLANGIATFAAAVGAIIGIFTLWYYWRKRKHNIDRMVESDYTDIDVSYGKMYKEIIAYSIPFVIVSLNYPLFNLVDQFTHNGALSLVGIPSQLQDIFFNMLNMSTNKIVMIPTSLSAGFAVSLIPYITKTFAEGRLHEMHHQIRTSIGVLMFITVPASIGIMALAQPLFTVFYGYDPIVLGHDPNHDGSRLLFYYAPVAILISLLSVTASMLQGIDKQKLTVYVILASVVIKLALNYPLIMLFHTPGAILSTSIALLFAIGCNFYILKKYAKFKFSYSWIHFAKIFLYSFIMMLGVELVFFLANLFLEPTKLGYLIIIILGVPVGILIYGTITIKTRLADEFLGEIPEKLRRRVRFLR,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1700,NA,NA,NA,murJ,Lipid II flippase MurJ,P518T,SAB mortality and SAB persistence,NA,NA,NA,NA
254,MRKIQAKKGLSIECKGWEQEAVLRMLYNNLDPEVAERPEDLVVYGGIGKAARNWEAFEAIEKTLRELESDETMLVQSGKPVAVFKTHEEAPRVLISNSVLVPEWANWDHFNELDKKGLIMYGQMTAGSWIYIGSQGIVQGTYETFAELGNQHFNGDLAGTVTLTAGLGGMGGAQPLAITMNHGVAICVDVDETRVDKRIDTKYCDVKTADLDEALKLAEEAKERGEGLSIGLVGNAVDIHQAILEKGFKIDIITDQTSAHDPLNGYVPQGYSVEEAKVLREKDPKKYVELSQASMAKHVELMLEFQKRGAVAFDYGNNIRQVAFNNGVKNAFDFPGFVPAYIRPLFCEGKGPFRFAALSGDPKDIERADEEMRKLFPENEKLLRWLDLAEEKISYQGLPSRIAWLGYGERAKMGLALNRLVRDGEISAPIVIGRDHLDAGSVASPNRETESMKDGSDAVGDWAVLNALINTAAGGSWISFHHGGGVGMGYSLHAGMVVVADGSERAERRLERVLTTDPGMGVARHVDAGYDIAIQTAKEKGIHIPMIDKAGDK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2278,NE435,hutU,urocanate hydratase,hutU,Urocanate hydratase,V499I,SAB mortality only,NA,NA,NA,NA
255,MTRKFRTLILILIATIALSGCANDDGIYSDKGQVFRKILSSDLTSLDTSLITDEISSEVTAQTFEGLYTLGKGDKPVLGVAKAFPEKSKDGKTLKVKLRSDAKWSNGDKVTAQDFVYAWRKTVDPKTGSEFAYIMGDIKNASDISTGKKPVEQLGIKALNDETLQIELEKPVPYINQLLALNTFAPQNEKVAKKYGKNYGTAADRAVYNGPFKVDDWKQEDKTLLSKNQYYWDKKNVKLDKVNYKVIKDLQAGASLYDTESVDDAVITADQVNKYKDNKGLNFVLTTGTFFVKMNEKQYPDFKNKNLRLAIAQAIDKKGYVDSVKNNGSIPSDTLTAKGIAKAPNGKDYASTMNSPLKYNPKEARAHWDKAKKELGKNEVTFSMNTEDTPDAKISAEYIKSQVEKNLPGVTLKIKQLPFKQRVSLELSNNFEASLSGWSADYPDPMAYLETMTTGSAQNNTDWGNKEYDQLLKVARTKLALQPNERYENLKKAEEMFLGDAPVAPIYQKGVAHLTNPQVKGLIYHKFGPNNSLKHVYIDKSIDKETGKKKK,3,2,0,1,1,1,0,1,3,2,0,1,SAUSA300_0891,NE440,oppA,"oligopeptide ABC transporter, substrate-binding protein",dppE|oppA,Dipeptide-binding protein DppE|Oligopeptide-binding protein OppA,K89I|A493fs|T137fs|I89K,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
257,MVNLEEDFAYKIPFKDVIQVELDETLGNKPIRITYGDTKRSFTNYISIGTIKDSKEIINVIERGRDTQNHIHNIIEEVLVDNRPQLHPLNDRFEEVEINGKYYGALDGLLLDNPNQYKPNIDELDELNKEKDLLRITISKSKSKYFETAINLMKRFDNFEFEDNKYSIKVTSDMEYLEHRDDIENIFFLIKNWKNKEIYLEGKIYKKYLIEYREFVSHTENRIKRILNYSYGDSFDFVLNDDNRAHITYYPLDHQTKFFAFRDSFDQEPYMCSCTKKALHKLKVNKLNVKECLPPVIKAYLNDENTDIINEIQFKDNICFRCNKTTPNRIYSSNDSKFRKYHGWYIDQVQIENDLDNDIYGKEAENILREEYGVAKIGEGWISETMMFRIVEDIFEGYECERHCRPNFLEGLEIDIYIPELKLGFEYNGIQHYKPVEHWGGEESLKKQQARDKHKQQLCDQNDVKLIIIKYDEQLSKDLILSKIPVEYLVEDKSK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,L4Q,SAB mortality and SAB persistence,NA,NA,NA,NA
259,MKQRIGAYLIDAIHRAGVDKIFGVPGDFNLAFLDDIISNPNVDWVGNTNELNASYAADGYARLNGLAALVTTFGVGELSAVNGIAGSYAERIPVIAITGAPTRAVEQAGKYVHHSLGEGTFDDYRKMFAHITVAQGYITPENAATEIPRLINTAIAERRPVHLHLPIDVAISEIEIPTPFEVTAAKDTDASTYIELLVSKLHQSKQPIIITGHEINSFHLHQELEDFVNQTQIPVAQLSLGKGAFNEENPYYMGIYDGKIAEDKIRDYVDNSDLILNIGAKLTDSATAGFSYQFNIDDVVMLNHHNIKIDDVTNDEISLSSLLQQLTDISYTNNASFPAYHRPTSPDYTVGTEPLTQQTYFKMMQNFLKPNDVIIADQGTSFFGAYDLALYKSNTFIGQPLWGSIGYTLPATLGSQLADKDRRNLLLIGDGSLQLTVQAISTMIRQHIKLVLFVINNDGYTVERLIHGMYEPYNEIHMWDYKALPAVFGGKNVEIHDVESSKDLQEVFNTINGHPDVMYFVEVKMSVEDAPKKLIDIAKAFSQQNK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0190,NE1149,ipdC,indole-3-pyruvate decarboxylase,ipdC,Indole-3-pyruvate decarboxylase,L450P,SAB mortality and SAB persistence,NA,NA,NA,NA
260,MSKEIDWRKSVVYQIYPKSFNDTTGNGIGDINGIIEKLDYIKLLGVDYIWLTPVYESPMNDNGYDISNYLEINEDFGTMDDFEKLIKVAHQKDLKVMLDIVINHTSTEHEWFKEARKSKDNPYRDYYFFRSSEDGPPTNWYSKFGGNAWKYDSETDEYYLHLFDVSQADLNWDNPEVRQSLYRIVNHWIDFGVDGFRFDVINLISKGEFKDSDKIGKEFYTDGPRVHEFLHELNRQTFGNTDMMTIGEMSSTTIENCIKYTQPERQELNSVFNFHHLKVDYVDGEKWTNAKLDFHKLKEILMQWQRGIYDGGGWNAIFWCNHDQPRVVSRFGDDTSEEMRIQSAKMLAIALHMLQGTPYIYQGEEIGMTDPHFTSIAQYRDVESINAYHQLLSEGHAEADVLAILGQKSRDNSRTPMQWSDDVNAGFTAGKPWIDISENYHQVNVRQALQNKESIFYTYQKLIQLRHTHDIITYGDIVPRFMDHDHLFVYERHYKNQQWLVIANFSASAVDLPEGLAREGCVVIQTGTVENNTISGFGAIVIKTNA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0449,NE856,treC,"alpha,alpha-phosphotrehalase",treA,Trehalose-6-phosphate hydrolase,K543E,SAB persistence only,NA,NA,NA,NA
261,MSYSIGIDYGTASGRVFLINTTNGQVVSKFVKPYTHGVIESELNGLKIPHTYALQNSNDYLEIMEEGISYIVRESKIDPDNIVGIGIDFTSSTIIFTDENLNPVHNLKQFKNNPHAYVKLWKHHGAYKEAEKLYQTAIENNNKWLGHYGYNVSSEWMIPKIMEVMNRAPEIMEKTAYIMEAGDWIVNKLTNKNVRSNCGLGFKAFWEEETGFHYDLFDKIDPKLSKVIQDKVSAPVVNIGEAVGKLDDKMAQKLGLSKETMVSPFIIDAHASLLGIGSEKDKEMTMVMGTSTCHLMLNEKQHQVPGISGSVKGAIIPELFAYEAGQSAVGDLFEYVAKQAPKSYVDEAENRNMTVFELMNEKIKHQMPGESGLIALDWHNGNRSVLSDSNLTGCIFGLTLQTKHEDIYRAYLEATAFGTKMIMQQYQDWHMEVEKVFACGGIPKKNAVMMDIYANVLNKKLIVMDSEYAPAIGAAILGAVSGGAHNSINDAVDAMKEPILYEINPEAEKVQRYETLFKAYKALHDIHGYKKANIMKDIQSLRVEG,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0537,NE704,NA,L-ribulokinase,araB,Ribulokinase,E497G,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
262,MNKDKQLHNDKINLSQLVLLGLGSLIGSGWLFGAWEASSIAGPAAIISWVLGFLVIGTIAYNYIEIGTMFPQSGGMSNYAQYTHGSLLGFIAAWANWVSLVTIIPIEAVSAVQYMSSWPWHWAKPMRYLMENGSISTYGLLAVYLIIVIFSLLNYWSVKLLTSFTSLISVFKLGVPMLTIIMLMLSGFDTSNYGHSASTFMPYGSAPIFAATTASGIIFSFNSFQTIINMGSEIKNPEKNIARGIAISLSISAVLYIILQSTFITSMPQSMLQHSGWNGINFNSPFADLAILLGINWLAILLYIEAFVSPFGTGVSFVAVTGRVLRAMEKNGHIPKFLGKMNEKYNIPRVAIIFNAIISMIMVTLFRDWGTLAAVISTATLVAYLTGPTTVIALRKMGPTMTRPFRAKILKVMAPLSFVLASLAIYWAMWPTTAEVILIIILGLPIYFFYEYRMNWRNTKKQIGGSLWIIVYLIVLSILSFIGSKEFKGLNMIHYPFDFIVIIIVALIFYYIGTTSSFESVYFRRATRINTKMREALNNESKSSH,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2395,NE1131,-,amino acid permease,yveA,Aspartate-proton symporter,A536S,Growth rate and cell death,+,0,-,0
263,MKKLTTILFQYKIFPVLMFLVSTGLGILVITQNILIADFLAKIIRHQFQGLWIVLFILLGVLLLRATVQFLNQWLGDTLAFKVKHMLRQRVIYKNNGHPIGEQMTILTENIDGLAPFYKSYLPQVFKSMMVPLIIIIAMFFIHFNTALIMLITAPFIPLFYIIFGLKTRDESKDQMTYLNQFSQRFLNIAKGLVTLKLFNRTEQTEKHIYDDSTQFRTLTMRILRSAFLSGLMLEFISMLGIGLVALEATLSLVVFHNIDFKTAAIAIILAPEFYNAIKDLGQAFHTGKQSEGASDVVFEFLEQPNNNNEFLLKYEENQKPFIQLTDISFRYDNSDRLVLNDLNLEIYNGDQIALVGPSGAGKSTLTHLIAGVYQPTIGTISTNQRDLNIGILSQQPYIFSASIKENITMFKDIENNTIEEVLDEVGLLDKVQSFTKGINTIIGEGGEMLSGGQMRRIELCRLLVMKPDLVIFDEPATGLDIQTEHMIQNVLFQHFKDTTMIVIAHRDNTIRHLQRRLYIENGRLIADDRNISVNITENGDDL,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0670,NE844,-,ABC transporter ATP-binding protein,cydD,ATP-binding/permease protein CydD,R225L,Growth rate and cell death,-,5,+,0
266,MYERKLVMQKSALFAPEKYNIISEIEKYSHIPDKKAILYHNTEGEDISVTYQQLIEQSNKVGNVLASHGLSKGDKVLIMMPRSIATYELYIAALKLGVAIIPCSEMLRTKDLQYRITHGEINAVIALEPFTVEFEKIKEYDALTKFVIAGQKDGWISLEAEKENASNKLEMADTTRDDMAILSYTSGTTGNPKAVTHCHGWGFAHLQMAPKHWLCINEDDLVWATAAPGWQKWVWSPFLSVLGSGATAFVFNGRFSPETYLELLQKYQINVLCCTPTEYRMMAKLQNLNDYDLTHLHSAVSAGEPLNREVVEQFKKYFNLTVRDGYGQTESTLLIGFLKDTPQRIGSMGKGIPGSSVTVVDDEGNSVPANTKGNIAVPLDLPALFKGYYKEPERTAKAQTGKYYITA,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2542,NE1036,-,putative AMP-binding enzyme,acsA_1,Acetyl-coenzyme A synthetase,A407fs,SAB mortality and SAB persistence,NA,NA,NA,NA
268,MDCKVVSLNEKDQFIPKIKSSDPVITGLFQYDAAQQTSFEKRMSKENNGREAALANVIREYMSDLKLSSEQELNIQHLANGSKVVIGGQQAGLFGGPLYTFHKIFSIITLSKELTDTHKQQVVPVFWIAGEDHDFDEVNHTFVYNENHGSLHKVKYHTMEMPETTVSRYYPDKAELKQTLKTMFIYMKETVHTQGLLEICDRIIDQYDSWTDMFKALLHETFKAYGVLFIDAQFEPLRKMEAPMFKKILKKHQLLDDAFRATQQRTQNQGLNAMIQTDTNVHLFLHDENMRQLVSYDGKHFKLNKTDKTYIKEEIINIAENQPELFSNNVVTRPLMEEWLFNTVAFVGGPSEIKYWAELKDVFELFDVEMPIVMPRLRITYLNDRIEKLLSKYNIPLEKVLVDGVEGERSKFIREQASHQFIEKVEGMIEQQRRLNKDLLDEVAGNQNNINLVNKNNEIHIQQYDYLLKRYLLNIERENDISMKQFREIQETLHPMGGLQERIWNPLQILNDFGTDVFKPSTYPPLSYTFDHIIIKP,2,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1071,NE230,NA,conserved hypothetical protein,bshC,Putative cysteine ligase BshC,Y186H,SAB mortality only,NA,NA,NA,NA
269,MSTNQTFLIFVIAIILLTSVIGIVGRYMSRQRLLKSMETLWQTISPLEAFIRPNSHFDYEYKLYKEKFESHSLVDDKTWSDLNMNAIFHKMNYNLTAIGEMKLYACLRGMLSITNKSLLSLFNDNAEFRKNVTYHLALIGKTVYPTFPDQITPVKRQNILFLCPFLPVISFAVIFINSQVGILLFLMSCLFNIILSATLKRTYEDDLKSIFYASNVLKQGYTISKIKHAPQPEVNFKQFRTARHLTSVLAEVNDEDIGAMVIKLVKLIFMLDYVLFHSIQKSYTTHMNELKNCFDYIAELDNHYALAMYRRTLECYTEPQIDDSNDGIVFSELTHPLIADAVANDFSLSQNILLTGSNASGKSTFMKSIAINIILASAIQTVTASKFVYQPGIVFTSMANADDVLSGDSYFMAELKSIKRIVEIPDNQKIYCFIDEIFKGTNTTERIAASESVLSFLHEKSNFRVIAATHDIELAELLKQRYENYHFNEVIENNNIHFDYKIKPGKANTRNAIELLKITSFPAKIYERAKDNVPKI,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_2001,NE93,NA,similar to DNA mismatch repair protein,mutS_2|mutS_1,DNA mismatch repair protein MutS,N131fs,all,NA,NA,NA,NA
270,MNAIKRFGSAMIVPVLMFAFFGIVLGFATLFKNPTIMGSLADQHTFWFKFWSVIESGGWVIFTHMEVVFVVGLPLSLAKKAPGHAALAALMGYLMFNTFINAILTQWPHTFGANLEKGVENVPGLKSIAGIATLDTNILGGIIISAIITWIHNRYYSKRLPEMVGVFQGLTFVVTISFFVMLPLAAITCVIWPTVQHGIGSMQHFIIASGYIGVWLYHFLERVLIPTGLHHFIYAPIEVGPVVVNHGLKAEWLQHLNEFAKSTKLLKEQFPYGFMLQGNGKVFGCLGIALAMYATTPKENRKKVAALLIPATLTAVVVGITEPLEFTFLFIAPYLFVLHAVLAASMDTLMYAFGVVGNMGGGLLDFISTNWLPLGKEHWGTYVAQVIIGLIFVAIYFFLFRFLILKFDIPLPGRKKTEEEVKLFSKQDYKNKKGDSVDSKRASSGNEYEDKAAYYLDGLGGKENIKDVTNCTTRLRLTVYDESKVADTEYFTHQQMAHGLVKSGKSIQVVVGMTVPQVREAFEQMVEDQSSEDK,2,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_2270,NE648,glvC,"PTS system, arbutin-like IIBC component",malP,PTS system maltose-specific EIICB component,L265P,all,NA,NA,NA,NA
273,MSNLLEVNSLNVQFNYDETTVQAVKNVSFELRKKHILGIVGESGSGKSITAKSILGLLPDYPDHTLTGEIIFNGQSLTNLSTSALQQIRGKDISMIFQDPLSSLNPRLTIGKQITEVLFQHKRVSKSEAKSMTIDILEKVGIKHATRQFDAYPHELSGGMRQRVMIAMALILKPQILIADEPTTALDASTQNQLLQLMKSLYEYTETSIIFITHDLGAVYQFCDDVIVMKDGSVVESGTVESIFKSPQHTYTKRLIDAIPDIHQTRPPRPLNNDILLKFDRVSVDYTSPSGSLYRAVNDINLDIRKGETLGIVGESGSGKSTLAKTVVGLKEVSEGFIWYNELPLSLFKDDELKSLRQEIQMIFQDPFASINPRFKVIDVIKRPLIIHGKVKDNDDIIKTIVSLLEKVGLGQSFLYRYPHELSGGQRQRVSIARALAVEPKVIVCDEAVSALDVSIQKDIIELLKQLQLDFGITYLFITHDMGVINEICDRVAVMKNGEIVELNNTEDIIKHPQSDYAKQLISEVAVIAK,1,1,1,2,1,1,1,1,1,2,1,1,SAUSA300_0200,NE392,NA,"peptide ABC transporter, ATP-binding protein",gsiA,Glutathione import ATP-binding protein GsiA,R89L,all,NA,NA,NA,NA
275,MSEPQKLHPISYFNGIINAIKQNIVVFFIFIIFQLKDFDYTNPESYLWIGIVFVFFLISYISQIVGIMNTRYWIEDNYFILTTGIFNKKRKELNIKRIQSVDMTQGVVNQIIGGVDLQIKTPSDGIVLSVISKKQGEYLERYIDQLQTELKTEVAQKSSAEKNDNCNHDIEGNVEDIAEGRLDEVQNTDSMLNKKNKRIPIYQMNFKESLFMAMTSGAIGVTLAALVPIYGAVRELIPWSKLNHEISQWVQIVSISVLIIILLVLIVAYIIGTIITMIRFYGFSVMLENEQLKIEYGLFNKKKVTVPTKRLQAVVERQSYIRRLFGYTAIHFIITSDFENKKIEDDDNDSGSVPILPFIKRDKAYQIIQNLVPDLSYQQVNEGMPLSGFHRHFLIPSIIVIAMAGIGCYFWNQLLLLFTIITIVIIGLFVIKGYLYVKHAGFKMTEEQITIQNFELLKRNIYYFKAHHIIGFDTWQHTLLKRNNLNNFSFIVAKGVGAQSINLKYARSEDANKLKSWYLRGENDEGL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2030,NE1520,-,hypothetical protein,NA,hypothetical protein,K194Q,SAB mortality and SAB persistence,NA,NA,NA,NA
276,MYDFLEYLHRYCVKSINNWEAVADISCKVVREKVSKGYYVKQDSVVIDDNDIPSIIKISGNYVAADILVTRYLDGMGEFIKVSELDQSSYYEWFMFVEETRRIFRGTEIVYRFLKYLFTHTYEHKNEEQKIEKYMKNIIIDNHFRGGHSNDIVRLDMKDDNVLFYNFDIYDTNILYEKIDEEKLLRILDEISNTDNYKALFNIVSENQKKFCKSNIKKIVSEFLEDINTIPFDLYVYVNKYISNKIFNCDNYLITKNEVVDFYFNHGSDFNNFKMGQKWTKSKFKQENKLKIHEYIIAVTYVNFLNHSDMKYINAENYYDPSKKITKGMKNNYHKFTDSFSDFVEMVDDITWRIRDSFDYIGGLKNKEFNEDENEYIEQLIQFVILSKFGYMNVENHFDYIENLNTLNNELTTILKSEFAHISNDMYNNLFSNLFDVVNTWKKDYSNNFYNNTQNTITTEKLDIISRFIKQYDKPVDRDKHGKRVKAEVFEGISDFHRRVKEGFDNNDVLLQLRLEMSVHENDKFTS,0,1,0,0,0,1,0,0,0,4,0,0,NA,NA,NA,NA,NA,hypothetical protein,D309Y|F304L|F223C|K218P,SAB persistence only,NA,NA,NA,NA
278,MMPRKFRVLQIGGDDLEPIFQHKKGVSWDYFDIGLFEFDSGYVEAIEAIVEAEGRFDFIYIQAPYSETLTNLLQMISEPYNTYVDESFWSVEYEQDENVQKIRCSTITLPEH,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2586,NE975,NA,accessory secretory protein Asp2,NA,hypothetical protein,K4fs,Growth rate and cell death,NA,NA,NA,NA
285,MENTINESEKKKRFKLKMPGAFMILFILTVVAVIATWVIPAGAYSKLSYEPSSQELKIVNPHNQVKKVPGTQQELDKMGVKIKIEQFKSGAINKPVSIPNTYERLKQHPAGPEQITSSMVEGTIEAVDIMVFILVLGGLIGVVQASGSFESGLLALTKKTKGHEFMLIVFVSILMIIGGTLCGIEEEAVAFYPILVPIFIALGYDSIVSVGAIFLASSVGSTFSTINPFSVVIASNAAGTTFTDGLYWRIGACIVGAIFVISYLYWYCKKIKNDPKASYSYEDKDAFEQQWSVLKDDDSAHFTLRKKIILTLFVLPFPIMVWGVMTQGWWFPVMASAFLIFTIIIMFIAGTGKSGLGEKGTVDAFVNGASSLVGVSLIIGLARGINLVLNEGMISDTILHFSSSLVQHMSGPLFIIVLLFIFFCLGFIVPSSSGLAVLSMPIFAPLADTVGIPRFVIVTTYQFGQYAMLFLAPTGLVMATLQMINMRYSHWFRFVWPVVAFVLIFGGGVLITQVLIYS,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1064,NE496,NA,"transporter, TRAP family",NA,hypothetical protein,I484L,SAB persistence only,NA,NA,NA,NA
286,MKYMIGVDIGTTSTKSVLYDENGTFIMKHQIGYDLHTPNVDVSEENPDELFDAVLMTIKYVMRESKVNKDDIKFVSFSAQMHSLIAMDQQHQRLTNNITWADNRAARYATVINEVHDGNAIYQRTGTPIHPMSPLAKIFWMKHEWQDVFQRTAKFADIKTYIFYHLFDTYIIDYSMASATGMFNLETLDWDVEALELLGISKEMLPELVPTTYVMKGMKERYATLMGLNKDTPFVIGASDGVLSNLGVNSVGKGEVAVTIGTSGAIRTVIDKPRTDYKGRIFCYVLTEDHYVIGGPVNNGGVVLRWLRDELLASEVETAKRLGVDPYDVLTQIAKRVKPGADGLIFHPYLAGERAPLWNANARGSFFGLTLSHKKEHMIRAALEGVLYNLYTVYLALIEVMNETPKMIKATGGFAKSEVWRQMMSDIFDTELVVPESYESSCLGACVLGLKAVGDIEDFSIVSSMVGATNNHTPIEENVTVYQEIVSIFINLSRSLTENYEQIADFQRQHIAENKTQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2443,NE1124,gntK,gluconate kinase,xylB,Xylulose kinase,R107K,SAB mortality only,NA,NA,NA,NA
287,MKKKLGMLLLVPAVTLSLAACGNDDGKDKDGKVTIKTTVYPLQSFAEQIGGKHVKVSSIYPAGTDLHSYEPTQKDILSASKSDLFMYTGDNLDPVAKKVASTIKDKDKKLSLEDKLDKAKLLTDQHEHGEEHEHEGHDHEKEEHHHHGGYDPHVWLDPKINQTFAKEIKDELVKKDPKHKDDYEKNYKKLNDDLKKIDNDMKQVTKDKQGNAVFISHESIGYLADCYGFVQKGIQNMNAEDPSQKELTKIVKEIRDSNAKYILYEDNVANKVTETIRKETDAKPLKFYNMESLNKEQQKKDNITYQSLMKSNIENIGKALDSGVKVKDDKAESKHDKAISDGYFKDEQVKDRELSDYAGEWQSVYPYLKDGTLDEVMEHKAENDPKKSAKDLKAYYDKGYKTDITNIDIKGNEITFTKDGKKHTGKYEYNGKKTLKYPKGNRGVRFMFKLVDGNDKDLPKFIQFSDHNIAPKKAEHFHIFMGNDNDALLKEMDNWPTYYPSKLNKDQIKEEMLAH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2351,NE568,NA,Zn-binding lipoprotein adcA-like protein,NA,hypothetical protein,H147dup,SAB mortality and SAB persistence,NA,NA,NA,NA
288,MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSIMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATTLVGGIIMIIISIVVYLLIPKSLDITKQK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,qacA,Antiseptic resistance protein,T486A,SAB mortality only,NA,NA,NA,NA
291,MSQTEEKKGIGRRFQAFGSFLSSMIMPNIGAFIAWGFIAAIFIDNGWLPNKDLATLAGPMITYLIPLLIAFSGGRLIYDLRGGIIAATATMGVIVALPDTPMLLGAMIMGPLVGWLMKKTDQLIQPRTPQGFEMLFNNFSAGILGFIMTIAGFKILAPLMKFIMHILSVAVEALVHAHLLPLVSILVEPAKIVFLNNAINHGVFTPLGADQAAKAGQSILYTIESNPGPGLGILLAYMIFGKGTAKATSYGAGIIHFLGGIHEIYFPYVLMRPLLFIAVILGGMTGVATYQATGFGFKSPASPGSFIVYCLNAPRGEFLHMLLGVFLAALVSFVVAALIMKFTREPKQDLEAATAQMENTKGKKSSVASKLVSSDKNVNTEENASGNVSETSSSDDDPEALLDNYNTEDVDAHNYNNINHVIFACDAGMGSSAMGASMLRNKFKKAGINDITVTNTAINQLPKDAQLVITQKKLTDRAIKQTPNAIHISVDNFLNSPRYEELLNNLKKDDQA,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_2105,NE929,mtlF,"PTS system, mannitol specific IIBC component",mtlA,PTS system mannitol-specific EIICB component,A57T,all,NA,NA,NA,NA
297,MKSLFEKAQQFGKSFMLPIAILPAAGLLLGIGGALSNPNTVKAYPILDITLLQNIFTLMSAAGSIVFQNLPVIFAIGVAIGLSRSDKGTAGLAALLGFLIMNATMNGLLTITGTLAKDQLAQNGQGMVLGIQTVETGVFGGIITGIMTAILHNKYHKVVLPPYLGFFGGSRFVPIVTAFAAIFLGVLMFFIWPSIQAGIYHVGGFVTKTGAIGTFVYGFILRLLGPLGLHHIFYLPFWQTALGGTLEVKGHLVQGTQNIFFAQLGDPDVTKYYSGVSRFMSGRFITMMFSLCGAALAIYHTAKPEHKKVVGGLMLSAALTSFLTGITEPLEFSFLFVAPILYVIHAFFDGLAFMMADIFNITIGQTFSGGFIDFLLFGVLQGNSKTNYLYVIPIGIVWFCLYYIVFRFLITKFNFKTPGREDKAAAQQVEATERAQTIVAGLGGKDNIEIVDCCATRLRVTLHQNDKVDKVLLESTGAKGVIQQGTGVQVIYGPHVTVIKNEIEELLGD,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0236,NE450,NA,"PTS system, IIBC components",ptsG_1,PTS system glucose-specific EIICBA component,S290G,SAB mortality and SAB persistence,NA,NA,NA,NA
298,MKKQSEEFLKEIEGIKKDNPELKDFNEEEQLKCYLELNKLENQILMLGKTFYQNYRDDVESLYSKLDLIMGYKDEERANKKAVNKRMLENKKEDLETIIDEFFSDIDKTRPNNIPVLEDEKQEEKNHKNMAQLKSDTEAAKSDESKRSKRSKRSKRSLNTQNHKPASQEVSEQQKAEYDKRAEERKARFLDNQKIKKTPVVSLEYDFEHKQRIDNENDKKLVVSAPTKKPTSPTTYTETTTQVPMPTVERQTQQQIIYNAPKQLAGLNGESHDFTTTHQSPTTSNHTHNNVVEFEETSALPGRKSGSLVGISQIDSSHLTEREKRVIKREHVREAQKLVDNYKDTHSYKDRINAQQKVNTLSEGHQKRFNKQINKVYNGK,1,1,0,0,1,1,0,0,2,2,0,0,SAUSA300_0773,NE1181,-,putative staphylocoagulase,NA,hypothetical protein,G14D|Y34D,SAB mortality and SAB persistence,NA,NA,NA,NA
301,MGSSIVLKLLKVTHYYRNKQNKKWYLPFGYDAEDIDLNNISLHIYQGEALGIIGEPESSKALVGQLLAGAIKPDKGKVVCTEDLFYGYIEDQSLIHQTVEAYTAQLVQLFPYEINDHKAEQIIQYAHLGDYKTKPVNHISKAAYAQLLLSIARSSKSNIIILNHVIDYLTPQFMERAIELTNDYIENNLTIVSIGDDIDKISQVSNYIAWFSHGQLRMEGSLKQVIPSFKEHERDRLSLNSKEEIENFDLDWKKNRTRIPEMTYNFKRVERYNHAKPPKFLVRFWTLASGTILGLALMMLLIFNNIGIISITDFTNRATMQNENKDPYGEKLAYGIAFNGSVDMQGDKQVTIPKYSVVTITGENSKNYRVTADNKTYYVSKDKLEYFNPAGLYQTHSFKKLAPYMKSNYSNYYAYFNSQLHKKHSSVIKTLVPDDDNRFVASVTQQPIQLLFNDNNQ,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1852,NE977,NA,"putative ABC transporter, ATP-binding protein",tagH_2,Teichoic acids export ATP-binding protein TagH,Ter458Lext*?,SAB persistence only,NA,NA,NA,NA
305,MIYSVGNRLGNKLTGIEKAMINRHNLFKNHSITSKLIFASWSPRLHFNASLFQIEDDDILSLYDVLQDSINIKSIHKDWITHWTKECNYTLKFIENTNDIKIYEKSNYRMYVHFNDSNYQHLDYINHFDVNQRKIRRDLYDSRGFLSCSRTLTTNQKVVCEHYYTPEGTIKFQKFFNPELENSQSQLIIYNTDSQLKYFNNDQELLAFAIEKLYKNGDIFLSDKNINTAPIFNNTSETIPVLAVLHSTHVKNIDMVYESDIKNTYKHVFNNLNRYSGIIVSTKQQQLDISARINNEIPVHTIPVGYIDEHFTNLKRNNHSINNNKIISVARYSPEKQLNHQIELVSKLIKEFPNIQLHLYGFGKEEEKYKQLITEYNLENNVFLRGFRRNLSAEIQDAYMSLITSNMEGFNLGLLETITEGIPPVGYNSKYGPSELILNNENGYIINKNDKDELYNRVRNLLLDKTLRDTFSQECIKHSKAFSSKIVMKLWEDRFSTINSSYE,2,1,0,0,1,1,0,0,2,1,0,0,NA,NA,NA,NA,gtfA_4,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase GtfA subunit,I445L|Y328S,SAB mortality and SAB persistence,NA,NA,NA,NA
306,MRENFKLRKMKVGLVSVAITMLYIMTNGQAEASENQNALISNINVDNQEKQNNVNQAVQPQNNTNETSKVPANFVKLNDIKPGDTSIQGTTLPNQFILLTIDKKDVSSVEDSDSSFVMSDKDGNFKYDLNGRKIVHNQEIEVSSSDPYLGDDEEDEEVEETSTEEVGAEEESTEAKATYTTPRYEKAYEIPKEQLKEKDGHHQVFIEPITEGSGIIKGHTSVKGKVALSINNKFINFETNANGGPNKEEAKSGSEGIWMPIDDKGYFNFDFKTKRFDDLELKKNDEISLTFAPDDEDEALKSLIFKTKVTSLEDIDKAETKYDHTKVEKVKVLKDVKEDLHVDEIYGSLYHTEKGKGILDKEGTKVIKGKTKFANAVVKVDSELGEGQEFPDLQVDEKGEFSFDVDHAGFRLQNGETLNFTVVDPITGELLSGNFVSKNIDIYESPEEKADREFDERMENTPAYHKLHGDKIVGYDTNGFPITWFYPLGEKKVERKAPKLEK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0408,NE985,-,hypothetical protein,NA,hypothetical protein,D84Y,SAB mortality and SAB persistence,NA,NA,NA,NA
307,MNFDWIKTRSDFDDDKPAVIDHAKQTSWTYQQLNARADNMAHYLTSQGVKKGDVIGIFAPNDIAILDLLFACFKTGAVFLPLNWRLNPKEIAAIVEDAQLKLLFYAEKHLSSLTDIDQNLLHMDIDVAQYDEIVNPDYHQPFQATPVEPQDLAALIYTSGTTGSPKGVMFSYESFVHNGANLELTYKFNSNYITIVSTPMFHVLGFNDTVLPVLMSGGTLILQRYFNGEELNDMIAQYHPTFIIMIPTMYYSTLRASNFNPENFKAMDYIIQGGSQPLPSIQAAFKQYGINIINGYGLTEAPLVLVNTPENSKRKPMSIGKAVMFVDARILDDNGEEVPTGEIGELAIKAKNATPGYWNKPAETAKAFHGRYLLTGDLAKMDDDGDIFIIDRKKELIITGGENVLPSEVENALAEHPLVDRCVVVGYDHPKYGESIAAAIILREDEPHYAEILDQHMRSRLAGYKVPRMYVPVTHMPLNSTQKPDKLAIRQMMNDKVSQTL,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0228,NE539,fadE,acyl-CoA synthetase FadE,lcfB,Long-chain-fatty-acid--CoA ligase,K166I,SAB mortality and growth rate,NA,NA,NA,NA
308,MRVAIIGMGTAGVSVLRELVKHPKFNQLDIDLYDDKVNMGQGVPFQNDSSELLINMPSKKMSLNLDDETEFWKWYKQQTDFNFDEPAYLPRFVFGHYMKSYLSMFTKKYPNISTNYNKVQEIYTNSNIDETNLTYYICTTNSGQSWQAYDYVFLTCGTFAYHDPYNLKGKKGYIATPYPTYNTLDEVNELDDIAIIGTGLASLDVVRYVAAHHPKLPITMTSRSAHLPSVRGTMIDVTFKYLTKDKLNDIKKHHFGNAPLDTLVSLFLKECADYDIDFKKLVHRRTGNHIADLKYDLARPTEMGIFQSMIEHLKENLNWIWNSLSIEDQHQFNQKYSKMIQLNSNPMPPRTAELIIELIENKSLILKKDLEDVKHDGKLYYFSYKNQESVDIYNVVINATGAKSHLNELDQDNQLIRNLENRQIVQAHPMGGIQIIPETNQVISPRFGTLTNMIAIGQMTNGVNKLRNGVEMIVEQVAHTVSQLYDALESNEQQQRSDNQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1716,NE583,NA,conserved hypothetical protein,NA,hypothetical protein,E471K,SAB mortality only,NA,NA,NA,NA
312,MEKYILSIDQGTTSSRAILFNQKGEIAGVAQREFKQYFPQSGWVEHDANEIWTSVLAVMTEVINENDVRADQIAGIGITNQRETTVVWDKHTGRPIYHAIVWQSRQTQSICSELKQQGYEQTFRDKTGLLLDPYFAGTKVKWILDNVEGAREKAENGDLLFGTIDTWLVWKLSGKAAHITDYSNASRTLMFNIHDLEWDDELLELLTVPKNMLPEVKASSEVYGKTIDYHFYGQEVPIAGVAGDQQAALFGQACFERGDVKNTYGTGGFMLMNTGDKAVKSESGLLTTIAYGIDGKVNYALEGSIFVSGSAIQWLRDGLRMINSAPQSESYATRVDSTEGVYVVPAFVGLGTPYWDSEARGAIFGLTRGTEKEHFIRATLESLCYQTRDVMEAMSKDSGIDVQSLRVDGGAVKNNFIMQFQADIVNTSVERPEIQETTALGAAFLAGLAVGFWESKDDIAKNWKLEEKFDPKMDEGEREKLYRGWKKAVEATQVFKTE,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1192,NE1587,glpK,glycerol kinase,glpK,Glycerol kinase,M391V,SAB persistence only,NA,NA,NA,NA
313,MTKHIIVIGGGLGGISAAIRMAQSGYSVSLYEQNNHIGGKVNRHESDDFGFDLGPSILTMPYIFEKLFEYSKKQMSDYVTIKRLPHQWRSFFPDGTTIDLYEGIKETGQHNAILSKQDIEELQNYLNYTRRIDRITEKGYFNYGLDTLSQIIKFHGPLNALINYDYVHTMQQAIDKRISNPYLRQMLGYFIKYVGSSSYDAPAVLSMLFHMQQEQGLWYVEGGIHHLANALEKLAREEGVTIHTGTRVDNIKTYERCVTGVRLDTGEFVKADYIISNMEVIPTYKYLLHLDTQRLNKLEREFEPASSGYVMHLGVACQYPQLAHHNFFFTENAYLNYQQVFHEKVLPDDPTIYLVNTNKTDHTQAPVGYENIKVLPHIPYIQDQPFTTEDYAKFRDKILDKLEKMGLTDLRKHIIYEDVWTPEDIEKNYRSNRGAIYGVVADKKKNKGFKFPKESQYFENLYFVGGSVNPGGGMPMVTLSGQQVADKINAREAKNRK,3,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2501,NE468,NA,phytoene dehydrogenase,crtP,"4,4'-diaponeurosporene oxygenase",Y140fs,SAB mortality only,NA,NA,NA,NA
314,MNYFVGNSLGVNLTGIEKAIINRLNLFKEMGRPAQCVFLSWNRYLYRNAQNYITSSDYINMYDFFQEATYLERNEPFDWLSYWTDECHYTLKHVENSHDFRIYDQERFLMYAHFQDPKYRILDYVNHFDSQRRKVKRDFYDVRGFLSCSRILVDKQQTLCEFFYNPEGDTKLEKYFSYKDGKPEVQKIIVYYANKQYFFNNETELGAFFIKQLYQHGDLFFSDRNVYTAPIFNLTPESIPVVAVLHSTHIKNIDALDSSPFKNVYKAMFENLSRYRAIIVSTEQQKLDVEKRINHTIPVVNIPVGYSETIDTPVQTLDQRSVKLISVARYSPEKQLHQQIELIKRLVSYVPKIELHMYGFGSESKKLNELIQKYGLENHVYLRGFLSNLDQEYSDAYLSLITSNMEGFSLALLESLAHGVPVISYDIKYGPNELITSDFNGYLITKNDEDALFDKVKYVIDHPEVQQRLSKGSLAKAQQYSKASLIKQWDQFVRLI,2,0,1,1,1,0,1,1,2,0,1,1,SAUSA300_0550,NE105,NA,"glycosyl transferase, group 1 family protein",gtfA_2|gtfA_1,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase GtfA subunit,A477V|N3Y,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
316,MDDKQHTSSSDDERAEIATSNQDQETNSSKRVHLKRWQFISILIGTILITAVITVVAYIFINQKISGLNKTDQANLNKIENVYKILNSDYYKKQDSDKLSKAAIDGMVKELKDPYSEYLTKEQTKSFNEGVSGDFVGIGAEMQKKNDQIMVTSPMKGSPAERAGIRPKDVITKVNGKSIKGKALDEVVKDVRGKENTEVTLTVQRGSEEKDVKIKREKIHVKSVEYKKKGKVGVITINKFQNDTSGELKDAVLKAHKDGLKKIVLDLRNNPGGLLDEAVKMANIFIDKGKTVVKLEKGKDTEAIQTSNDALKEAKDMDISILVNEGSASASEVFTGALKDYNKAKVYGSKTFGKGVVQTTREFKDGSLLKYTEMKWLTPDGHYIHGKGIKPDVTIDTPKYQSLNVIPNTKTFKVGDDDKNIKTIKIGLSALGYKVDNESTQFDKALENQVKAFQQANKLEVTGEFNKETNNKFTELLVEKANKHDDVLDKLINNLK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1313,NE847,ctpA,carboxyl-terminal protease,NA,putative CtpA-like serine protease,N494I,SAB mortality only,NA,NA,NA,NA
317,MKTIQLHKTTLILIAILLFYTFMGILLPLMHDDLQWFSNYNTDILKVGFASLNGRYIGNIFEIIAVHVSWLRWLSYGLISMGIIWMIMHITRCKAWTSYYLLAFSLMLILPSAIYADTYGWFAGFYNYATSTLISLFIIYYCINAIIYKEKQPVSVTVLFYVLCFFGQLFMENVTLFHCIILILAFLYEFTANRTLNYKLLFSFMIATIGTIIMFSNPNYRKILFEGSEYQQVSNNQGIFSKFAEMISTSLPYGVIFSQIIILSMIAALIIYLLLRSDRYVHLTILKRRIIMIGFITLPLYYLLFYNQFLLNKNTDIGLVGFVNVIVCGYFAFSIFVGIYLSINDRKTQITLYSLLIAICVSASTLVIVTPIEPGNFLIVYTIHVIILIILLKEFRKYKSINVNLIKGASLVLAVIYLSAFIYVHYEHEKRVQLLKQQIKDYPRQEVYTVESLPFEHYMHHPSPINKNYQEWFNNYEELPKMTKVKYIPFGSDDS,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_1637,NE716,NA,putative membrane protein,NA,hypothetical protein,Y442H,all,NA,NA,NA,NA
319,MFNYSGLNEECGVFGIWNHPEAAQLTYMGLHSLQHRGQEGAGIVVSDQNELKGERGLGLLTEAIKDDQMERLKGYQHAIGHVRYATSGNKGIENIQPFLYHFYDMSVGICHNGNLINAKSLRQNLEKQGAIFHSSSDTEVIMHLIRRSKAPTFEEALKESLRKVKGGFTFAILTKDALYGAVDPNAIRPLVVGKMKDGTYILASETCAIDVLGAEFVQDIHAGEYVVINDKGITVKSYTHHTTTAISAMEYIYFARPDSTIAGKNVHAVRKASGKKLAQESPVNADMVIGVPNSSLSAASGYAEEIGLPYEMGLVKNQYVARTFIQPTQELREQGVRVKLSAVKDIVDGKNIILVDDSIVRGTTIRRIVKMLKDSGANKVHVRIASPEFMFPSFYGIDVSTTAELISASKSPEEIKDYIGADSLAYLSVDGLIESIGLDYDAPYSGLCVESFTGDYPAGLYDYEANYKAHLSHRQKQYISKNKHFFDSEGNLNV,1,2,2,2,1,1,1,1,1,1,2,2,SAUSA300_0972,NE581,purF,amidophosphoribosyltransferase,purF|purF_1|purF_2,Amidophosphoribosyltransferase,S32N|Ter279Qext*?,all,NA,NA,NA,NA
325,MNQAVIVAAKRTAFGKYGGTLKHLEPEQLLKPLFQHFKEKYPEVISKIDDVVLGNVVGNGGNIARKALLEAGLKDSIPGVTIDRQCGSGLESVQYACRMIQAGAGKVYIAGGVESTSRAPWKIKRPHSVYETALPEFYERASFAPEMSDPSMI,3,1,0,0,1,1,0,0,3,1,0,0,SAUSA300_0560,NE1227,vraB,acetyl-CoA c-acetyltransferase,yhfS|fadA_1,Putative acetyl-CoA C-acetyltransferase YhfS|3-ketoacyl-CoA thiolase,Ter154Qext*?|M1fs|M372fs,SAB mortality and SAB persistence,NA,NA,NA,NA
328,MYQLEDDSLMLHNDLYQINMAESYWNDNIHEKMAVFDLYFRKMPFNSGYAVFNGLKRVIDFIEHFGFSESDLEYLKSIGYKDDFLSYLKDLKFTGSIRSMQEGELCFGNEPLLRVEAPLIQAQLIETILLNIVNFHTLITTKASRIRQIASNDKLMEFGTRRAQEIDAALWGARAAYIGGFDSTSNVRAGKLFGIPVSGTHAHAFVQTYGDEYVAFKKYAERHKNCVFLVDTFHTLKSGVPNAIKVAKELGDKINFVGIRLDSGDIAYLSKEARRMLDEAVFTETKIIASNDLDEETITSLKAQGAKVDSWGVGTKLITGYDQPALGAVYKLVAIENEDGSYSDRIKLSNNAEKVTTPGKKNVYRIINKKTGKAEGDYITLENENPYDEQPLKLFHPVHTYKMKFIKSFEAIDLHHNIYENGKLVYQMPTEDESREYLALGLQSIWDENKRFLNPQEYPVDLSKACWDNKHKRIFEVAEHVKEMEEDNE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1894,NA,NA,NA,pncB2,Nicotinate phosphoribosyltransferase pncB2,V281G,SAB mortality and SAB persistence,NA,NA,NA,NA
329,MENVTNDEVFEMIDSRTGVLNANDWKSQLRRSATTQALKKTTTNAEIILCNDESLKGVVQYDAFEKVTKLKRLPYWRSKGDANYYWADIDTTHVISHIDKLYNVQFSRDLIDTVIEKEAYQNRFHPIKSMIESKSWDGIKRIETLFIDYLGAEDNHYNREVTKKWMMGAVARIYQPGIKYDSMIILYGGQGVGKSTAVSKLGGHWYNQSIKTFKGDEVYKKLQGSWICEIEELSAFQKSTIEDIKGFISAIVDIYRASYGKRTERHPRQCVFVGTTNNYEFLKDQTGNRRFFPITTDKNKATKSPFDDLTPDVVQQMFAEAKVYFDENPTDKALLLDKEASEMALKVQEAHSEKDALVGEIEEFLERPIPSDYWYRTLEEKRVSAHDVIDQDYIKLYGDGKLIELPNTKPGAYVWRDKVCSMEIWKVMMKRDDQPQQHHLRKIDKALRNTNYCGTVKKQTRYGEGIGKQYGFSVDLASYYKNLKV,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,V58L,SAB mortality only,NA,NA,NA,NA
330,MYKFFQNLGRSLMLPVAILPAAAIIAGIGNTLNALHATPKIAMFFTTVGTTILEQLGILFAIGVAIGMAKKNDGAVALAATLGYFLVTVVLSPMKLAPLLGMKASEINSAFEKMNNGNVFVGIVIGLIAAYAYNKFSETELPLALSFFSGKRLVPIMTAFYCTFLVVILLFLWPLLYSWIVKFGESIVGLGSFGAFIYGVANRLLIPTGLHHALNSVFWFDTIGINDIGKFQSGKDAIKGITGRYQAGFFPIMMFGIPAAALAMYHTAKTTQKKQVYGWFLASSVAAFFVGVTEPIEFAFMFVAPILYVVHALLTGLSLFIAATFHWTAGFSFSAGLIDYVLSLINPVSNHPLMLLVQGVVFFILYYVIFRVVIQVFNLNTIGRGENELVDPTVVKDNIAPGENDIKQSKYHQHAIQILEGLGGQENIVNLTNCATRLRLELKDTSIIDKQKIKNAGAVGVTVNGKHSTQVIVGTHVQQVADEIEKHL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1672,NE1457,nagE,"phosphotransferase system, N-acetylglucosamine-specific IIBC component",nagP,PTS system N-acetylglucosamine-specific EIICB component,T50A,SAB persistence only,NA,NA,NA,NA
335,MSNNFKDDFEKNRQSIDTNSHQDHTEDVEKDQSELEHQDTIENTEQQFPPRNAQRRKRRRDLATNHNKQVHNESQTSEDNVQNEAGTIDDRQVESSHSTESQEPSHQDSTPQHEEEYYNKNAFAMDKSHPEPIEDNDKHDTIKNAENNTEHSTVSDKSEAEQSQQPKPYFTTGANQSETSKNEHDNDSVKQDQDEPKEHHNGKKAAAIGAGTAGVAGAAGAMAASKAKKHSNDAQNKSNSGKANNSTEDKASQDKSKDHHNGKKGAAIGAGTAGLAGGAASKSASAASKPHASNNASQNHDEHDNHDRDKERKKGGMAKVLLPLIAAVLIIGALAIFGGMALNNHNNGTKENKIANTNKNNADESKDKDTSKDASKDKSKSTDSDKSKEDQDKATKDESDNDQNNANQANNQAQNNQNQQQANQNQQQQQQRQDGGQRHTVDGQENLYRIAIQYYGSGSPENVEKIRRANGLSGNNIRNGQQIVIP,1,1,0,0,1,1,0,0,1,2,0,0,SAUSA300_1370,NE1561,ebpS,cell surface elastin binding protein,ebpS,Elastin-binding protein EbpS,D434G|I340M,SAB mortality and SAB persistence,NA,NA,NA,NA
341,MNYKQSAEEILNAIGGEENLDAMAHCATRLRLVLNDESLVNEEALNNMDVVKGTFSTGGQYQIIIGSGTVNKVFSELEKLTGKKASTTSEVKAQSAKNMNPLQRFVKMLSDIFVPIIPAIVAGGLLMGLNNILTAKDLFFSGKSLIDVYSQFAGLAEMINVFANAPFTLLPILIGFSAAKRFGGNPFLGAALGMILVHPSLMSAYDFPKAVEAGKAIPYWDVFGLHINQVGYQGQVLPMLVAAYILASIEKGLRKVIPTVLDNLLTPLLSIFITAFLTFSFVGPITRQLGYWLSDGLTWLYEFGGAIGGLIFGLLYAPIVITGMHHSFIAVETTLIADATKTGGSFIFPIATMSNVAQGGAAIAAFFIIKQNKKLKGVASAAGISALLGITEPAMFGVNLKLRYPFIGAIVGSGIGSAYIAFFKVKAIALGTAGLPGFISINPVHAGWLHYFVGMTISFIIAITVTLILSKRKANKEVVE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2324,NE767,NA,"PTS system, sucrose-specific IIBC component",treP_1,PTS system trehalose-specific EIIBC component,K84E,SAB mortality and SAB persistence,NA,NA,NA,NA
342,MANVELTTRRRNFIIAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIALVAFIFGLISISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALIISMVIIYLFIRRQFNISNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFSSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2126,NE12,NA,"drug resistance transporter, EmrB/QacA subfamily",farB_2,Fatty acid resistance protein FarB,I15V,SAB persistence only,NA,NA,NA,NA
343,MSKKQKLTMIITMLMGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQVFLVGISIFFLGTLLSGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYMGIFGLVIGLAPAIGPTLSGYLVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTSSISEKGFDNPIVLVSMIGGVVLVALFVLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMIGSETILPIFVQNLFHRSALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRNLALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVMTHTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYNGMNKIDMMNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2360,NE179,NA,multidrug resistance protein,emrB,Multidrug export protein EmrB,F291L,SAB mortality and SAB persistence,NA,NA,NA,NA
344,MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYDGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD,4,2,1,1,1,1,1,1,3,2,1,1,NA,NA,NA,NA,aacA-aphD,Bifunctional AAC/APH,E104G|Q438K|P361T,all,NA,NA,NA,NA
346,MLCLPIHKCVNLFYTFVYHSNLLKIILQGVISIITYLESFKSLYHKAFYKFVLSVLSLPLFLYAVIKFFFSAKRKNFYANNSEISEIEQALHQKYKYLSQQKSSTQIHKEALKIFKTQSSNTNSKNIEQAHFSTYFENVLFHKFIIIKVILALPMFILLTIYLQPLVRYIFERIVMAVIVIIGVIVSVFSILYFSPLDAAYSILGQNATKAQIHQFNVLHHLNEPYFIQLWDTIKGVFTFDLGTTYKGNDVVTKAVGERIPITIIVAVLALIVALIIAIPIGIISAMKRNSWLDITLMIIALIGLSIPSFWQGLLFILAFSLKLDILPPSYMPEHPISLILPVLVIGTSIAASITRMTRSSVLEVMRSDYVLTAYAKGLSTTQVVIKHILKNAIIPIVTLVGLLVAELLGGSAVTEQVFNINGIGRYIVQKQLIPDIPAVMGGVVYISIVISLANLIIDIFYALIDPKLRSEINERK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0201,NE541,NA,"peptide ABC transporter, permease protein",NA,hypothetical protein,L22P,SAB mortality only,NA,NA,NA,NA
350,MLSVKKATKFAVANLIIVSTVFSSVTPAIAQSDKSSKDESFAVGNTKNPKNVIFLVGDGMGPSFNTAYRYYKNDPHAKEMTPTAFDSYLKGTNRTYSNDPKQNITDSAAGGTAFSSGHKTYNGAIGVDSNKQKVKTVLERAKEKGKSTGLVSTAELTDATPAAYAAHVTSRDDKNEIAKQFYKDKINGKHKVDVLLGGGAKYFGKSNGNLDKKFKKDGYDLATNSKELSKSDKDKVLGLFADKNMPLAIDASKDEPSLADMQQSALSKLERNKKGFFLMVEGASIDKSAHSNDITGVMSEMEGFEKAFDDAIQYAKKHKDTLVVATADHSTGGLTIGKDKGYEWNPQPIKSMKHSASYMTEKMAKGEDPEKVINEGYGFEFSQDDMKKVKKENKKLKRLLKKRKR,2,2,0,0,1,1,0,0,2,1,0,0,SAUSA300_2561,NE1081,phoB,alkaline phosphatase,phoB,Alkaline phosphatase 3,R403fs|S417A,SAB mortality and SAB persistence,NA,NA,NA,NA
351,MSEKQYDLVVLGGGTAGYVAAIRASQLGKKVAIVERQLLGGTCLHKGCIPTKSLLKSAEVFQTVKQAAMFGVDVKDANVNFENMLARKEDIINQMYQGVKHLMQHNHIDIYNGTGRILGTSIFSPQSGTISVEYEDGESDLLPNQFVLIATGSSPAELPFLSFDHDKILSSDDILSLKTLPSSIGIIGGGVIGMEFASLMIDLGVDVTVIEAGERILPTESKQASQLKKKSLSARGVKFYEGIKLSENDINVNEDGVTFEISSDIIKVDKVLLSIGRKPNTSDIGLNNTKIKLSTSGHILTNEFQQTEDKHIYAAGDCIGKLQLAHVGSKEGVVAVDHMFEGNPIPVNYNMMPKCIYSQPEIASIGLNIEQAKAEGMKVKSFKVPFKAIGKAVIDSHDTNEGYSEMVIDQSTEEIVGINMIGPHVTELINEASLLQFMNGSALELGLTTHAHPSISEVLMELGLKAESRAIHV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1467,NE1896,lpdA,dihydrolipoamide dehydrogenase,NA,Dihydrolipoyl dehydrogenase,K228L,SAB mortality and SAB persistence,NA,NA,NA,NA
353,MGIGHVTQVMGPVIDVRFEHNEVPKINNALVIDVPKEEGTIQLTLEVALQLGDDVVRTIAMDSTDGVQRGMDVKDTGKEISVPVGDETLGRVFNVLGETIDLKEEISDSVRRDPIHRQAPAFDELSTEVQILETGIKVVDLLAPYIKGGKIGLFGGAGVGKTVLIQELINNIAQEHGGISVFAGVGERTREGNDLYFEMSDSGVIKKTAMVFGQMNEPPGARMRVALSGLTMAEYFRDEQGQDVLLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLATEMGQLQERITSTTKGSVTSIQAVFVPADDYTDPAPATAFAHLDATTNLERKLTEMGIYPAVDPLASTSRALEPSIVGQEHYEVACDVQSTLQKYRELQDIIAILGMDELSDEDKQTVERARRIQFFLSQNFHVAEQFTGQKGSYVPVKTTVANFKDILDGKYDHIPEDAFRLVGSMDDVIAKAKDMGVEV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2058,NE1049,atpD,F0F1 ATP synthase subunit beta,atpD,ATP synthase subunit beta,H5R,SAB mortality and SAB persistence,NA,NA,NA,NA
354,MEEHYYVSIDIGSSSVKTIVGEKFHNGINVIGTGQTYTSGIKNGLIDDFDIARQAIKDTIKKASIASGVDIKEVFLKLPIIGTEVYDESNEIDFYEDTEINGSHIEKVLEGIREKNDVQETEVINVFPIRFIVDKENEVSDPKELIARHSLKVEAGVIAIQKSILINMIKCVEACGVDVLDVYSDAYNYGSILTATEKELGACVIDIGEDVTQVAFYERGELVDADSIEMAGRDITDDIAQGLNTSYETAEKVKHQYGHAFYDSASDQDIFTVEQVDSDETVQYTQKDLSDFIEARVEEIFFEVFDVLQDLGLTKVNGGFIVTGGSANLLGVKELLSDMVSEKVRIHTPSQMGIRKPEFSSAISTISSSIAFDELLDYVTINYHDNEETEEDVIDVKDKDNESKLGGFDWFKRKTNKKDTHENEVESTDEEIYQSEDNHQEHKQNHEHVQDKDKDKEESKFKKLMKSLFE,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1079,NA,NA,NA,ftsA,Cell division protein FtsA,N317T,SAB mortality and SAB persistence,NA,NA,NA,NA
356,MWKEKVQQYEDQIINDLKGLLAIESVRDDAKASEDAPVGPGPRKALDYMYEIAHRDGFTTHDVDHIAGRIEAGKGNDVLGILCHVDVVPAGDGWDSNPFEPVVTEDAIIARGTLDDKGPTIAAYYAIKILEDMNVDWKKRIHMIIGTDEESDWKCTDRYFKTEEMPTLGFAPDAEFPCIHGEKGITTFDLVQNKLTEDQDEPDYELITFKSGERYNMVPDHAEARVLVKENMTDVIQDFEYFLEQNHLQGDSTVDSGILVLTVEGKAVHGMDPSIGVNAGLYLLKFLASLNLNNNAQAFVAFSNRYLFNSDFGEKMGMKFHTDVMGDVTTNIGVITYDNENAGLFGINLRYPEGFEFEKAMDRFANEIQQYGFEVKLGKVQPPHYVDKNDPFVQKLVTAYRNQTNDMTEPYTIGGGTYARNLDKGVAFGAMFSDSEDLMHQKNEYITKKQLFNATSIYLEAIYSLCVEE,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1697,NE1898,-,dipeptidase PepV,NA,Putative dipeptidase,N293D,SAB mortality only,NA,NA,NA,NA
357,MSIDMYLDRSRNQASSVGNLSQTMNSNYDALEKAITQFINDDALKGKAYTSAKQFFSTVLIPLSTSMKTLSDLTKQACDNFVSRYTSEVDSISLKESELEEDIRSLSQQITRYENLNNNLKKHASDNQQAISSNQQIIRTLGQQKHELEEKLRKLREFNQKSPEIFKEVEEFQKIVQQGLTQAQNFWNFSTNQFNIPSGKELDWAKASHEKYLKVAMGKIEHKAEKETLNKADFAVIKAYAKEHPEDDIPKSILKYINDNKDSFKRDIGLDITSTLLEQGGINASKFGVFINTAGGVKGPAGPNSFVEVKRTSGNVFIENGSKFAKGGKYLGKGVAGVGFGIGMYDDLANDDKTFGEALSHNGMTLAAGSAGTAVGAGLATFVLGSNPVGWVILAGLAMSTVFALGTDLIYQNNIFGLKDKVDWVGHKIDNSIDVVKKTTEKSMDSVGNAVSEAKNIISNHINPMKWAW,2,2,2,1,1,1,1,1,1,1,1,1,SAUSA300_0579,NE219,NA,conserved hypothetical protein,NA,hypothetical protein,F264I|I264F,all,NA,NA,NA,NA
358,MNNSNFLNVELIGTKIITMEDFYKMKEEEFFLKSKLPLYLYSFNYVDEYTMKLLDRGRISILNTKTNKDCIFDISKYIHENIIFRRDIFELNDIRDDDLKYKINGYNIEVYLSGELEKIVKHLFENKFDVEYGFYILFIKPIFEIVFSSNYVKEEFNTKIESSEYRESLDSFNEILMKYLENEINFKEVWKKYIDELFKKLNVQKLLIHKKIDSLISSYDKKISDDCSMYSKVFEQYKKTLYWIKYITLKFINIVII,5,2,1,0,1,1,1,0,9,4,1,0,SAUSA300_2167,NE1088,NA,conserved hypothetical protein,NA,hypothetical protein,T240fs|N142fs|F3I|N67fs|V47D|N25K|Ter85Eext*?|K181N|L160I,"SAB mortality, SAB persistence and growth rate",+,2,+,0
361,MDTAGIRLTPKEIVSKLNEYIVGQNDAKRKVAIALRNRYRRSLLDEESKQEISPKNILMIGPTGVGKTEIARRMAKVVGAPFIKVEATKFTEVGYVGRDVESMVRDLVDVSVRLVKAQKKSLVQDEATAKANEKLVKLLVPSMKKKASQTNNPLESLFGGAIPNFGQNNEDEEEPPTEEIKTKRSEIKRQLEEGKLEKEKVRIKVEQDPGALGMLGTNQNQQMQEMMNQLMPKKKVEREVAVETARKILADSYADELIDQESANQEALELAEQMGIIFIDEIDKVATNNHNSGQDVSRQGVQRDILPILEGSVIQTKYGTVNTEHMLFIGAGAFHVSKPSDLIPELQGRFPIRVELDSLSVEDFVRILTEPKLSLIKQYEALLQTEEVTVNFTDEAITRLAEIAYQVNQGTDNIGARRLHTILEKMLEDLSFEAPSMPNAVVDITPQYVDDKLKSISTNKDLSAFIL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1147,NE1708,hslU,ATP-dependent protease ATP-binding subunit HslU,hslU,ATP-dependent protease ATPase subunit HslU,G410D,SAB mortality and SAB persistence,NA,NA,NA,NA
362,MEKPSREAFEGNNKLLIGIVLSVITFWLFAQSLVNVVPILEDSFNTDIGTVNIAVSITALFSGMFVVGAGGLADKYGRIKLTNIGIILNILGSLLIIISNIPLLLIIGRLIQGLSAACIMPATLSIIKSYYIGKDRQRALSYWSIGSWGGSGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSISLNKFDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITLLAIAIGSFSLFIVLEKRATNPLIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYSSLQAGSLSITYLVMVLIMIRVGEKLLQTLGCKKPMLIGTGALIVGECLISLTFLPEIFYVICCIIGYLFFGLGLGIYATPSTDTAIANAPLEKVGVAAGIYKMASALGGAFGVALSGAVYAIVSNMTNIYTGAMIALWLNAGMGILSFVIILLLVPKQNEIMIIEN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1328,NE1184,-,putative drug transporter,norB_4,Quinolone resistance protein NorB,A341V,SAB mortality only,NA,NA,NA,NA
363,MLKVSDLRLKYPSGQRKIFDHLNITIQDKKKVLLLGPSGCGKSTLLNVLSGIVPNLIELPMKYDELIVDPLSGVIFQDPDSQFCMPKVYEELAFVLENRQLPREDMDALIINALNMVNLNVTPETYIKDLSGGMKQKLAIVETILQQSKTLFLDEPTAMLDVQATEDLWTKLIELWEDQTVVIVEHKVKHIWNHVDRVILMDYNGNIIADECPEIILQKYVHLLSEYGVWHPRAWEFAPSRVDFPTTNSHLLQFKNGRIIRGKSTLLSFSDLEIGLGEWITITGANGSGKTTLLESIMQLIKYQGDVYFENQRLTKIKHAAKHMYLVYQNPELQFITNSVYDEINIHFNHLSKDQSDDETIQLLKLLDLQNVKDQHPYELSIGQKRRLSVATALSSKADIIFLDEPTFGLDSHNTFQLIKLFQKRINLGQSIVMVTHDDEIIERYPSRRLKISDGALLDCDGDTNV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0978,NE1380,NA,"ABC transporter, ATP-binding protein",ykoD_2,Putative HMP/thiamine import ATP-binding protein YkoD,K30E,SAB mortality and SAB persistence,NA,NA,NA,NA
369,MAKDMDTIVSLAKHRGFVFPGSDIYGGLSNTWDYGPLGVELKNNVKKAWWQKFITQSPFNVGIDAAILMNPKVWEASGHLNNFNDPMIDNKDSKIRYRADKLIEDYMQDVKGDENFIADGLSFEQMKKIIDDEGIVCPVSKTANWTEIRQFNLMFKTFQGVTEDSTNEIFLRPETAQGIFVNYKNVQRSMRKKLPFGIGQIGKSFRNEITPGNFIFRTREFEQMELEFFCKPGEEIEWQNYWKTFASDWLTSLNMSSENMRLRDHDEDELSHYSNATTDIEYKFPFGWGELWGIASRTDFDLRKHAEHSGEDFRYHDPETNEKYIPYCIEPSLGADRVTLAFLCDAYDEEGVEGSKDARTVLHFHPALAPYKAAILPLSKKLSGEAIKIFEQLSSKFSIDFDESQSIGKRYRRQDEIGTPYCVTFDFDSLEDNQVTVRDRDSMEQVRMPISELEAFLTEKTKF,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1525,NA,NA,NA,glyQS,Glycine--tRNA ligase,I294V,SAB mortality only,NA,NA,NA,NA
370,MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGADMGTISIAVSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPALLILGRIIQGVSAACIMPSTLAIMKTYYEGAERQRALSYWSIGSWGGSGICSLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEVTNTHKFDVAGLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKVDNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQAGYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVIIGIALISLVFLPGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMASSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFAIPNDDKRVKDAK,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_0106,NE1804,-,putative drug transporter,norB_3|norB_4|norB_2,Quinolone resistance protein NorB,L53I,SAB mortality and cell death,NA,NA,NA,NA
374,MNKSSNSIPMSTQLLEEYTSEEGDIRFTKVKLWLMHTGLNLNGSVFNKDVVEKAIPTLANTPIMASVSYNFDGEKDFEGHETDIEITEDGEIKLINSTVPFGVIPETNNAKFETRLGDDMVEREYLTCEGILWNKWDDAVEILQSKGGVTGQSMEISPNYTGYFDGENMIFETFSFYGACLLGDDVTPAMKNSTVEIKYAAKTDELIKEKLQVFNNIVYANKGGNEVPKKDTTVFDEQETHVNAQGDSTTGKNVEGEPKANANEASTKEEKSLETDGQEGQEREEKASEETLIDSPLSAEEQVTVQVENVEDIIDTHKEVKEDIDNLPEAVDMITVAGVEYSAEDIAAKLTELASVKSQLAEYQSKFEALQKEVHAEKVEKLFSTHKDSLSIESIEKLKAQADGITLPELETLIFAEIGRQNYSAKPKAETKATNFSQIAIPVNKTSNNSLEDIVASWK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,P328L,SAB mortality only,NA,NA,NA,NA
375,MENNELQRGLSARQIQMIALGGTIGVGLFMGATSTIKWTGPSVILAYLIAGIFLFLIMRAMGEMIYLNPTTGSFATFASDYIHPAAGYMTAWSNIFQWIVVGMSEVIAVGEYMKFWFPELPTWIPGVIAILLLMAANLFSVKAFGEFEFWFALIKVVTIILMIIAGFGLIFFGFGNGGHAVGISNLWTNGGFMPNGIVGFFFALSIVIGSYQGVELIGITAGETKDPQKNIVKAVNGVIWRILIFYLGAIFVIVSVYPWNQLGDIGSPFVATFAKIGITFAAGLINFVVLTAAMSGCNSGIFSASRMIYTLAHKGEMPKIFTKIMRNGVPLYTVVAVSLGILIGALLNVILPLYIDGAKSIFVYVYSASILPGMIPWFMILFSHLRFRKLHPEELEGHPFKMPGGAVTNYLTILFLILALVGMVFNVETRISVLIGVIFLTIVTIYYFIRYNKNNVKAK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2265,NE1435,NA,putative amino acid permease,yifK,putative transport protein YifK,A419V,SAB mortality only,NA,NA,NA,NA
380,MTAETNYFWLNCGYNRWNHNEPLVGQTALFESGAHFNPSQGFRAFKKAKVGDQVIFYQVQTDTGLLGCGEIISVETGAQNKIRVQFRFNEQLKPLTADYLKRSEALEFRISNMKETLFNQITAEEFDLISGLGKGEIKIPRYFFLAETEEFEPGNQYTIYTHTYNGIKRNGYHFYTQLEEGDNIIFYNRTKNQSVVGIGEVSKHIHEKPPIPGRTNSTVIEVSYEKDITPITLSTLNKHPKLKNLYFLQENAKQAIASMSQAQYDAIIEMSDNNGLKSPFEMVQKPDMLESEKEEALKPFILLVVDRKEEGLKAANDLLQKANANPVITTGHPDFSEDMLYGKYLPNETGALYYREGFITQLMPKKDKSYLVIDNFNRIDTDIFQTYINVLEGYEVTLPRYNKDGNMIKWSRQKDSFYYFNPNWHIVGITYDSLEEIKEKYSEQFLKYTRIVKVKHD,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_2094,NE1458,NA,conserved hypothetical protein,NA,hypothetical protein,P209T,SAB mortality and cell death,NA,NA,NA,NA
382,MKIIKRAIISLIILSLLISITMSNASASEELYYSVEYKNTATFNKLVKKKSLNVVYNIPELHVAQIKMTKMHANALANYKNDIKYINATCSTCITSEKTIDRTSNESLFSRQWDMNKITNNGASYDDLPKHANTKIAIIDTGVMKNHDDLKNNFSTDSKNLVP,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1763,NE1019,epiP,lantibiotic epidermin leader peptide processing serine protease EpiP,NA,hypothetical protein,Ter164Lext*?,SAB mortality only,NA,NA,NA,NA
384,MTIFPDFLENKTMFDEKDFFDGNKFKFYEFALFLYEEYHGCYIDNRPHVFTGKKYEPLNIDVVRKITIKYIPSLREQQNKEVFQKLKTLCLGNHQEQCPARYIGLKNGIYDTVEERLNPFSPQYYITNIIDVDFDKGAQSDLIERFIKDISNEDEEVEQLIYEMIGYGLYRDNFLQVAFFYYSPGGNGKTTLLKLLHHFYNPENTTALSFNDLNDKFKPANLQGKLVNIADDIDPNRIKDTGNFKIIVTGNYITLEFKGQDAFEFKPYVKLIFASNELPMSNDKSEGFYRRMVIIPMLRKFGKGGQKKDPMLLNKLITPHNMSALLNLALKGLKRTLENNEIIEPKIARKTKEEYQFENNPVLQFIEVATDKDYRQLPVVEGRNTDKAYEIYQIWCVNNGYHHLNKFNFSKELAKIGYKTVSYYSRVEEKSKRFYKKENTINIYDVDGSILKKLTE,1,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,V368D|H95Q,SAB mortality only,NA,NA,NA,NA
385,MDSFSRKEIVIGRLKFITMSLIGILLFLVPIPVEQDGQKQTTLPVAFLAGVLKDVLGGVMPFLIVTIITLSGIITLICSTILKDKLKPDGLMNNAFNVRIGWLILRILAVVFAWMTFLRIGSKVIYSDETGGLLFSSLLPTLVAVFLFAALFLPLLMEYGLLEMLGPIFRPVMRPLFTLPGRSTVDNLASFIGDGTVGVLITSRQYGEGYYSRREATVISTIFSVVSITFAIVVAETVHMQNQFFAFYLSVIVSCLVAAVIMPRIWPLNKIPDEYAKEVPESARTEALPEGKTALRHGFDTATEVGIKAPGVIDFFKSGLKTVIDMWFVILPVVMSIGTIATIIANYTPFFVILGKPFVPFLELMQIPEAAQASQTIIIGFADMFLPSILIEGVQNDITRFVIGALSISQLIYLSEVGGVILGSKIPVSIGKLFMIFLIRTIITLPIISLMAHLLL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2133,NE1478,-,transporter gate domain-containing protein,NA,hypothetical protein,I222T,SAB mortality and SAB persistence,NA,NA,NA,NA
387,MDTVEISRFLTAMTLAVHIIFATIGVGMPLMFAIAEFLGIRKNDLQYIAMAKRWAKAYTITVAVGVVTGTIIGLQLSLIWPTFMEMGGHVIALPLFMETFAFFFEAIFLSIYLYTWDRFKNKWTHFLISIPVIIGGSFSAFFITSVNSFMNTPAGFELKNGKMVNVQPIEAMFNPSFIVRSFHVITTAGMTMAFVIASIAAFKLLRNRQPKDTVYHKKALKMSMIVGFFSTLLSMLAGDLSAKFLHKFQPEKLAAYEWHFDTSSHAKLLLFGVLDEKTQQVKGAIELPGLLSFLADNSVKTKVQGLNDFPKSLHPPMIVHYFFDLMVTMGILCFVISGVYVLTLMFKKLRKFSTHKWMLYGILLTGPASMLAIEFGWFLTEMGRQPWIVRGYMRVAEAATQAGGITFVTILFGILYIILMYTCAYVLIRMFKNKPAYEDVNRLAKKQGGEIEK,1,2,1,1,1,1,1,1,2,3,1,1,SAUSA300_0986,NE117,NA,"cytochrome D ubiquinol oxidase, subunit I",ythA,Putative cytochrome bd menaquinol oxidase subunit I,R390C|G33A,all,NA,NA,NA,NA
388,MAEKLQRELSNRHIQLIAIGGAIGTGLFLGAGQTIALTGPSILLTYIIIGFMLFMFMRGLGEIIIQNTEFKSFADVTNTYIGPFAGFVAGWTYWFCWIITGMAEVTAVAKYVSFWFPEIPNWISALFCVLLLMSFNLLSARLFGELEFWFSIIKIATIIGLIVVGFVMILFAFKTQFGHASFTNLYEHGIFAKGASGFFMSFQMALFSFVGIEMIGVTAGETKDPVKTIPKAINSVPIRILIFYVGALAVIMSIIPWQQVDPDNSPFVKLFALIGIPFAAGLINFVVLTAAASSCNSGIFSNSRMLFGLSSQQQAPPNFTKTNKYGVPHVAIFASSALLLVAALLNYIFPDATKVFTYVTTISTVLFLVVWGLIIIAYINYSRKNPDLHKNATYKLLGGKYMGYLIFVFFIFVFGLLFINVDTRRAIYFIPIWFILLGFMYLRYKRIAAKSNK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1642,NE810,-,D-serine/D-alanine/glycine transporter,cycA_2,D-serine/D-alanine/glycine transporter,A89T,SAB persistence only,NA,NA,NA,NA
389,MLRCLIANRGEIAVRIIRACREYGIETVAVYAKGDEQSLHVHLADQAICIGEANALDSYLNIDRIISAAQITGANAIHPGYGFLSESTKFAQTVEEQGIAFIGPTKKTMEMMGDKITARQTVHHAGVPVIPGSNGAVNHVSEIENLAKDIGYPVVIKAASGGGGKGIRIVKKAEDLEKAFKEAKSEGKKYFDDDRVYVEAFIPVAKHVEVQVMGDGQDNYVHLGERDCSVQRKNQKLIEESPCAALTEERRQQICNDAVKVARAANYRSAGTIEFLVTDTAHYFIEMNARIQVEHTVTEMRAERDLVAAQLYLLEHNHLPFSQSDIQFNGHVIEARINAENPEKKFQPTPGKVTALHLPQGFNVRVDSLLYHGYQVSPYYDSLVAKVIVKSHDRASAIDKLKVTLDEMVIDGFSTTADFLYAVLNYPLYRDGDAKDVDIKFLEKHQIVKGVEL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1563,NE1519,accC,"acetyl-CoA carboxylase, biotin carboxylase",accC,Biotin carboxylase,Y152C,SAB persistence only,NA,NA,NA,NA
390,MIMNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVDIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWIYMIGALIAIIVFALYIKNAKRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK,3,2,2,1,1,1,1,1,1,1,1,1,SAUSA300_0139,NE144,NA,putative tetracycline resistance protein,tet(38),tetracycline efflux MFS transporter Tet(38),D37A,all,NA,NA,NA,NA
392,MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLAMPALQEQGFTKAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLALTAIVNLLMGFVPFFTSGIGIMFVLLFLNG,1,2,0,1,1,1,0,1,1,2,0,1,SAUSA300_0337,NE1388,NA,glycerol-3-phosphate transporter,glpT_1,Glycerol-3-phosphate transporter,Ter131Wext*?,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
393,MINVTLKQIQSWIPCEIEDQFLNQEINGVTIDSRAISKNMLFIPFKGENVDGHRFVSKALQDGAGAAFHQRGTPIDENVSGPIIWVEDTLTALQQLAQAYLRHVNPKVIAVTGSNGKTTTKDMIESVLHTEFKVKKTQGNYNNEIGLPLTILELDNDTEISILEMGMSGFHEIEFLSNLAQPDIAVITNIGESHMQDLGSREGIAKAKSEITIGLKDNGTFIYDGDEPLLKPHVKEVENAKCISIGVATDNALVCSVDDRDTTGISFTINNKEHYDLPILGKHNMKNATIAIAVGHELGLIYNTIYQNLKNVSLTGMRMEQHTLENDITVINDAYNASPTSMRAAIDTLSTLTGRRILILGDVLELGENSKEMHIGVGNYLEEKHIDVLYTFGNEAKYIYDSGQQHVEKAQHFNSKDDMIEVLINDLKAHDRVLVKGSRGMKLEEVVNALIS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2038,NA,NA,NA,murF_1,UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D- alanine ligase,H69Y,SAB mortality and SAB persistence,NA,NA,NA,NA
397,MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWEKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF,3,3,0,0,1,1,0,0,3,2,0,0,SAUSA300_1307,NE1183,arlS,sensor histidine kinase protein,arlS,Signal transduction histidine-protein kinase ArlS,E262G|Y142H|K70N,SAB mortality and SAB persistence,-,0,-,1
398,MKKKLTFKENMFIGSMLFGLFFGAGNLIFPIHLGQAAGSNVFIANLGFLITAIGLPFLGIIAIGISKTSGLFEIASRVNKTYAYIFTIALYLVIGPFFALPRLATTSFEIAFSPFLSPKQITLYLFIFSFVFFVIAWFFARKPSRILEYIGKFLNPVFLVLLAIILLFAFIHPLGGISDAPISKQYQSNALFNGFLDGYNTLDALASLAFGIIIVATIKKLGIENPTDIAKETIKSGTISIIMMGIIYTLLAIMGTLSIGHFKLSENGGIALAQITQYYLGNYGIVLLSLIVMVACLKTAIGLITAFSETFEHLFPKMNYLAIATVVSFISFLFANVGLTKIIMYSVPVLMFLYPLAIALIVLTLFSSKFHHSKIIYQCTIFFTMIAALVDGLKAQSSFQAHHSHKL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0188,NE945,brnQ,branched-chain amino acid transport system II carrier protein,brnQ_1,Branched-chain amino acid transport system 2 carrier protein,Q396fs,SAB mortality and SAB persistence,NA,NA,NA,NA
399,MKKVLIANRGEIAVRIIRACRDLGIQTVAIYSEGDKDALHTQIADEAYCVGPTLSKDSYLNIPNILSIATSTGCDGVHPGYGFLAENADFAELCEACQLKFIGPSYQSIQKMGIKDVAKAEMIKANVPVVPGSDGLMKDVSEAKKIAQKIGYPVIIKATAGGGGKGIRVARDEKELETGFRMTEQEAQTAFGNGGLYMEKFIENFRHIEIQIVGDSYGNVIHLGERDCTIQRRMQKLVEEAPSPILDDETRREMGNAAVRAAKAVNYENAGTIEFIYDLNDNKFYFMEMNTRIQVEHPVTEMVTGIDLVKLQLQVAMGEVLPYKQEDIKLTGHAIEFRINAENPYKNFMPSPGKIEQYLAPGGYGVRIESACYTNYTIPPYYDSMVAKLIIHEPTRDEAIMAGIRALSEFVVLGIDTTIPFHIKLLNNDIFRSGKFNTNFLEQNSIMNDEG,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1475,NA,NA,NA,cfiB,2-oxoglutarate carboxylase small subunit,Q148R,SAB mortality only,NA,NA,NA,NA
405,MTKKYDLIVIGTGSAGSITAAKCNKAGWNVAMVDDRPFGGTCALRGCDPKKVLHGAAELIDWNKRMVKNGVPSEVSINWKDLMNFKRTFTDDVPEKKEEALNKQGIDTYHGNASFVSEDKLEVNKEVLEGSHFLIASGAKPTPLPIKGEEHLTYSDEFLELDELPQRIVFVGGGYISFEFAHIAARAGSEVHIIHRGQRPLENFDIDLVDILLEKSKEIGIQVHLQHSVESIEKEQGKFHVYARKKEDITRFEADIVIHGAGRGPALDMNLEKGNIERKKHGVHVNEYLQSVSNPNVYAAGDAAATDGLPLTPVASADSHVVASNLLKGNSKKIEYPVIPSAVFTVPKMASVGMSEEEAKNSGRNIKVKQKNISDWFTYKRTNEDFAAFKVLIDEDHDQIVGAHLISNEADELINHFATAIRFGISTKELKQMIFAYPTAASDIAHML,0,2,0,0,0,1,0,0,0,6,0,0,NA,NA,NA,NA,garB,Glutathione amide reductase,I400V|H397S|G264V|G24V|H157S|I160V,SAB persistence only,NA,NA,NA,NA
406,MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAYFIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIISRVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVSSVWGISSIIGPLLGGGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLTLFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPVVEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPLSVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAFVLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTIMGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2128,NE531,NA,putative drug transporter,sdrM,Multidrug efflux pump SdrM,S136G,SAB mortality and SAB persistence,NA,NA,NA,NA
407,MNKNTWVIGFTLFAMFFGAGNLIFPPNLGLDSGQFFWPAILAFVLTGIGLPLLGVIVGALDKEGYIGALNKISPKFSILFLIIIYLTIGPLFAIPRTASTSFEMTITPIIHSNSSIALFIFTIIYFIVVLYICLNPSKLIDRIGSLLTPLLLITILAMIIKGYLDFSGNSAGKGNEALYHSNFSSFAEGFTQGYLTMDAIAAIAFSMIVVNAVKLTGITKTNQIFKQTLTAGLIAAVALIFIYISLGYIGNHMPVSDMTLDQLKSKDRNIGTYLLTTMASTGFGSFGKYLLGIIVALACLTTACGLIVAVSEYFHRIVPKVSYKAFVLVFILMSFIIANQGLNAVISMSIPVLSIVYPVAITVVLLILIAKFIPTKRISQQIPVIIVFILSIFSVISKLGWLKINFIESLPLRAYSLEWFPVAIIATILGYLVGIFVKQDPIKYQQE,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1300,NE44,brnQ,branched-chain amino acid transport system II carrier protein,brnQ_3,Branched-chain amino acid transport system 2 carrier protein,L275I,SAB persistence only,NA,NA,NA,NA
409,MPKRTFTKDDIRKFAEEENVRYLRLQFTDILGTIKNVEVPVSQLEKVLDNEMMFDGSSIEGFVRIEESDMYLHPDLDTWVIFPWTAGQGKVARLICDVYKTDGTPFEGDPRANLKRVLKEMEDLGFTDFNLGPEPEFFLFKLDEKGEPTLELNDDGGYFDLAPTDLGENCRRDIVLELEDMGFDIEASHHEVAPGQHEIDFKYADAVTACDNIQTFKLVVKTIARKHNLHATFMPKPLFGVNGSGMHFNVSLFKGKENAFFDPNTEMGLTETAYQFTAGVLKNARGFTAVCNPLVNSYKRLVPGYEAPCYIAWSGKNRSPLIRVPSSRGLSTRIEVRSVDPAANPYMALAAILEAGLDGIKNKLKVPEPVNQNIYEMNREEREAVGIQDLPSTLYTALKAMRENEVIKKALGNHIYNQFINSKSIEWDYYRTQVSEWERDQYMKQY,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1201,NA,NA,NA,glnA,Glutamine synthetase,P293S,SAB mortality only,NA,NA,NA,NA
412,MNNKEHIKSVILALLVLMSVVLTYMVWNFSPDIANVDNTDSKKSETKPLTTPMTAKMDTTITPFQIIHSKNDHPEGTIATVSNVNKLTKPLKNKEVKSVEHVRRDHNLMIPDLSSDFTLFDFTYDLPLSTYLGQVLNMNAKVPNHFNFNRLVIDHDADDNIVLYAISKDRHDYVKLTTTTKNDHFLDALATVKKDMQPYTDIITNKDTIDRTTHVFAPSKPEKLKTYRMVFNTISVEKMNAILFDDSTIVRSSKSGVTTYNNNTGVANYNDKNEKYHYKNLSEDEASSSKMEETIPGTFDFINGHGGFLNEDFRLFSTNNQSGELTYQRFLNGYPTFNKEGANQIQVTWGEKGVFDYRRSLLRTDVVLNSEDNKSLPKLESVRSSLANNSDINFEKVTNIAIGYEMQDNPDHNHIEVQINSELVPRWYVEYDGEWYVYNDGRLE,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0022,NE1693,-,hypothetical protein,NA,hypothetical protein,N270del,SAB mortality and growth rate,NA,NA,NA,NA
414,MVKNHDPKNEMQDMLTPLDAEEAAKTKLRLDMREIPKSSIKPEHFHLMYLLEQHSPYFIDAELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRTRYTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLPVSEAEFLTRYKALVICAFNEKQSFDALVEGNLELHKGTPFETKVIEAATLDLLTAFLDEQYQKQEQDYSQNYAYVRKVGHTVFKWVAIGMTTLSVLLIAFLAFLYFSVMKHNERIEKGYQAFVKEDYTQVLNTYDDLDGKKLDKEALYIYAKSYIQTNKQGLEKDKKENLLNNVTPNSNKDYLLYWMELGQGHLDEAINIATYLDDNDITKLALINKLNEIKNNGDLSNDKRSEETKKYNDKLQDILDKEKQVKDEKAKSEEEKAKAKDEKLKQQEENEKKQKEQAQKDKEKRQEAERKK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0282,NE878,NA,conserved hypothetical protein,essB,Type VII secretion system protein EssB,Q429*,SAB mortality and growth rate,NA,NA,NA,NA
416,MLSRKYKIDLKAINQNTESTSAISKASYEVENANNNGLSKRDVINQFNDLKKMKKFPSNLEYVDSYTDSLTGVTTSAFLNKDTGKVTLGMTGTNLQDEAFKKLKEGEFSRQNVTNALETVKDGYADLKILYSPASDQNYRYANTQEFINKIKSKYDIDFITGHSLGGRDAVVLGMSNGIPNIVVYNPAPISITSLNPNSPDGKRLLELYKNYKGNITRFVAENDALTENLKKYKHYVFFGNDKVFKNGKGHEMEGFLTEEEQKAIKKELKKLQGYAEENNKSFVKNSNNAISKLASIELLRANMMTTNGGGLSSSQQKVLESLTALTIAQSFSQLIDDEINQIKKMYNEKKKKFGKNWEDAQKAGKAVGEDLSVNGVLNALDEGQVNESSMVREPEQMISAKERQLSTIGSSVSNYIMRVRLSINEIVDKDQVLASQIGGLL,2,1,1,1,1,1,1,1,2,1,1,1,SAUSA300_0420,NE1106,-,hypothetical protein,NA,hypothetical protein,E31G|K346M,all,NA,NA,NA,NA
418,MDDKTKNDQQESNEDKDELELFTRNTSKKRRQRKRSKATHFSNQNKDDTSQQADFDEEIYLINKDFKKEESNDKNNDSASSHANDNNIDDSTDSNIENEDYRYNQEIDDQNESNVISVDNEQPQSAPKEQNSDSIDEETVTKKERKSKVTQLKPLTLEEKRKLRRKRQKRIQYSVITILVLLIAVILIYMFSPLSKIAHVNINGNNHVSTLKINKVLGVKNDSRMYTFSKKNAINDLEENPLIKSVEIHKQLPNTLNVDITENEIIALVKYKGKYLPLLENGKLLKGSNDVKINDAPVMDGFKGTKEDDMIKALSEMTPEVRRYIAEVTYAPSKNKQSRIELFTTDGLQVIGDISTISKKMKYYPQMSQSLSRDSSGKLKTRGYIDLSVGASFIPYRGNTSSQSESDKNVTKSSQEENQAKEELQSVLNKINKQSSKNN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1078,NA,NA,NA,divIB,Cell division protein DivIB,L211S,SAB mortality and SAB persistence,NA,NA,NA,NA
419,MINAVVIAVILMIVLCLCRLNVVISLFISALVGGLISGMSIEKVINVFGKNIVDGAEVALSYALLGGFAALISYSGITDYLVGKIINAIHAENSRWSRVKVKVTIIIALLAMSIMSQNLIPVHIAFIPIVIPPLLSLFNDLTIDRRLIGLIIGFGLCFPYVLLPYGFGQIFQQIIQSGFAKANHPIEFNMIWKAMLIPSMGYIVGLLIGLYVYRKPREYETRKISDSDNVTELKPYILIVTIVAILATFLVQTFTDSMIFGALAGVLVFFISRAYNWYELDAKFVEGIKIMAYIGVVILTANGFAGVMNATGDIDELVKTLTSITGDNKLFSIIMMYVIGLIVTLGIGSSFATIPIIASLFIPFGASIGLDTMALIALIGTASALGDSGSPASDSTLGPTAGLNVDGQHDHIRDTCVPNFLFYNIPLMIFGTIAAMVL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0846,NE967,-,Na+/H+ antiporter family protein,NA,hypothetical protein,T142K,SAB mortality and SAB persistence,NA,NA,NA,NA
421,MEVHKKSNAWALFPLLLFVALFLGVGIITGDFTSMPLNVAITITVIVALLMNRKESFAKKVEVFTKGAGHSNIVLMMLIFILAGAFSNTAEKMGGVKSTVNLGLSLIPENLIIVGLFVICMFVSISMGTSVGTVAAIAPVGYGFAQATDVPTALAMATVVGGAMFGDNLSMISDTTIAAVRTQHTKMKDKFRVNFKIVLPGAILTIIILYFLTNGISLNHAKNYDYNLIKVVPYILVLVLALLGVNVIIVLIGGTLLAGIIGLIDGSFGWMGLLDAVSKGIISMEDIAMIALLIGGLVGIIQHNGGIEWLLQFVRSKVKSKRGAELGIASLVSVADIATANNTISIIMSGPLAKNIADEYDVDSRKSASILDVFGGCFQGLLPYSPQVISAAGVAGISPLMLFPYSIYPILLGVCGLIAILFNFPKLKKNTSQEMKH,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2273,NE1214,-,Na+/H+ antiporter family protein,mleN_2,Malate-2H(+)/Na(+)-lactate antiporter,V373I,SAB mortality and growth rate,NA,NA,NA,NA
423,MTTDILNISEEQLVDYSKAHNEPSWMTELRKKALKLTETLEMPKPDKTKLRKWDFDSFKQHDVKGDVYQSLSQLPESVREIIDVDHSKNLVIQHNNTIAYTQVDDNASKDGVIVEGLADALMNHSDLVQKYFMKDAVTVDEHRITALHTALVNGGVFVYVPKNVVVEHPVQYVVLHDDENASFYNHVIIVTEESAEVTYVENYLSNASGEGNQLNIISEVIAGANSNITYGSVDYMDKGFTGHIIRRGITEADASINWALGLMNEGSQIIDNTTNLFGDRSTSSLKSVVVGTGEQKINLTSKIVQYGKETDGYILKHGVMKEHASSVFNGIGYIKHGGTKSIANQESRVLMLSEHARGDANPILLIDEDDVQAGHAASVGRVDPDQLYYLMSRGISQREAERLVIHGFLDPVVRELPIEDVKRQLREVIERKVSK,3,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0819,NA,NA,NA,NA,hypothetical protein,A343V,SAB mortality only,NA,NA,NA,NA
425,MIENVRSLAFDTIQDILNEGAYSNLRINEVLSENELNAMDKALFTEIVYGTVKRKYTLDFYLKPFVKTKIKAWVRQLLWMSIYQYVYLDKVPNHAIINEAVEIAKERGGYHNGNVVNGILRTMMRSDLPDFNEIADPKKRMAIEYSMPKWIIDHWATHYGLEETETILQSFLETTSTTVRANLTRASLDDIIEKLQDEGYDVGKDHDLPYCLHIGGQPIIHSRSFKDGFVSIQDKSSMFVAHIMNVDRHDHVLDACSAPGGKACHIAEVLMPEGQVDAPDIHDHKIDLINFNIKKLRLTNIKAFQHDATKPYDKTYDKILVDAPCSGLGVMRHKPEIKYTQSKQHIESLVELQLEILENVKNNVKIGGEIIYSTCTIEQLENENVIYTFLKNNKNFEFEPFQHPITGELVKTLQIMPQDFNSDGFFITKIKRKDN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1110,NE924,sun,ribosomal RNA small subunit methyltransferase B,rsmB,Ribosomal RNA small subunit methyltransferase B,G203E,SAB mortality only,NA,NA,NA,NA
427,MKKQVIISGLMLFSLFFGAGNLIFPPMLGHTAGQNMWIGMLGFALTGILLPFITVIVVAFYDEGVESVGNRIHPWFGFIFAVVIYMSIGAFYGIPRAANVAYEIGTRHILPVHNQWTLIIFAAIFFAIVYWISLNPSKIVDNLGKLLTPLLLLMVALLSIAVIFNPESALSAPKDKYITHPFISGSLEGYFTMDLVAALAFSVVIVNGYKFKGLTDRMKILKYVCFSGLISAILLGMIYFALAYVGASTAPGNFKDGTDILTYNSLRVFGSFGNLVFGMTVILACLTTCIGLVNACATFTKKHVPKFSYKIFALVFSIIGFLFTTLGLEMILKIAVPLLTLIYPESIALVLISFANMFSTFRFSWAYRLATVITLIISILQILNSFNLLHGVILKSFMMLPLADIDLAWLVPFMLFAIIGFIIDVLIRRPKQATT,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0306,NE605,brnQ,branched-chain amino acid transport system II  carrier protein,brnQ_2,Branched-chain amino acid transport system 2 carrier protein,S231A,SAB mortality only,NA,NA,NA,NA
430,MTATWKKKEGNEGLLTVTVPAEKVNKALDQAFKKVVKQINVPGFRKGKVPRPIFEQRFGVEALYQDAIDILLPDAYGEAIDETDIKPVAQPEVSVTQIEKGKDFIFEATVTVEPEVKLGDYKGLEIEKQETELSDDELQEAIDHSLGHLAEMVVKEDGVVENGDTVNIDFSGSVDGEEFEGGQAEGYDLEIGSGSFIPGFEEQLEGMKVDEEKDVVVTFPEEYHAEELAGKEATFKTKVNEIKFKEVPELTDEIANELDAEANTVDEYKENLRKRLAEQKATDAENVEKEEAITKATDNTTIDIPEAMVNTELDRMVSEFAQRIQQQGLDLQTYFQISGQDETQLREQMKDDAEQRVKTNLTLTAIAEAEKIEATDEDIDKELEKMSKQFNISVEDIKNTLGNTDIIKNDVRIQKVIDLLRDNAKFVEGTKED,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1622,NE914,tig,trigger factor,tig,Trigger factor,K6E,SAB mortality only,NA,NA,NA,NA
432,MSFLRKHAEIIFSYLIGIVSLFTGLIILINLPLIKQLNGGKKVDTHVHNVWEFLNAFFSEIIKVMSRFIGNFPIVSAIVIIIFGILVMLIGHTLLRTIKYDYDISIFFLVIGIMYFIITLILMTQVYGFFAVIFIIPFTIHIGYIVYKDELNQENVKNHFMWIIVSYGISYLITQIALYGRIDANEIESIDILSVNAFFIIMWLLGQMAIWNFLFLRRALPLTKQELGEEEPELSRTSKGNVTNQTKIHLKQLQDKTTEYARKTRRSVDLDKIRAKRDKFKKKVNDIIDIQEDDIPDWMRKPKWVKPMYVELFCGVVIFLFTFLEFNNRNALFVSGDWKLSQTQYVIEWVTLLILLFIIIAYIATTLTFHLKGKFYYLQLFMGSILFFKLLTEFINIMIHGLLLSVFITPTLLLMLLAIIISYSLQLRERP,1,1,1,0,1,1,1,0,1,1,1,0,SAUSA300_0980,NE1044,-,hypothetical protein,NA,hypothetical protein,R217C,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
435,MYIVIYAYITKISDSIFVIFPSFFVVYVTISILFSYIINRVLKKISTPYLILNKGFLIVISTILLLTFSLFFFYSQINSDEAKVIRQYSFIFIGITIFLSILTFVISQFLLKEMKYKRNQEEIETYYEYTLKIEAINNEMRKFRHDYVNILTTLSEYIREDDMPGLRDYFNKNIVPMKDNLQMNAIKLNGIENLKVREIKGLITAKILRAQEMNIPISIEIPDEVSSINLNMIDLSRSIGIILDNAIEASTEIDDPIIRVAFIESENSVTFIVMNKCADDIPRIHELFQESFSTKGEGRGLGLSTLKEIADNADNVLLDTIIENGFFIQKVEIINN,4,2,1,1,1,1,1,1,5,4,1,1,SAUSA300_1991,NE873,agrC,accessory gene regulator protein C,NA,hypothetical protein,I45fs|C91R|R7fs|I139fs|L165F,all,-,5,-,0
439,MKERYYELIDERVFEQELENGLRLFIIPKPGFQKTFVTYTTQFGSLDNQFKPLGQDQFVTVPDGVAHFLEHKLFEKEEEDLFTAFAEDNAQANAFTSFDRTSYLFSATDNIENNIKRLLTMVETPYFTKETVDKEKGIIAEEIKMYQEQPGYKLMFDTLRAMYQQHPIRVDIAGSVESIYDITKDDLYLCYETFYHPSNMVLFVVGDVDPEAICRIVKQHEDARNKVDQPKIERGLVDEPEDVKEAFVTESMKIQSPRLMLGFKNKPLQEAPQKYVQRDLEMSLFFELIFGEETDFYQNLLNEGLIDDTFGYQFVLEPTYSFSIVTSATEEPDKLKKLLLDELRDKKGNFQDAEAFELLKKQFIGEFISSLNSPEYIANQYTKLYFEGVSVFDMLDIVENITLDSINETSSLYLNLDQQVDSRLEIKK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1172,NE1517,-,M16 family peptidase,NA,hypothetical protein,D228N,SAB mortality only,NA,NA,NA,NA
440,MLDIRLFRNEPDTVKSKIELRGDDPKVVDEILELDEQRRKLISATEEMKARRNKVSEEIALKKRNKENADDVIAEMRTLGDDIKEKDSQLNEIDSKMTGILCRIPNLISDDVPQGESDEDNVEVKKWGTPREFSFEPKVHWDIVEELKMADFDRAAKVSGARFVYLTNEGAQLERALMNYMITKHTTQHGYTEMMVPQLVNADTMYGTGQLPKFEEDLFKVEKEGLYTIPTAEVPLTNFYRNEIIQPGVLPEKFTGQSACFRSEAGSAGRDTRGLIRLHQFDKVEMVRFEQPEDSWNALEEMTTNAEAILEELGLPYRRVILCTGDIGFSASKTYDLEVWLPSYNDYKEISSCSNCTDFQARRANIRFKRDKAAKPELAHTLNGSGLAVGRTFAAIVENYQNEDGTVTIPEALVPFMGGKTQISKPVK,1,1,0,0,1,1,0,0,2,2,0,0,SAUSA300_0009,NA,NA,NA,serS,Serine--tRNA ligase,V139A|L426P,SAB mortality and SAB persistence,NA,NA,NA,NA
450,MSTEPLASRMRPKNIDEIISQQHLVGPRGIIRRMVDTKKLTSMIFYGPPGIGKTSIAKAISGSTQYKFRQLNAVTNTKKDMQLVVEEAKMSGQVILLLDEIHRLDKAKQDFLLPHLENGKIVLIGATTSNPYHAINPAIRSRAQIFELYPLNDEDVRQALTRAIEDDENGLKTYQPKIDEDAMTYFSTQSQGDVRSALNALELAVLSADNDKDGYRHVTLQDAKDCLQKGAFVSDKDGDMHYDVMSAFQKSIRGSDVNAALHYLARLIEAGDLPTIVRRLLVISYEDIGLASPNAGQRTLAAIESAERLGLPEARIPLSQAVIELCLSPKSNSTMSAIDSALSDIRNGHVGQIPNHLKDGHYQGAKDLGRSIGYKYPHQYVNGYVSQQYLPDKLKNKIYYEPKTTSKSEQQLKEIYNNLLKQRP,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1584,NE341,NA,"ATPase, AAA family",NA,putative AAA domain-containing protein,T334A,SAB mortality only,NA,NA,NA,NA
452,MKTIEEIKSTPKTVMKKPELLAPAGNLEKLKIAVHYGADAVFLGGQEYGLRSNADNFTMEEIAEGVEFANRYGAKIYVTTNIIAHDENIEGLESYLRNLEKTGATGIIVADPLIIETCKEVAPKLEIHLSTQQSLSNYKAVEYWKEEGLDRVVLARETGAMEMREMKEKVDIEIEAFIHGAMCIAYSGRCTLSNHMTARDSNRGGCCQSCRWDYELLEVDDNGELDVFYNQGEVTPFAMSPKDLKLIESIPQMMDIGVDSLKIEGRMKSIHYIATVVSVYRKVIDAYAADPDNFKINLEWLIELDKCANRDTAPAFFEGTPGYEEQMFGQQQSKKSPFDFCGLVLDYNEDTKIATIQQRNNFKPGQEIEFFGPEIETFTQVVEAIYDEEGNSLDAARHPLQIVQIKVDRPIYPNNMMRKEIG,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1569,NE1874,-,U32 family peptidase,NA,hypothetical protein,L298P,SAB mortality and SAB persistence,NA,NA,NA,NA
455,MKLPKKNVDNYVQVDEGAVCSTILDMYSKQAIVAEPAGALSVSALENYKDHIKGKTVVCVISGGNNDINRMKEIEERSLLYEEMKHYFILNFPQRPGALREFVNDVLGPQDDITKFEYLKKSSQNTGTVIIGIQLKDDDDLIQLKQRVNHFDPSNIYINENKMLYSLLI,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2014,NE340,ilvA,threonine dehydratase,ilvA_2,L-threonine dehydratase biosynthetic IlvA,K260fs,SAB mortality only,NA,NA,NA,NA
456,MEKMHITNQEHDAFVKSHPNGDLLQLTKWAETKKLTGWYARRIAVGRDGEVQGVAQLLFKKVSKLPYTLCYISRGFVVDYSNKEALNALLDSAKEIAKAEKAYAIKIDPDVEVDKGTDALQNLKALGFKHKGFKEGLSKDYIQPRMTMITPIDKNDDELLNSFERRNRSKVRLALKRGTTVERSDREGLKTFAELMKITGERDGFLTRDISYFENIYDALHEDGDAELFLVKLDPKENIAKVNQELNELHAEIAKWQQKMKTSEKQAKKAQNMINDAQNKIAKNEDLKRDLEALEKEHPEGIYLSGALLMFAGSKSYYLYGASSNEFRDFLPNHHMQYTMMKYAREHGATTYDFGGTDNDPDKDSEHYGLWAFKKVWGTYLSEKIGEFDYVLNQPLYQLIEQVKPRLTKAKIKISRKLKRK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2214,NA,NA,NA,femX,Lipid II:glycine glycyltransferase,S63P,SAB mortality and SAB persistence,NA,NA,NA,NA
459,MIKIPRGTQDILPEDSKKWRYIENQLDELMTFYNYKEIRTPIFESTDLFARGVGDSTDVVQKEMYTFKDKGDRSITLRPEGTAAVVRSYIEHKMQGNPNQPIKLYYNGPMFRYERKQKGRYRQFNQFGVEAIGAENPSVDAEVLAMVMHIYQSFGLKHLKLVINSVGDMASRKEYNEALVKHFEPVIHEFCSDCQSRLHTNPMRILDCKVDRDKEAIKTAPRITDFLNEESKAYYEQVKAYLDDLGIPYIEDPNLVRGLDYYTHTAFELMMDNPNYDGAITTLCGGGRYNGLLELLDGPSETGIGFALSIERLLLALEEEGIELDIEENLDLFIVTMGDQADRYAVKLLNHLRHNGIKADKDYLQRKIKGQMKQADRLGAKFTIVIGDQELENNKIDVKNMTTGESETIELDALVEYFKK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1587,NA,NA,NA,hisS,Histidine--tRNA ligase,E23K,SAB mortality only,NA,NA,NA,NA
460,MAQEVIKIRGGRTLNGEVNISGAKNSAVAIIPATLLAQGHVKLEGLPQISDVKTLVSLLEDLNIKASLNGTELEVDTTEIQNAALPNNKVESLRASYYMMGAMLGRFKKCVIGLPGGCPLGPRPIDQHIKGFKALGAEIDESSTTSMKIEAKELKGAHIFLDMVSVGATINIMLAAVYATGQTVIENAAKEPEVVDVANFLTSMGANIKGAGTSTIKINGVKELHGSEYQVIPDRIEAGTYMCIAAACGENVILNNIVPKHVETLTAKFSELGVNVDVRDERIRINNNAPYQFVDIKTLVYPGFATDLQQPITPLLFMANGPSFVTDTIYPERFKHVEELKRMGANIEVDEGTATIKPSTLHGAEVYASDLRAGACLIIAGLIAEGVTTIYNVKHIYRGYTDIVEHLKALGADIWTETV,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2078,NE939,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,murA2,UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2,R123H,SAB persistence only,NA,NA,NA,NA
463,MAQQQIHDTKNKLEKAVLVGVHAQDDKQFNFESTMEELSSLSETCQLEVLGQITQNRDRVDRKYYVGKGKIEEIQAFIEFKDIDVVITNDELTTAQSKSLNEALGVKIIDRTQLILEIFALRARSKEGKLQVELAQLDYLLPRLQGHGKSLSRLGGGIGTRGPGETKLEMDRRHIRTRMNEIKHQLRTVEEHRERYRNKRNQNQVFQVALVGYTNAGKSSWFNVLANEETYEKDQLFATLDPKTRQIQINDGFNLIISDTVGFIQKLPTTLIAAFKSTLEEAKGADLLVHVVDSSHPEYRTQYDTVNDLIKQLDMSHISQIVIFNKKDLCDHASNRPASDLPNVFVSSKNDGDKLLVKTLFIDEIKRQLTYYDETIATNNADRLYFLKQHTLVTELKYDEIENVYRIKGFKK,3,0,1,1,1,0,1,1,2,0,1,1,SAUSA300_1198,NE1325,-,putative GTP-binding protein,hflX,GTPase HflX,G252R|S99A|A99S,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
466,MKRLSTTLKVRLISNFLQLIITTAFIPFIALYLTDMLSQSIVGIYLVGLVVLKFPLSIISGYLIEIFPKKLLVLIYQATMVIMLVFMGIFGSHQLWQIIGFCVAYAIFTIVWGLQFPVMDTLIMDAITEDVEHYIYKISYWMTNLSVAIGALLGGLMYGYSMLLLFLIAACIFLIVLFILYIWLPQDRNQVKQSDDKKHASRYQKLQIMNIFRSYKLVLKDRNYMLLISGFSIIMMGEFSISSYIAIRLKDQFETISIGSYDITGAKMLAILLMINTVVVILLTYSISKIVLKIDFKKALITGLLIYIVGYSGLTYLNQFGLLVVFMIIATVGGIIYSPIVSEQRFKIIPKAKRGTYSAVNALGIHFSETLARLGIVLGAFLTTLQMGLYMFIVLTIGASMLVAGVFGGQKQVNTN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0180,NE743,NA,integral membrane protein LmrP,mdrP,"Na(+), Li(+), K(+)/H(+) antiporter",G334E,SAB mortality and SAB persistence,NA,NA,NA,NA
467,MTNYKEKLQQYAELLVKVGMNVQPKQPVFIRSSVETLELTHLIVEEAYHCGASDVRVVYSDPTLKRLKFENESVEHFANHEIKSYDVEARMDYVKRGAANLALISEDPDLMDGIDSQKLQAFQQQNARAFKGYMESVQKNQFPWVVAAFPSKAWAKRVYPELSVEEAYIKFIDEVFDIVRIDGNDPVENWRQHIANLSVYAQKLQQKNYHALHYVSEGTDLTVGLAKNHIWEDATSYVNGKEQAFIANIPTEEVFTAPDRNRVDGYVTNKLPLSYNGTIIDQFKLMFKDGEIIDFSAGKGEAVLKDLINTDEGSRRLGEVALVPDDSPISNRNTIFYNTLFDENAACHLAIGSAYAFNIQGGTEMTVEEKIASGLNDSNVHVDFMIGSSDLTIYGIFEDGSKELVFENGNWASTF,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_1860,NE444,pepS,aminopeptidase PepS,pepS,Aminopeptidase PepS,I371V|D177E,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
468,MEDIYKLIDDINLQKLENLDSRVNEAITTDNDDALFILGETLYNFGLMPQGLEVFRVLYHKYPDESELLIYFIEGLMSENQTDEALEYLSYVEPSPEKLMLEADLYQQINMMEVAIDKLQEALELEPNDPIIHFALAEMLYYDGQYLRATSEYETVLETGEYQVNGVNLFSRMADCSLQSGNYSDAIRLYDEINEDEMTSEDYLKKAISYDKNDITQEAIKIMTTLLSKDPDYIQGYLYLQSLYENEKNYPDAIETGKEGLRLSQFYKELMYTTGCLEIEHGDANEGVLLLKQALEVDNAYQEPLLVLSDLYRNEEDYEAIIELLTYVDEEDLDPTFMWHLAFAYGQEERDKEAQHFFELAYPTMKTNIDFMSDYYFYLIEIGQKEQAITILNQLLELEPSNENWHDELSRLQS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1354,NE842,-,hypothetical protein,bepA,Beta-barrel assembly-enhancing protease,V307I,SAB mortality and SAB persistence,NA,NA,NA,NA
469,MKFSTLSEEEFTNYTKKHFKHYTQSIELYNYRNKINHEAHIVGVKNDKNEVIAACLLTEARIFKFYKYFYSHRGPLLDYFDAKLVCYFFKELSKFIYKNRGVFILVDPYLIENLRDANGRIIKNYNNSVIVKMLGKIGYLHQGYTTGYSNKSQIRWISVLDLKDKDENQLLKEMEYQTRRNIKKTIEIGVKVEDLSIEETNRFYKLFQMAEEKHGFHFMNEDYFKRMQEIYKDKAMLKIACINLNEYQDKLKIQLLKIENEMMTVNRALNENPNSKKNKSKLNQLNMQLSSINNRISKTEELIFEDGPVLDLAAALFICTDDEVYYLSSGSNPKYNQYMGAYHLQWHMIKYAKSHNINRYNFYGITGVFSNEADDFGVQQFKKGFNAHVAELIGDFIKPVRPILYKFAKLIYKV,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_1141,NE1446,NA,endopeptidase resistance gene,femA_2|femA_1,Aminoacyltransferase FemA,A390E|D37H,SAB mortality and SAB persistence,+,0,-,0
470,MIDMNLILKKKFQEISEVDDFISKASTETDYFEPSTLSHGIPGIILFLDAYQKVFDINTEQIVHKYIMKLAPYLQSGQYNNSLFGGLSGIAFSMDLASQNGKNYQNILNNIDGHIVNEIENKFDQILQEPLNPLNYDTVSGLAGIGRYLLNRVDENEFNVKALKSILVYFKDIQYSKNSWVVPQESQFLESDKNYFTEGNINLGLAHGVLGPMSLFALCVIKGITIENHQHILKDMYKFIMDEKFCNHERWLQRYDLISERNHFNFIRNGWCYGNTGVMTTLFLIGQALQDDEIIKMSKKVMLQVVNDKDENLISPTICHGLSSQILMLTIMNLNFELNEVSDYITVLINKLISHYKEDYLVNFIDINENKQDVFKSRKVGLLEGELGVYLTLMTLKNTKILNEKNWTNAFLIS,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_1765,NE1856,epiC,lantibiotic epidermin biosynthesis protein EpiC,nisC,Nisin biosynthesis protein NisC,Q99*,all,NA,NA,NA,NA
471,MSQNKRVVITGMGALSPIGNDVKTTWENALKGVNGIDKITRIDTEPYSVHLAGELKNFNIEDHIDKKEARRMDRFTQYAIVAAREAVKDAQLDINENTADRIGVWIGSGIGGMETFEIAHKQLMDKGPRRVSPFFVPMLIPDMATGQVSIDLGAKGPNGATVTACATGTNSIGEAFKIVQRGDADAMITGGTEAPITHMAIAGFSASRALSTNDDIETACRPFQEGRDGFVMGEGAGILVIESLESAQARGANIYAEIVGYGTTGDAYHITAPAPEGEGGSRAMQAAMDDAGIEPKDVQYLNAHGTSTPVGDLNEVKAIKNTFGEAAKHLKVSSTKSMTGHLLGATGGIEASFSALSIKDSKVAPTIHAVTPDPECDLDIVPNEAQDLDITYAMSNSLGFGGHNAVLVFKKFEA,0,1,0,1,0,1,0,1,0,1,0,1,SAUSA300_0886,NA,NA,NA,fabF,3-oxoacyl-[acyl-carrier-protein] synthase 2,S352I,SAB persistence and cell death,NA,NA,NA,NA
473,MSYSIVRVSKVKSGTNTTGIQKHVQRENNNYENEDIDHSKTYLNYDLVNANKQNFNNLIDEKIEQNYTGKRKIRTDAIKHIDGLITSDNDFFDNQTPEDTKQFFEYAKEFLEQEYGKDNLLYATVHMDEKTPHMHYGVVPITDDGRLSAKEVVGNKKALTAFQDRFNEHVKQRGYDLERGQSRQVTNAKHEQISQYKQKNRIS,2,3,1,1,1,1,1,1,2,2,1,1,NA,NA,NA,NA,NA,Plasmid recombination enzyme|hypothetical protein,N200fs|M134I,all,NA,NA,NA,NA
474,MAEHSFDVNEVIKDFPILDQKVNGKRLAYLDSTATSQTPVQVLNVLEDYYKRYNSNVHRGVHTLGSLATDGYENARETVRRFINAKYFEEIIFTRGTTASINLVAHSYGDANVEEGDEIVVTEMEHHANIVPWQQLAKRKNATLKFIPMTADGELNIEDIKQTINDKTKIVAIAHISNVLGTINDVKTIAEIAHQHGAIISVDGAQAAPHMKLDMQEMNADFYSFSGHKMLGPTGIGVLFGKRELLQKMEPIEFGGDMIDFVSKYDATWADLPTKFEAGTPLIAQAIGLAEAIRYLERIGFDAIHKYEQELTIYAYEQMSAIEGIEIYGPPKDRRAGVITFNLQDVHPHDVATAVDTEGVAVRAGHHCAQPLMKWLNVSSTARASFYIYNTKEDVDQLINALKQTKEFFSYEF,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0820,NA,NA,NA,csd,putative cysteine desulfurase,P148S,SAB persistence only,NA,NA,NA,NA
475,MNDLIINHIAELILPRSTDKPLKGKELDELNVVKNGTVVIKDGKIVYAGTYTDDYDATETIDASGKVVSPALVDAHTHLTFGGSREHEMSLKRQGKSYLEILEMGGGILSTVNATRETSEDDLFKKAEHDLLTMIKHGVLAVESKSGYGLDRENELKQLKVSNRLAEKYDLDMKHTFLGPHAVPKEASSNEAFLEEMIALLPEVKQYADFADIFCETGVFTIEQSQHYMQKAKEAGFKVKIHADEIDPLGGLELAIDEQAISADHLVASSDKGKEKLRNSDTVAVLLPATTFYLGKEDYADARGMLDNNGAIALATDYNPGSSVTNNLQLVMAIAALKLKLSPNEVWNAVTVNAAKAIDINAGTINTGDKANLVIWDAPNHEYIPYHFGINHAEKVIKDGKVIVDNTVSFKA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2277,NE586,hutI,imidazolonepropionase,hutI,Imidazolonepropionase,Y51H,SAB mortality and SAB persistence,NA,NA,NA,NA
476,MKDISKIVADVESTLAPYFKEIEETAYINQEKVLNAFHHVKATESDLQGSTGYGYDDFGRDHLEEIYAQAFKAEDAIVRPQIISGTHAITIALQSLLKHGDELIYITGSPYDTLLEVIGVNGNGIESLMEHGVSYKDIALKEGKIDIESVLDGVSERTKVIAIQRSKGYDQRPSIPLDEIEKVITRLKNVHPNILIFVDNCYGEFVERREPIECGADLIAGSLIKNPGGGLAKIGGYIAGRKDLIERCGYRLTAPGIGKEAGASLNALLEMYQGFFLAPHVVSQSLKGALFTSLFLEKMNMNTTPKYYEKRTDLIQTVKFETKEQMISFCQSIQHASPINAHFSPEPSYMPGYEDDVIMAAGTFIQGSSIELSADGPIRPPYEAYVQGGLTYEHVKIAVTRAVNQLKEQRLI,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1199,NE1294,NA,hypothetical protein,NA,hypothetical protein,R410G,SAB mortality and SAB persistence,NA,NA,NA,NA
477,MSYITKQDKVIAEAIEREFQRQNSNIELIASENFVSEAVMEAQGSVLTNKYAEGYPGRRYYGGCEFVDVTESIAIDRAKALFGAEHVNVQPHSGSQANMAVYLVALEMGGTVLGMNLSHGGHLTHGAPVNFSGKFYNFVEYGVDKDTERINYDEVRKLALEHKPKLIVAGASAYSRTIDFKKFKEIADEVNAKLMVDMAHIAGLVAAGLHPNPVEYADFVTTTTHKTLRGPRGGMILCKEEYKKDIDKTIFPGIQGGPLEHVIAAKAVAFGEALENNFKTYQQQVVKNAKVLAEALINEGFRIVSGGTDNHLVAVDVKGSIGLTGKEAEETLDSVGITCNKNTIPFDQEKPFVTSGIRLGTPAATTRGFDEKAFEEVAKIISLALKNSKDEEKLQQAKERVAKLTAEYPLYQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2067,NE213,glyA,serine hydroxymethyltransferase,glyA,Serine hydroxymethyltransferase,G110D,SAB mortality and SAB persistence,NA,NA,NA,NA
479,MVQGPIQVNSEIGKLKTVLLKRPGKELENLVPDHLSGLLFDDIPYLKVAQEEHDKFAQTLRDEGIEVVYLEKLAAESITEPEVRENFINDILTESKKTILGHETEIKEFFSKLSDQELVNKIMAGVRKEEIQLETTHLVEYMDDRYPFYLDPMPNLYFTRDPQASIGRGMTINRMYWRARRRESIFMTYILKHHPRFKDKDVPVWLDRNSPFNIEGGDELVLSKDVLAIGISERTSAQAIEKLARNIFKDANTSFKKIVAIEIPNTRTFMHLDTVLTMIDYDKFTVHAAIFKEENNMNIFTIEQNDGKDDIKITRSSKLRETLAEVLEVEKVDFIPTGNGDVIDGAREQWNDGSNTLCIRPGVVVTYDRNYVSNQLLRDKGIKVIEITGSELVRGRGGPRCMSQPLFREDI,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0065,NE1594,arcA,arginine deiminase,arcA_2,Arginine deiminase,T159S,SAB mortality only,NA,NA,NA,NA
481,MEIKEYFEIANTILRWLSIFVIPLFGIIISKLVDRNNIMNPNKERLGRLFKNILRFIGLVILLDILMFLSISEIFSEVKNINSIKSDLWSAFHIFTAFNVVYAIFLFPLFIKEKKYYEVELTHNNKKMKYIVRDRVEDKDDGKLIYVDEDENKEYEENIIDIKKRESRVTFIPHVVALFSINKDALKETKVFPMWLRWSLFIILVGVDTYIAITCLKALYDLWRWDFGKLLIPFRIFLSTFPVVLVLEITVLVVFLYKTWLGKNKLKYHNKKKGDSEMKLNEKEAFRMISLLKNEFRGVRNKTPEIMKDDTLNYQQKKQQLDDIENKCVKNVFRYSEINKDFVYGLSSLLISYKVGTNGREQAYRNFITQYVNGNVEELIQFMNRELLGEYDHAIRRHQVLIEMFMEKRE,1,1,1,0,1,1,1,0,1,1,1,0,NA,NA,NA,NA,NA,hypothetical protein,H93Y,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
486,MKNQLIDRLTRYTTIDTQSDPKSTTTPSTEKQWDLLHLLEKELQQLGLPTDLDENGYLFATLESNIDVDVPTVGFLAHVDTSPDFNASNVKPQIIENYDGKPYKLGNTKRVLDPKVFPELNSLVGHTLMVTDGTSLLGADDKAGIVEIMEAICYLQEHPEIKHGTIRIGFTPDEEIGRGPHKFDVDRFNADFAYTMDGSQYGELQYESFNAAEAVITCHGVNVHPGSAKNAMVNAIRLGEQFDSLLPDSEVPERTEGYEGFYHLMNFEGTVEKATLQYIIRDHDKKQFELRKKRILEIRDDINAHFENYPVKVDISDQYFNMAEKILPLPHIIDIPKRVFAKLDIPANTEPIRGGTDGSQLSFMGLPTPNIFTGCGNFHGPYEYASIDVMEKAVQVIIGIVEDIAENH,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0727,NE483,pepT,peptidase T,pepT_2,Peptidase T,G198D,Growth rate and cell death,+,3,+,0
489,MKYDHLLVRYGELTLKGSNRKKFVNQLRNNVNKSLKGLDGFVVKGKRDRMYIELEDHADINEITYRLSKIFGIKSISPVLKVEKTIEAISAAAIKFAQQFEENSTFKIDVKRADKNFPMDTYELQRELGGAVLKHFDNISVNVKRPDHEIRVEVRLDAIYMYEEVVPGSGGLPVGTGGKTLLMLSGGIDSPVAGMEVMRRGVTIEAIHFHSPPFTSDQAKEKVIELTRILAERVGPIKLHIVPFTELQKQVNKVVHPRYTMTSTRRMMMRVADKLVHQIGALAIVNGENLGQVASQTLHSMYAINNVTSTPVLRPLLTYDKEEIIIKSKEIGTFETSIQPFEDCCTIFTPKNPVTEPNFDKVVQYESVFDFEEMINRAVENIETLEITSDYKTIKEQQTNQLINDFL,3,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1661,NE538,thiI,thiamine biosynthesis protein ThiI,thiI,putative tRNA sulfurtransferase,H135R,SAB mortality only,NA,NA,NA,NA
490,MGYRTLKSIFHEHNESKMKEEYIKRFNSLASFNTNINIIPMENGKKVNDLEYPLFFMVTKNLSKKQELISINSRKIDRALNSLPYAAREQYFNDLLIDELQSTNEIENVFSTKQEIAHALNNQASEFLKFRGLVDQYKEIELNKKIKVDNVRDIRAIYDKLVSNEINEQDKLDGELFRKNFVGVHDGSTNKHIHVGLQPETKIVEFIGEMLTFLKYFDAPQPFKIMASHYLFEYIHPFYDGNGRVGRFIIAKLLSDYYDNYTALTFSYVINRNKSKYYKAFMTASNHLNCGDLTEFIDTMLELLIAGQERILDELIPKMDATEKLTLYLTSHYKQIDYEFLYLLSMDKLFGNKRNRLTIIDLENILGVGRVKINNTIKKYDNYLVKIKSRPTIYEISDEFLNSIIK,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_1560,NE130,NA,conserved hypothetical protein,NA,hypothetical protein,I359L|N77D,SAB mortality and SAB persistence,+,0,-,0
491,MTINLSETFANAKNEFINAVNNGEPQERQNELYGDMINQLFEETKLQAKAEAERVSSLPKSAQSLSANQRSFFMDINKNVNYKEEKLLPEETIDRIFEDLTTNHPLLADLGIKNAGLRLKFLKSETSGVAVWGKIYGEIKGQLDAAFSEETAIQNKLTAFVVLPKDLNDFGPAWIERFVRVQIEEAFAVALETAFLKGTGKDQPIGLNRQVQKGVSVTEGAYPEKEEQGTLTFANPRATVNELMQVFKYHSTNEKGKSVAVKGNVTMVVNPSDAFEVQAQYTHLNANGVYVTALPFNLNIIESTVQEAGKVLTYVKGLYDGYLAGGINVQKFKETLALDDMDLYTAKQFAYGKAKDNKVAAVWKLDLKGHKPALEGTEETL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1938,NE918,-,phi77 ORF006-like protein capsid protein,NA,hypothetical protein,E43K,SAB mortality only,NA,NA,NA,NA
494,MIPYGDFTFFLIALIALLPVIILGFLGKRSYIYNGVVTAFMIVLIFSSDKHNLFDQKYLSVQLISFIIYVVWQVLLIMFYYHSKPKNNSFSKFVTVMVLSILPLALVKVLQSTWLGGHQIHFHESKLIEFVGFLGISYVTFKSVQLIMEIRDGSIKEIKVWKLIQFISFFPTISSGPIDRYKRFVKDDKKVPTGNEYRELVLKAIHMIMLGFLYKYIVAYFINTYAIMPLQLDLHGFVNLWLYMYAYSLYLFFDFAGYSLFAIAFSYLFGIKTPPNFDKPFKAKNIKDFWNRWHMTLSFWFRDCIYMRSLFYMSRKKLLKSQFAMSNVAFLINFFIMGIWHGIEVYYIVYGLYHAALFIGYGYYERWRKKHPPRWQNGFTTALSIVITFHFVTYGFLIFSGKLI,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0836,NA,NA,NA,patA,Peptidoglycan O-acetyltransferase,Y394F,SAB mortality only,NA,NA,NA,NA
497,MTNQGSLNKSPIFTKSFTINFLVNFIVYLCMYLLLVVIAGYSKQAFDASDSLAGLVVGLFIVGSLIGRFATGKFVNQIGPKRLLFIGLIALIITQLLYFIDGSLAFLIFVRLINGIATAVVTTATGTIAAYVTPVNRKSEGISLFSLSLVLGTAIGPFLGMLLITKYAIDLLFIICVILGILGLIISLFIKVDFEVTNNKTEINVIDKPRFSIHQFIAKEAIPVAVIMLLIGVTYASILTYLQAFALERHLVTAASYFFICYAIASLITRPIAGRLMDDKNENIIVYPAFIMLFLSFVCLISSYQSWLILLAGACLGLGYGNLSSAMQSIAIKVSPPIKYGIATSTFYVGLDAGVGFGPSFLGLFTHMFSYSEIFGFMAALAIITMLVYFLIHGRHVTRNAMN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2217,NE1041,-,putative drug transporter,yfcJ,putative MFS-type transporter YfcJ,I203T,SAB mortality and SAB persistence,NA,NA,NA,NA
498,MQSTKTKTKHFSFLLLITLGVMTAFGPLTIDMYVPSLPKVQGDFGSTTSEIQLTLSFTMIGLALGQFIFGPLSDAFGRKRIAVSILIIFILVSGLSMFVDQLPLFLTLRFIQGLTGGGVIVIAKASAGDKFSGNALAKFLASLMVVNGIITILAPLAGGLALSVATWRSIFTILTIVALIILIGVASQLPKTSKDELKQVNFSSVIKDFGSLLKKPAFIIPMLLQGLTYVMLFSYSSASPFITQKLYNMTPQQFSIMFAVNGVGLIIVSQVVALLVEKLHRHILLIILTIIQVVGVALIILTLTFHLPLWVLLIAFFLNVCPVTSIGPLGFTMAMEERTGGSGNASSLLGLFQFILGGAVAPLVGLKGEFNTSPYMIIIFITAILLVSLQIIYFKMIKKQHVA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2379,NE771,-,putative transporter protein,bcr_2,Bicyclomycin resistance protein,S204R,SAB persistence only,NA,NA,NA,NA
500,MIELNAITTLCLACILYLLGKAIVNHVNFLKRICIPAPVIGGLIFAILVAALDSFGMVKIKLDASFIQDFFMLAFFTTIGLGASLKLFKLGGKVLLLYFMFCAIISVIQNIVGVSLAKVLNIKPLLGLTAGSMSMEGGHGNAAAYGKTIQDLGIDSALTAALAAATLGLVFGGLIGGPVVKFLIKRYNLKPQHSDDTFKDYSQVAYNEHLHSKFNATEVFFIQFTIVVFCMAVGSYFSHLFTAQTGINVPIYVGSLFVAVIVRNISESFNFNIVDLKITNQISDVALGIFLSLALMSIQLIEIYKLAIPLIIIVLVQVVVMILFAVLILFRGLGKDYDAAVMVGGFIGHGLGATPNAMANLDVITKKYGNSPKAYLVVPIVGAFLIDLIGVIVIMGFIQWFS,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2291,NE560,gltS,sodium/glutamate symporter,gltS,Sodium/glutamate symporter,S283G,SAB persistence only,NA,NA,NA,NA
503,MNDLKRFNKRSPIFIIILGSLTAIGALSIDMFLPGLPDIRHDFQTTTSNAQLTLSMFMIGLAFGNLFAGPISDSNGRRKPLIIAMIIFTLASLGIVFVHNIWLMIALRFLQGVTGGAAAVISRAIASDMYSGNELTKFMALLMLVNGIAPVVAPTIGGIILNYSVWRMVFVILTIFGFVMVIGSLLKVPESLTVTNRESSSGLKTMFKNFKILLKTPRFVLPMLIQGMTFVILFTYISASPFIIQKIYGMTAIQFSWMFAGIGITLIISSQLTGYLVDFIDSQKLMRVMTMIQIIGVILVTIVLLNHWNFWILAIGFIILIAPVTGVATLGFTIAMDESSSGRGSSSSLLGLVQFLFGGIASPLVGVKGEDNPIPYIIIIIATAVILIILLIYNMKVFKTNR,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2301,NE240,tcaB,teicoplanin resistance associated membrane protein TcaB protein,bcr_2,Bicyclomycin resistance protein,L391Q,SAB persistence only,NA,NA,NA,NA
506,MSNTQKKNVPELRFPGFEGEWEEKKLGNLTTKIGSGKTPKGGSENYTNKGIPFLRSQNIRNGKLNLNDLVYISKDIDDEMKNSRTYYGDVLLNITGASIGRTAINSIVETHANLNQHVCIIRLKKEYYYNFFGQYLLSRKGKRKIFLAQSGGSREGLNFKEIANLKIFTPTIFEEQQKIGKFFSKLDRQIELEEQKLELLQQQKKGYMQKIFTQELRFKDENGEEYPEWENKFIKDIFIFENNRRKPITSSLREKGLYPYYGATGIIDYVKDYLFNNEERLLIGEDGAKWGQFETSSFIANGQYWVNNHAHVVKSNDHNLFFMNYYLNFKELRAFVTGNAPAKLTHANLCNINLKIPCLTEQDKVSALLKSIDNKINNQMNRIELLKERKKVILKKMFI,1,0,0,0,1,0,0,0,3,0,0,0,SAUSA300_1751,NE982,hsdS,"type I restriction-modification enzyme, S subunit",NA,hypothetical protein,I376M|VI392GL|K395Q,SAB mortality only,-,0,-,3
507,MSKLILAINAGSSSLKFQLIRMPEEELVTKGLVERIGLKDSIFTIEVNGEKVKTVQDIKDHVEAVDIMLDAFKAHNIINDINDIDGTGHRVVHGGEKFPESVAITDEVEKEIEELSELAPLHNPANLMGIRAFRKLLPNIPHVAIFDTAFHQTMPEKAYLYSLPYHYYKDYGIRKYGFHGTSHKFVSQRAAEMLDKPIEDLRIISCHIGNGASIAAIDGGKSIDTSMGFTPLAGVTMGTRSGNIDPALIPFIMEKTGKTAEQVLEILNKESGLLGLSGTSSDLRDLSEEAESGKARSQMALDVFASKIHKYIGSYAARMHGVDVIVFTAGIGENSVEIRAKVLEGLEFMGVYWDPKKNENLLRGKEGFINYPHSPVKVVVIPTDEESMIARDVMTFGGLK,3,1,1,0,1,1,1,0,3,1,1,0,SAUSA300_1657,NA,NA,NA,ackA,Acetate kinase,H151Y|V119A|T71A,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
511,MKRTLVLLITAIFILAACGNHKDDQAGKDNQKHNNSSNQVKEIATDKNVQGDNYRTLLPFKESQARGLLQDNMANSYNGGDFEDGLLNLSKEVFPTDKYLYQDGQFLDKKTINAYLNPKYTKREIDKMSEKDKKDKKANENLGLNPSHEGETDPEKIAEKSPAYLSNILEQDFYGGGDTKGKNIKGMTIGLAMNSVYYYKKEKDGSTFSKKLDDSEVKKQGKQMASEILSRLRENDDLKDIPIHFAIYKQSSEDSITPGEFITQATAEKSQTKLNEWHNINEKSALLPSSTAADYDENLNNNFKQFNDNLQSYFSNFTQAVGKVKFVDKKPQRLVVDLPIDYYGQAETIGITQYVTEQANKYFDKIDNYEIRIKDGNQPCALISKTKDDKEPQVHIYSN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1884,NE1087,-,CamS sex pheromone cAM373,NA,hypothetical protein,C380R,SAB mortality and SAB persistence,NA,NA,NA,NA
512,MKKILLAVTGGIAAYKAIDLTSKLTQSGYEVRVMLMNHAQKFVTPLAFQAISRNAVYTDTFIEENPSEIQHIALGDWADAIIVAPATANTIAKLSVGIADDLVTSTLLATETPKFIAPAMNVHMYENKRTQQNINILKEDGYHFIEPGSGFLACGYVAKGRMEEPLQIVSVIDAHFQNSNRLANSSFQDKRALVTAGPTIEVIDPVRFVSNRSSGKMGYAIAEALRNRGAIVTLVAGPTTLEDPKDIEVIHVQSAEEMFEQVTSRFDEQDIVVKAAAVSDYTPVDVLEHKMKKQDGDLSVSFKRTKDILKYLGEHKTSQYLIGFAAETEDIENYAQQKLRKKNADVIISNNVGDMSIGFSSDDNELTMHFKNNEKVNIKKGKKVVLAAQILDELETRWQ,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_1104,NA,NA,NA,coaBC,Coenzyme A biosynthesis bifunctional protein CoaBC,M36T|V82I,SAB mortality and SAB persistence,NA,NA,NA,NA
513,MTQQQNDKRTLKNKHTYQNEPLPNRKDFVVSFITGALVGSALGLYFKNKVYQKADDLKVKEQELSQKFEERKTQLEETVAYTKERVEGFLNKSKNEQAALKAQQAAIKEEASANNLSDTSQEAQEIQEAKREAQAEADKSVAVSNKESKAVALKAQQAAIKEEASANNLSDTSQEAQEIQEAKKEAQAEKDSDTLTKDASAAKVEVSKPESQAERLANAAKQKQAKLTPGSKESQLTEALFAEKPVAKNDLKEIPQLVTKKNDVSETETVNIDNKDTVKQKEAKFENGVITRKADEKTTNNTAVDKKSGKQSKKTTPSNKRNASKASTNKTSGQKKQHNKKSSQGAKKQSSSSKSTQKNNQTSNKNSKTTNAKSSNASKTPNAKVEKAKSKIEKRTFND,0,1,0,0,0,1,0,0,0,2,0,0,SAUSA300_1684,NE1783,-,hypothetical protein,NA,hypothetical protein,I179V|S8P,SAB persistence only,NA,NA,NA,NA
515,MTNNGNEPNLTLSDLYDKDVVYTSRPSYISNPWLKPDEHQSNFLTGRELLIANQLPVIVHEASATDKLHQLFQVIGKEVPNSIYTFNNQQSYENLIKQLAHKENKKIYFQYIHDETILNQQYYALDKTLFVALNNKARIPEWTNGKFLPKRKVVKIEQFENEIKNWEFPLVIKPGDDLPTAGGYGVMICYHDADLQKAITRIKGATAETNSLIIEQKIEEKANYCVQFAYSESLGIQYLGAATQLTDKYGFYNGNENTTNVPEHVIEAGRQIMENGVNQGFFGVAGFDLLVDEDDNVYAIDLNFRQNGSTSMLLLANELNSGYQKFYSYHSKGDNTHFFNTILKYVKEGSLYPLSYYDGDWYGEDKVKSRFGCIWHGDSKETVLENERAFLAELEHY,2,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2086,NE688,NA,conserved hypothetical protein,NA,hypothetical protein,G204E,SAB mortality and SAB persistence,NA,NA,NA,NA
516,MLYLEVLKNRNFTYLLIGNFLRRSCFVLFSLQIIWFTVELTNQSSLKLSMMVMSQTLPFIIFGIFGGAYSDKHNKKKILYLSDLILSLIIIIIPLLAITSNLNYLTLLTISTAITIINCYTDPAFRAILPEIIDEEHLATSNALIDSLQRGSNIILPALIGVIVILVGNVGVFFICSILLFLGFIFNALLKYTNNNMIDRHSKEDFSETWEFLKQSKEIPFIIIIQFACILINTGLWHVVLPLFISNILKEGVGVYGLATSCLGIASLLMSLIMGLLSEKRLIFKFSIGVLVWGIGLSIINVFPSVAILYIGATLLGLGQSIEGLTRSVAIQIKTPNHLMGKVFSISSTSNYAADTLSLGLISIIIPLLSLSNIFILGGVIISILSLAGLKFVKKSM,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2434,NE1115,-,transporter protein,NA,hypothetical protein,H238R,SAB mortality and SAB persistence,NA,NA,NA,NA
518,MKGAMAWPFLRLYILTLMFFSANAILNVFIPLRGHDLGATNTVIGIVMGAYMLTAMVFRPWAGQIIARVGPIKVLRIILIINAIALIIYGFTGLEGYFVARVMQGVCTAFFSMSLQLGIIDALPEEHRSEGVSLYSLFSTIPNLIGPLVAVGIWNANNISLFAIVIIFIALTTTFFGYRVTFAEQEPDTSDKIEKMPFNAVTVFAQFFKNKELLNSGIIMIVASIVFGAVSTFVPLYTVSLGFANAGIFLTIQAIAVVAARFYLRKYIPSDGMWHPKYMVSVLSLLVIASFVVAFGPQVGAIIFYGSAILIGMTQAMVYPTLTSYLSFVLPKVGRNMLLGLFIACADLGISLGGALMGPISDLVGFKWMYLICGMLVIVIMIMSFLKKPTPRPASSL,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_2406,NE14,NA,putative transporter,cntE,Staphylopine export protein,A50V,all,NA,NA,NA,NA
519,MKFNKVKLVIHACVLLFIIISIALIFHRLQTKTHSIDPIHKETKLSDNEKYLVDRNKEKVAPSKLKEVYNSKDPKYKKIDKYLQSSLFNGSVAIYENGKLKMSKGYGYQDFEKGIKNTPNTMFLIGSAQKFSTGLLLKQLEEEHKININDPVSKYLPWFKTSKPIPLKDLMLHQSGLYKYKSSKDYKNLDQAVKAIQKRGIDPKKYKKHMYNDGNYLVLAKVIEEVTGKSYAENYYTKIGDPLKLQHTAFYDEQPFKKYLAKGYAYNSTGLSFLRPNILDQYYGAGNLYMTPTDMGKLITQIQQYKLFSPKITNPLLHEFGTKKYPDEYRYGFYAKPTLNRLNGGFFGQVFTVYYNDKYVVVLALNVKGNNEFRIKHIYNDILKQNKPYNTKGVIVQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0959,NE1022,fmt,fmt protein,fmtA,Teichoic acid D-alanine hydrolase,F373V,SAB mortality and SAB persistence,NA,NA,NA,NA
521,MTKYFFSSSFLLFLGNWIGQIGLNWFVLTTYHNAVYLGIVNFCRLVPILLLSVWAGAIADKYDKGRLLRITISSSFLVTAILCVLTYSFTAIPISVIIIYATLRGILSAVETPLRQAILPDLSDKISTTQAVSFHSFLINICRSIGPAIAGVILAVYHAPTTFLAQAICYFIAVLLCLPLHFKVTKIPEDASRYMPLKVIIDYFKLHMEGRQIFITSLLIMATGFSYTTLLPVLTNKVFPGKSEIFGIAMTMCAIGGIIATLVLPKVLKYIGMVNMYYLSSFLFGIALLGVVFHNIVIMFICITLIGLFSQWARTTNRVYFQNNVKDYERGKVLSIIMMDRGMIPLGSLLMSICADVFGIVRTFSIMGISTICITMVFYFINRKLKLKLEESNHGIS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2139,NE548,NA,putative transporter,NA,hypothetical protein,A167T,SAB mortality and SAB persistence,NA,NA,NA,NA
522,MTKSEKIIELTNHYGAHNYLPLPIVISEAEGVWVKDPEGNKYMDMLSAYSAVNQGHRHPKIIQALKDQADKVTLVSRAFHSDNLGEWYEKICKLAGKDKALPMNTGAEAVETALKAARRWAYDVKGIEPNKAEIIAFNGNFHGRTMAPVSLSSEAEYQRGYGPLLDGFRKVDFGDVDALKAAINENTAAVLVEPIQGEAGINIPPEGYLKAIRELCDEHNVLFIADEIQAGLGRSGKLFATDWDNVKPDVYILGKALGGGVFPISVVLADKEVLDVFTPGSHGSTFGGNPLACAASIAALDVIVDEDLPGRSLELGDYFKEQLKQIDHPSIKEVRGRGLFIGVELNESARPYCEALKEEGLLCKETHDTVIRFAPPLIITKEELDLALEKIRHVFQ,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0860,NE930,rocD,ornithine--oxo-acid transaminase,rocD2_2,Ornithine aminotransferase 2,R337C,Growth rate and cell death,NA,NA,NA,NA
523,MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYALTFAICGPILVKLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRIISSAAALIIVKVLAITAMLSAPKNRGKMIGLVYTGFSGANVFGVPIGTVIGDLVGWRYTFLFLIIVSIIVGFLMMIYLPKDQEIQRGPVNHEAPSHENHVTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNGHDMSFVSLALLVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGLLLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGGIIGGLVMTHVSVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2397,NE996,-,putative transport protein,pbuE,Purine efflux pump PbuE,A106dup,Growth rate and cell death,+,0,-,0
525,MSEKQQILDYIETNKYSYIEISHRIHERPELGNEEIFASRTLIDRLKEHDFEIETEIAGHATGFIATYDSGLDGPAIGFLAEYDALPGLGHACGHNIIGTASVLGAIGLKQVIDQIGGKVVVLGCPAEEGGENGSAKASYVKAGVIDQIDIALMIHPGNETYKTIDTLAVDVLDVKFYGKSAHASENADEALNALDAMISYFNGVAQLRQHIKKDQRVHGVILDGGKAANIIPDYTHARFYTRAMTRKELDILTEKVNQIARGAAIQTGCDYEFGRIQNGVNEFIKTPKLDDLFAKYAEEVGEAVIDDDFGYGSTDTGNVSHVVPTIHPHIKIGSRNLVGHTHRFREAAASVHGDEALIKGAKIMALMGLELITNQDVYQDIIEEHAHLKGNGK,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2087,NE600,NA,putative peptidase,abgB,p-aminobenzoyl-glutamate hydrolase subunit B,A81V,Growth rate and cell death,NA,NA,NA,NA
526,MSLNITRGDNETLAQYHFRLYKNKEEMGLSNIQIADLLNSEYGTNYDESKFRKEYQAYINVWKDMIEEKHKASLPNSIVEELRYERNELKKEKIRFSDQKREFNNILRKMARLEHLQDYLKETVEQLEPVNLNIQPTHIGVKEAMVVISDMHIGMQINSQFNVYNKDVAKQRLEKLCNKTYDKVQKENITTLHIASLGDQINGLIHSTTRINNEENVIEQIITVSEYLKQFVKVFLDLGINVKFYNVVGNHSRVVANKKDSIGTSESFERLITTILDTSFEKYTNYHSESDTEGFIVINISGKNIVLAHGDLDRGANSITKLSQLLGIQIHYIFTGHVHHHFVKEHGLTVQYGVGSFCGLDQYAISGRFSGRPSQLLVTFNETDIEETNTVYLD,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,S77G,SAB mortality only,NA,NA,NA,NA
527,MNIPKSVWWLVIGMALNITGSSFLWPLNTIYMKQELGKSLTVAGLVLMINSFGMVIGNLLGGSLFDKLGGYKTILIGTFTCLCSTTLLNFFHGWPWYAVWLVMLGFGGGMIIPAIYAMAGAVWPNGGRQTFNAIYLAQNIGVAVGAAMGGFVAEFSFNYIFLANLIMYVVFALVAVTQFNIEINAKVKYPTHLDITGKKNKARFISLVLICAMFAICWVAYIQWESTIASFTQSINISMAQYSVLWTINGIMILVAQPLIKPILYLLKGNLKKQMFVGIIIFMLSFFVTSFAENFTIFVVGMIILTFGEMFVWPAVPTIANQLAPDGKQGQYQGFVNSAATVGKAFGPFLGGVLVDAFNMRMMFIGMMLLLVFALILLMVFKENNTQPKKIDA,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_1705,NE17,NA,putative drug transporter,mdtH,Multidrug resistance protein MdtH,A345V|V345A,"SAB mortality, growth rate and cell death",+,0,-,1
528,MQFDNIDSALMALKNGEPIIVVDDENRENEGDLVAVTEWMNDNTINFMAKEARGLICAPVSKDIAQRLDLVQMVDDNSDIFGTQFTVSIDHVDTTTGISAYERTLTAKNLIDPSSEAKDFNRPGHLFPLVAQDKGVLARNGHTEAAVDLAKLTGAKPAGVICEIMNDDGTMAKGQDLQKFKEKHQLKMITIDDLIEYRKKLEPEIEFKAKVKMPTDFGTFDMYGFKATYTDEEIVVLTKGAIRQHENVRLHSACLTGDIFHSQRCDCGAQLESSMKYINEHGGMIIYLPQEGRGIGLLNKLRAYELIEQGYDTVTANLALGFDKDLRDYHIAAQILKYFNIEHINLLSNNPSKFEGLKLYGIDIAERIEVIVPETVHNHDYMETKKIKMGHLI,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1713,NE573,ribBA,riboflavin biosynthesis protein,ribBA,Riboflavin biosynthesis protein RibBA,K324E,SAB mortality and SAB persistence,NA,NA,NA,NA
529,MTRVVLAAAYRTPIGVFGGAFKDVPAYDLGATLIEHIIKETGLNPSEIDEVIIGNVLQAGQGQNPARIAAMKGGLPETVPAFTVNKVCGSGLKSIQLAYQSIVTGENDIVLAGGMENMSQSPMLVNNSRFGFKMGHQSMVDSMVYDGLTDVFNQYHMGITAENLVEQYGISREEQDTFAVNSQQKAVRAQQNGEFDSEIVPVSIPQRKGEPIVVTKDEGVRENVSVEKLSRLRPAFKKDGTVTAGNASGINDGAAMMLVMSEDKAKELNIEPLAVLDGFGSHGVDPSIMGIAPVGAVEKALKRSKKELSDIDVFELNEAFAAQSLAVDRELKLPPEKVNVKGGAIALGHPIGASGARVLVTLLHQLNDEVETGLTSLCIGGGQAIAAVVSKYK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0355,NE1901,-,acetyl-CoA acetyltransferase,NA,putative acetyl-CoA acyltransferase,E369K,SAB mortality and SAB persistence,NA,NA,NA,NA
530,MSELIIYNGKVYTEDGKIDNGYIHVKDGQIVAIGEVDDKAAIDNDTTNKIQVIDAKGHHVLPGFIDIHIHGGYGQDAMDGSYDGLKYLSENLLSEGTTSYLATTMTQSTDKIDNALTNIAKYEAEQDVHNAAEIVGIHLEGPFISENKVGAQHPQYVVRPFIDKIKHFQETANGLIKIMTFAPEVEGAKEALETYKDDIIFSIGHTVATYEEAVEAVERGAKHVTHLYNAATPFQHREPGVFGAAWLNDALHTEMIVDGTHSHPASVAIAYRMKGNERFYLITDAMRAKGMPEGEYDLGGQKVTVQSQQARLANGALAGSILKMNHGLRNLISFTGDTLDHLWRVTSLNQAIALGIDDRKGSIKVNKDADLVILDDDMNVKSTIKQGKVHTFS,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0686,NE395,nagA,N-acetylglucosamine-6-phosphate deacetylase,nagA,N-acetylglucosamine-6-phosphate deacetylase,I332M,SAB persistence only,NA,NA,NA,NA
531,MSYHWFKKMLLSTSILILSSSSLGLATHTVEAKDNLNGEKPTTNLNHNITSPSVNSEMNNNETGTPHESNQTGNEGTGSNSRDANPDSNNVKPDSNNQNPSTDSKPDPNNQNPSPNPKPDPDNPKPNPDPKPDPDKPKPNPDPKPDPDKPKPNPNPKPDPNKPNPNPSPDPDQPGDSNHSGGSKNGGTWNPNASDGSNQGQWQPNGNQGNSQNPTGNDFVSQRFLALANGAYKYNPYILNQINKLGKDYGEVTDEDIYNIIRKQNFSGNAYLNGLQQQSNYFRFQYFNPLKSERYYRNLDEQVLALITGEIGSMPDLKKPEDKPDSKQRSFEPHEKDDFTVVKKQEDNKKSASTAYSKSWLAIVCSMMVVFSIMLFLFVKRNKKKNKNESQRR,0,1,0,2,0,1,0,1,0,2,0,1,NA,NA,NA,NA,NA,hypothetical protein,N127K|N138K,SAB persistence and cell death,NA,NA,NA,NA
532,MLFANFALNLTIIQGGGMSNSAVFFVIFLKQATCNTYFKEVKIYHLGEMDMKIVALFPEAVEGQDNQLLNTKKALGLKTFLEERGQEFIILADNGEDLDKHLPDMDVIISAPFYPAYMTRERIEKAPNLKLAITAGVGSDHVDLAAASEHNIGVVEVTGSNTVSVAEHAVMDLLILLRNYEEGHRQSVEGEWNLSQVGNHAHELQHKTIGIFGFGRIGQLVAERLAPFNVTLQHYDPINQQDHKLSKFVSFDELVSTSDAITIHAPLTPETDNLFDKDVLSRMKKHSYLVNTARGKIVNRDALVEALASEHLQGYAGDVWYPQPAPADHPWRTMPRNAMTVHYSGMTLEAQKRIEDGVKDILERFFNHEPFQDKDIIVASGRIASKSYTAK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0179,NE497,NA,putative D-isomer specific 2-hydroxyacid dehydrogenase,NA,Formate dehydrogenase,F25fs,SAB mortality only,NA,NA,NA,NA
533,MLDWFQLANNKENKTIQLRRYLHQYPELSFEEFQTHDYIVNQLSQLSCDIETPIGRNGIKATFKGLGTGPTIALRADFDALPVEELNDVPYKSKNPGCMHACGHDGHTAILLTVAEILDEHKHLLEGNVVLIFQYGEEITPGGSQEMIDAGCLENVDRIYGTHLWSGYPTGTIHSRAGAIMASPDEFSVTFKGRGGHGAKPHETIDPIVIMAEFILSAQKIISRTIDPVKQAVLSFGMIQAGTTDSVIPDQAFCKGTVRTFDSDIQNHVMDKMDKLLQGLAIANDINYDLNYIKGYLPVHNNEKAYQVIKEATNDLHVRFNESDLMMIGEDFSHYLKVRPGAFFLTGCGNESKGITAPHHNPKFDIDEKSLKYAVAVFLKIIELEQVFKTN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0534,NE1455,NA,amidohydrolase,scmP_1|scmP_3|scmP_2,N-acetylcysteine deacetylase,L371S,SAB persistence only,NA,NA,NA,NA
534,MASYEKRGSTWRYRISLGKDAKTGKYKYISNSGFKRKSDAKHHAEMVERQLRTGDYIAPSTSTFKQVANDWLKQYANEVKVSSVRAREKAIHHAIERFNNKPIQTINKHDYQRFVNDISAQYSKNYIDSIIASTNMIFKYAYDMKLIRILPSEGIKRSKKKVSVEELEDTEIHKKFLEKDELFQFLEVAKNHHSPQNSFEVFCTLAYTGMRAGELLALKWSDIDFENNTINITKTYYNPNNNKKQYQILTPKTESSIGKISVDPHVIKLLKNYKTDVQDTWKNKLYVDNNFVFTDVNGYPLVIKKLQLWIKAILKKTDITNKQISTHSFRHTHCALLIEAGVHIKEIQERLRHKDINTTMNIYAKITNSYKKDASQKFSKLMENVSKDLF,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,xerC_4,Tyrosine recombinase XerC,S158P,SAB mortality only,NA,NA,NA,NA
535,MYKIKDVETRIKNDGVDLGDIGCRFYTEDENTASIRIGINDKQGRIDLKAHGLTPRLHLFMEDGSIFKNEPLIIDDVVKGFLTYKIPKKVIKHAGYVRCKLFLEKEEEKIHVANFSFNIIDSGIESAVAKEIDVKLVDDAITRILKDNATDLLSKDFKEKIDKDVISYIEKNESRFKGAKGDKGEPGQPGAKGEAGKKGEQGVPGKNGTVVSINPDTKMWQIDGKDTDIKAEPELLDKINIANVEGLEDKLQEVEKIKDTTLNDSKMYTDTKIAELVDSAPESMNTLRELAEAIQNNSISESVLQQIGSKVSTEDFEEFKQTLNDLYAPKNHNHDERYVLSSQAFTKQQADNLYQLKSASQPTVKIWTGTENEYNYIYQKDPNTLYLIKG,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,I21V,SAB persistence only,NA,NA,NA,NA
537,MKTIHLFRIYHSFLLKKWYLIIYLLFILAALLITLTTIQHVTEDDNHFNIGVVDKDQSSETKLILNSIGKGSNLGKNVSIKAYDDKQAHTLLKQQKLQGYFVFDKGMTKAFYKQGELPISVYTYDQQSMKSVVLSQLTDSVYQRLMRSMGGILAFQDLAPKASHSDSINVMTDLLITGLNRSGAFNLEPIHLYDTGSYYAITGFLTTVFIFALSLFTVLKMNQDTVLKARLKMFHFSKERLLIIRALITWFYTMLWSIVGVVWIVFSIPNTFELYN,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0273,NA,NA,NA,NA,hypothetical protein,Ter277Wext*?,Growth rate and cell death,NA,NA,NA,NA
538,MINEREVFILIYLDNAATTKAFEEVLDTYLKVNQSMYYNPNSPHKAGLQANQLLQQAKTQINAMINSKTNYDVVFTSGATESNNLALKGIAYRKFDTAKEIITSVLEHPSVLEVVRYLEAHEEFKVKYVDVKKDGSINLEHFKELMSDKVGLVTCMYVNNVTGQIQPIPQMAKVIKNYPKAHFHVDAVQAFGKISMDLNNIDSISLSGHKFNGLKGQGVLLVNHIQNVEPTVHGGGQEYGVRSGTVNLPNDIAMVKAMKIANENFEALNAFVTELNNDVRQFLNKYHGVYINSSTSGSPFVLNISFPGVKGEVLVNAFSKYDIMISTTSACSSKRNKLNEVLAAMGLSDKSIEGSIRLSFGATTTKEDIARFKEIFIIIYEEIKELLK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1662,NE222,NA,"aminotransferase, class V",iscS_2,Cysteine desulfurase IscS,E123G,SAB mortality only,NA,NA,NA,NA
540,MNIHEYQGKEIFRSMGVAVPEGRVAFTAEEAVEKAKELNSDVYVVKAQIHAGGRGKAGGVKIAKSLSEVETYAKELLGKTLVTHQTGPEGKEIKRLYIEEGCAIQKEYYVGFVIDRATDQVTLMASEEGGTEIEEVAAKTPEKIFKETIDPVIGLSPFQARRIAFNINIPKESVNKAAKFLLALYNVFIEKDCSIVEINPLVTTADGDVLALDAKINFDDNALFRHKDVVELRDLEEDPKEIEASKHDLSYIALDGDIGCMVNGAGLAMATMDTINHFGGNPANFLDAGGSATREKVTEAFKIILGDENVKGIFVNIFGGIMKCDVIAEGIVEAVKEVDLTLPLVVRLEGTNVELGKKILKDSGLAIEPAATMAEGAQKIVKLVKEA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1138,NE569,sucC,"succinyl-CoA synthetase, beta subunit",sucC,Succinate--CoA ligase [ADP-forming] subunit beta,E237dup,SAB mortality and SAB persistence,NA,NA,NA,NA
542,MKRNFPKLIALSLIFSLSVTPIANAESNSNIKAKDKKHVQVNVEDKSVPTDVRNLAQKDYLSYVTSLDKIYNKEKASYTLGEPFKIYKFNKKSDGNYYFPVLNTEGNIDYIVTISPKITKYSSSSSKYTINVSPFLSKVLNQYKDQQITILTNSKGYYVVTQNHKAKLVLKTPRLEDKKLKKTESIPTGNNVTQLKQKASVTMPTSQFKSNNYTYNEQYINKLENFKIRETQGNNGWCAGYTMSELLNATYNTNKYHAEAVMRFLHPNLQGQRFQFTGLTPREMIYFGQTQGRSPQLLNRMTTYNEVDNLTKNNKGIAVLGSRVESRNGMHAGHAMAVVGNAKLDNGQEVIIIWNPWDNGFMTQDAKNNVIPVSNGDHYRWYSSIYGY,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1890,NE1278,-,staphopain A,sspP,Staphopain A,D45G,SAB mortality and SAB persistence,NA,NA,NA,NA
543,MVKLTTKIASLKLFASYAIATYILVILTSALNLFKGYVADTFYIAETLLIVLTIILIIILTTEQTWKHHDLWRRIVEVLLLLMTLTGNVFTLLMFVSIRRYERTSQIHSYNGWESFIRKTTRHRIAIIGLLILVYMLTLSIVSKFTFDTTLATKNQFNALLHGPSLAYPFGTDDFGRDLFTRVVVGTKLTFSISIISVVIAVIFGVLLGTIAGYFNHIDNLIMRILDVVFAIPSLLLAVAIIASFGASIPNLIIALSIGNIPSFARTMRASVLEIKRMEYVDAARITGENTWNIIWRYILPNAIAPMIVRFSLNIGVVVLTTSSLSFLGLGVAPDVAEWGNILRTGSNYLETHSNLAIVPGVCIMFVVLAFNFIGDAVRDALDPRIH,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0202,NE457,NA,"peptide ABC transporter, permease protein",NA,hypothetical protein,K144Q,SAB persistence only,NA,NA,NA,NA
544,MYYHQPLLLTPGPTPVPDAIMREIQAPMVGHRSKDFEDIAQQAFQGLKPIFGSQNDVLILTSSGTSVLEASMLNIVNPEDHFVVIVSGAFGNRFKQIAQTYYKNVHIYDVTWGRSCRC,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1669,NE1652,-,"aminotransferase, class V",NA,Soluble hydrogenase 42 kDa subunit,R114fs,SAB mortality only,NA,NA,NA,NA
546,MRIIRAAMGYAAIPTGFPILLSERMAIIEPAFAWLIELATIPGRSHAAETIRTYGEHLHDWFDSLEQMGLDWRGVSEAEIAAWRNRMLSQPSPHTKRPYARSTVNDRVRTVCRFYAWAQDRGWIESLPFHFVDVRVGSGRRQSFLAHVDGRPGIVAANILTVAEHERLPRPLRVDQLRRVYAHLEMPYRLMAEWGLATGLRRKELCGLAVFQVPETAHLDDEDHPLIGVPLTITKGDKPRTIYPPIRLVDRTQRYVDEVRTPQVRALRRNRPGYRPPSALFLNAQGYAVSKARLTAVFAEAFRAARVIGTLHYLRHTFAMTMLVRLQRQAMTTPDLNPLKIVQMLLGHSSIQSTAIYLRCVELNARDLADSIDYLYGELIPDGR,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,xerC_9,Tyrosine recombinase XerC,M68T,SAB mortality only,NA,NA,NA,NA
547,MRIEYNYRYYLTENEYKQYHIQLKGFIKKYVATKLADVGEVIHFAQAQQRQGRYVSLYLSYEAAKYFNHAMCTHSLAKDDIYAAAYSFEKAGSINSTYEHQTSYVSKYHFSFVESSEVMMTNIKRVQQAIVEGETYQVNYTARLTDNIYYPISTLYERLTQFSNGNYTALLQTDEIQVASISPELFFQKGQFNNVDNVIISKPMKGTMPRGKTEAEDQQYYKTLQTSSKDRAENVMIVDLLRNDIGRISQSGSIKVYKLFFIEAYKTVFQMTSMVSGTLKNNTDLTQILTSLFPCGSITGAPKLNTMKYIKQLESSPRGIYCGAIGLLLPTEDDKMIFNIPIRTIEYKYGQAIYGVGAGITIDSKPKDEVNEFYAKTKILEML,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0699,NE1063,-,chorismate-binding domain-containing protein,menF,Isochorismate synthase MenF,G92E,SAB mortality only,NA,NA,NA,NA
551,MIRIQDNTIRDGMQQSNVRKSIIVKKEVLQEINKISINSVEVGMCTTFEDEYNIHQYREILNNDKEIVVLTRLDENEINKILNLKIHNLAVKILLPISDLHIKEKLNFTSEYYNERINKCLNMIKVNQVAIDICFEDATRCSLEKLCEYMEMISKFPIRTVTFADTVGCSTPFEYGNIFKEFVKKYPNITFSAHCHNDLGLATANTFAAILNGAQQIETTFLGIGERAGNASIEEIIAILTKKQIVMTSLNLPDIYKTSMNISKILDIRLAENKPVIGKNIFKHESGIHQDGTNKNISMYQYILPSDLGLKNSKAVQFPISNISSKKILKNKFKSIVHPKDIEDNISFYKLINKFIPEVVPEDTADLLQVIKGRSKDGNFK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,leuA_1,2-isopropylmalate synthase,D344E,SAB persistence only,NA,NA,NA,NA
552,MFQLLAVCPMGLEAVVAREIQELGYETNVENGRIFFEGEASAIVKANLWLRTADRIKIVVGRFNATTFDELFEQTKALPWESIIDKEGNFPVQGRSVKSTLHSVPDCQAITKKAIVERLRRAYNEKGWLNESGAKYPVEVAILKDNVLLTIDTSGSGLNRRGYRLAQGEAPIKETLAASLIRLANWKGDTPLIDPFCGSGTIAIEACLIAQNIAPGFNREFVSEQWNIMPANIYDDYRDEADKMADYDKEIEVYASDIDPEMVEIAKRNAEEVGLSDIIKFSVKDVNTLTIDTEEPVALIGNPPYGERIGDREEVEEMYRYIGKLMKQHPFLSTYILTSNKEFEYLVDRKATKRRKLFNGYIECTYYQYWGKKTERKTIEN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1336,NE1691,-,hypothetical protein,rlmL,Ribosomal RNA large subunit methyltransferase L,E39D,SAB mortality and SAB persistence,NA,NA,NA,NA
553,MIRIQDNTIRDGMQQSNVRKSLIIKKEVLKQINKLNINSVEVGMCTTIEDEFNIHQFRDILSPEKELVVLTRLNEKEIKKIVKLKIHNLVVKILLPISDLHIKEKLNFSNKYYIQKIKDCLDILKKDKKGVDICFEDGTRTSREKLKEYMEIISKYQVRTVTFADTVGCSTPLEYGDIFNYFVKKYSNIIFSAHCHNDLGLATANTLAAILNGAKQIETTFLGIGERAGNAPIEEIITILTKKQIESTEFTLPDVYKTSINISKILDFQISENKPIIGENIFKHESGIHQDGTKKNINMYQYLVPSDLGLKNSQVVQFPISNISSKKILHNKFKSIVNTEEIDENISFYKLVNKFSPDVAPEDTVDLLQIIKRRSKDGNFK,2,1,0,0,1,1,0,0,2,1,0,0,SAUSA300_0879,NE178,NA,isopropylmalate synthase-related protein,leuA_2|leuA_1,2-isopropylmalate synthase,D358E|R325S,SAB mortality and SAB persistence,-,0,-,0
555,MNKKTKLIHGGHTTDDYTGAVTTPIYQTSTYLQDDIGDLRQGYEYSRTANPTRSSVESVIATLENGKHGFAFSSGVAAISAVVMLLDKGDHIILNSDVYGGTYRALTKVFTRFGIEVDFVDTTHTDSIVQAIRPTTKMLFIETPSNPLLRVTDIKKSAEIAKEHGLISVVDNTFMTPYYQNPLDLGIDIVLHSATKYLGGHSDVVAGLVATSDDKLAERLAFISNSTGGILGPQDSYLLVRGIKTLGLRMEQINRSVIEIIKMLQAHPAVQQVFHPSIESHLNHDVHMAQADGHTGVIAFEVKNTESAKQLIKATSYYTLAESLGAVESLISVPALMTHASIPADIRAKEGITDGLVRISVGIEDTEDLVDDLKQALDTL,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0434,NE60,metB,cystathionine gamma-synthase,mccB,Cystathionine gamma-lyase,I167F|F167I,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
557,MEIYADYAATTPVKPEVVDAMMTIYNSHYGNPSSIHAKGRDARKYLDESRRQIAQLLGADTHEIIFTSGATESNNTAIKGIVKANEQLGNHIITSKIEHHSVLHVFEQLEREGFDVTYLDVDDTGAIDLDQLEETITDKTILVSIMFVNNEVGTVQQIYDIQDIIAETNAYFHVDAVQAIGHLDVKFDEFEIDAMSITAHKFGGPKGVGALLVKDHVTLDYPQLGGEQELKRRAGTENLAQIVGMAKALQLAEKNRDNNNIHLMNIKEQFLVKLQERAIPFELNGSMTDATGHIVNLYFPFVEVETMLTLLDMAQIYVSSGSACTAGSTQPSHVLDAMFEDEERSNHSIRFSFNELTTENEINAIVAEIHKIYFKFKEES,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1579,NA,NA,NA,iscS_1,Cysteine desulfurase IscS,N258D,SAB mortality only,NA,NA,NA,NA
558,MAKRDYYEVLGISKDASKDEIKKAYRKLSKKYHPDINKEEGADEKFKEISEAYEVLSDDNKRASYDQFGHDGPQGFGGQGFNGSDFGGFSGFGGGGFEDIFSSFFGGGRQRDPNAPQKGDDLQYTMTLTFEEAVFGTTKEISIRKDVTCETCHGDGAKPGTSKKTCSYCNGAGHVAVEQNTILGRVRTEQVCPKCNGSGQEFEEACPTCHGKGTENKTVKLEVKVPEGVDNEQQIRLAGEGSPGVNGGPAGDLYVVFRVKPSETFKRDGDDIYYKLNVSFPQAALGDEIKIPTLNNEVMLTIPAGTQTGKQFRLKEKGIKNVHGYGYGDLYVDIKVVTPTKLTDRQKELMKEFAQLNGEEINEQPSNFKDRAKRFFKGE,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_1539,NA,NA,NA,dnaJ,Chaperone protein DnaJ,G156S,SAB mortality and cell death,NA,NA,NA,NA
559,MPAVTYEHIKTCKQSGARLGIVHTPHGSFETPMFMPVGTKATVKTMSPEELRQIEAKIILGNTYHLWLQPGNDIIKHAEGLHKFMNWDGPILTDSGGFQVFSLSNLRKITEEGVEFRHHTNGSKLFLSPEKSMQIQNDLGSDIMMAFDECPPMPAEYDYVKKSIERTTRWAKRCLDAHQRPEDQALFGIIQGGEYEDLREQSAKDLVELDFPGYAIGGLSVGEPKPVMYKMVEHTEQFMPKDKPRYLMGVGSPDALIECSIRGMDMFDCVLPTRIARNGTCMTSQGRLVIKNAKFADDLRPLDENCDCYTCQNYSRAYIRHLIKAEETFGIRLTTIHNLHFLLKLMEDIRQAIREDRLLDFKEEFFEQYGLNVENPKNF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1595,NE1885,tgt,queuine tRNA-ribosyltransferase,tgt,Queuine tRNA-ribosyltransferase,E79G,SAB mortality and SAB persistence,NA,NA,NA,NA
561,MVTPPVDDVTKHGPKAGEPEVTKEEIPFEKKREFNPDLKPGEEKVTQEGQTGEKTTTTPTTINPLTGEKVGEGEPTTEVTKEPIDEIVNYAPEIIPHGTREEIDPNLPEGETKVIPGKDGLKDPETGEIIEEPQDEVIIHGAKDDSDSDADSDSDSDSDSDADSDSDADSDSDADSDSDADSDSDADSDSDADSDSDADSDSDSDSDSDADSDSDSDSDSDADSDSDADSDSDADSDSDADSDSDADSDSDSDSDSDADSDSDADSDSDADSDSDADSDSESERDTEADSDSDSDSDSDSDSVSEADRDSDSDSDSDADSDSDADRDHNDKTDKPNNKELPDTGNDAQNNGTLFGSLFAALGGLFLVGRRRKNKNNEEK,0,1,0,0,0,1,0,0,0,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,R308S|S312A,SAB persistence only,NA,NA,NA,NA
563,MEIHVYTGPLCGFNEYINSEVKEYHRFMELIREYNIIVRASDTFGTHDVDGIFDTEIENLVIFSNDFASVTTHVITNFINIVTLGRNIKKIYIQNPPKRVFQSLNSFHDSEIIEINYEYTTLKKDDVINFYKEQMAGSKIIGQTDAKKQMSIDLYKHTSLENNKPTVMLYYGPSGVGKTELAKEIAKKYKGNITRIQFSMMQNDESFNYIFGDEHAKVSLSKDLVDRETNVVLIDEFDKVLPIYYNVFYQMFDEGIIEDANYKVDVSNCIFILTSNFNSIEEAIVNIGEPVFSRIDSCIKFLYLTQEEKQKVIENNLYEILSSLNEKEKRIVTAYNLLEKYKETEIDIDNIRYLKKIITNDIYTIIFEDELFNTDIID,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2168,NE1220,-,hypothetical protein,NA,hypothetical protein,NLY316KLN,SAB mortality only,NA,NA,NA,NA
564,MSVNARDLLVLHTNVNRLVGEEIFANKCLANNDVQIMNSIKKLIEAELLTTTNDFEVSIYKKTRPELQSILKSFGIKTTGNKPDLIKRIDDNFHIIINLDLPYVYIPTKKGEEILKKTEYLTSFIQSYGEISLERAYYLVENYIDENCDDKVAEIYKFEFQRKYDNGEFDFNHGYNFELNMLIDHYKRDVKDYDNARKYSNIYLYFGLRDFLKKLMSNYSYYDSKGNIDLNEIQNDLNRFINSSASGMYERLIYNENLSNNIMFELFKKDTQDYSDLEEQLIEKFINYVVSNVKKESRSNTLIELSKILENGYTIDKEEFKKEDDYLSKYIFTDIDYLKKLESKINVAIDIRSGEIHLVLDDDSLDILIQNQKYGNEF,2,1,0,0,1,1,0,0,2,1,0,0,SAUSA300_2101,NE372,NA,SAP domain protein,NA,hypothetical protein,I97N|V207G,SAB mortality and SAB persistence,NA,NA,NA,NA
565,MEAVVDWVQVTFHIDPISAVIEDVIGLPITLFKKRNSGIYFYNRGYEFSNIKLYYSSDDESMGIHLQLTGTGCREFEHHLQQLNKTWQDFFDKCLSVNANFTRIDIAIDDYKTYLKVPLLIKKAEKAECVSRFRAGSAINGFNLSDGRSKGATFYIGSKQSNLYCRFYEKNYEQAFKRHCDVEDIGLWNRYEIQMRKAYAVNCAKVLSRTDNISEIVKSILHNNLRFISPPKDGNDKNRKRWPLYRPWALFIKDTEKLNLTTRPTLKSIEDNLDWLCKQVATTLDTVLTAESMAQSEGLLTDTDFLDKILAHSQFNDEHTNRINHYLEALKQKKHLSKDKC,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1487,NE1440,NA,replication initiation factor family protein,NA,hypothetical protein,Y114H,SAB mortality and SAB persistence,NA,NA,NA,NA
566,MKSKYEPLFDKVELPNGVELRNRFVLAPLTHISSNDDGTISDVKLPYIEKRSQDVGITINAASNVSDVGKAFPGQPSIAHDSNIEGLKRLATAMKKNGAKALVQIHHGGAQALPELTPDGDVVAPSPISLKSFGQKQEHSAREMTNEEIEQAIKDFGEATRRAIEAGFDGVEIHGANHYLIHQFVSPYYNRRNDVWANQYKFPVAVIEEVLKAKEAYGNKDFIVGYRLSPEEAESPGITMEITEELVNKISHMPIDYIHVSMMDTHATTREGKYAGQERLPLIHKWINGRMPLIGIGSIFTADEALDAVENVGVDLVAIGRELLLDYQFVEKIKDGREDEIINYFDPEREDNHHLTPNLWHQFNEGFYPLPRKDK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0859,NE1665,-,NADH-dependent flavin oxidoreductase,NA,putative oxidoreductase,K44E,SAB mortality and SAB persistence,NA,NA,NA,NA
567,MEKLKLMTIVGTRPEIIRLSSTIKACDQYFNQILVHTGQNYDYTLNQIFFDDLELRQPDHYLEAVGSNLGETMGNIIAKTYDVLLREQPDALLILGDTNSCLAAVSAKRLKIPVFHMEAGNRCFDQNVPEEINRKIVDHVSDVNLPYTEHSRRYLLDEGFNKANIFVTGSPMTEVIEAHRDKINHSDVLNKLGLEPQQYILVSAHREENIDNEKNFKSLMNAINDIAKKYKIPVIYSTHPRSWKKIEESKFEFDPLVKQLKPFGFFDYNALQKDAFVVLSDSGTLSEESSILKFPGVLIRTSTERPEVLDKGTVIIGGITYNNLIQSVELAREMQNNNEPMIDAIDYKDTNVSTKVVKIIQSYKDIINRNTWRK,3,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0158,NE580,cap5G,capsular polysaccharide biosynthesis protein cap5G,wbpI,"UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase",M334V,SAB mortality only,NA,NA,NA,NA
569,MKIIHTADWHLGKILNGKQLLEDQAYILDMFVEKMKEEEPDIIVIAGDLYDTTYPSKDAIMLLEQAIGKLNLELRIPIIIISGNHDGKERLNYGASWFEHNQLFIRTDFTSINSPIEINGVNFYTLPYATVSEMKHYFEDDTIETHQQGITRCIETIAPEIDEDAVNILISHLTVQGGKTSDSERPLTIGTVESVQKGVFDIFDYVMLGHLHHPFSIEDDKIKYSGSLLQYSFSEAGQAKGYRRVTINDGIINDVFIPLKPLRQLEIISGEYNDVINEKVHVKNKDNYLHFKLKNMSHITDPMMSLKQIYPNTLALTNETFNYNEENNAIEISEKDDMSIIEMFYKHITDKELSDIQSKKIKNILENELRKED,4,1,0,0,1,1,0,0,4,3,0,0,SAUSA300_1242,NE959,NA,exonuclease SbcD,sbcD|sbcD_2|sbcD_1,Nuclease SbcCD subunit D,M134T|Ter279Kext*?|L4I|I9M,SAB mortality and SAB persistence,NA,NA,NA,NA
570,MNKLILGIYLYRIFSRAYFYLPFLLIYFLIQGYSIIQLEILMASYGIAAFLFSLYKEKCFKICNLKDSNKLVVSEIFKIIGLLLLLYQNQYLILVVAQILLGLSYSMMAGVDTAIIKRNITNEKYVQNKSNSYMFLSLLISGIIGSYLYGINIKWPIIMTGIFSILTIIIIRCTLVENRELNLIGETKGKIKKFLPEEKFWILHYSFLRALILGFFIGFIPINIYNDFKDKVRIIV,2,2,1,0,1,2,1,0,3,2,1,0,SAUSA300_0881,NE317,NA,putative membrane protein,NA,hypothetical protein,F228L|V143I|N250K,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
571,MAELQRGLEGVIAAETKISSIIESQLTYAGYDIDDLAENAQFEEVIFLLWNYRLPNEEELAHLKGKLNQYMTLNPRVYTHFEEYVTDHVHPMTALRTSLSYIAHFDPDAENESDENRYERAMRIQAKVASLVTAFARVRQDKEPLKPNPDLSYAANFLYMLRGELPTDIEVEAFNKALILHADHELNASAFTARCAVSSLSDMYSGIVAAVGSLKGPLHGGANEQVMTMLSEIGSIENVDAYLDEKFANKDKVMGFGHRVYKDGDPRAKYLREMSRQITKDAGREELFEMSVKMEKRMAEEKGLIPNVDFYSASVYHCMEIPHDLFTPIFAVSRSAGWIAHILEQYKDNRIMRPRAKYIGETNRKYIPLEERK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1641,NE594,gltA,citrate synthase II,citZ,Citrate synthase 2,N349Y,SAB mortality and growth rate,-,5,-,0
574,MKIGIPREIKNNENRVGLSPSGVHALVESGHTVLVETNAGSGSFFEDVDYKEAGAEIVAEQAKVWDVDMVIKVKEPLESEYPYFKEGLVLFTYLHLANEEKLTQALIDRKVISIAYETVQLPDRSLPLLSPMSEVAGRMSAQVGAEFLQKLNGGMGILLGGVPGVPKGKVTIIGGGQAGTNAAKIALGLGADVTILDVNPKRLQQLDDLFGGRVHTIMSNPLNIELYVKQSDLVIGAVLIPGAKAPRLVTEDMIKQMKNGSVIIDIAIDQGGIFETTDKITTHDDPTYIKHGVVHYAVANMPGAVPRTSTLALNNAIRYLMRSC,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1655,NE198,ald,alanine dehydrogenase,ald2_2,Alanine dehydrogenase 2,I317fs,SAB persistence only,NA,NA,NA,NA
576,MEQRTRLALLKEIAEFLNEETEMYSMTQGALKYLIEGSNFTTGWIFFINSVGEHELVSHVALPQSLTADHCHYIKDGSCWCVKAFNQRRLMKASNIVNCSRINLASKAFPSQNDNITHHATVPLKSGQEQFGILNVASPNTEIYSDEDLELLESVAFQLGSAIKRIYLTDREKEAAKINERNRLARDLHDSVNQMLFSVKLTAHAAYGMSNESIAKQAFKTIEETSQNAVNEMRALIWKLKPVGLEQGLIHALTAYSKLMHIQLNVNVEGLIDLSNEIEENIYRALQECINNVKKHADTNKMDLTLKQMNDILYIDVIDYGQGFEIDNVQIASSHGINNIKQRVKLLRGKVTFHSQPTKGTQIQFTIPIK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1799,NE1053,-,putative sensor histidine kinase,NA,hypothetical protein,K239Q,SAB mortality and SAB persistence,NA,NA,NA,NA
577,MLREIYNHHNISRTQISKNLEINKATISSILNKLKYKSLVNEVGEGDSTKSGGRKPILLKVNHLYGYFISLDLTYSSVEVMYNYFDGNVIKHESYDLPDEKVSSILSIIKKHIDIQEKLDTYNGLLGVSVSIHGVVDNEQHVTYLPFHETEGISIAKKIKEITNVPVVVENEANLSALYERNFNHNLSYNNLIALSIHKGIGAGLIINNQLYRGANGEAGEIGKTLVSKVSDNVEIFHKIEDIFSQEALLHNLSNQLNEKMTLSKLIQFYNEKNPVVVEEMEQFINKIAVLIHNLNTQFNPNAIYINCPLFNEMPEILEAIKNQFKQYSRNEIQIKLTSNVKFATLLGGALAIIQKVLQINDIYLDIKA,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,nagC,N-acetylglucosamine repressor,A350T,SAB mortality and SAB persistence,NA,NA,NA,NA
578,MQHHKVAIIGAGAAGIGMAITLKDFGITDVIILEKGTVGHSFKHWPKSTRTITPSFTSNGFGMPDMNAISMDTSPAFTFNEEHISGETYAEYLQVVANHYELNIFENTVVTNISVDDAYYTIATTTETYHADYIFVATGDYNFPKKPFKYGIHYSEIEDFDNFNKGQYVVIGGNESGFDAAYQLAKNGSDIALYTSTTGLNDPDADPSVRLSPYTRQRLGNVIKQGARIEMNVHYTVKDIDFNDGQYHISFDSGQSVLTPHEPIVATGFDATKNPIVQQLFATTNQDIKLTTHDESTRYPNIFMIGATVENDNAKLCYIYKFRARFAVLAHLLTQREGLPAKQEVIENYQKNQMYLDDYSCCEVSCTC,2,2,0,0,1,1,0,0,2,1,0,0,SAUSA300_2521,NE1057,-,hypothetical protein,NA,Putative flavoprotein monooxygenase,E101G|H228R,SAB mortality and SAB persistence,NA,NA,NA,NA
582,MSDILKCIGCGAPLQSEDKNKPGFVPEHNMFRDDVICRRCFRLKNYNEVQDVGLESEDFLKLLSGLADKKGIVVNVVDVFDFEGSFINAVKRIVGNKKIILAANKLDLLPKQINKRRVKEWLKRTARKYGLEADDVVLISAEKGWGIDDLLSSIANIRENEDVYTVGTTNVGKSTLINKLIEASVGEKDVVTTSRFPGTTLDMIDIPLDETSFMYDTPGIIQDHQMTHLVSEKELKIIMPKKEIKQRVYQLNEAQTLFFGGLARIDYVSGGKRPLVCFFSNDLNIHRTKTEKANDLWRNQLGDLLTPPGNPQNFDLNEVKAVRLETGKEKRDVMISGLGFITIGPGAKVIVRVPKNVDVVLRNSIL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1556,NA,NA,NA,yqeH,putative protein YqeH,S2Y,SAB persistence only,NA,NA,NA,NA
585,MYINMKDYGLTGINKTKDTRAIQRALNRGRCKPTTVYIPKGTYDICKPLTIYGNTTLLLDNETILRRCHSGPLLKNGRRFGFYRGYNGHSHIHIKGGKFDMNGVSYPYNNTAMCIGHAEDIQLIGVTIKNVVSGHAIDACGINGLYIKSCSFEGFIDYSGERFYSEAIQLDIQVPGAFPKFGTTDGTITKNVIIEDCYFGPSELPEMGSWNRAIGSHASRHNRYYENIHIRNNIFEDIQGYALTPLKYKDAFIINNKFINCEGGIRYLGVRDGKNAADVMTGKDLGSQAGINMNIIGNEFKGSMSKDAIHVRNYNNVKHKDVLIVGNTFNNSTQSIHLEDIDTVFISPVEAGIQVTTINVDEIKK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1898,NE261,NA,conserved hypothetical protein,pfbA,Plasmin and fibronectin-binding protein A,I346L,SAB mortality and SAB persistence,NA,NA,NA,NA
586,MKKKNIYSIRKLGVGIASVTLGTLLISGGVTPAANAAQHDEAQQNAFYQVLNMPNLNADQRNGFIQSLKDDPSQSANLLAEAKKLNESQAPKADNKFNKEQQNAFYEILHLPNLNEEQRNGFIQSLKDDPSQSANLLAEAKKLNDAQAPKADNKFNKEQQNAFYEILHLPNLTEEQRNGFIQSLKDDPSVSKEILAEAKKLNDAQAPKEEDNNKPGKEDNNKPGKEDGNKPGKEDNKKPGKEDGNKPGKEDGNKPGKEDGNKPSKEDGNGVHVVKPGDTVNDIAKANGTTADKIAADNKLADKNMIKPGQELVVDKKQPANHADANKAQALPETGEENPFIGTTVFGGLSLALGAALLAGRRREL,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,spa,Immunoglobulin G-binding protein A,S264G,SAB persistence only,NA,NA,NA,NA
587,MRGDQRTQGEKSRKEGGKIFGSGSRAPIAISILVKDGSYNHDIYYNDIGEYLTREQKLDTLMKHQSIVNLKSLNVLPDKNNDWINQRDINYENYLPMYDSKDIENSIYLDQFNGVNSARDNWVTNFSNEKALVNAKLLVDNYNSEIDRLIDIFDSRERINLVNKDETFISWTRGLTQKFSKGKNISINPERIVKFMHRPFTKKWIVYDKNIMEMPSRYYNIMENTGQVIYIQGQGMNKEFSAMITDILPNFQFIGNGKGFATYKGKDSLRLVDNISNSFKKKINLNSEEIVYYIYAILHHKYYVNKYSSDLSKGFPRIPILKDVYGFVEIGRELVELHLNYEKQLNWDGVEIIYNNMNPNYKVEK,1,1,0,0,1,1,0,0,1,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,F153L|A154D,SAB mortality and SAB persistence,NA,NA,NA,NA
588,MEPLLSLKSVSKSYDDLNILDDIDIDIESGYFYTLLGPSGCGKTTILKLIAGFEYPDSGEVIYQNKPIGNLPPNKRKVNTVFQDYALFPHLNVYDNIAFGLKLKKLSKTEIDQKVTEALKLVKLSGYEKRNINEMSGGQKQRVAIARAIVNEPEILLLDESLSALDLKLRTEMQYELRELQSRLGITFIFVTHDQEEALALSDFLFVLKDGKIQQFGTPTDIYDEPVNRFVADFIGESNIVEGRMVRDYVVNIYGQDFECVDMGIPENKKVEVVIRPEDISLIKAEDGLFKATVDSMLFRGVHYEICCIDNKGYEWVIQTTKKAEVGSEVGLYFDPEAIHIMVPGETEEEFDKRIESYEEVDNA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0999,NE1159,potA,spermidine/putrescine ABC transporter ATP-binding protein,potA,Spermidine/putrescine import ATP-binding protein PotA,D287E,SAB persistence only,NA,NA,NA,NA
590,MFTYFKSAFKNAKPQLLITLIYALIAFTVIAVVYLLANFQLAKYAQTIAIYSQFGQKPPVDAYLKVIAVLLIAAVVSLFVLVQIFIGITNVMKRAMSHEKVKFTDLFIAFKKGNYLKSVLIGLVSIAMIIVLSLLTSLLYKLFSPVSEMIMNSVQSSYADSTHLIGIAITTQSIIIIVVLLIKAIITWLLLIPIFNFMTSFVESTNDKVKTHLANGFKAMKNGQKTFFKFFIGILLLNLIIILFKTPVGYLISFNTQSLSQSVAENIIRVYTVMTIILFVVIHAIILMGIVQYYLKRGQKITKDKVKTADKNKKVVTEPKNTKVENDKVTTSVETKTEKAQDSLNDNTTKTMTSDKPEDNQPK,2,2,2,2,1,1,1,1,2,2,2,2,SAUSA300_2100,NE721,NA,lytic regulatory protein,NA,hypothetical protein,A340S|T28A|A28T,all,NA,NA,NA,NA
591,MSNKLESYRSEIVSLNHQILDLLSKRGELAQKIGEEKLKQGTRIYDPQREKEMLNDLIDSNKGPFNDNTIKQLFKEIFKASTDLQKSENEKHLYVSRKLKPEDTIVTFDNGGIIGDGNKSFVFGPCSVESFEQVEAVAKNLHAKGEKFIRGGAFKPRTSPYDFQGLGVEGLKILKQIKDKYDLNVVSEIVNPNDFEVADEYLDVFQIGARNMQNFELLKEAGRTKKPILLKRGLSATIEEFVYAAEYIASQGNQNIILCERGIRTYEKATRNTLDISAVPILKQGTHLPVMVDVTHSTGRKDIMLPTAKAALAVGADGVMAEVHPDPSVALSDAGQQMDLDEFQAFYDELKPLADLYNAKKLK,2,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1683,NE1276,-,bifunctional 3-deoxy-7-phosphoheptulonate synthase/chorismate mutase,aroA_2|aroA_1,Protein AroA(G),L99F|F99L,SAB mortality and SAB persistence,NA,NA,NA,NA
592,MKFLKDTSIAEISSILYLIFPIAGIFFNEVYGPKWLYIISVIVFSLSYLILVIVNNRLNTLMFYILLIIHYFIICYFVFSVHPMLSLFFFYSAFAVPFTFKNNVKKTATNLFILTMIICTIITYLLYDNYFVAMMVYYVVISLIMLDNFKKMKNREYQKEIAEKNRHINTLIAEQERHRIGQDLHDTLGHVFASLSLKSELAYKLIDADVEKVKAELLAINKLSRESLNKVREIIDDVKLPSFIEEIDSIRKVLKDADIDFTFENKELAQVLSPTKQSMLVMITREAINNVIKHANASKVHGKLKTVNNHKLLLMIEDDGKGIDSDCEVKSISQRVQHLNGTLAVDSTNGTKIIIEISTGGIA,1,1,0,0,1,1,0,0,1,5,0,0,SAUSA300_1219,NE116,NA,putative sensor histidine kinase,NA,hypothetical protein,D128N|N42I|Y44F|T47S|I62M,SAB mortality and SAB persistence,NA,NA,NA,NA
593,MTATWSVNKKIFLQNAITVKNNQPLMAVVKNNAYHYDLEFAVTQFIHAGIDTFSTTSLREAIQIRQLSPDATIFLMNAVYEFDLVREHQIHMTLPSLTYYYNHKNDLAGIHVHLEFENLLHRSGFKDLNEIKEVLKDHHHNQNAKMIISGLWTHFGYADEFDVSDYNVERSQWMEIVEALLSEGYQFDLIHAQNSASFYREGQILLPHHTHARVGIALYGSRPYSSLNQHDIVQSLTLKAHVIQVREVQAGDYCGYSFAFEVTKNNTKLAVVDIGYGDGILRTRAKHEALINGKRYPIRALMMSHMFVEVDGNVHAQDEVILYNNDIRIDEYTFKGVGANSEQLSAMNHDSLKKEYISNDC,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1292,NE799,alr2,alanine racemase,alr1_2|alr1_1,Alanine racemase 1,S68A,SAB mortality and SAB persistence,NA,NA,NA,NA
594,MDRVTYHNKDLDFAFGLSMTSKNVARYESINNENLKGWHTGAGMSYLYNSNVKHYRDNFWATADMKRLAGTTTLENEEPKGTDVKMSSKTFVGGTKFDDQHASIGMDFENQDKTLTAKKSYFILNDKIIFLGTGIKSTDSSKIPVTTIENRKANGYTLYTDDKQITASDNQETNSVFLESTNSTQNNIGFQFLNKSKITVKKESHTGKWSDINKSQKSEDKKDEYYEVNQKHSNTDDKYGYVLYPGLSKDDFKTKKDEVTVVKQGDDFHVVKDNESVWAGVNYSDSTKTFEINGTKVEVKAKGMFILKKKDDKTYECSFFNPESTNSVSDIESKIFIKGYTITNKSVTNSNDAGLNFELTK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,Hyaluronate lyase,T235K,SAB persistence only,NA,NA,NA,NA
595,MKVQRIEVENKPYPLYLLLDKEYQLIEPVMKFIKYLDNTGKSPNTIKAYCYHLKLLYEFMEQRGVILNDINFELLADFVGWLRYPSASNVIDLQSKKAIREETTVNTILNVVMSFLDYLSRLGEFKSIDVFKQAKGRNFKGFLHHVNKGRYQKNVLKLRVKKKQIRTLRSKEVKQIIDACHTKRDKLILMLMYEGGLRIGEVLSLRLEDIVTWDNQIHLTPRDVNVNEAYIKLRKERTIHVSKELMSLYTDYLIYEYSEELEHDYVFISLKEGYFGKPLKYQSVLDLVRRIVKRTGIEFTSHMLRHTHATQLIREGWDVAFVQKRLGHAHVQTTLNTYVHLSDQDMKNEFNKYLERKEHKK,1,2,1,0,1,1,1,0,1,2,1,0,NA,NA,NA,NA,xerC_7|xerC_6|xerC_5|xerC_4|xerC_8,Tyrosine recombinase XerC,N227fs,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
596,MSNTQKKNVPELRFPGFEGEWEEKKLGEFCEFNNGINAKKEQYGIGRKFINVLDILNNNFITYESIIGKVSVPENVEKNNKVEFGDLVFLRSSETREDVGLCNVYLDKNYALYGGFIIRGKKVSDYNPIFLKEALNIPKKRYEIGAAAGGSTRFNVSQDILRKINVKFPPIKEQQKIGDLFSKLDRQIELEEQKLELLKQQKKGYMQKIFSQELRFKDENGNDYPDWEEKKMGAITTMFSGGTPQSTNTRYYKGDIPFIRSGEISKTYTELKINEEALNNSSAKLVEVGDLLYALYGATSGEVAISKINGAINQAVLCIRTNESVEFLLNYLFFSKNKILNTFIQGGQGNLSANIIKNLII,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,Ter362Eext*?,SAB persistence only,NA,NA,NA,NA
597,MKIAIVGSGNGAVTAAVDMVSKGHDVKLYCRNQSISKFQNAIEKGGFDFNNEGDERFVKFTDISDDMEYVLKDAEIVQVIIPSSYIEYYADVMAEHVTDNQLIFFNMAAAMGSIRFMNVLEDRHIETKPQLAEANTLTYGTRVDFENAAVDLSLNVRRIFFSAYDRSCLNDCYDKVSSIYDHLVKEESLIKTNLENGNPEVHPGPTLLNVGRIDYAGEFALYKEGITKHTVRLLHAIELERLNLGRRLGFELSTAKESRIERGYLERDKEDEPLNRLFNTSPVFSQIPGPNHVESRYLTEDIAYGLVLWSSLGRVIDVPTPNIDAVIVIASTILERDFFEEGLTVEEIGLDKLDLEKYLK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2251,NE1151,-,dehydrogenase family protein,odh,Opine dehydrogenase,A163T,SAB mortality and SAB persistence,NA,NA,NA,NA
601,MSNAKNADNKQFFSKILNSIGAGVVIALVPNALLGEVLKIFKSGNEILELTYQLVILIQSFMAFIIGVLAAHQFKFNGAGAAIVGTSAMIGSGAVVYSNNSFMLKGIGDIINTSLVVIIACLIYMVLQNKLGSFELIILPVLVPIVSGGIGLITLPYIRKITQAIGNVIHSFTDLNPLLMSILISVAFSLLMVTPISLVAIATAISLNGLGSGAANLGIVAACVTFLFGSLRVNSIGVNAVLLIGAAKMMIPVYLKNLIISIPLTINGIITGIIAYVLQVKGTPLSAGFGYTGLVGPINAFNRMSGDPTMNIILLALGYFVIPFVSAFIVHELSIKFIPIYSYDIYKFVVPKQSFIAS,0,0,0,1,0,0,0,1,0,0,0,5,SAUSA300_1809,NE634,NA,putative membrane protein,NA,hypothetical protein,S358*|S354*|V349E|Y343N|SI334CK,Cell death only,NA,NA,NA,NA
603,MTIKVGIIGCGGIANGKHMPSLQKVENVEMIAFCDVDISKAACAAEAYGTDNAKVYDDYKALLKDDTIDVIHVCTPNDSHCEITVAGLHAGKHVMCEKPMAKTTAEAQKMIDTAKSTGKKLTIGYQNRFRPDSQFLYKSAQRGDLGDIYFGKAHAIRRRAVPTWGVFLDEEAQGGGPLIDIGTHALDLTLWMMDNYEPESVMGSTFYKLNKQHDAANAWGSWNPDEFTVEDSAFGFIKMKNGATIILESAWAINSLEVNEAKCSLSGTKAGADMKDGLRIHGEDMGTLYTKHVELENKGVDFYEGNEVDKAEEEAKAWIDAVVNDTEPVVKPEQAMVVTKILEAIYQSAKSGKVIYFE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0212,NE312,NA,"oxidoreductase, Gfo/Idh/MocA family",gfo,Glucose--fructose oxidoreductase,Y207H,SAB mortality and SAB persistence,NA,NA,NA,NA
604,MLFKEAQAFIENMYKECHYETQIINKRLHDIELEIKETGTYTHTEEELIYGAKMAWRNSNRCIGRLFWDSLNVIDARDVTDEASFLSSITYHITQATNEGKLKPYITIYAPKDGPKIFNNQLIRYAGYDNCGDPAEKEVTRLANHLGWKGKGTNFDVLPLIYQLPNESVKFYEYPTSLIKEVPIEHNHYPKLRKLNLKWYAVPIISNMDLKIGGIVYPTAPFNGWYMVTEIGVRNFIDDYRYNLLEKVADAFEFDTLKNNSFNKDRALVELNYAVYHSFKKEGVSIVDHLTAAKQFELFERNEAQQGRQVTGKWSWLAPPLSPTLTSNYHHGYDNTVKDPNFFYKKKESNANQCPFHH,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_1895,NE27,NA,nitric oxide synthase oxygenase,nos,Nitric oxide synthase oxygenase,G127fs|E170K,SAB mortality only,NA,NA,NA,NA
606,MRNVKQIATKSIIAIISLGILTYTTMIGSVLADEIKYPSAKFNQPEAKDKTELTTSIFDEKIKENKALELLIFNQENKNVTEEQQLVDEKAQLISDMTGKIYLQVKLKGQIDKEQLVFQNDKNEEFPFVIKDEKDDTIVRILIEQHMDKINMHVKTLAEKKNLDNKEMVYSIHFKEKKVQHDDAKEVPSKHQNQENNQDQLKKDIDDKKDSQKSDTKERRTSLFTEKGLNDIPVQKDKVQQDSNKKIENERPKASGTLKVENSPPTIKKVENNHKEQPKHKDEKSKKEKKKVVEKEKALPAFNRDDDSKNSSQLSSDIKELDEPNHKKQYMLFAAGIVLATILLISAHLYSRKRGNQV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1031,NE1020,NA,conserved hypothetical protein,NA,hypothetical protein,R251*,SAB mortality and SAB persistence,NA,NA,NA,NA
608,MNIVKLMVIIIYLIIGSALGIIIIPEIANDLGLQNSSFLKNHYVDGIIGSIFMFLIFGVFIRRVTNAIKGLEHFIMRRSAVEILFATIGLIIGLLISVMVSFILESIGNSIFNHFIPVIITILLCYFGFQFGLKKRDEMLMFLPENIARSMSQHTKSATPKIIDTSAIIDGRILEVIRCGFIDGNILIPQGVINELQIVADSNDSVKREKGKRGLDILNELYDLDYPTKVIHPTKTHSDIDTMLLKLAKQYHASIITTDFNLNKVCHVHGIKALNVNDLSEAIKPNVHQGDQLHILLTKMGKEPGQAVGYLDDGTMVVVDNAKNLIGSHVNLEVVSLLQTSSGRIVFAKKIEDTVSL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0512,NE29,NA,PIN domain protein,yacL,putative PIN and TRAM-domain containing protein YacL,P189fs,SAB mortality only,-,3,-,0
609,MKLQWINTFKLHSKKRQLSKAQQIDLLSNLCNLLKYGFTLYQSFQFLNLQMTYKNKQLGITILSEISNGAPCNQILSLIGYSDTIVMQVYLAERFGNIIDVLEETVNYMKVNRKSEQRLLKTLQYPLILVSIFIAMIIILNFTVIPQFQQLYTSMNIQLSSFQKTLSFFITSLPTIIVVMLIIVSMLAIIMKLIYNKLNILNKINFVMKLPLISGYFQLFKTYFVTNELVLFYKNGITLQSIVDVYINHSSDPFRQFLGKYLLTYSEMGYGLPQILEKLKCFKPQLIKFVLQGEKRGKLEVELKLYSQILVRQIEDKAIKQTQFLQPILFLILGLFIVAIYLVIMLPMFQMMQSIK,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_1503,NE250,NA,putative competence protein ComGB,NA,hypothetical protein,I200M,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
610,MSSTYNTCKIKSYFLRWIPSFHILQSGLFIVSSQIRLLILILSDAFFYDGVYKLFGKKNLKWLGVVATLMMTFVQLGGALVTKTGSADGCGSSWPLCHGALIPEFFPIDTIIELSHRAVSALSLLMVLWLVITAWKHIGYIKEIKPLSIISVGFLLLQALIGAAAVIWQQNDYVLALHFGISLISFSSVFLITLIIFSIDQKYEADELYIKKPLRRLTWLMAIIIYCGVYTGALVRHADASLAYGGWPLPFHDLVPHSEQDWVQLTHRIMAFIVFTIIMITYIHAVKNYPNNRTVHYGYTAAFILVILQVITGALSIMTNVNLIIALFHALFITYLFGMTTYFIMLMLRSVRSDKQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1015,NE769,ctaA,cytochrome oxidase assembly protein,ctaA,Heme A synthase,V189L,SAB mortality only,NA,NA,NA,NA
611,MTKENICIVFGGKSAEHEVSILTAQNVLNAIDKDKYHVDIIYITNDGDWRKQNNITAEIKSTDELHLENGEALEISQLLKESSSGQPYDAVFPLLHGPNGEDGTIQGLFEVLDVPYVGNGVLSAASSMDKLVMKQLFEHRGLPQLPYISFLRSEYEKYEHNILKLVNDKLNYPVFVKPANLGSSVGISKCNNEAELKEGIKEAFQFDRKLVIEQGVNAREIEVAVLGNDYPEATWPGEVVKDVAFYDYKSKYKDGKVQLQIPADLDEDVQLTLRNMALEAFKATDCSGLVRADFFVTEDNQIYINETNAMPGFTAFSMYPKLWENMGLSYPELITKLIELAKERHQDKQKNKYKID,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2039,NA,NA,NA,ddl,D-alanine--D-alanine ligase,A72V,SAB mortality and SAB persistence,NA,NA,NA,NA
612,MAENKNNLSINDDHSNAAMTHTSDAIASSDFIIRELDLNQEPEMQRESKNFWQDAWAQLKRNKLAVVGMIGLIIIVIFAFIGPVINKHDYAEQNVEHRNLPAKIPVLDKVPFLPFDGKDADGKDAYKAANAKENYWFGTDQLGRDLWTRTWKGAQISLFIGVVAAMLDIFIGVVYGAISGFFGGRVDTIMQRILEVIASIPNLIVVILFVLIFEPSIWTIILAMSITGWLGMSRVVRGEFLKLKNQEFVMASKTLGASKFKLIFKHILPNTLGAIVVTSTFTVPSAIFFEAFLSFIGIGVPAPQTSLGSLVNDGRAMLLIYPHELFIPAMILSLLILFFYLFSDGLRDAFDPKMRK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0888,NE1436,oppC,"oligopeptide ABC transporter, permease protein",oppC,Oligopeptide transport system permease protein OppC,T280M,SAB mortality only,NA,NA,NA,NA
613,MWNKNRLTQMLSIEYPIIQAGMAGSTTPKLVASVSNSGGLGTIGAGYFNTQQLEDEIDYVRQLTSNSFGVNVFVPSQQSYTSSQIENMNAWLKPYRRALHLEEPVVKITEEQQFKCHIDTIIKKQVPVCCFTFGIPSEQIISRLKAANVKLIGTATSVDEAIANEKAGMDAIVAQGSEAGGHRGSFLKPKNQLPMVGTISLVPQIVDVVSIPVIAAGGIMDGRGVLASIVLGAEGV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0825,NE1365,NA,"oxidoreductase, 2-nitropropane dioxygenase family",pnoA,Nitronate monooxygenase,Ter237Qext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
614,MKNLVLLGGGYGNMRIMSRILTTSLPQDYTVTLVDRMPFHGLKPEFYALAAGTKSDKDVRMKFPNHPQVNTVYGEINDIDLDAQIVSVGNSKIDYDELIIGLGCEDKYHNVPGAEEYTHSIQTLSKARDTFHSISELPEGAKVGIVGAGLSGIELASELRESRSDLEIYLYDRGPRILRNFPEKLSKYVAKWFAKNNVTVVPNSNINKVEPGKIYNCDEPKDIDLVVWTAGIQPVEVVRNLPIDINSNGRVIVNQYHQVPTYRNVYVVGDCADLPHAPSAQLAEVQGDQIADVLKKQWLNEPLPDKMPELKVQGIVGSLGDKQGFAYIMDRTVTGRLASILKSGVLWLYKYHNG,2,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_0841,NE1801,-,hypothetical protein,yjlD,NADH dehydrogenase-like protein YjlD,L137R,all,+,0,-,0
615,MKKIRLELVYLRAIICAIIIVTHLLTQITLKHENMEGGSLVLQFYIRNIVIFGTPCFIILSQLLTTLNYQKVTYRYLTTRVKYILIPYILMGLFYSYSESLLTDTSFQKQFIENVLLGQWYGYFIVVIMQFFILSYIIFKINYNLFNSKILLLLSFILQQSFLYYFTNNTAFHDTVLHYYPLSENTIIFGWIFYFFLGAYMGYNYERVLNFLERYLVIMIVLAVATYFVFIALANGDYWNVTSFSYSLTPYNSIMFIVILGICTHFKTMLFNTIQMISAFSFFIYLFIYYIQSF,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_2602,NE766,icaC,intercellular adhesion protein C,icaC_2|icaC_1,"putative poly-beta-1,6-N-acetyl-D-glucosamine export protein",Y290fs,all,NA,NA,NA,NA
616,MKLQTTYPSNNYPIYVEHGAIDHISTYIDQFDQSFILIDEHVNQYFADKFDDILSYENVHKVIIPAGEKTKTFEQYQETLEYILSHHVTRNTAIIAVGGGATGDFAGFIAATLLRGVHFIQVPTTILAHDSSVGGKVGINSKQGKNLIGAFYRPTAVIYDLDFLKTLPFEQILSGYAEVYKHALLNGESATQDIEQHFKDREILQSLNGMDKYIAKGIETKLDIVIADEKEQGVRKFLNLGHTFGHAVEYYHKIPHGHAVMVGIIYQFIVANALFDSKHDINHYIQYLIQLGYPLDMITDLDFETLYQYMLSDKKNDKQGVQMVLIRQFGDIVVQHVNQLTLQHACEQLKTYFK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1356,NE1741,aroB,3-dehydroquinate synthase,aroB,3-dehydroquinate synthase,N338D,SAB persistence only,NA,NA,NA,NA
624,MTSIKTITPKDFIFRVLSGVAIGIVAGLVPNAILGEIFKYFMDYHPIFKTLLGVVVAIQFTVPALIGALVAMKFDLSPLAIAVVASAAYVGSGAAQFKNGAWMITDIGDLINTMITAAIAVLFILLIQHRVGSMALIVFPTVVVGISGAIGILILPYTKMITTAIGNMVNGFTELQPIVMSILISMVFSLIIISPLSTVAIAFAIGITGLAAGSASIGISATEAVLIIGTSKVNRLGVPLSVFFGGVKMMIPNMVKYPILMLPILTTAIVSGLVSALVGIHGTKESAGFGFIGMVGPINAFKFMEVDSAWLSVLLIVVAFFVVPFVTAWLADIIYRKVFRLYTNDIFKFMG,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2507,NE1834,-,hypothetical protein,NA,hypothetical protein,D106G,Growth rate and cell death,NA,NA,NA,NA
625,MKLAIKEIMFYKFRYILITLIILLLSIMVLFISGLAQGLGRENISLFEHFDNDEYVVQKMKEPQIEKSQLSDTQQNQIKKVIHQEPYKMNIQTLKLSNKEQDVITMNDVKQQRIQLKKGDYPKNAHEVAINDKLAADNIRVGDRLHFKNNSTSYRVSGILNDTMYAHSSIVLLNDNGFNALNKVNTAFYPVKNLTQQQRDELNKINDVQVVSEKDLTGNIASYQAEQAPLNMMIVSLFAITAIVLSAFFYVMTIQKISQIGILKAIGIKTRHLLSALVLQILTLTIIGVGIAVIIIVGLSFMMPVTMSFYLTTQNILLMVGIFILVAILGASLSFIKLFKVDPIEAIGGAE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2307,NE521,NA,"ABC transporter, permease protein",NA,hypothetical protein,S308P,SAB mortality and SAB persistence,NA,NA,NA,NA
626,MVLSIRSQIIIGVVSSILLTSTILAIAYILMWFNGHMTLTLTLTTIITSCLTLLICSIFINPLIQKIKQFNIKTKQFANGNYASNDKTFNSPKEIYELNQSFNKMASEITQQMNQIKSEQQEKTELIQNLAHDLKTPLASIISYSEGLRDGIITKDHEIKESYDILIKQANRLSTLFDDMTHIITLNTGKTYPPELIQLDQLLVSILQQYEQRIKHENRTLEVNFCNEIDAFYQYRTPLERILTNLLDNALKFSNVGSRIDINISENEDQDTIDIAISDEGIGIIPELQERIFERTFRVENSRNTKTGGSGLGLYIANELAQQNNAKISVSSDIDVGTTMTVTLHKLDITS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0690,NE1296,saeS,sensor histidine kinase SaeS,saeS,Histidine protein kinase SaeS,Q209P,SAB mortality and SAB persistence,NA,NA,NA,NA
628,MTGFSVYLGQPLDEAYIKRMIKQGYQMIFTSVQIPEEDDETKYHYFTKLLNLLKHEQVTYLIDANPSILTPSFYEHLRQYDAQFMIRIDHSTSIEAIEAIMAQGLKCCLNASIISRELLTSLHQQLNDFTLLSFCHNYYPRPDTGLSVDLVNKKNELIYQFNPKAQIYGFIVGSGLRGPLHKGLPTIEATRHSHPVVAAKLLQETGVSEVLVGDSLIEIRQAKQLIDFCKHRHFTLCIEEVFDTTVTYLFDMCHKVRPDNPENVIRSETSRQIYPHSIQPQFTTQRRIGLVTVDNLNNGRYQGEMQIVRQTLSAHDSVNVVAQIIKEDLPLLSCIEPNDTFDFQKTRECKK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0192,NE224,NA,conserved hypothetical protein,NA,hypothetical protein,Y274C,SAB mortality and SAB persistence,NA,NA,NA,NA
630,MSDFQREQRKNEHVEIAMAQSDAMHSDFDKMRFVHHSIPSINVNDIDLTSQTPDLTMAYPVYINAMTGGSEWTKNINEKLAVVARETDLAMAVGSTHAALRNPRMAETFTIARKMNPEGMIFSNVGADVPVEKALEAVELLEAQALQIHVNSPQELVMPEGNREFVTWLDNIASIVSRVSVPVIIKEVGFGMSKELMHDLQQIGVKYVDVSGKGGTNFVDIENERRANKDMDYLSSWGQSTVESLLETTAYQSEISVFASGGLRTPLDAIKSLALGAKATGMSRPFLNQVENNGIAHTVAYVESFIEHMKSIMTMLDAKNIDDLTQKQIVFSPEILSWIEQRNLNIHRG,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2292,NA,NA,NA,fni,Isopentenyl-diphosphate delta-isomerase,D88G,SAB mortality only,NA,NA,NA,NA
632,MVNKKDIAKKVIGKTPIGVKLKLAKVIIILCVVAFLTFPVIVMFLLAPDSNKDKDDAGCTVSGGNVSANGIDKFNENAKGGKLEGKGKEIQKIAEKNKVPVNIFMAIIASESQWGKGENATRQNNPLSVMGSKSIHDSTYPTIEDGLNAGAKNLYDVYISKGLDTPKKIGPKYAPVGASNDPNNMNARWIPTVEKIMKDLGGSEAKTSCSNGKGKSIKFNGKLPHWSNDDPGKGNLYTAGQCTWYAYGMRQKMGKPVSTYWHDAHKWNDRAKAEGYKVDKNPEPGALFIAEQGAGGHDGHYGHVAVVIGVSDGGKTFRITEMNWEGAFKVNERTLKMTDGYSFIHDKE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1480,NE1763,-,putative traG membrane protein,NA,hypothetical protein,R613H,SAB mortality and SAB persistence,NA,NA,NA,NA
633,MDTKIWDVREYNEDLQQYPKINEIKDIVLNGGLIGLPTETVYGLAANATDEEAVAKIYEAKGRPSDNPLIVHIHSKVQLKDFTYTLDPRVEKLMQAFWPGPISFILPLKPGYLCRKVSGGLSSVAVRMPSHSVGRQLLQIINEPLAAPSANLSGRPSPTTFNHVYQDLNARIDGIVQAEQSEEGLESTVLDCTSFPYKIARPGSITAAMITEILPNSIAHADYNDTEQPIAPGMKYKHYSPNTPLTIITDIESKIGNDGKDWSSIAFIVPSNKVAFIPSEAQFIQLCQDDNDVKQASHNLYDVLHSLDENENISAAYIYGFELNDNTEAIMNRMLKAAGNHIIKGCEL,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_2070,NA,NA,NA,ywlC,Threonylcarbamoyl-AMP synthase,A60D,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
634,MIFYFLISLFLKSRYNELNHYHTPTYFMLLVLSFKGVRYLANNHSALRLKGIILAIVGACLWGLGGTVSDFLFKYKNINVDWYVTARLVVSGVFLLIMYKMMQPKRSIFSVFQDRRMLGKLLIFSILGMLVVQYAYMASINTGNAAIATLLQYIAPVYIIIWFVIRGVAKLTLFDVLAIIMTLLGTFLLLTNGSFSNLVVNPASLFWGILAGVALAFYTIYPSDLLNRFGSILIVGWAMLISGVAMNLRHPIWHIDITKWDISIILFLIFGIIGGTALAFYFFIDSLQYISAKETTLFGTVEPVVAVIASSLWLHVAFKPFQIVGIILIMILILLLSLKRQPETLDE,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_2472,NE82,NA,putative membrane protein,yicL,putative inner membrane transporter YicL,Y4fs,all,NA,NA,NA,NA
635,MNKDNKWTMITALFITVISVLLAFHLKQHYDQITNENHANKDKINIKNKNVRIYQNLTYNRVFPNSKLDIITPVDMSSNAKLPVIFWMHGGGYIAGDKQYKNPLLAKIAEQGYIVVNVNYALAPQYKYPTPLIQMNQATQFIKENKMNLPIDFNQVIIGGDSAGAQLASQFTAIQTNDRLREAMKFDQSFKPSQIKGAILFGGFYNMQTVRETEFPRIQLFMKSYTGEEDWEKSFKNISQMSTVKQSTKNYPPTFLSVGDSDPFESQNIEFSKKLQELNVPVDTLFYDGTHHLHHQYQFHLNKPESIDNIKKVLLFLSRNTSSSGIQTEEKPQIENPSNELPLNPLN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0641,NE104,NA,putative lipase/esterase,aes,Acetyl esterase,G91S,SAB mortality and SAB persistence,NA,NA,NA,NA
636,MKALKLYGVEDLRYEDNEKPVIESANDVIVKVRATGICGSDTSRYKKMGPYIQGMPFGHEFSGVVDAIGSDVTHVNVGDKVTGCPAIPCYQCEYCLKGEYARCEKLFVIGSYEPGSFAEYVKLPAQNVLKVPDNVDYIEAAMVEPSAVVAHGFYKSNIQPGMTVAVMGCGSIGLLAIQWARIFGAAHIIAIDIDAHKLDIATSLGAHQTINSKEENLEKFIENHYANQIDIAIESSGAKVTIGQILTLPKKRWRGGITRNTI,2,2,2,1,1,1,1,1,2,3,1,1,SAUSA300_0244,NE1702,-,zinc-binding dehydrogenase family oxidoreductase,gatD_2|gatD_1,Galactitol 1-phosphate 5-dehydrogenase,R252fs|V147A|G252fs,all,-,0,-,0
637,MINIKNIYNMLSYAFTVLNKKGYQKLATEQFENIFDLYSAILIKGISSQLNSGLHHEYIEQTDSLKVIRGKVDVKNSIQGLGVLSQRINCIYDEFSLNTYMNKILKTTMKCLIKTDISRKNKIKLRKLLVHFNNVDTLDYRNIQWYHSFDRNNQTYKMLISICYLIFQGVIQTESKGQNDLMVFVDEQQISRLYEKFILEYYKKEFPELVVTSSNIQWSLDNDDNVNMLPVMRSDIMLRYKDKCLIIDAKFYKNTLHNYYDTKKIHSTNLYQIFTYVKNQQLNLKKKAIQVSGMLLYAKTDENIVLNDKFHMSGSQIIIKTLDLNCNFTIIKKQLNGIVNDIFLLK,0,1,2,0,0,1,1,0,0,1,2,0,NA,NA,NA,NA,mcrC,Protein McrC,N9Y,SAB persistence and growth rate,NA,NA,NA,NA
640,MKTRCYDGKKWQYEFKYEGKRYRKKGFRTKREANSAGLDKLNELRSGFNIDNYITLEEYFENWIKTYKQPVVKENTYRHYRNALQHIQKHKIGKMELSKINRQVYQKFINDYSKEHAKETIRKTNGAIRSALDDALYDGLIFKNPAYKVNYKAGKPTKSEQEKFISVTEYEILKDHVRKKRTRSSLALFIMICTGCRVSGARNIKIEHINQVKNTIFIDERKTDTSPRYISIAKSDMKHIMDVISTFAISYDGYIFKEAGSIINLHAINNALKSACRVNNIPIITSHALRHTHCSYLLAKGVSIHYISKRLGHKNIAITTSVYSHLLEEKFNEEDKKTTKILESM,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_1972,NE327,int,integrase,xerC_5|xerC_6|xerC_7|xerC_8|xerC_4,Tyrosine recombinase XerC,E14K,all,NA,NA,NA,NA
642,MYQQSSFKENLIHWFDENQREMPWRQTTNPYYIWLSEVMLQQTQVKTVIDYYHRFVERFPTVEVLSQASEDEVLKYWEGLGYYSRARNFHTAIKEVHDKYEGLVPKDPDQFKALKGVGPYTQAAVMSIAYNVPLATVDGNVFRVWSRLNDDYRDIKLQSTRKSYEQELLPYVTTEAGTFNQAMMELGALICTPKNPLCLFCPVQENCEAFDKGTFEKLPVKSKNVSKKVIEQSVFLIRNNQGQYLLQKRSEKLLYGMWQFPMFESEHARRKMTEKIGHDIQPVETPIFELKHQFTHLTWKIKVYAVSGAINIETLPDDMIWFDLSDRDQYTFPVPMSKIYQFING,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1849,NE1040,mutY,A/G-specific adenine glycosylase,mutY,Adenine DNA glycosylase,Y255H,SAB mortality only,NA,NA,NA,NA
643,MINEDSIQLDTLLKKYYEHSIEKIVFADDNGKIIAMNDAAKDILSEEDNYSAVANAICHRCEGYTNAYDVQSCKDCFLESMQVQATNFQVFMKTKDQKVMPFTATYQLIDQDRGIHAFTLQNVSSQIEQQEKLHQQRMMRKTISAQENERKRISRELHDSVIQEMLNVDVQLRLLKYQEDTTKLLEDAENIEYIVAKLIDDIRNMSVELRPASLDDLGLEAAFKSYFKQFEENYGIKIIYTSNIKNTRFDSDIETVVYRVVQEAILNALKYADVNEINVGIRQTGRHLVAEVIDAGNGFDPSSKPKGSGLGLYGMNERAELVSGSVNIETKIGEGTNVTLNIPI,2,2,1,1,1,1,1,1,2,1,1,1,SAUSA300_2338,NE1157,NA,sensor histidine kinase,nreB,Oxygen sensor histidine kinase NreB,G324fs|R140H|H140R,all,NA,NA,NA,NA
647,MAIKEISSQSAIDHKRKRRTTLTYIVSLCFLFICIYLNMAIGSSKINFSDIIHYVTGHTDTKATFLLHNVRMPRMIAGLFIGGALAVSGLLMQAMTRNPLASPKIFGVSSGASFFIVFVTIIIPALEYYALYLGVIGAFIGGLTVYTLSGATKGMTPIKLALAGMAIHLFFSSMTEGIIILNENSNEQVMFWLVGSLSSMKWDEILTILPWIIGALIVTIFIGRQLTIMELGDDIAKGLGQNINKVRIIIGLLVIILTGMSVSVAGPIGFVGLIVPHIVKRYVSKNYLVMIPLTFIIGADLLLLSDVLSRLITYPYESPVGIVTSFVGALYFLFITIKGVKRI,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2135,NE869,-,iron compound ABC transporter permease,yfiZ_2,putative siderophore transport system permease protein YfiZ,D13fs,SAB mortality only,NA,NA,NA,NA
651,MTNGYIGSYTKKNGKGIYRFELNENQSRIDLLETGFELEASTYLVRNNEVLYGINKEGEQCGVASLKIDDNGELHLLNKCLSSKAGTGCYVSISEDKRYLFEAVYGAGIIRMYELNTHTGEIIRLIQELAHDFPTGTHERQDYPHAHYINQTPDGKYVAVTDLGADRIVTYKLDDNGFEFYKESLFKDSDGTRHIEFHDNGKFAYVVHELSNTVSVAEYNDGKFEELERHLTIPENFDGDTKLAAVRLSHDQQFLYVSNRGHDSIAIFKVLDNGQHLELVTITESGGQFPRDFNIASSDDLLVCAHEQGDSVVTVFERNKETGKITLCDNTRVASEGVCVIF,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1902,NE202,NA,conserved hypothetical protein,NA,hypothetical protein,L173F,SAB persistence only,NA,NA,NA,NA
652,MSKAYEQSGVNIHAGYKAVERMSSHVKRTMRKEVIGGLGGFGATFDLSQLNMTAPVLVSGTDGVGTKLKLAIDYGKHDSIGIDAVAMCVNDILTTGAEPLYFLDYIATNKVVPEVIEQIVKGISDACVETNTALIGGETAEMGEMYHEGEYDVAGFAVGAVEKDDYVDGSEVKEGQVVIGLASSGIHSNGYSLVRKLINESGIDLASNFDNRPFIDVFLEPTKLYVKPVLALKKEVSIKAMNHITGGGFYENIPRALPAGYAARIDTTSFPTPKIFDWLQQQGNIDTNEMYNIFNMGIGYTVIVDEKDVSRALKILAEQNVEAYQIGHIVKNESTAIELLGV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0973,NE1101,purM,phosphoribosylaminoimidazole synthetase,purM,Phosphoribosylformylglycinamidine cyclo-ligase,K17E,SAB mortality and SAB persistence,NA,NA,NA,NA
653,MKKTVLYLVLAVMFLLAACGNNSDKEQSKSETKGSKDTVKIENNYKMRGEKKDGSDAKKVKETVEVPKNPKNAVVLDYGALDVMKEMGLSDKVKALPKGEGGKSLPNFLESFKDDKYTNVGNLKEVNFDKIAATKPEVIFISGHTANQKNLDEFKKAAPKAKIVYVGADEKNLIGSMKQNTENIGKIYDKEDKAKELNKDLDNKIASMKDKTKNFNKTVMYLLVNEGELSTFGPKGRFGGLVYDTLGFNAVDKKVSNSNHGQNVSNEYVNKENPDVILAMDRGQAISGKSTAKQALNNPVLKNVKAIKEDEVYNLDPKLWYFAAGSTTTTIKQIEELDKVVK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0721,NE275,NA,transferrin receptor,yclQ,Petrobactin-binding protein YclQ,H144R,SAB persistence only,NA,NA,NA,NA
663,MTGEQFTQIKRPVSRLTEKVLGWLCWVMLLVLTVITMFIALVSFSNNTSIANLENTLNNNAFIQQLLAGNGYNTTQFVIWLQNGIWAIIVYFIVCLLISFLALISMNIRILSGFLFLISAIVTIPLVLLIVTLIIPILFFIIAMMLFIRKDKVEMVAPQYYEEYNGPIYDYREPVYERPQPKDDYYDVPKYEKELDKSNTVYDQEQERDKYDQFPKRAVESEYNHDERTEEEPSVLSRQAKYKQKSTEELGIEDDGYYAEPEVDPKELKAQQKREKAEIKAKKKEKRKAYNQRMKERRKNQPSAVSQRRMNFEERRQIYNNDISEERNSSEVKDKKEQE,2,2,2,1,1,1,1,1,2,1,2,1,SAUSA300_1003,NE1420,NA,conserved hypothetical protein,NA,hypothetical protein,G84V|E285G|V84G,all,NA,NA,NA,NA
668,MTSLKERDYFFDNARAILILLVVFGHMLQPYTSGDKYLSALYLVIYSFHMPTFLFISGYFAKNIDKPYYLEKISKRLIVPYMIFFAFFSIYYFLTGKSDELQLDPFNPVFALWFLITLFFFHVILVIVRRFNPYKVLSVSIIISIGAGFSDNIDSYLSISRTIVFFPIFYLGYIFTKKHTAIFKNKKLIPVSIITFILFFIVYVIHPINADWLLGSSPYTSLENEGQSIFSPFKRLILYGIILIAMTAFLNLMSTKKKLYTYIGSRTLYVYLLHGLIIGIVRGFEWYPFDNPISLMTNLYLISISVIIVYVLSTNFVCKWTNPIINLQRPSQFKDS,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_0953,NE488,NA,putative membrane protein,NA,hypothetical protein,N298Y,"SAB mortality, SAB persistence and cell death",+,1,-,2
671,MAVKVAINGFGRIGRLAFRRIQEVEGLEVVAVNDLTDDDMLAHLLKYDTMQGRFTGEVEVVDGGFRVNGKEVKSFSEPDASKLPWKDLNIDVVLECTGFYTDKDKAQAHIEAGAKKVLISAPATGDLKTIVFNTNHQELDGSETVVSGASCTTNSLAPVAKVLNDDFGLVEGLMTTIHAYTGDQNTQDAPHRKGDKRRARAAAENIIPNSTGAAKAIGKVIPEIDGKLDGGAQRVPVATGSLTELTVVLEKQDVTVEQVNEAMKNASNESFGYTEDEIVSSDVVGMTYGSLFDATQTRVMSVGDRQLVKVAAWYDNEMSYTAQLVRTLAYLAELSK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0756,NA,NA,NA,gapA1,Glyceraldehyde-3-phosphate dehydrogenase 1,A149V,SAB mortality only,NA,NA,NA,NA
672,MKLSDREWKAFTTDELFSIKSGTTSDFSKLNLKNDSKLPCIGAKYKNNGVVGFANNEELKVEGNALVFIKTGEGSVGLTLYKAEDFIPHKNVYIGYNVSLNKYIGLFIATMYNKQKFIYNYGYGLNQLRVKRRKILLPSKNNSPDYEFMERYIKEKYFNLKSHIKEKQKHKISDWRELDEVEWLPFSTSEVFNTIQRGKRLTKSNQIKGLTPYISSSGINNGLDNFISNSEKIRVFDNCLTIANSGSVGSTFYHTYRFIASDHVTQLKNNNLNKFTYLFIANMLRRLEGKYSFNREINDFRIKRERILLPTKNNQPDYEFMEQYMKRKENKILDRL,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,bcgIB,Restriction enzyme BgcI subunit beta,Q266H,SAB mortality only,NA,NA,NA,NA
673,MSYIIIITIAVVIFSLIFDFINGFHDTANAVATAVSTRALTPKTAILMAAVMNFIGALTFTGVAGTITKDIVDPFKLENGLVVVLAAILAAIIWNLATWFYGIPSSSSHALIGSIAGAAIASEGSFGVLHYQGFTKIIIVLIVSPIIAFCVGFLMYSIFKVIFKNANLTRANRNFRFFQIFTAALQSFSHGTNDAQKSMGIITLALIVANVQNDGSVEPQLWVKFACATAMGLGTAIGGWKIIKTVGGNIMKIRPANGAAADLSSALTIFVASSLHFPLSTTHVVSSSILGVGASNRAKGVKWSTAQRMIITWVITLPISALLAGLLFYILNLFF,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0650,NE187,NA,phosphate transporter family protein,NA,hypothetical protein,I7V,SAB mortality and SAB persistence,NA,NA,NA,NA
675,MMQNKQILFNKIPEGMPQEDTFKIEEIDTPKLESDGVLVQTLYISVDPYMRGRMTKADSYVQPFEIGKPIVSHVVAKVIDSTLADYKKGDVVVGMLPWRIINHVQADQITKVPTTDVPLDLYLSVLGMPGQTAYHGLLDIGQPKAGDTVVVSAASGAVGSVVGQIAKIKGCRVVGIAGGDKKVNYLTETLGFDAGIDYKKEDFAEALAQAVPDGIDVYFENVGGTVGDEVFKHLNRFARVPVCGAISSYNHPEADIGPRIQGTLIKKQVMMRGFLVSEFANAFKEASEQLATWVQEGKIQSQVTIEDGFENAPHAFKNLFTGDNFGKQVIKVTE,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_2147,NE1416,NA,"alcohol dehydrogenase, zinc-containing",yfmJ,Putative NADP-dependent oxidoreductase YfmJ,S247L,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
679,MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQLTQTDKQQTPKIQKGGNLKPLEQRERANVILPNNDRHQITDTTNGHYAPVTYIQVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTAEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMSNNAETQVNQNITVTGYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNQFNGAVFINENVRNFLKQNIEDINFANDDNPNNPDNPNNPDNPNNPDNPNNPDQPNNPNNPDNGDNNNSDNPDAA,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0951,NE1506,sspA,V8 protease,sspA,Glutamyl endopeptidase,L41Q,SAB mortality only,NA,NA,NA,NA
681,MTLLTRIKTETILLESDIKELIDILISPSIGTDIKYELLSSYSEREIQQQELTYIVRSLINTMYPHQPCYEGAMCVCGTGGDKSNSFNISTTVAFVVASAGVKVIKHGNKSITSNSGSTDLLNQMNIQTTTVDDTPNQLNEKDLVFIGATESYPIMKYMQPVRKMIGKPTILNLVGPLINPYHLTYQMVGVFDPTKLKLVAKTIKDLGRKRAIVLHGANGMDEATLSGDNLIYELTEDGEIKNYTLNATDYGLKHAPNSDFKGGSPEENLAISLNILNGKDQSSRRDVVLLNAGLSLYVAEKVDTIAEGIELATTLIDNGEALEKYHQMRGE,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1264,NE35,trpD,anthranilate phosphoribosyltransferase,trpD2,Anthranilate phosphoribosyltransferase 2,A98S,SAB mortality and growth rate,-,0,-,0
682,MTKITVFGMGSFGTALANVLAENGHDVLMWGKNQDAVDELNTCHTNKKYLKYAKLDVNIIATSDMTKAIQFADIYLMALPTKAMREVASQINDKLTSKKTFIHVAKGIENGTFKRVSEMIEDSISPEYNAGIGVLSGPSHAEEVVVKQPTTVAASSKDKSVSKLTQDLFMNDYLRVYTNDDLIGVELGGALKNIIAVASGIVAGIGYGDNAKAALMTRGLAEISRLGEKLGADPITFLGLGGIGDLIVTCTSTHSRNFTLGYKLGQGESMDQALSEMNMVVEGIYTTKSVYHLAKEKNVDMPITNALYRVLFENISVKECVKDLMERDKKSE,2,2,1,2,1,1,1,2,1,1,1,2,SAUSA300_1363,NE965,gpsA,NAD(P)H-dependent glycerol-3-phosphate dehydrogenase,gpsA,Glycerol-3-phosphate dehydrogenase [NAD(P)+],I235M,all,NA,NA,NA,NA
683,MLLKPKYQIVIAGLCLAIVAILSLMIGNTLVSPGTVIQALFNFDSENDLHDVVTGARASRTIIALLTGAALAVSGLLMQALTRNPIASPGLFGVNAGAVFFVIFSITFIQIQSFKMIVVIAFLGAIVVTVLVVALGMFRQTLFSPHRVILAGAAIAMLFTAFTQGILIMNETDLQGLLFWLSGSVSLRNIWDIPWIIPLVLILILIAFSMAAHINILMTSDDIATGLGQNIKLIKWMIIMLISMLAGISVAVAGSIVFVGLIVPNISKRLLPPNYKYLIPFTALTGAILMIISDIVARIIIKPLELPIGVVTAVIGAIVLIYLMKKGRQRL,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0116,NE675,sirB,"iron compound ABC transporter, permease protein  SirB",yfiZ_1,putative siderophore transport system permease protein YfiZ,V36M,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
684,MKNSYQAQKVIEEVIKEKPKARWLFLTLSTKNAIDGDTLEQSLKHLTKAFDRLSRYKKVKQNLVGFMRSTEVTVNKNDGSYNQHMHVLLCVENAYFRKKENYITQEEWVNLWQKALQVDYRPVANIKAIKPNQKGDKDIESAIKETSKYSVKSSDFLTDNDEKNQEIVSDLEKGLYRKRMLSYGGLLKQKHKILNLDDAEDGNLINTSDEDKITDEEAKAHSITAIWNFEKQNYYLRH,1,1,0,0,1,1,0,0,6,3,0,0,NA,NA,NA,NA,NA,hypothetical protein,N160D|A124V|S80N|S173N|A217V|N253D,SAB mortality and SAB persistence,NA,NA,NA,NA
685,MRQIKVVLIGGGTGLSVMARGLREFLIDITAIVTVADNGGSTGKIRDEMDIPAPGDIRNVIAALSDSESVLSQLFQYRFEENQISGHSLGNLLIAGMTNITNDFGHAIKALSKILNIKGRVIPSTNTSVQLNAVMEDGEIVFGETNIPKKHKKIDRVFLEPNDVQPMEEAIDALREADLIVLGPGSLYTSVISNLCVNGISDALIHSDAPKLYVSNVMTQPGETDGYSVKDHIDAIHRQAGQPFIDYVICSTQTFNAQVLKKYEEKHSKPVEVNKAELEKESINVKTSSNLVEISENHLVRHNTRVLSTMIYDIALELISTIPFVPSDKRK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0749,NA,NA,NA,NA,Gluconeogenesis factor,L26P,SAB mortality and SAB persistence,NA,NA,NA,NA
690,MNKVIKMLVVTLAFLLVLAGCSGNSNKQSSDSKDKETTSIKHAMGTTEIKGKPKRVVTLYQGATDVAVSLGVKPVGAVESWTQKPKFEYIKNDLKDTKIVGQEPAPNLEEISKLKPDLIVASKVRNEKVYDQLSKIAPTVSTDTVFKFKDTTKLMGKALGKEKEAEDLLKKYDDKVAAFQKDAKAKYKDAWPLKASVVNFRADHTRIYAGGYAGGILNDLGFKRNKDLQKQVDNGKDIIQLTSKESIPLMNADHIFVVKSDPNAKDAALVKKTESEWTSSKEWKNLDAVKNNQVSDDLDEITWNLAGGYKSSLKLIDDLYEKLNIEKQSK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0117,NE1767,sirA,iron compound ABC transporter iron compound-binding protein SirA,yfiY,putative siderophore-binding lipoprotein YfiY,G215E,SAB mortality and SAB persistence,NA,NA,NA,NA
691,MTKLAVVGATGLVGTKMLETLNRKNIPFDELVLFSSARSAGQEVEFQGKTYTVQELTDARASEHFDYVLMSAGGGTSEHFAPLFEKAGAIVIDNSSQWRMAEDIDLIVPEVNEPTFTRGIIANPNCSTIQSVVPLKVLQDAYGLKRVAYTTYQAVSGSGMKGKKDLAEGVNGKAPEAYPHPIYNNVLPHIDVFLENGYTKEEQKMIDETRKILNAPDLKVTATCARVPVQDSHSVEIDVTLDKETTAEDIKALFDQDDRVVLVDNPENNEYPMAINSTNKDEVFVGRIRRDDSLENTFHVWCASDNLLKGAALNAVQVLEQVMRLKGAN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1287,NE1144,asd,aspartate semialdehyde dehydrogenase,asd,Aspartate-semialdehyde dehydrogenase,A303T,SAB mortality and SAB persistence,NA,NA,NA,NA
692,MFSLSFIVIAVIIIVALLILFSFVPIGLWISALAAGVHVGIGTLVGMRLRRVSPRKVIAPLIKAHKAGLALTTNQLESHYLAGGNVDRVVDANIAAQRADIDLPFERAAAIDLAGRDVLEAVQMSVNPKVIETPFIAGVAMNGIEVKAKARITVRANIARLVGGAGEETIIARVGEGIVSTIGSSKHHTEVLENPDNISKTVLSKGLDSGTAFEILSIDIADVDISKNIGADLQTEQALADKNIAQAKAEERRAMAVATEQEMKARVQEMHAKVVEAESEVPLAKAEALRSGNISVKDYYNLKNIEADTGMRNAINKRTDQSDDESPEH,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1533,NE184,NA,conserved hypothetical protein,NA,hypothetical protein,K285M,SAB persistence only,NA,NA,NA,NA
693,MLVALNEEKERVLATTALRKIKYFCPVCGKQVILKRGLKVISHFAHKHLTEQKCFNNESFKHYKSKLILAQMIQQQGCKVEIEPFLKEIKQIPDILINNKYVIELQYSPIPYKQILQRTEGLKKLGYKVSWLLNDVDYCYNKVKFNHFQSIFINPITRKLHTFNLEKKQIMMFQQIQYLGGHKYVAEKRNAKISELFNEAPCDYHAVYKLSKFAINQYIKYCRWQNSVLEPTLSAMYQLQLTDQEVVHNYGYIFPEQIYIENHPIEWQLQVDLWLKNGKSKLLSDNLNYFKLKKFIVALESKTAIIEKLINNYLNISSNRGNDVQILF,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_0901,NE780,-,putative competence protein,NA,hypothetical protein,L125M,Cell death only,NA,NA,NA,NA
694,MKENFWSELPRPFFILAPMEDVTDIVFRHVVSEAARPDVFFTEFTNTESFCHPEGIHSVRGRLTFSEDEQPVVAHIWGDKPEQFRETSIQLAKMGFKGIDLNMGCPVANVAKKGKGSGLILRPDVAAEIIQATKAGGLPVSVKTRLGYYEIDEWKDWLKHVFEQDIANLSIHLRTRKEMSKVDAHWELIEAIKNLRDEIAPNTLLTINGDIPDRKTGLELAEKYGIDGVMIGRGIFHNPFAFEKEPREHTCKELLDLLRLHLSLFNKYEKDEIRQFKSLRRFFKIYVRGIRGASELRHQLMNTQSIAEARALLDEFEAQMDEDVKLEL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0089,NA,NA,NA,dus,putative tRNA-dihydrouridine synthase,R297C,SAB mortality and SAB persistence,NA,NA,NA,NA
695,MADLLNVLKDKLSGKNVKIVLPEGEDERVLTAATQLQATDYVTPIVLGDETKVQSLAQKLNLDISNIELINPATSELKAELVQSFVERRKGKATEEQAQELLNNVNYFGTMLVYAGKADGLVSGAAHSTGDTVRPALQIIKTKPGVSRTSGIFFMIKGDEQYIFGDCAINPELDSQGLAEIAVESAKSALSFGMDPKVAMLSFSTKGSAKSDDVTKVQETVKLAQQKAEEEKLEAIIDGEFQFDAAIVPGVAEKKAPGAKLQGDANVFVFPSLEAGNIGYKIAQRLGGYDAVGPVLQGLNSPVNDLSRGCSIEDVYNLSIITAAQALQ,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0570,NA,NA,NA,pta,Phosphate acetyltransferase,T220A,SAB persistence only,NA,NA,NA,NA
697,MNVIIDERKENAMTFNKVLLSWIVILIITTSIYLFWQLGDINDVFNQSILINVRLPRLLEALLTGMILTVAGLIFQTVLNNALADSFTLGLASGATFGSGLALFLGLTTLWIPVFSITFSLITLITVLVITSVLSQGYPVRILILSGLMIGALFNSLLYFLILLKPRKLNTIANYLFGGFGDAEYSNVSIIAITFIIALFGIFIILNQLKLLQLGELKSQSLGLNVQLITYIALCIASMITAINVAYVGIIGFIGMVIPQLIRKWQWKQSLGRQLALNIVTGGQIMVMADFIGSHILSPVQIPASIIIVLIGIPVLFYMLISQSKRLH,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0599,NE578,NA,"iron compound ABC transporter, permease protein",NA,putative ABC transporter permease protein,V309A,SAB mortality and SAB persistence,NA,NA,NA,NA
702,MLKLNPYKIGFRTIKTAVGMTLGVIISKLLGLDNYASSAILVVLCIKHTKVHSLQAIISRLVSCFLVLFLGSAIFSLLGQSPIVLGIIVLLFIPLTVVLKVQEGVITSCVILLHVFNAKSIDTHLIVNETLLLLIGLSIAFTMN,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_1462,NA,NA,NA,NA,hypothetical protein,Ter145Lext*?,Cell death only,NA,NA,NA,NA
703,MKIFDYEDIQLIPNKCIVESRSECDTTIQFGPKKFKLPVVPANMQTVMNEKLAKWFAENDYFYIMHRFDEEARIPFIKHMQNSGLFASISVGVKKAEFDFIEKLAQEKLIPEYITIDIAHGHSDSVINMIKHIKTHIPDSFVIAGNVGTPEGVRELENAGADATKVGIGPGRVCITKIKTGFGTGGWQLAALNICSKAARKPLIADGGIRTHGDIAKSIRFGASMVMIGSLFAAHEESPGETVELDGKQYKEYFGSASEFQKGEHKNVEGKKMFVEHKGSLMDTLKEMQQDLQSSISYAGGKDLKSLRTVDYVIVRNSIFNGDRD,2,1,0,1,1,1,0,1,2,1,0,1,SAUSA300_1235,NE369,guaC,guanosine monophosphate reductase,guaC,GMP reductase,K34fs|A111P,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
704,MSVEEYGKVYLIGAGPGNPNYLMKKAERLIREADVILYDRLVNPLILQYANLTTEIIDVGKKPYTKHIQQEKINDCIVEAARRYNKVVRLKGGDPAIFGRVQEEVDTLNEHHIAFEIVPGVTSASAAVATMQTGLTMRTVAKSVTFSTGHFKDSEENEVDVNSLVNGGTLAIYMGVKRLGKIITQIQQYTDIDYPIAIVFQASCFNEFVVKGRLSNIISKLQHYSIEAKPGICIIGEVVDYTENTPKSYDPMKQFYVVSGSKHDALMLCEHLYDEGYGCLLNPNDTSNGTYHSSQYDYYDAFIKQQENVTYISTDRADANTVLCH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2344,NE991,-,uroporphyrin-III C-methyl transferase,nasF,Uroporphyrinogen-III C-methyltransferase,M23T,SAB mortality and SAB persistence,NA,NA,NA,NA
705,MERVLITGGAGFIGPHLVDDLQQDYDVYVLDNYRTGKRENIKNLADDHVFELDIREYDAVEQIMKTYQFDYVIHLAALVSVAESVEKPILSQEINVVATLRLLEIIKKYNSHIKRFVFASSAAVYGDLPDLPKSDQSLILPLSPYAIDKYYGERTTLNYCSLYNIPTAVVKFFNVFGPRQDPKSQYSGVISKMFDSFEHNKPFTFFGDGLQTRDFVYVYDVVQSVRLIMEHKDAIGHGYNIGTGTFTNLLEVYRIIGELYGKSVEHEFKEARKGDIKHSYADISNLKALGFVPKYTVETGLKDYFNFEVDNIEEVTAKEVEMSKK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0130,NE585,NA,NAD-dependent epimerase/dehydratase family  protein,wbgU,UDP-N-acetylglucosamine 4-epimerase,P15S,SAB mortality only,NA,NA,NA,NA
710,MMSQQDLPTLFYSGKSNSAVPIISESELQTITAEPWLEISKKGLQLEGLNFDRQGQLFLLDVFEGNIFKVNPETKEIKRPFVSHKANPAAIKIHKDGRLFICYLGDFKSTGGIFAATENGDNIQDIIEDLSTEYCIDDMVFDSKGGFYFTDFRGYSTNPLGGVYYVTPDFKTVTPIIQNISVANGIALSTDEKVLWVTETTANRLHRIALEDDGVTIQPFGATIPYYFTGHEGPDSCCIDSDDNLYVAMYGQGRVLVFNKRGYPIGQILIPSRDEGHMLRSTHPQFIPGTNQLIICSNDIEMDGGSMLYTVNGFAKGHKSYQFQ,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_2621,NE443,NA,conserved hypothetical protein,NA,Lactonase drp35,E128K,all,NA,NA,NA,NA
713,MKVIEVTHPIQSKQYITEDVAMAFGFFDGMHKGHDKVFDILNEIAEACSLKKTVMTFDPHPSVVLNPKRKRTTYLTPLSDKIEKISQHDIDYCIVVNFSSRFANVSVEDFVENYIIKNNVKEVIAGFDFTFGKFGKGNMTVLQEYDAFNTTIVSKQEIENEKISTTSIRQDLINGELQKANDALGYIYSIKGTVVQGEKRGRTIGFPTANIQPSDDYLLPRKGVYAVSIEIGTENKLYRGVANIGVKPTFHDPNKAEVVIEVNIFDFEDNIYGERVTVNWHHFLRPEIKFDGIDPLVKQMNDDKSRAKYLLAVDFGDEVAYNI,2,3,0,0,1,1,0,0,2,2,0,0,SAUSA300_1165,NA,NA,NA,ribF,Bifunctional riboflavin kinase/FMN adenylyltransferase,C48R|K200R,SAB mortality and SAB persistence,NA,NA,NA,NA
716,MSLDIFSPTLSVVPKGLEGKTILLYGSNSVGKTLNATKLSKPFYLGFEKGLNAISGIPFNYITKWSDFKKLNKQFTGKDKDKARELYDTIIFDTVDIASMYCQKYVANAHGAKDIASGNGGFGLWSNYKEEFWLEIDKLTSCGYTVVFIGHTSVDKNTDQIIPAGDSRSMGIVRDLVDITVYIKSNGVDEDGNVVLSTGYVRETEEFFARSRFDLMPNKIEPFTAENLEKAVIKGIEREEQQGGTTVSYDEFVENTKSEELDFGELKEKLTELGKTYLKADRLEEFTQAMEDTFGVDVKVADLKERQVEAVSILIDELNENL,0,0,1,1,0,0,1,1,0,0,1,1,NA,NA,NA,NA,NA,hypothetical protein,P58L,Growth rate and cell death,NA,NA,NA,NA
717,MKSKIYILLLFLIFLSACTNTRHSESDKNVLTVYSPYQSNLIRPILNNFEKQEHVKIEIKHGSTQVLLSNLHNEDLSERGDVFMGGVLSETIDHPEDFVPYQDTSVTQQLEDYRSNNKYVTSFLLMPTVIVVNSDLQGDIKIQGYQDLLQPILKGKIAYSNPNTTTTGYQHMRAIYSMHHRVSDVHQFQDHAMQLSKTSKVIEDVAKGKYYAGLSYEQDARTWKNKGYPVSIVYPIEGTMLNVDGIALVKNAHPHPKRKKLVQYLTSRSVQQRLVAEFDAKSIRKDVSEQSDQSIENLKNIPLIPKSKLPDIPHHKFLEMIQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0219,NE1522,-,"putative iron compound A C transporter, iron compound-binding protein",NA,hypothetical protein,N48D,SAB mortality and SAB persistence,NA,NA,NA,NA
718,MKPFESHNKQLKILRRRGMEVPSSAKRDLENENYYNIINGYKDLFLELDVNGNFLVPDKYKQGTHFKEVFSLYKLDRKFRNVLLEYLLVFETHIKSRISYYFSEKYREPHSYLYFKNYSSDTSKTDSIVKMVVTFSSVMSNRKNKPLKHYINTHNGVPLWILVNYLTLGNVSKMYSNLDDDLRLEVAKDYKRKLERDYKTRVQITPSDVDSILQQAHMFRNVCAHEERLYDYKIDRAKSRANIFANYNKIYDKEYVPTMNGSYVFDLLISLCLFLNKHDYIKLVKNMDKLISNYSHSFYTITIDDLYTKMNFPDQTKILDML,2,1,1,1,1,1,1,1,1,2,1,1,SAUSA300_0814,NE305,NA,conserved hypothetical protein,NA,hypothetical protein,E5K|V133A|K5E,all,NA,NA,NA,NA
720,MRKKWSALAFGFLVAAYAHIRIKEKRSVKSYMLEQGIRLSRAKRRFMYKEEAMKALEKMAPQTAGEYEGTNYQFKMPVTVDKHFGSTVYTVNDKQDKHQRVVLYAHGGAWFQDPLKIHFEFIDELAETLNAKVIMPLYPKIPHQDYQATYVLFEKLYHDLLNQVADSKQIVVMGDSAGGQIALSFAQLLKEKHIAQPGHIVLISPVLDATMRHPEVPDYLKKDPMVGVDGSVYLAEQWAGDTSLDDYKVSPINGDLDGLGRITLTVGTKEVLYPDALNLSQLLSAKGIEHDFIPGYYQFHIYPVFPIPERRRFLYQIKNIIN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2473,NE532,NA,conserved hypothetical protein,lipR,Putative acetyl-hydrolase LipR,L137V,SAB mortality and SAB persistence,NA,NA,NA,NA
724,MLLNLLLIFILIVICPLIFNYTLTLNLTCYILVVISIFLSLIYSIMTYTFPWSMFVTFIIISIIMLFKHRYLFSHTSSHLFIKKLLSFSYKFVLYTSALLFISTIQSPIVKGLSMWLAILCLSLLLTFICYLVWTVSYRHRSYNKEVDIIIVLGAGIFTEFVTPMLAARLDRALDIYQQQASATKIIVSGGQGPDEPISEALAMQRYLIAHGVDKTDILMESHSINTYTNFLYSKQIINNLYHEAVKIVCVTSQFHVLRALRLAQKLGLSIDGVGSHTPYHFFLHVLIKDYLGVMYQYRLLLTLYCSSSWFICLYAAFIYNS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2304,NE299,NA,putative membrane protein,NA,hypothetical protein,H79R,SAB mortality and SAB persistence,NA,NA,NA,NA
727,MKKIMITGALGQIGTELVVKCREIYGTDNVLATDIREPEADSPVQNGPFEILDVTDRDRMFELVRDFETDSLMHMAALLSATAEKNPILAWDLNMGGLMNALEAARTYNLHFFTPSSIGAFGDSTPKVNTPQVTIQQPTTMYGVNKVAGELLCQYYFKRFGVDTRSVRFPGLISHVKEPGGGTTDYAVEIYFKAVREGHYTSFIDKGTYMDMMYMDDAIEAIIKLMEADDAKLETRNGYNLSAMSFDPEMVKEAIQEYYPNFTLDYDVDPIRQGIANSWPDSIDTSCSRGEWGFDPKYDLASMTKLMLEAIEQKDTVKNNN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0538,NE1071,-,NAD-dependent epimerase/dehydratase family protein,NA,putative epimerase/dehydratase,N86D,SAB persistence only,NA,NA,NA,NA
729,MTYMKVVGLNRMREVETELQQRFSDLDFKFYKKASEIPESDLADLDILVGYDGGINEAFLRRCPNLKWIAWFATGVNTLPLDYIADHGILLTNGKGVQAKQLSEYILAFILDDYKKMKLSYDNQRQHIYDSKITGKRLSGQTVLFLGTGAIATRTAKLAKAFNMNLIGLSKSGQNKDEFDEIYTIESLESTLPNADIIINALPETQETIHLLKKKHFELMKDEALFINIGRGSIVKEALLIEVLKSKVIRHAYLDVFENEPLKPNHELYELDNVTITAHITGNDYEAKYDLLDIFKNNLVNFLNKNGLIENEVDAKKGY,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1843,NE1460,NA,D-isomer specific 2-hydroxyacid dehydrogenase family protein,ghrB_1,Glyoxylate/hydroxypyruvate reductase B,G318fs,Growth rate and cell death,NA,NA,NA,NA
730,MIKLILKRLGLMIPLLILISIVVFSLAIIQPGDPFSDLQNGKIKQEAINAQREKLGLNDSIPHQYIRWVNHVIHGDLGESIKYKRPVIDVIEERIPNTILLGAMSLIITYIISFALGITSGRYSYSLTDYTVQIFNYLMLAIPSFIAGVFAIFIFSFELQWFPFQGSVDINLKEGTFEYYMSKIYHTFLPAFTLGLLSTAGYIQYLRNDIIENSKKDYVLTARSKGLSMNKIYNKHILRNSLIPIITFLGVDIVSILGGAVITETIFSYNGIGKLFLESVIGQDYPLMMALTLFFSFLGLLGNLISDITYGFIDPRIRSN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0895,NE683,oppB,"oligopeptide ABC transporter, permease protein",gsiC,Glutathione transport system permease protein GsiC,V251A,SAB mortality only,+,1,-,1
732,MPNNKKDLTIKNQNDIDEYIDSLISKAEKPIEQLFANRLKEIKQIIADMFEKYQSDDVYVTWTEFNKYNRLNKELTRIGTMLTDDYRQVAKMIQKSQEDAYIEKFLMSFYLYETASQTSMQFDVPSKEVITSAIEQPIEFIRLVPTLQKHRDEVLKKIRLHITQGIMSGEGYSKIAKAIRDDIGMSKAQSLRVARTEAGRAMSQAGLDSALVAQKNGLQMYKYWQATKDTRTRDTHRHLDGAKKKIDEPFKSSGCVGQAPKLFVGVNSAKENINCRCKLMYYIDEDDLPSTTRVRKDDGTTEVIPQMDYREWEKYKRKRK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,F109L,SAB mortality and SAB persistence,NA,NA,NA,NA
736,MLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTISKFGHQLRFDLSKGFPLLTTKKVSFKLVATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYIKSDEYKGPDMTDFGHRALSDPEFNEQYKEQMKQFKQRILEDDTFAKQFGDLGNVYGKQWRDWVDKDGNHFDQLKTVIEQIKHNPDSRRHIVSAWNPTEIDTMALPPCHTMFQFYVQDGKLSCQLYQRSADIFLGVPFNIASYALLTHLIAKECGLEVGEFVHTFGDAHIYSNHIDAIQTQLARESFNPPTLKINSDKSIFDINYEDLEIVDYESHPAIKAPISV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1320,NA,NA,NA,thyA_1,Thymidylate synthase,S317A,SAB mortality and SAB persistence,NA,NA,NA,NA
737,MYNPFDEAYHGLCEEILEIGNRRDDRTHTGTISKFGHQLRFDLTKGFPLLTTKKVSFKLVATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYVQSDDYHGPDMTDFGHRSQQDPEFNEQYKEEMKKFKERILNDDAFAKKYGNLGNVYGKQWRDWEDKNGNHYDQLKSVIQQIKTNPNSRRHIVSAWNPTEIDSMALPPCHTMFQFYVQEGKLNCQLYQRSADIFLGVPFNIASYALLTHLVAKECGLEVGEFIHTFGDAHIYSNHMDAIHTQLSRDSYLPPQLKINTDKSIFDINYEDLELINYESHPAIKAPIAV,2,1,1,2,1,1,1,1,1,1,1,1,NA,NA,NA,NA,thyA_2,Thymidylate synthase,T51I|I51T,all,NA,NA,NA,NA
738,MLKKAKLILIAALVLSGCSTIENESKKDRNTETNTETKSVPEEMEASKYVGQGFQPPAEKDAIEFAKKHKDKIAKRGEQFFMDNFGLKVKATNVVGSGDGVEVYVHCDDHDIVFNASIPFDKSIIDSDSSLRSEDKGDDMSTLVGTVLSGFEYRAHKEELDNLTEVLKEYKSKYKYTGYTENAIMKTQNSGFRNEYYYLTAIPYTLDEYKRYFQPLIKEDDKSFRDGMRNSKKQLKDKSRPYVVTTLFSTKDNFTKDNTIDEMIEFSEVLKKKKNIPHDLNVSLQISNKYINTKRPNYSKKEVIEVGVFNHEKANTND,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,E265D,SAB persistence only,NA,NA,NA,NA
741,MQHIIKTALQQTFNYKTNKSIYNILVGKKSHQTFFDACSQQQLSLYHSLPLLKYPSFELFLEKINEFNAEMEIMLHPRYTFESMGQTFQAIQLLVQTMSNTKQHVFHFVPISQNNKIQETVKIVYNYIKENQLQIDFENELHNLFKAITLKGPCYLHYYLQGYDEPMYTRQQVSLIEKLSQQQLFEYEMNNLVTMMFELESGEYTILTKIIMKPTLLNQTYITYTKLLEQFTMEDIAAQQQVKINTIEDHVLEILIKGYMSNYDDYVELEDQLQFLNFYQQHRGERLKFYKEQFDTLSYFQLKVLIVGFERGDLNVA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1372,NE1349,NA,conserved hypothetical protein,NA,hypothetical protein,T208S,SAB persistence only,NA,NA,NA,NA
742,MKKLTAAAIATMGFATFTMAHQADAAETTNTQQAHTQMSTQSQDVSYGTYYTIDSNGDYHHTPDGNWNQAMFDNKEYSYTFVDAQGHKHYFYNCYPKNANANGSGQAYVNQATAGDNNDYTASQSQQHINQYGYQSNVGPDASYYSHSNNNQAYNSHNGNGKVNYPNGTSNQNGGSASKATASGHAKDASWLTSRKQLQPYGQYHGGGAHYGVDYAMPENSPVYSLTDGTVVQAGWSNYGGGNQVTIKEANSNNYQWYMHNNRLTVSAGDKVKAGDQIAYSGSTGNSTAPHVHFQRMSGGIGNQYAVDPTSYLQSR,1,2,0,0,1,1,0,0,1,2,0,0,SAUSA300_0270,NE641,lytM,peptidoglycan hydrolase,lytM,Glycyl-glycine endopeptidase LytM,A107T,SAB mortality and SAB persistence,NA,NA,NA,NA
744,MAEQQTIMERLFHTLDEKAKTLNNENGQSFIENLGLAMEQVYTNERGLLEQSTLQDRRKAFQFAYLSLMQEEKIQANHQITPDSIGLILGFLVERFMNNQEELHIVDIASGAGHLSATVKEVLPEIAVMHHLIEVDPVLSRVSVHLANFLEIPFDVYPQDAIMPLPLEEADIVIGDFPVGYYPIDERSKEFKLGFEEGHSYSHYLLIEQAINALKDAGYAFLVVPSNIFTGEHVKQLEKYIATETEMQAFLNLPPTLFKNEKARKSILILQKKKSGETKPVEVLLANIPDFKIPSQFQGFMTELNQWMDTNRPKK,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_1658,NE807,-,hypothetical protein,NA,hypothetical protein,W307R,SAB mortality and cell death,NA,NA,NA,NA
753,MIVICFYSLLAILLILLLASFIKATRAYNDSKEAVNKTNMIQKKYEDNANTVQYSPKLKLYADKFIDTYMNISKDSKELESREKELLKYFPSDYKKPDEKISDTERKLNSKEFYNIKRKDKQTIIQYIVNYDVNITEKKEVKVKKKKKSEKDKDEYETKTEEKQRKVNQNILINIPIKSENNKYVVVEYPYFTPIPDSQLNKAKMVEDNLKDNKREDNPKAKAFIEDFFNKYASSKSDDMAYLMDNPEGLEGTREVSQIREIRLYPKGDDYVAKVEILMKDKDSPLENLEHYTLDITKKDGKYYVKNMTNSIGG,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1486,NE1059,-,hypothetical protein,NA,hypothetical protein,Y28N,SAB persistence only,NA,NA,NA,NA
754,MKNDEVLLSIKNLKQYFNAGKKNEVRAIENISFDIYKGETLGLVGESGCGKSTTGKSIIKLNDITSGEILYEGIDIQKIRKRKDLLKFNKKIQMIFQDPYASLNPRLKVMDIVAEGIDIHHLATDKRDRKKRVYDLLETVGLSKEHANRYPHEFSGGQRQRIGIARALAVEPEFIIADEPISALDVSIQAQVVNLLLKLQRERGITFLFIAHDLSMVKYISDRIAVMHFGKIVEIGPAEEIYQNPLHDYTKSLLSAIPQPDPESERSRKRFSYIDDEANNHLRQLHEIRPNHFVFSTEEEAAQLRENKLVTQN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0890,NE482,oppF,"oligopeptide ABC transporter, ATP-binding protein",oppF_1,Oligopeptide transport ATP-binding protein OppF,A225T,SAB mortality only,NA,NA,NA,NA
756,MTEAAAAESENQLEDFVDDSPPEDIEKAKAIGWKDPSEWKGAPPKFGFIKAKQYLERAETVIPIMRSENKKLKDDLAEARQELKTFKDETSKTVAKMAQMSRIALNRQREQLEEKYASAIDAAAEVGDKDEVRKLRAAEREDLKKFDDAAEAKDEQKEEAKKSVNDALPKEVQETIGSWIADNNWYSTDPEMQMVANAHHGKLLKEKPGMTLAENLEETRKYVAKRYPEKFKGEEEPGDEGEEDKPSRGSRVEGGSRMAGGSGGSKFSKLPADAKAQADKFIKEDGLFLEKGETVEKTLSQARERYAAAYLES,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,T298N,SAB mortality only,NA,NA,NA,NA
757,MANIVFKLSDKDITTLMSRISFDTENLPQGMKARAKYQNTTVNIYQSGKVMFQGNHAEAASEELLPQHSQLNTNKTKKKNMANSFLEQTLMYDQFNCIGSDEAGSGDYFGPLTVCAAFVTKEHVPILKTLGVDDSKKLTDTKIVELAEQLVTFIPHSLLTLHNEKYNIQQAKGWTQVKMKAALHNEAIKNVLKKIDSSQLDYIVIDQFAKREVYSHYALSDIPLPKKTKFETKGESKSLAIAVASIISRYAFVTYMDQISKNINMTIPKGAGAKVDVIAAKIIKKYGLSRLDTISKKHFKNREKAQKILKPL,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1039,NA,NA,NA,rnhC,Ribonuclease HIII,A60V,Growth rate and cell death,NA,NA,NA,NA
759,MFFKQFYEDNFSQASYLIGCQRTGEAMIIDPIRDLTKYLKVADKEGFTITKAAETHIHADFASGIRDVANKLNASIYVSDEGKDEFNYKNMPKQTHFVKHQDIIYLGKIKLEVLHTPGHPPESISFLLTDEGGGSSIPMGLFSGDFIFVGDVGRPDLLEKAVNVEGSTKIGAKQMYQSIQFAATLPDYIQIWPGHGAGSPCGKALGSLPTTTLGYEKINNWAFNVKDETSFIETLTLNQPAPPHHFSQMKKINQFGMQMYQPYNVYPSSSNTQTAFDLRSKEAFHGGHMHGTINIPFNKTFINQIGWYLDYD,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,gloB,Hydroxyacylglutathione hydrolase,M1fs,SAB persistence only,NA,NA,NA,NA
761,MKRKIIMDCDPGHDDAIALILAGAIDSPLEILAVTTVAGNQSVDKNTTNALNVLDIMGRQDIVVAKGADRPLIKPVAFASEIHGESGLDGPKLPSTPSRQAVAMPASDVIINKVMTSDTPVTIVATGPLTNVATALIREPRIAEHIESITLMGGGTFGNWTPTAEFNIWVDAEAAKRVFESGITINVFGLDVTHQVLADEHVIERFESINNPVTQFVVELLQFFKKTYKTHFNMDGGPIHDACTILYLLQPELFTMVPVNIDIEHQSPLTYGTMAVDLNHVTGKPANAYFATAVDVEEVWNLIDHKLRTYE,1,2,0,0,1,1,0,0,1,2,0,0,SAUSA300_0237,NE1637,-,inosine-uridine preferring nucleoside hydrolase,rihA,Pyrimidine-specific ribonucleoside hydrolase RihA,T214A,SAB mortality and SAB persistence,NA,NA,NA,NA
762,MYKQGEPNLWTGRLDSETDPKKFRHFQTVTFEDLSKLEKSSMPSGVGILGYAVDKGVALNKGRIGAKEGPDAIKQAFAGLPDLNQCETLVDYGNVYHDHEELIDTQKEFAMLAAKSIANHRQTFLLGGGHDIAYAQYLATRKVYPTQSIGVINIDAHFDTRAEQQSTSGTSFRQILEEDENTDYLVLGIAQGGNTQSLFDYAKEKKIDYVFADELLSHVSPTIKDMIERFVHEHDVIMFTICMDVIDSAFAPGVSAPAVLGLYPHTVLELAKRIIPSDKVSSVSIAEMNPTYDADNRTAKIVANLVHHFFK,1,3,0,0,1,2,0,0,1,3,0,0,SAUSA300_2281,NE1553,hutG,formimidoylglutamase,hutG,Formimidoylglutamase,I301L,SAB mortality and SAB persistence,NA,NA,NA,NA
763,MMAKIVVALGGNALGKSPQEQLELVKNTAKSLVGLITKGHEIVISHGNGPQVGSINLGLNYAAEHNQGPAFPFAECGAMSQAYIGYQLQESLQNELHSIGMDKQVVTLVTQVEVDENDPAFNNPSKPIGLFYNKEEAEQIQKEKGFIFVEDAGRGYRRVVPSPQPISIIELESIKTLIKNDTLVIAAGGGIPVIREQHDGFKGIDAVIDKDKTSALLGANIQCDQLIILTAIDYVYINFNTENQQPLKTTNVDELKRYIDENQFAKGSMLPKIEAAISFIENNPKGSVLITSLNELDAALEGKVGTVIKK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1063,NE1719,arcC,carbamate kinase,arcC1,Carbamate kinase 1,G190dup,SAB mortality and SAB persistence,+,3,+,0
764,MNKNKPFIVVIVGPTASGKTELSIELAKRINGEIISGDSMQVYKHMNIGTAKVTPEEMDGIPHHLIDILNPDDTFSAYEFKRLAEDLITDITNRGKVPIIAGGTGLYIQSLIYNYELEDETVTPAQLSIVKQKLSALEHLDNQQLHDYLAQFDAVSAENIHPNNRQRVLRAIEYYLKTKKLLSNRKKVQQFTENYDTLLLGIEMSRKTLYSRINKRVDIMLDHGLFREVQQLVEQGYESCQSMQAIGYKELIPVINGQMIYEDAVNDLKQHSRQYAKRQMTWFKNKMSVHWLDKENMSLQMMLDEITTQIK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_1195,NE897,miaA,tRNA delta(2)-isopentenylpyrophosphate transferase,miaA,tRNA dimethylallyltransferase,T197A|A197T,SAB mortality and SAB persistence,NA,NA,NA,NA
767,MSKIVVALGGNALGQSPKEQLDLLKSTSKSLVSLIDKGYEIVISHGNGPQVGSINLGLNYAAEHKQGPPFPFPECGAMSQAYIGYQMQESLQNELHSMGIDKEVVTLVTQVQVASDDSAFNNPTKPIGLFYTKEQADKFTKEKGYTFVEDSGRGYRRVVPSPQPISIVELDSIETLITHGTLVIAAGGGGIPVIKENEVYTGVDAVIDKDKTSALLAAHLQSDQLIILTAVDHVYINYGKENQRGLDEVSVDEMKKHISDGQFAKGSMLPKVEAALQFLEKNTKGSVLITSLAGLGDALDGKIGTLIKN,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0061,NE511,arcC,carbamate kinase,arcC1_2,Carbamate kinase 1,P160T,SAB mortality only,NA,NA,NA,NA
773,MSKTAIIFPGQGAQKVGMAQDLFNNNDQATEILTSAANTLDFDILETMFTDEEGKLGETENTQPALLTHSSALLAALKNLNPDFTMGHSLGEYSSLVAADVLSFEDAVKIVRKRGQLMAQAFPTGVGSMAAVLGLDFDKVDEICKSLSSDDKIIEPANINCPGQIVVSGHKALIDELVEKGKSLGAKRVMPLAVSGPFHSSLMKVIEEDFSSYINQFEWRDAKFPVVQNVNAQGETDKEVIKSNMVKQLYSPVQFINSTEWLIDQGVDHFIEIGPGKVLSGLIKKINRDVKLTSIQTLEDVKGWNEND,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1123,NA,NA,NA,fabD,Malonyl CoA-acyl carrier protein transacylase,G196E,SAB persistence only,NA,NA,NA,NA
774,MNIVGHHHISMYTKDAKRNKDFYTNVLGLRLVEKSVNQDNPSMYHLFYGDEVGTAGTILSFFEIPNAGHKQPGTETIYRFSLLVPNQAALHYFEKRLENNGIKSERLYYLGQEGVVFKDEDDLEIILLVNDSFEVPHQWQHNAYSEIPQAYQILGIGPVELRVRNAARTVEFLENVLGYRKRDNKSFDVLTLAPQGLYSDFVVIEQQGQRERPGRGYIHHIAVNTPQMSDLDAIYKKLQQQPQSNSGIIDRYFFKSLYYRHNSIMYEFATEAPGFTIDTPVEQLGSQLNLPDFLEAEREQIESKLHEI,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0338,NE1236,-,glyoxalase family protein,mhqA_1|mhqA_3|mhqA_2,Putative ring-cleaving dioxygenase MhqA,A67V,SAB mortality and SAB persistence,NA,NA,NA,NA
781,MFKRTKLILIATLLLSGCSTTNNESNKETKSVPEEMEASKYVGQGFQPPAEKDVVEFAKKHKDKIAKRGEQFFMDNFGLKVKATNVVGSGKGVEVFVHCDDHDIVFNASIPFDKSIIESDSSLRSEDKGDDMSTLVGTVLSGFEYRTQKEKYDNLYKFFKDNEEKYQYTGFTKEAINKTQNVGYKNEYFYITYSSRSLKEYRKYYEPLIHKNDKEFKEGMEQARKEVNYAANTDTVTTLFSTKENFTKDNTVDDVIELSDKLYNFKNKPEKSTITIQIGKPTNNTKKAFYDDNDPI,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1379,NE707,NA,putative lipoprotein,NA,hypothetical protein,Ter297Eext*?,SAB mortality only,NA,NA,NA,NA
782,MLKKAKFILMATILLSGCSTTNNESNKETKSVPEEMDASKYVGQGFQPPAEKDAIEFAKKHKDKIAKRGEQFFMDNFGLKVKATNVIGSGDGVEVFVHCDDHDIVFNASIPFDKSIIDSDSSLRSKDKGDDMSTLVGAVLSGFEYRAQKEKYDKLYKFFKDNEEKYQYTGFTKEAINKTQNSGYENEYFYISAIPYNLAEYRDYFEPLLNKSDSEFSKELSNVKKQLKDKSKVSVTTTLFSKKKNYTEKSNSENVIKMAEEIKKDKEIPNGIELSIKFSDNKINTVKPNFNGESTSEYGVFDQE,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1376,NE717,NA,putative lipoprotein,NA,hypothetical protein,N251D,Growth rate and cell death,NA,NA,NA,NA
783,MRLKDNVKISYCDIEKKTKINQGTIEYIIADENKYYYNVFTQEKIELNNTPKEQYDFLINNALICNDSSYDNIDERFKRNMYFFEAFSEKVGINPEKIHNRIQNKTILIIGFGGIGTIVVDNIQRMGFKNFILIDYDIVEPSNLNRQMFFNEQYYGEFKVDVAESELLNGCNIKKCYKNINSVSDLEKLNVNNVDFLINCADTPTNIVNIVNEFAKKYKIPTISGSVGTETGTWGPIYDTNNLYHPIDIENNDMSIKGSNASTNSIISSFIAFEVMLYITNLYEDYLFYKEKILNFKTLFMEVN,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,I123L,SAB mortality only,NA,NA,NA,NA
787,MSVFIDKNTKVMVQGITGSTALFHTKQMLDYGTKIVAGVTPGKGGQVVEGVPVFNTVEEAKNETGATVSVIYVPAPFAADSILEAADADLDMVICITEHIPVLDMVKVKRYLQGRKTRLVGPNCPGVITADECKIGIMPGYIHKKGHVGVVSRSGTLTYEAVHQLTEEGIGQTTAVGIGGDPVNGTNFIDVLKAFNEDDETKAVVMIGEIGGTAEEEAAEWIKANMTKPVVGFIGGQTAPPGKRMGHAGAIISGGKGTAEEKIKTLNSCGVKTAATPSEIGSTLIEAAKEAGIYESLLTVNK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1139,NE1770,sucD,succinyl-CoA synthetase subunit alpha,sucD,Succinate--CoA ligase [ADP-forming] subunit alpha,N187S,SAB mortality only,NA,NA,NA,NA
790,MKKLLLPLIIMLLVLAACGNQGEKNNKAETKSYKMDDGKTVDIPKDPKRIAVVAPTYAGGLKKLGANIVAVNQQVDQSKVLKDKFKGVTKIGDGDVEKVAKEKPDLIIVYSTDKDIKKYQKVAPTVVVDYNKHKYLEQQEMLGKIVGKEDKVKAWKKDWEETTAKDGKEIKKAIGQDATVSLFDEFDKKLYTYGDNWGRG,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2235,NE933,-,iron compound ABC transporter iron compound-binding protein,fhuD_1,Iron(3+)-hydroxamate-binding protein FhuD,Ter201Gext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
791,MTNQDNNHQLNHRIYHFEKIYKAIKHVIVFIFMIFIAIVAIAVIAISLYFHHLTKTSDSLSDDALIKKVRQIPGDELLDHNNKNLLYEYNHSQNSLIIGPKTSSPNVIKALTSSEDTLFYKHDGILPKAILRAMIQDIFNTDQSSGGSTITQQLVKNQVLTNEKTYSRKANELRLAIRLEHLLSKDEIIYTYLNIVPFGRDYNGANISGIASASYSLFGIPPKDLSIAQSAYLIGLLQSPYGYTPYEKDGTLKSDKDLKYSIQRQHYVLKRMLIEDQITEKEYNDALKYDIKSHLLNRKKR,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1676,NE267,sgtA,probable transglycosylase,mrcA,Penicillin-binding protein 1A,I46M,SAB persistence only,NA,NA,NA,NA
793,MALDKDIVGSIEFLEVVGLQGSTYLLKGPNGENVKLNQSEMNDDDELEVGEEYSFFIYPNRSGELFATQNMPDITKDKYDFAKVLKTDRDGARIDVGLPREVLVPWEDLPKVKSLWPQPGDYLLVTLRIDRENHMYGRLASESVVENMFTPVHDDNLKNEVIEAKPYRVLRIGSFLLSESGYKIFVHESERKAEPRLGESVQVRIIGHNDKGELNGSFLPLAHERLDDDGQVIFDLLVEYDGELPFWDKSSPEAIKEVFNMSKGSFKRAIGHLYKQKIINIETGKIALTKKGWSRMDSKE,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_1284,NE1182,-,hypothetical protein,cvfB,Conserved virulence factor B,V258A,SAB mortality and cell death,NA,NA,NA,NA
794,MKFLSFKYNDKTSYGVKVKREDAVWDLTQVFADFAEGDFHPKTLLAGLQQNHTLDFQEQVRKAVIAAEDSGKAEDYKISFNDIEFLPPVTPPNNVIAFGRNYKDHANELNHEVEKLYVFTKAASSLTGDNATIPNHKDITDQLDYEGELGIVIGKSGEKIPKALALDYVYGYTIINDITDRKAQSEQDQAFLSKSLTGGCPMGPYIVTKDELPLPENVNIVTKVNNEIRQDGNTGEMILKIDELIEEISKYVALHPGDIIATGTPAGVGAGMQPPKFLQPGDEVKVTIDNIGTLTTYIAK,2,2,0,1,1,2,0,1,2,3,0,1,SAUSA300_0871,NE1493,-,hypothetical protein,NA,hypothetical protein,I65V|I28T,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
795,MPAGTITTGNHPKALWPGMHAFFGTTYGEYQEEGRDRVTVEKSSKNYEEDTLVTGFGQMPIKPEGSGVSYDSETQGFTKRYTHTVWGLGYIVTQEELEDNLYEVVSKKRIKRLAFSARQTKENVVANVYNRAFTSGYTGGDGVVLLSTAHPSTAGNWSNKLATDADLSEAALEDMMIQIAQAKNDRGHVINLKAMKLIVPSNLMFDAKRILKSDQQSGSANNDINALKGMLDYSVNHYLTDTDAWFIKTDAQYGLQLFERRALSFTQDNDFDTENAKAKCTMRFSVGWTDPRGLYGTSGA,1,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,G34W|R37L,SAB mortality only,NA,NA,NA,NA
799,MFDSIRETIDYAVENNMSFADIMVKEEMELSGKSRDEVRAQMKQNLDVMRDAVIKGTTGDGVESVTGYTGHDAAKLRDYNETHHALSGYEMIDAVKGAIATNEVNAAMGIICATPTAGSSGTIPGALFKLEKTHDLTEEQMIDFLFTSALFGRVVANNASVAGATGGCQAEVGSASAMAAAAAVAIFGGSPEASGHAMALAISNLLGLVCDPVAGLVEIPCVMRNAIGSGNALISADLALAGIESRIPVDEVIEAMDKVGRNLPASLRETGLGGLAGTPTGEAIKRKIFGTAEDMVKNN,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2469,NA,NA,NA,sdhA,"L-serine dehydratase, alpha chain",G290D,SAB mortality and growth rate,NA,NA,NA,NA
806,MNKISKYIAIASLSVAVTVSAPQTTNSTAFAKSSAEVQQTQQASIPASQKANLGNQNIMAVAWYQNSAEAKALYLQGYNSAKTQLDKEIKKNKGKHKLAIALDLDETVLDNSPYQGYASIHNKPFPEGWHEWVQAAKAKPVYGAKEFLKYADKKGVDIYYISDRDKEKDLKATQKNLKQQGIPQAKKSHILLKGKDDKSKESRRQIVQKDHKLVMLFGDNLLDFTDPKEATAESREALIEKHKDDFGKKYIIFPNPMYGSWEATIYNNNYKASDKAKDKLRKNAIKQFDPKTGEIK,3,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0307,NE619,NA,"5'-nucleotidase, lipoprotein e(P4) family",hel,Lipoprotein E,K248E,SAB mortality only,NA,NA,NA,NA
807,MLLGSHVSMSGKKMLEGSAIEAHEYGETTFMIYTGAPQNTRRKSIEDLNITKGHEVMEKYGLSNIVVHAPYIINIANTTKPETFNLGVDFLQQEIERTQAIGAKDIVLHPGAHVGAGVDAGINKIIEGLNEVLTNDNNVRIALETMAGKGTEIGRSFEELARIIDGVHNNERLSVCFDTCHTHDAGYNVKEDFDGVLNEFDKIIGVDRIKVVHVNDSKNDRGAQKDRHENIGFGYIGFDALNYMVHHDCFKDIPKILETPYVGEDKKNKKPPYKLEIEMLKQQQFDPELKNKVMQQ,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1517,NE1028,-,endonuclease IV,nfo,putative endonuclease 4,M244I,SAB persistence only,NA,NA,NA,NA
811,MTGWIKLHRKLLDSPIFQNEKLFKVFAYCLMKASHKDHTQLVGRRVVELEKGQFVFGRKRASEELRLKESTVRDYIKLLENLGTIVVKSDNKFSVITVVNWAIYQSMEENSDSKNDNKSTTNGQQINNKSTTNGQQINTNKNVKNGDNVKNDENEKKKAAAFDFFQDNGFGFITPYNLDDLNYYLDSFENDSDQIVTASLKIAKDRNKVTWGYAKSILNTWLNANLKSIEQVRAFEKQQLESKKQTNKPNVKPSKEKTPKWLTDSTRETKTPEVDENLEKDREAFIKRLNSKWE,0,1,1,1,0,1,1,1,0,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,N250Y,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
812,MVIQWYPGHMAKAKREVSEQLKKVDVVFELVDARIPYSSRNPMIDEVINQKPRVVILNKKDMSNLNEMSKWEQFFIDKGYYPVSVDAKHGKNLKKVEAAAIKATAEKFEREKAKGLKPRAIRAMIVGIPNVGKSTLINKLAKRSIAQTGNKTGVTKQQQWIKVGNALQLLDTPGILWPKFEDEEVGKKLSLTGAIKDSIVHLDEVAIYGLNFLIQNDLARLKSHYNIEVPEDAEIIAWFDAIGKKRGLIRRGNEIDYEAVIELIIYDIRNAKIGNYCFDIFKDMTEELANDANN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1136,NA,NA,NA,rbgA,Ribosome biogenesis GTPase A,T152P,SAB mortality and SAB persistence,NA,NA,NA,NA
814,MATISAKLVKELREKTGAGMMDCKKALTETDGDIDKAIDYLREKGIAKAAKKADRIAAEGLVHVETKGNDAVIVEINSETDFVARNEGFQELVKEIANQVLDTKAETVEALMETTLPNGKSVDERIKEAISTIGEKLSVRRFAIRTKTDNDAFGAYLHMGGRIGVLTVVEGSTDEEAARDVAMHIAAINPKYVSSEQVSEEEIIHEREVLKQQALNEGKPENIVEKMVEGRLRKYLQEICAVDQDFVKNPDVTVEAFLKTKGGKLVDFVRYEVGEGMEKREENFADEVKGQMK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1150,NA,NA,NA,tsf,Elongation factor Ts,I204N,SAB mortality and SAB persistence,NA,NA,NA,NA
815,MNKDLKGLYAALLVPFDENGQVNEQGLKQIAQNAIETEELDGLYVNGSSGENFLLNTEQKKQVFKVAKEAVGDKVKLIAQVGSLDLNEAIELGKYATELGYDALSAVTPFYYPFTFEEIRDYYFDIIEATQNNMIIYAIPDLTGVNISIEQFSELFNHEKIVGVKYTAPNFFLLERIRKAFPDKLILSGFDEMLVQATISGVDGAIGSTYNVNGRRARKIFDLARQGQIQEAYQLQHDSNDIIETVLSMGIYPTLKEILRHRGIDAGLPKRPFKPFNEAHRQTLDQLIAKYDL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0315,NE1835,NA,N-acetylneuraminate lyase,nanA,N-acetylneuraminate lyase,Q196H,SAB mortality only,NA,NA,NA,NA
819,MMTNILYRIDKQLSDFTKTEKIIADYILKNPHKIIDMTVNDLADVTNVSTASIVRFSRKMTHQGFQELKIAISRYLPEDIATNPHLELIENESVETLKNKMIARATNTMRFVATNIMDAQIDAICDVLKNARTIFLFGFGASSLTIGDLFQKLSRIGLNVRLLHETHLLVSTFATHDDRDCMIFVTNQGSHSELQSIAQVATHYSIPIITISSTANNPVAQIADYALICGRTDENEMRMAATTSLFAQLFTVDILYYRFVALNYHAILDCITQSKMALDNYRKHLATIDFKH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0195,NE1659,-,transcriptional regulator,ybbH_2|ybbH_1,putative HTH-type transcriptional regulator YbbH,C229Y,SAB mortality and SAB persistence,NA,NA,NA,NA
821,MSQDVNELSKQPTPDKAEDNAFFPSPYSLSQYTAPKTDFDGVEHKGAYKDGKWKVLMIAAEERYVLLENGKMFSTGNHPVEMLLPLHHLMEAGFDVDVATLSGYPVKLELWAMPTEDEAVISTYNKLKEKLKQPKKLADVIKNELGPDSDYLSVFIPGGHAAVVGISESEDVQQTLDWALDNDRFIVTLCHGPAALLSAGLNREKSPLEGYSVCVFPDSLDEGANIEIGYLPGRLKWLVADLLTKQGLKVVNDDMTGRTLKDRKLLTGDSPLASNELGKLAVNEMLNAIQNK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0536,NE1221,-,chaperone protein HchA,hchA,Protein/nucleic acid deglycase HchA,W53*,SAB mortality and growth rate,NA,NA,NA,NA
823,MKKIEAWLSKKGLKNKRTLIVVIAFVLFIIFLFLLLNSNSEDSGNITKTENAELHTGPNAAYPVIYKVEKGDHFKKIGKVGKWIEVEDTSSNEKGWIAGWHTNLDIVADNTKEKNPLQGKTIVLDPGHGGSDQGASSNTKYKSLEKDYTLKTAKELQRTLEKEGATVKMTRTDDTYVSLENRDIKGDAYLSIHNDALESSNANGMTVYWYHDNQRALADTLDATIQKKGLLSNRGSRQENYQVLRQTKVPAVLLELGYISNPTDETMIKDQLHRQILEQAIVDGLKIYFSA,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1588,NE1369,NA,N-acetylmuramoyl-L-alanine amidase,NA,hypothetical protein,H55R,SAB persistence only,NA,NA,NA,NA
825,MKYRKLIILVLSILIILPVSKLDGHHIANADDDPPKKLKYKENSALALNYHRVRKANFLNNFIYFFSSSKEIKNYSVSQSQFESQIKWLKSHDAKFLTLKEFLYYKKKGKFPKRSVWINFDDMDETIYENAYPILKKYKIPATGFIITGHVGEENFHNLDMISKKELKEMYKTGLWEFETHTHDMHNLSKNNKSKLMKASEATIIKDLNKSEKYLTKNFKKSQKTIAYPYGLMNDDKLPVIKKAGLKYGFSLEEKAVTPNSNDYYIPRILISDDAFEHLIKRWDGFHEKD,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_2601,NE1167,icaB,intercellular adhesion protein B,icaB,"Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase",M197I,SAB mortality and cell death,NA,NA,NA,NA
826,MIKIFLLKLYWAHFSTKQIHQFLMAYPNVIKEEGRKKDSYLCEWVNREENVHLLRKYYAFIKLDHNDIIKELQKLKVSYITYMDSEYPVLLKEIYQFPLLLFYKGNIKLINNMHHLAVVGARDSTSYTQQSLEFLLSNDKSKYLTIVSGLAQGADAMAHQIALKYNLPTIAVLAFGHQTHYPKSTLALRNKIEEKGLVISEYPPHTPIAKYRFPERNRIISGLSKGVLITEAKEQSGSHITIDFALEQNRNVYVLPGSMFNPMTKGNLLRIQEGAKVVLNANDIFEDYYI,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1142,NE242,dprA,DNA protecting protein DprA,NA,hypothetical protein,I4L,SAB mortality and SAB persistence,+,0,+,0
827,MKLEHITKKYGSNVVLNDIDFDFGDSRIVGLIGKNGVGKTTVMKVMNGNIIKFDGKVDIDNADNIGFLIEHPKLYDNKSGLYNLKLFAQVLGKGFDKAYTDKIIDAFGMRPYIKKKVKKYSMGMKQKLAIAVSLMNKPKFLILDEPTNGMDPDGSIDVLTTIKSLVNELDMRILISSHKLEDIELICDRAVFLRDEHFVQDVNMEEGVASDTTIVTVDHKDFDRTEKYLAEHFQLQNVDKADGHLMINAQKNYQVILKALSELDIYPKYIETRKSSLRDTYFNINQRGDK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1911,NE1908,-,ABC transporter ATP-binding protein,bcrA_2,Bacitracin transport ATP-binding protein BcrA,E196G,SAB persistence only,NA,NA,NA,NA
829,MSNVLTEIDSQYPYMTKNEKKIAKFILNSPQKVIKMRSQDLASLLDISTSSVIRFSKKITDGGFHDLKINISKYVPKASSIYNVELMNNESTESLRTKLHTRTTRALNHANNELNDKTIDQICHCLKRSETIFIYGFGASFVVATDLYQKLSRIGLNIQLVQETHIFATLLATHNSNDSVILITNNGTQSEMQSMVKVIDDYHIPIITITSTRDNPVAQASNIVLTYGKTDENEMHMGATTSLFAQMFTIDILYYRYVALNYHASLDFITQSKMALDNYRKHLSNINFKH,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2264,NE1142,-,RpiR family phosphosugar-binding transcriptional regulator,ybbH_1,putative HTH-type transcriptional regulator YbbH,D116N,SAB mortality only,NA,NA,NA,NA
830,MNLDWYYTFVILAKTLNYRLASEEINLTIPSIHKQIKNLEQHLNVKLFETYKNQIILTEDGHTFLPIAQSFIEQYESGIKHIQLKKTMFQSKLNVVVSSYIATFIMPKFLKSFFNEHPFIDVSLHVKNENIEKDINNHTYDIGISRNQPKLREVHSEKVCEGKIVLIAPNKENNHLLTEASLFEKYKIISDNHPEYWSSLKNNILNIYEKAQFLSINDVHTSIKLIEMNQGISFLPLYITTNSDYNISVINTKILQAPISFTYIYSKKESPEILVFIKSFKKYIANEQL,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0878,NA,NA,NA,ampR,HTH-type transcriptional activator AmpR,P236S,SAB mortality and growth rate,NA,NA,NA,NA
832,MNEIKLEYDTHVSVVHYESLDSRSFKSFSKPKWSKLINKLSVPIEANYKYARGVAVYGDIKNGANDHGEIIKKHRNDVNVVYRDVIVLDYDEINDLKQLHEAISSALSNVAWFWHTSFSHTTEQARIRLYIPLNERISADDYRKYTKVLANKIGHKVDEGSYQPSRCFALPVIQKGHIFIKRVNDCPIIDVDMLEQWSKEFEQSNGSPNIKGYTRRDSAYWRDIAFGVSEGERNSTLASITGYLLRRYVDPNLVYGLVSAWASVCKPAINQSEVNNTFKSILKKDSKSS,0,0,1,1,0,0,1,1,0,0,1,1,NA,NA,NA,NA,NA,hypothetical protein,S259G,Growth rate and cell death,NA,NA,NA,NA
833,MDVIKQIQQAIVYIEDRLLEPFNLQELSDYVGLSPYHLGQSFKMIVGLSPEAYARARKMTLAANDVINGATRLVDIAKKYHYANSNDFANDFSDFHGVSPIQASTKKDELQIQERLYIKLSTTERAPYPYRLEETDDISLVGYARFIDTKYLSHPFNVPDFLEDLLIDGKIKELRRYNDVSPFELFVISCPLENGLEIFVGVPSERYPAHLESRFLPGKHCAKFNLQGEIDYATNEAWYYIESSLQLTLPYERNDLYVEVYPLDISFNDPFTKIQLWIPVKQSPYDED,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1455,NE1903,-,AraC family transcriptional regulator,NA,hypothetical protein,D87G,SAB mortality and growth rate,NA,NA,NA,NA
834,MKIEDYRLLITLDETKTLRKAAEILYISQPAVTQRLKAIENAFGVDIFIRTKKQLIITTEGTMIIEHARDMLKRERLFFDKMQAHIGEVNGTISIGCSSLIGQTILPEVLSLYNAQFPNVEIQVQVGSTEQIKANHRDYHVMITRGNKVMNLANTHLFNDDHYFIFPKNRRDDVTKLPFIEFQADPIYINQIKEWYNDNLEQDYHATITVDQVATCKEMLISGVGVTILPEIMMKNISKEQFEFEKVEIDNEPLIRSTFMSYDPSMLQLPQVDSFVNLMASFVEQPKA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0658,NE1560,-,LysR family transcriptional regulator,hdfR_3,HTH-type transcriptional regulator HdfR,I57T,SAB mortality and SAB persistence,NA,NA,NA,NA
835,MKHINHFSESTLAYLEKDHEHAFYVYCLIDPRNDECFYVGKGKGNRIFKHKQDAQRQLLYEDIFREENKDNLKFNRINEICSNDLNVLGYIISYGLTESEAFSAENVLINFLNLTNKTTLTNMINGHGSKAYLVEDLENEFGYDSINLENINTNELILAVKIRDAFLLDKDESKEYPINESKRDRNNLKSRTLGSWIIGKDKIHKIKYIIGINTGANNAVVSAYEVSFEQAESIETNNGRMRYAFIGLSERDATLKKLNLYKKALPDLRFGSGSATAYINNGTMKVD,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,A253D,SAB mortality and cell death,NA,NA,NA,NA
838,MAKELCFEGITLKAFDEQYRSAINDFDLNERQQIYSSLPKEVIDDAINDADRIANVAINDKNEVVGFFVLHRYYQHEGYDTPENVVYIRSLSINEKYQGFGYGTKIMMSLPQYVQGVFPDFNHLYLVVDAENDNAWNLYERAGFMHTATKEEGPIGKERLYYLDLDSKHVSSLKLEEESRSEVTNVHIINLLIDGQKVGFIALEQIGERMNIAAIEVDKSYRFNGIGSSALRQLPTYLRKNYDNLNVITMILFGENNDFKPLCLNSNFVEIEQTDDYVVFEKYLNY,1,2,2,1,1,1,1,1,1,1,1,1,SAUSA300_2083,NE1485,-,acetyltransferase,NA,hypothetical protein,L192M|M192L,all,NA,NA,NA,NA
841,MNTFQMRDKLKERLSHLDVDFKFNREEETLRIYRTDNNKGITIKLNAIVAKYEDKKEKIVDEIVYYVDEAIAQMADKTLESISSSQIMPVIRATSFDKKTKQGVPFIYDEHTAETAVYYAVDLGKSYRLIDESMLEDLKLTEQQIREMSLFNVRKLSNSYTTDEVKGNIFYFINSNDGYDASRILNTAFLNEIEAQCQGEMLVAVPHQDVLIIADIRNKTGYDVMAHLTMEFFTKGLVPITSLSFGYKQGHLEPIFILGKNNKQKRDPNVIQRLEANRRKFNKDK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1689,NA,NA,NA,NA,hypothetical protein,N269Y,SAB mortality and SAB persistence,NA,NA,NA,NA
845,MSFYVVLIIIIVALIGILVLNQRYSNSKIDTEVYARKQLIKKNKALSAENAELRSQMLSSNNDVGHHAYKNAKRELRKILDSYLENGKLKYYDIIVTSNLATKHPFFEYARSFDFIIVSDIGLINVDVKSWGEKTFYHFDVPDEHDTEMSNSNIEKVVGHYISQQYHDQFNSSRKSIYTFTETVQPNRVIYDFYDYDPYQLAANNAKALKDHIEQKFNFKVQSTGVIYFSDGTVNIIQGSEERDKYVDTVSTKSSLRRIISEAIELSKHPLNKEQVDQITAIFK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1223,NE1108,-,hypothetical protein,NA,hypothetical protein,P198L,SAB persistence only,NA,NA,NA,NA
846,MVENIRTELFFLKQFGFNNTLLQEIFIKGLDPIKTIFSNEYLIRANIGRKFTDKDVLLANDYYKYREFKYYLFNKDEFFRDSKSKIYFKFDETNITKLLPEKIMPLFMYTKGNNSLLDIKKQRVAIIGTRHPSNRAIKITKKITQKFLEDNYVIVSGLAEGIDTISHKTAIKYNGNTIAILPTNFKNIYPKENIELAKEILYKGLLLTSIGPNENTYKSSFLDRNKYIANISDIVVVTETNLKSGTMNTIRSASIAGKKILFVNQGDNLINNKIYEFGGEMIDD,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,Y202D,SAB mortality only,NA,NA,NA,NA
847,MSKIFVTGATGLIGIKLVQRLKEEGHEVAGFTTSENGQQKLAAVNVKAYIGDILKADTIDQALADFKPEIIINQITDLKNVDMAANTKVRIEGSKNLIDAAKKHDVKKVIAQSIAFMYEPGEGLANEETSLDFNSTGDRKVTVDGVVGLEETARMDEYVVLRFGWLYGPGTWYGKDGMIYNQFMDGQVTLSDGVTSFVHLDDAVETSIQAIHFENGIYNVADDAPVKGSEFAEWYKEQLGVEPNIDIQPAQPFERGVSNEKFKAQGGTLIYQTWKDGMNPIK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2387,NE1138,-,NAD dependent epimerase/dehydratase family protein,hldD,ADP-L-glycero-D-manno-heptose-6-epimerase,E151dup,SAB mortality and SAB persistence,NA,NA,NA,NA
848,MAKTLAQTKQISQSHTFDVSQSHHKTPDDTNSHSVIYSTQNLDLWYGENHALQNINLDIYENQITAIIGPSGCGKSTYIKTLNRMVELVPSVKTAGKILYRDQDIFDQKYSKEQLRTNVGMVFQQPNPFPKSIYDNITYGPKIHGIKNKKVLDEIVEKSLRGAAIWDELKDRLHTNAYSLSGGQQQRVCIARCLAIEPEVILMDEPTSALDPISTLRVEELVQELKEKYTIIMVTHNMQQAARVSDKTAFFLNGYVNEYDDTDKIFSNPSNKKTEDYISGRFG,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1280,NA,NA,NA,pstB3,Phosphate import ATP-binding protein PstB 3,K3Q,SAB mortality and growth rate,NA,NA,NA,NA
850,MEVKTFYNGNTMPQIGLGTFRVENDENCMESVKYAIEQGYRSIDTAKVYGNKEQVGAGIRAGLESTGIAREDLFITSKLYFEDFGRENVAAAYEASLSRLGLKYLDLYLVHWPGTNEAVMVDTWKGMEDLYKNNNVKNIGVSNFEPEHLEALLAQVSIKPVINQVEYHPYLTQHKLKLYLAAQRIVMESWSPLMNAQILNDETIKDIAQELGKSPAQVVLRWNVQHAVVTIPKSVTPNRISENFQIFDFELSDEQMTRIDGLNQDKRIGPDPKNLKARLKSLN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1728,NE1441,NA,"oxidoreductase, aldo/keto reductase family",yvgN,Glyoxal reductase,K52E,SAB persistence only,NA,NA,NA,NA
854,MINIGLTGWGDHYSLYEDLERQTDKLKTYAGHFPVVELDATYYAIQPERNILKWIKETPDTFEFVVKIHQALTLHADYKTFADTRQELFDQFKNMLEPLHTQKKLAMVLVQFPPWFDCNAQNIKYILYVRQQLQAFPMCVEFRHQSWFSDAFKEQTLAFLTEHQIIHAVVDEPQVKDGSVPLVNRITNEIAFVRYHGRNHYGWTKKDMSDQEWRDVRYLYDYNEQELIDLAQKAQILAQKAKKVYVIFNNNSGGHAANNAKTYQRLLNIEYEGLAPQQLKLF,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_0826,NE1013,-,hypothetical protein,NA,hypothetical protein,L105fs,Cell death only,-,2,+,0
856,MLIPLIARAKEYENEKPIIKDALSKKIFDGLDDIYKNVTCDDMSQIGISIRSVIIDSVTKRLIKDNKNLIVINIGCGLDTRFQRFNNEKISWIDLDVPESIEIRKTFFKETDSYKMIAKSMLDYSWIEDVINYKFFNSKSNILFIFEGVLMYFDESVMTKLLHTIIKKFGDHNLTFAIEFCSKTIANNTKRHKSVSKLSSQPVFKYGYNDLNELDKVLPNKMKVINEYNYFDYHKKRWGLFGYCRYIPYLKKRLNNKIVIMEYKPAKLITHN,2,2,0,0,1,1,0,0,2,4,0,0,NA,NA,NA,NA,NA,hypothetical protein,N14Y|I156F,SAB mortality and SAB persistence,NA,NA,NA,NA
857,MEKIFLNGEFVSPSEAKVSYNDRGYVFGDGIYEYIRVYNGKLFTVTEHYERFLRSANEIGLDLNYSVEELIELSRKLVDMNQIETGAIYIQATRGVAERNHSFPTPEVEPAIVAYTKSYDRPYDHLENGVNGVTVEDIRWLRCDIKSLNLLGNVLAKEYAVKYNAVEAIQHRGETVTEGSSSNAYAIKDGVIYTHPINNYILNGITRIVIKKIAEDYNIPFKEETFTVDFLKNADEVIVSSTSAEVTPVIKLDGEPVNDGKVGPITRQLQEGFEKYIESHSI,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1696,NE1305,dat,D-alanine aminotransferase,dat,D-alanine aminotransferase,W140C,SAB persistence only,NA,NA,NA,NA
859,MIYETAPAKINFTLDTLFKRNDGYHEIEMIMTTVDLNDRLTFHKRKDRKIVVEIEHNYVPSNHKNLAYRAAQLFIEQYQLKQGVTISIDKEIPVSAGLAGGSADAAATLRGLNRLFDIGASLEELALLGSKIGTDIPFCIYNKTALCTGRGEKIEFLNKPPSAWVILAKPNLGISSPDIFKLINLDKRYDVHTKMCYEALENRDYQQLCQSLSNRLEPISVSKHPQIDKLKNNMLKSGADGALMSGSGPTVYGLARKESQAKNIYNAVNGCCNEVYLVRLLG,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0472,NE597,ispE,4-diphosphocytidyl-2C-methyl-D-erythritol  kinase,ispE,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,A199V|V199A,SAB mortality and SAB persistence,NA,NA,NA,NA
863,MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKEDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFIYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,blaZ,Beta-lactamase,E91D,SAB mortality and cell death,NA,NA,NA,NA
865,MLVVYVVDDSTARATWYPDDSNDEYTKYKIGGTWYQFYKKVDEELTKKFVEETANNALNQAKQYVDDKFGTTSWQQHKMTEANGQSIQVNLNNAQGDLGYLTAGNYYATRVPDLPGSVESYEGYLSVFVKDDANKLFNFTPSNSKKVYTRSITNGRLDSQWATPNEHKTAVLFDGAANGVGTRINLTEAYTNYAILFISGTYPGGVIEAFSLTSIPNAIQLSKTNVVDSDGNGGGSYECLITKESGTTLKIDNDVYLDLGSKTGSGANANRVTINKIVGWK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,A54S,SAB persistence only,NA,NA,NA,NA
866,MLKFFKINKLIVVLCAIIVFIALIGLSIRSQSQSPPEQYIGDSVSFGQRVVSYPVNFVAGTIGDFFKKGDSKESKNKISQLESKNQQLEAENEKLKKELDLKDISKFDPISTTVLARNPDQWMNTIVIDKGSKSGITSNMAVMTSQGFVGRVTKVNKFSSQVDLISTNTRAGKLSVNIQHGSKNIFGLIDRYDEKNSELVISDINNRDNISKGDKVVTSGLADQLPSNLYIGEVTKVQNDQYGLAKEVRVKTGADLTDLSHVYVAKRDPKTIPDDESRDK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1605,NE1404,mreC,rod shape-determining protein MreC,mreC,Cell shape-determining protein MreC,I7N,SAB mortality only,NA,NA,NA,NA
867,MKKSLTVTVSSVLAFLALNNAAHAQQHGTQVKTPVQHNYVSNVQAQTQSPTTYTVVAGDSLYKIALEHHLTLNQLYSYNPGVTPLIFPGDVISLVPQNKVKQTKAVKSPVRKASQAKKVVKQPVQQASKKVVVKQAPKQAVTKTVNVAYKPAQVQKSVPTVPVAHNYNKSVANRGNLYAYGNCTYYAFDRRAQLGRSIGSLWGNANNWNYAAKVAEFKVDKTPEVGAIFQTAAGPYGHVGVVESVNPNGTITVSEMNYAGFNVKSSRTILNPGKYNYIH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0739,NE1640,-,LysM domain-containing protein,NA,putative autolysin LDP,E216G,SAB mortality and SAB persistence,NA,NA,NA,NA
871,MVNYKEKLDEAIHLTQQKGFEQTRAEWLMLDVFQWTRTDFVVHMHDDMPKAMIMKFDLALQRMLLGEPIQYIVGFASFYGRTFDVNSNCLIPRPETEEVMLHFLQQLEDDATIVDIGTGSGVLAITLKCEKPDLNVIATDISLEAMNMARNNAEKHQSQIQFLTGDALKPLINEGIKLNGLISNPPYIDEKDMVTMSPTVTRFEPHQALFADNHGYAIYESIIEDLPHVMEKGSPVVFEIGYNQGEALKSIILNKFPDKKIDIIKDINGHDRIVSFKW,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2071,NE997,-,HemK family modification methylase,prmC,Release factor glutamine methyltransferase,N135I,Growth rate and cell death,NA,NA,NA,NA
874,MDEQQWTGQLDLTVFFDGNRSVSRDIFFEKALKVIRPVYLNQSTIPTFYIVNVGGGYLDGDRYRMNVNVEDNAKVTLTSQGATKIYKTPSNHVEQYQTFNLKDNAYLEYVADPIIAYENAKFYQHNTFNLNNSSSLFYTDILTPGYSKTGEAFKYQYMHLINEIYIEDELVTYDNLLLNPNKQSINEIGYMEHYSHYGSAYFIHEDVNQKLIDSVYETISSYSNTFDCRVAISQLPTHGFAVRIFAYRTQIIEKILGTIQSYIAENIYDRKLDFLRKY,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2244,NE1308,ureD,urease accessory protein UreD,ureD1,Urease accessory protein UreD,G81D,SAB mortality and growth rate,NA,NA,NA,NA
878,MQPHLICLDLDGTLLNDNKEISSYTKQVLNELQQRGHQIMIATGRPYRASQMYYHELNLTTPIVNFNGAYVHHPKDKNFKTCHEILDLGIAQNIIQGLQQYQVSNIIAEVKDYVFINNHDPRLFEGFSMGNPRIQTGNLLVHLKESPTSILIEAEESKIPEIKNMLTHFYADHIEHRRWGAPFPVIEIVKLGINKARDIEQVRQFLNIDRNNIIAFGDEDNDIEMIEYARHGVAMENGLQELKDVANNITFNNNEDGIGRYLNDFFNLNIRYYC,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0874,NE670,NA,conserved hypothetical protein,yitU,5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU,D198G,SAB mortality only,NA,NA,NA,NA
881,MRYKRSEKIVFMTQYLMNHPNKLIPLTFFVKKFKQAKSSISEDVQIIKNTFQKEKLGTVITTAGASGGVTYKPMMSKEEATEVVNEVITLLEEKERLLPGGYLFLSDLVGNPSLLNKVGKLIASIYMEEKLDAVVTIATKGISLANAVANILNLPVVVIRKDNKVTEGSTVSINYVSGSSRKIETMVLSKRTLAENSNVLVVDDFMRAGGSINGVMNLMNEFKAHVKGVSVLVESKEVKQRLIEDYTSLVKLSDVDEYNQEFNVEPGNSLSKFS,2,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0473,NE1237,purR,pur operon repressor,purR,Pur operon repressor,K8R,SAB mortality only,NA,NA,NA,NA
882,MMECIKKIALYMSVLLLIIFIGGCGNMKDEQKKEAQTNKTDSKEEQIKKSFAKTLDMYPIKNLEDLYDKEGYRDGEFEKGDKGMWVLYSSIVSEFKGERLKSRGMVLKLDRNKRTAKGSYIIRELKEDKNHDVQKNEKKYPVKLVNNKIIPTEDVKNEDLKREIENFKLFSQYGEFKSLNTDRITNISYNSNAPNYSAEYKINDDDNNIKQLKNRFNIKSNKNPKLLFKGAGNIKGSSVGYKEIQIIFNRNKEESVSCIDSIEFKPSEGDHNE,0,0,0,1,0,0,0,1,0,0,0,1,NA,NA,NA,NA,NA,putative lipoprotein,S191P,Cell death only,NA,NA,NA,NA
888,MEKIKIIVASDSIGETAELVARAGISQFNPKQCKNELLRYPYIESFEDVDEVIQVAKDTNAIIVYTLIKPEMKQYMSEKVAEFQLKSVDIMGH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1523,NE87,NA,conserved hypothetical protein,yqfL_2,"Putative pyruvate, phosphate dikinase regulatory protein",H93fs,SAB mortality and SAB persistence,NA,NA,NA,NA
890,MKYKTERREAMGYLKRFALYISVMILIFAIAGCGKGNETKEDSKEEQIKKSFAKTLDMYPIKNLEDLYDKEGYRDSEFKKGDKGMWTIYTDFAKSNKPGELDDEGMVLNLDRNTRTAKGHYFVTTFYRNGKLPDEKNYKIEMKNNKIILLDEVKDDKLKQKIENFKFFGQYADFKSLKSYNNGDVSINSNVPSYDAKFKMSNKDENVKQLRSRYNIPTEKAPILKMHIDGDLKGSSVGYKKLEIDFSKEENSELSVVDSLNFQPAKKK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0410,NE1062,-,tandem lipoprotein,lpl2_1|lpl2_3,putative lipoprotein,K268fs,SAB mortality and SAB persistence,NA,NA,NA,NA
896,MMEYIKKIALYMSVLLLIIFIGGCGNMKDEQKKEEQTNKTDSKEEQIKKSFAKTLDMYPIKNLEDLYDKEGYRDGEFKKGDKGTWTILTGFSKSNKPGVLDDEGMVLYLNRNAKKATGYYFVNKVYDDISKNHNEKKYRVELKNNKIVLLDNVEDKKLKQKIENFKFFSQYADFKDLKNYQDGNITTNENVPSYEAQYKMNNSDKNVKKLREIYPITTNNSPNLKLYIDGDIKGSSVGYKKIEYKFSKDKGQETTLRDYLNFGPSEGENVE,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0419,NE1899,-,tandem lipoprotein,lpl2_1,putative lipoprotein,I8fs,SAB mortality and growth rate,NA,NA,NA,NA
897,METLNSINIPKRKEDSHKGDYGKILLIGGSANLGGAIMLAARACVFSGSGLITVATHPTNHSALHSRCPEAMVIDINDTKMLTKMIEMTDSILIGPGLGVDFKGNNAITFLLQNIQPHQNLIVDGDAITIFSKLKPQLPTCRVIFTPHLKEWERLSGIPIEEQTYERNREAVDRLGATVVLKKHGTEIFFKDEDFKLTIGSPAMATGGMGDTLAGMITSFVGQFDNLKEAVMSATYTHSFIGENLAKDMYVVPPSRLINEIPYAMKQLES,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0007,NE1533,-,hypothetical protein,nnrD,ADP-dependent (S)-NAD(P)H-hydrate dehydratase,V251T,SAB mortality and growth rate,NA,NA,NA,NA
898,MVFYNFFKVVINIDIYQHFRQEEYELIDQLTDKCDQAEQHYAPVLTHFLDPRGQYILEVICGSYEDLNVSFYGGPNAERKRAIISPNYYEPKESDFELTLMEIDYPEKFVTLKHQHILGTLMSLGIEREQVGDIIVNERIQFVLTSRLESFIMLELQRIKGASVKLYTIPVTDMIQSNENWKNESATVSSLRLDVVIKEMIRKSRTIAKQLIEKNVLK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1085,NE874,-,hypothetical protein,NA,hypothetical protein,N215fs,SAB mortality and SAB persistence,+,0,+,1
899,MQYEDFKLIVKYRGVGNVSEHVYNLVKKHHSVRKFKNKPLSEDVVKKLVEAGQSASTSSFLQAYSIIGIDDEKIKENLREVSGQPYVVENGYLFVFVIDYYRHHLVDQHAETDMENAYGSTEDLLVGAIDAALVAENIAVTAEDMGYGIVFLGSLRNDVERVREILDLPDYVFPVFGMAVGEPADDENGAAKPRLPFDHVFHHNKYHADKETQYAQMADYDQTISEYYDQRTNGNRKETWSQQIEMFLGNKARLDMLEQLQKSGLIQR,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_0381,NE662,NA,putative NAD(P)H-flavin oxidoreductase,nfrA,NADPH-dependent oxidoreductase,D123G,all,NA,NA,NA,NA
904,MPNVIGVQFQKAGKLEYYTPNDIQVDIEDWVVVESKRGIEIGIVKNPLMDIAEEDVVLPLKNIIRIADDKDIDKFNCNERDAENALILCKDIVREQGLDMRLVNCEYTLDKSKVIFNFTADDRIDFRKLVKILAQHLKTRIELRQIGVRDEAKLLGGIGSCGRSLCCSTFLGDFEPVSIKMAKDQNLSLNPTKISGACGRLMCCLKYENDYYEEVRAQLPDIGEAIETPDGNGKVVALNILDISMQVKLEGHEQPLEYKLEEIETMH,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0462,NE396,NA,conserved hypothetical protein,NA,hypothetical protein,L155F,Growth rate and cell death,NA,NA,NA,NA
905,MTHYKFYEANVETNQVLVFLHGFLSDSRTYHNHIEKFTDNYHVITIDLPGHGEDQSSMDETWNFDYITTLLDRILDKYKDKSITLFGYSMGGRVALYYAINGHIPISNLILESTSPGIKEEANQLERRLVDDARAKVLDIAGIELFVNYWEKLPLFQSQLELPVEIQHQIRQQRLSQSPHKMAKALRDYGTGQMPNLWPRLKEIKVPTLILAGEYDEKFVQIAKKMANLIPNSKCKLISATGHTIHVEDSDEFDTMILGFLKEEQND,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0947,NE28,NA,"hydrolase, alpha/beta hydrolase fold family",menH,"2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase",Y149D,SAB mortality and SAB persistence,NA,NA,NA,NA
909,MKIAYLNDLHIDSWIKFNNNEHKNRKKIEEFINTIFSKSEKECLEAEILVIAGDIPHHNSLSKLTIEVFSKYFNKVYVVLGNHDYYLISKTQMRRYKANSLNRIIELNDMLADNERVVLLHSAVNKVTDIYKGLRIAGCTMTSKPNTEEEISFYNGFMNDSRYIPNKVNDLNSMDMKSYEDIKEFKPDLFISHYPLLMTYSHKLHLHDGSNGSFLCKVDEHIAPINFFGHVHERGDYDIGSSFYTNAIGYKGELSNETIALKVINI,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,P56S,SAB mortality only,NA,NA,NA,NA
910,MNIAKLEDYLQIEPTRYNQPSIEALNYYATRFMLTVPFENIDVQNGKPISVDIDALFNKIVHDKRGGFCYELNTFFKAYLQQKGFNPELMSATIHTPGGGRSLNGSHASLVVSINDVFYVTDVGFGDLPLHVIPITSSEHTQPITDISGTFRAIFNNEDKDIFYVQKFENDHWHTKYEAEFKPKQIEDFNSNIEYNQTNPDSIFVQHLLITMPQSFGRATMSENHLTLTKAKDGISEKLAVTKDNYKHFLEKYFGLDITINRIEKQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2631,NE598,NA,putative N-acetyltransferase,nhoA,Arylamine N-acetyltransferase / N-hydroxyarylamine O-acetyltransferase,G124D,SAB mortality only,NA,NA,NA,NA
911,MYNRLFVSRVILIFALILVIYTPNVLAESQPDPKPDELHKASKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGNYDNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKTNDINSHQTDKRKTCMYGGVTEHNGNHLDKYRSITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNSPYETGYIKFIESENSFWYDMMPAPGDKFDQSKYLMMYNDNKLVDSKDVKIEVYLTTKKK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,entB,Enterotoxin type B,T45N,SAB persistence only,NA,NA,NA,NA
913,MKSIKRIGLCISLLILIIFVTSCDGDNKIIGDSKEEQIKKSFAKTLDIYPIKNLENLYDKEGYRDGEFKKDDKGTWLIRSEMKIQLKGENLESRGAVLEINRNTRTAKGHYIVREVVEDSDGMTHNHTKRYPVKMENNKMIPLKPIDDEKVKKEIEEFNFFVQYGNFKELENYKEDEVSYNPEVPIYSAKYQLKNSDYNVEQLRKRYNIPTQKAPKLLLKGSGNLKGSSVGYKNIEFTFIENKEENIYFTDSIYFNPSEDK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0418,NA,NA,NA,NA,putative lipoprotein,N56D,SAB mortality and SAB persistence,NA,NA,NA,NA
917,MFWACFFFSDCVILSFSDSDSNSDSESDSDSDSDSDSDSDSDSDSDSDTVSVSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSESDSESDSDSDSESDSDSESDSDSDSDSDSDSDSESDSDSESDSDSDSDSDSDSDSRVTPPNNEQKAPSNPKGEVNHSNKASKQHQTDALPETGDKSENTNATLFDAMVALLGSLLLFRKRKQDHKEKA,0,0,1,0,0,0,1,0,0,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,V52G,Growth rate only,NA,NA,NA,NA
918,MGNKYKDYAQDILTAVGGVENIVNVSYDTVRMTIHMHHAIPSTANEVTQIDGVASVDENETQLVIVFNEEVKYVYQQLQLLMDDAKHQEDTNHDAVDTQETEQKAQAKVTTPILVKAPIAGRRILLKEVRDSIFREKMVGEGLAIKAHEESKVIAPFNGLVSMIVPTKHAVGIQSEDGVDIVIHIGVNTVDLEGKGFECFVKQNDRVEAGQTLLQFDQQYIQQQGYNADVIVVISNSADLGKVELTMNEIITTEDVIFKIFKN,0,0,1,1,0,0,1,1,0,0,1,1,NA,NA,NA,NA,ptsG_1|ptsG_3,PTS system glucose-specific EIICBA component,I12T,Growth rate and cell death,NA,NA,NA,NA
919,MNDNFKKQPHHLIYEELLQQGITLGITTRGDGLSDYPKNAFNMARYIDDRPYNITQHQLQLAEEIAFDRKNWVFPIQTHENKVACITKDDIGTNIDTLTDALHGIDAMYTYDSNVLLTMCYADCVPVYFYSTKHRFIALAHAGWRGTYTEIVKEVLKHVNFDLKDLHVVIGPSTSSSYEINDDIKNKFETLPIDSANYIETRGRDRHGIDLKKANAALLIYYGVPKENIYTTAYATSEHLELFFSYRLEKGQTGRMLAFIGQQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1081,NE684,NA,conserved hypothetical protein,NA,Polyphenol oxidase,R135H,SAB mortality only,NA,NA,NA,NA
921,MNYLNKIRIENPLTICYTNDVVKNFTANGLLGIGASPAMSEAPEEAEEFYKVAQALLINIGTLTAENEQDIIAIAQTANEAGLPIVFDPVAVGASTYRKQFCKLLLKSAKVSVIKGNASEILALIDDTATMKGTDSDANLDAVAIAKKAYATYKTAIVITGKEDVIVQDNKAFVLANGSPLLARVTGAGCLLGGVIAGFLFRETEPDIEALIEAVSVFNIAAEVAVENENCGGPGTFSPLLLDTLYHLNETTYQQRIRIQEVE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2048,NE1473,thiM,hydroxyethylthiazole kinase,thiM,Hydroxyethylthiazole kinase,G32S,SAB mortality and SAB persistence,NA,NA,NA,NA
926,MTTFDAKKLKKEYLDWYNQTLEFSNLSNNVVRIDTPFKDNSLDNLIIYALYDQSRDMITLTDDGYTIFDLENNGISLNKSKKRKKIFEEHLSAYGIKYNDKTTEIFVQTNFKNFNKSKHNLLQCLIFVNDMYLLSNPKSQNIFTEDVANKLDEHNIYYGRDLPIIGSSGVVHNFDFFISAKKNQKEKFINAISNPNNSMIIKSKITDKVRIIV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1771,NE69,NA,conserved hypothetical protein,NA,hypothetical protein,T103H,SAB mortality only,NA,NA,NA,NA
930,MNAVFILALLLLFLMIIFGGKKGFISYLTLFLNFAILIISIVLIIFGVPIYVVTFFFCIIIGACNLFVLNSYNVKTQAAFISTIVTTILLITLIYLSVYFGHLQGFSTEQQDETYVYSMNIGIDMVQFMVFTIILAVIAAVIDLTITISSPIYELHQVNPTLTQYELFQSGMRVGREILATSANTIYLAFFGGQLALFIWFFKLKYSFGHIINSKIFAQEFISIILGGIAVAISIPITVWITAFLIKRPSRQRKNDESIN,2,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0442,NE1328,-,hypothetical protein,NA,hypothetical protein,V239A,SAB mortality and SAB persistence,NA,NA,NA,NA
931,MKITNIRLKSANKKSVKKLYFLEGIDAIEKIENNYEKKFF,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,S15fs,SAB mortality and SAB persistence,NA,NA,NA,NA
932,MKIFICEDDPKQRENMVTIIKNYIMIEEKPMEIALATDNPYEVLEQAKNMNDIGCYFLDIQLSTDINGIKLGSEIRKHDPVGNIIFVTSHSELTYLTFVYKVAAMDFIFKDDPAELRTRIIDCLETAHTRLQLLSKDNSVETIELKRGSNSVYVQYDDIMFFESSTKSHRLIAHLDNRQIEFYGNLKELSQLDDRFFRCHNSFVVNRHNIESIDSKERIVYFKNKEHCYASVRNVKKYNKIIKSVNGVFNCKSCWILTR,4,5,1,1,1,1,1,1,4,4,1,1,SAUSA300_1992,NE1532,agrA,accessory gene regulator protein A,agrA,Accessory gene regulator protein A,Y238fs|I26T|K7E|M88T|T88M|T26I,all,NA,NA,NA,NA
939,MGTLIKQECFKLFKKKSTFIAPIVFILLMVAQGYIATKYNEIFTPQESFTSAYNGFSWFAFLLIIQASTIISMEFHYGTIKNLLYREYSRTTMIVSKIITLFIISLIYFVITIIASIVIGSLFFNDLNIFESSGNQLSLLNQLLLVSLGTFVGVWLVLSLTLLLSSATNSTGVAIAVGIVFYFASSILAVIQTALLEKIDWLKWNPINMMNIMLQTVEKGFSKSTKLELHELFIGNIAYISIFLILVVFIFNKKNIY,1,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_2454,NE854,-,membrane spanning protein,NA,hypothetical protein,Y257*|N252K,SAB mortality only,NA,NA,NA,NA
940,MMKRLNKLVLGINILFLVISITAGCGMGKEAEIKKSFEKTLSMYPIKNLEDLYDKEGYCDDQFDKNDKGTWIVRSSMSIQPNGKDMNVKGMVLYMNRNSRTTNGYYYVDVIERQDKGIHRDNEKKYPVKMVDNKIIPTKDIKDENIKKEIENFKFFAQYGSFKDLSKYKDGDISYNPEVPSYSAKYQLTNDDYNVKQLRKRYDIPTNKAPKLLLKGTGNLKGSSVGYKDIEFTFVEKKGENIYFSDSLHLEPSEDK,1,1,0,1,1,1,0,1,1,1,0,1,NA,NA,NA,NA,NA,putative lipoprotein,I14L,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
942,MKLFAFIFICVKSCSLLFMLNGNPKPEQLNKASEFTGLMDNMRYLYDDKHVSETNIKSQEKFLQHDLLFKISGSKILKTEFNKKSLSDKYKNKNVDLFGTNYYNQCYFSSDNMELNDGRLIEKTCMYGGVTEHDGNQIDKNNSTDNSHNILIKVYENERNSLSFDIPTNKKNITAQEIDYKVRNYLLKHKNLYEFNSSPYETGYIKFIEGSGHSFWYDLMPESGKKFYPTKYLLIYNDNKTVESKSINVEVHLTKK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,entC3,Enterotoxin type C-3,K83N,SAB mortality only,NA,NA,NA,NA
943,MIDIHNHILVDIDDGPKKIEKSIALLKQAKDEGVTSIVATPHHLHPRYDNTFQQVLVKLAELRTHPEVQALDIKLFPGQEIRITDSILQGLDNGSIQGINRSKYLLIEFPTGEVPHYTKQLFFEIQSRGYIPIIAHPERNRSIAKNPEILYELVANGALSQLTSSSLVGGFGKNIQKLSLQFIECNLAHFVASDAHSCDQRPFLMQELFHNHKLKKYSNDIEALLRNASSVINDNFVYLDRPTKPGKVKSFLKWF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2596,NE774,cap1C,capsular polysaccharide biosynthesis protein Cap1C,ywqE_2,Tyrosine-protein phosphatase YwqE,K18T,SAB mortality and SAB persistence,NA,NA,NA,NA
945,MLNVLLLILNLIAICSVNNAYANEEDPKIESLCKKSSVDPIALHNINDDYINNRFTTVKSIVSTTEKFLDFDLLFKSINWLDGISAEFKDLKVEFSSSAISKEFLGKTVDIYGVYYKAHCHGEHQVDTACTYGGVTPHENNKLSEPKNIGVAVYKDNVNVNTFIVTTDKKKVTAQELDIKVRTKLNNAYKLYDRMTSDVQKGYIKFHSHSEHKESFYYDLFYIKGNLPDQYLHIYNDNKTIDSSDYHIDAYLFT,0,1,1,1,0,1,1,1,0,2,2,2,NA,NA,NA,NA,entD,Enterotoxin type D,A250V|H233Q,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
948,MFLDEHINRNFDKLNDNDLHIAHFINTHIDECKNMKIQDLAQFTHASNATIHRFTRKLGFDGYSDFKSYLKFESNKTHQLPSNSIDSFKQEIDSTFSYLERVDYQLLTKKMHTASTIYLYGTGRAQLNVASEAQRILLTLHNHVIVLHDEHELKMILNKSEPNDLFFIISLSGETHELLEVTNLLQLRQKYFISVTTMKDNTLAQKANYNVYVPSNTFYLTDGTDYSSFISYHIFFETLVRKYNEYLLHNDISN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2271,NE434,NA,phosphosugar-binding transcriptional regulator,glvR,HTH-type transcriptional regulator GlvR,P214S,SAB mortality and SAB persistence,NA,NA,NA,NA
949,MDINSEEYKQEVLIKDVVMLAARILLESGAEGTRVEDTMTRIAKKLGYSESNSFVTNTVIQFTLHSESFPRIFRITSRDTNLIKISQANKISRQITNNEISLAEAKTQLEKIYVAKRDSSLPFKGFAAAMIAMSFLYLQGGRLIDVLTAILAGSLGYLVTEILDRKLHAQFIPEFIGSLVIGIIAVIGHTLIPTGDLATIIIAAVMPIVPGVLITNAIQDLFGGHMLMFTTKSLEALVTAFGIGAGVGSVLILV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0568,NE1780,-,hypothetical protein,NA,hypothetical protein,K45fs,SAB mortality only,NA,NA,NA,NA
953,MSKEAGHTFLAKLGKTRLRPGGKEATDWLIQQGAFSQDKQVLEVACNMCTTSIYLAHTYGCHIQGVDINKKALEKAQENISAAGLESYIQVQQANAVKLPFDDNQFDIVLNEAMLTMLPIAIKEKALREYYRVLKPGGILLTHDIVIVNESHATHVVKSLSAAINVNVSPQTKLGWLDLYHQAGFNHVHYHTGPMSLMTPKGLIYDEGIVGTIKIINNALKKENRPMFCKMFKTMTKLRKDMNYITFVAKKEH,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0261,NE553,NA,conserved hypothetical protein,COQ5_1,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial",M1?,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
955,MIVKTEEELQALKEIGYICAKVRNTMQAATKPGITTKDLDNIAKELFEEYGAISAPIHDENFPGQTCISVNEEVAHGIPSKRVIREGDLVNIDVSALKNGYYADTGISFVVGESDDPMKQKVCDVATMAFENAIAKVKPGTKLSNIGKAVHNTARQNDLKVIKNLTGHGVGLSLHEAPAHVLNYFDPKDKTLLTEGMVLAIEPFISSNASFVTEGKNEWAFETSDKSFVAQIEHTVIVTKDGPILTTKIEEE,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1869,NA,NA,NA,map_3,Methionine aminopeptidase,G242C,SAB mortality only,NA,NA,NA,NA
956,MKGQHFIVTGGTSGLGLSIVRKLLENKVHVTLLVRDVDKATRIFEQELGKTINVIPCDLNDLKSIQALQFEDNTSFDGFIYSAGLGYFKSISDHSFSEMIETYQLNLISFNVLYTVLRPYLTSNAHIVGISSQAAFSTQANAAHYGASKAGFYALMNALRLESPNLHIMTVNVGPIDTPFHQKADPSMKYAKKMGEIMLDANQLAEDIIYGIKTKQLEINRPKWMYHALKMYQIAPRFFERCFPKLFKNKA,2,1,1,0,1,1,1,0,2,1,1,0,SAUSA300_1451,NE903,-,short chain dehydrogenase/reductase family oxidoreductase,NA,putative oxidoreductase,P244L|G129_Q130insISS,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
960,MQALQTKSNIGEMFNIQEKENGEIAISGRELHQALEVKTPYKKWFERMSDYGFEENIDYVVTDIFVHNPLGGRQNQTDHALTLDTAKEIAMIQRSEPGKRARQYFIQIEKAWNSPEMIMQRALKIANNTINQLETKIERDKPKIVFADAVAITKTSILVGELAKIIKQNGINIGQRRLFEWLRQNGFLIKRKGVDYNMPTQYSMERELFEIKETSITHSDGHTSISKTPKVTGKGQQYFVNKFLGEK,0,0,1,0,0,0,1,0,0,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,I152T,Growth rate only,NA,NA,NA,NA
963,MRQKGIIIKAVDYGESDKIITILNEHGAKVPLMARRAKKVKTGLQAQTQLFVYGLFIYNQWRGMGTLNSVDVISQHYKLQMDLYVSSYAALAAETIERSMDEGDIAPYNYQLLQFVLEKIESGTSAQLMSVVVMLKCMKRFGFTASFNRCAVSGNDTQADLIGYSFKFDGAISRQEASKDLHAVILSNKTLYLLDVLQKLPIDKMNSLNIHQEIIDEMSDIILMLYREYAGMFFKSQKLINQLKRLEQ,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_1526,NA,NA,NA,recO,DNA repair protein RecO,L181V,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
964,MDYQTFEKVNKFINVEAYIFFLTQELKQQYKLSLKELLILAYFYYKNEHSISLKEIIGDILYKQSDVVKNIKSLSKKGFINKSRNEADERRIFVSVTPIQRKKIACVINELDKIIKGFNKERDYIKYQWAPKYSKEFFILFMNIMYSKDFLKYRFNLTFLDLSILYVISSRKNEILNLKDLFESIRFMYPQIVRSVNRLNNKGMLIKERSLADERIVLIKINKIQYNTIKSIFTDTSKILKPRKFFF,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_2438,NE96,sarU,staphylococcal accessory regulator U,sarU,HTH-type transcriptional regulator SarU,G78fs,all,NA,NA,NA,NA
965,MLEAQFFTDTGQHRDKNEDAGGIFYNQTNQQLLVLCDGMGAGEVASKFVTDELKSRFEAENLIEEHQAENWLRNNIKDINFQLYHYAQENAEYKGMGTTCVCALVFEKSVVIANVGDSRAYVINSRQIEQITSDHSFVNHLVLTGQITPEEAFTHPQRNIITKVMGTDKRVSPDLFIKRLNFYDYLLLNSDGLTDYVKDNEIKRLLVKEGTIEDHGDQLMQLALDNHSKDNVTFILAAIEGDKV,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_1112,NE1919,NA,protein phosphatase 2C domain-containing protein,stp,Serine/threonine phosphatase stp,G40_A41insGHK,all,-,0,-,0
967,MTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAVKQSDFPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,knt,Kanamycin nucleotidyltransferase,F195L,SAB mortality and SAB persistence,NA,NA,NA,NA
970,MIKIQQLQHHFGSHKVIHNFNLDISKGEIITFIGKSGCGKSTLLNIIGGFIHPSSGRVIIDNEIKQQPSPDCLMLFQHHNLLPWKTINDNIRIGFQQKISDEEINAQLKLVDLEGRGKHFPEQLSGGMKQRVALCRAHVHKPNVILMDEPLGALDAFTRYKLQDQLVQLKHKTESTIILVTHDIDEAIYLSDRIVLLGEGCNIISQYEITASHPRSRNDSHLLKIRNEIMETFALNHHQVEPEYYL,3,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_0174,NE1311,-,hypothetical protein,nrtD,Nitrate import ATP-binding protein NrtD,I30V|V30I,all,NA,NA,NA,NA
971,MEQITSAQNNRIKQANKLKKKRERDKTGLALIEGVHLIEEAYQSGIVITQLFAIEPERLDQQIIAYAQEVFEINMKVAESLSGTVTPQGFFAIIEKPHYDISKAQQVLLIDRVQDPGNLGTLIRTADAAGMDAVIMEKGTTDPYQDKVLRASQGSVFHLPVMTQDLDTFITQFNGPVYGTALENAVAYKEVTSSDSFALLLGNEGEGVNPELLAHTTQNLIIPIYGKAESLNVAIAGSILLYHLKG,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1036,NE507,NA,"RNA methyltransferase, TrmH family",rlmB,23S rRNA (guanosine-2'-O-)-methyltransferase RlmB,E57A,SAB mortality and SAB persistence,NA,NA,NA,NA
974,MENEKKKYTFKDIAWRDLLIIPIIGVIFYALTIAAYIGPILFGYYEIDSNLIFVATITQALAYTIGIGAFYLFHLKVMPSRLRAGFAYIKKYWLRLSITYIIALILIYTYEYMTQFLPKHLQYSETANELELNKMFEVPAFLPVAFLLIVIVGPIVEEIVFRHILIGELGKKFNFIAMSIVSVFLFAFIHVTDAKSPFEFGPYLILSIILVFTYLKSGRNLGSTIALHIANNFVSFVISVISIYA,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2262,NE762,NA,putative membrane protein,NA,hypothetical protein,A84S,SAB mortality and growth rate,NA,NA,NA,NA
977,MEDFKLEMLGFGSAFNSVEYGNTSGYFESDDSIYIIDCGSTVFNEILRRKLDLSKTINLIITHTHTDHIGSVGTFVEYSYFALGNKLDIFCAKEIESSLITILLASGVTNEMFNIHSHHNNTLDIDEIIYITFYEVNHVDTLKAFAVVLEETENDRQLIYSGDINNYDDLKEMFISMIYKNVSSIYLDFSLNNSPVHENSLENLEQIVELFENSNIYLMHLDNTIEEYEWNLRKHYSDKKVKVAK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,rbn,Ribonuclease BN,Y130N,SAB mortality only,NA,NA,NA,NA
979,MTFGEILKKERVSWKLSVKELSTLSGVSQTYISKLENGKRNFPSLETIFNLLIGFKTHIEYKMGSESPFYEINNSYLDEILIMFINSSNCTISDRDPNELITQFNEYYDVTIKKKQNENSKIESDIFSNKIKLVKGTTKKEVIEKPYFDLNWLLTQNEYEVFFDRSFLLDNNFLNKKHFTEKDMYYYNVLNDNDLKTIKDLIVVFLLNKYNYIKNKDDFFNIFTNSEDDKTKRDALYKILYETD,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,C90S,SAB persistence only,NA,NA,NA,NA
984,MAKQKKFMKIYEALKEDILNGQIQYGEQIPSEHDLVQLYQSSRETVRKALDLLALDGMIQKIHGKGSLVIYQEVTEFPFSELVSFKEMQEEMGVAYLTEVVVNEVVEAHEVPEVQHALNINSSESLIHIVRTRRLNQHVKIVDEDYFLKSIVSDIGNDVASDSIYDYLEKVLNLNISYSSKSITFEPFDEQEYQLFGDVSVAYSATVRSIVYLENTMPFQYNISKHLANEFKFNDFSRRRIK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0450,NE1687,treR,trehalose operon repressor,treR_2,HTH-type transcriptional regulator TreR,E192A,SAB mortality and growth rate,-,0,-,0
987,MKKLISILLINIIILGVSNNASAQGDIGIDNLRNFYTKKDFVDLKDVKDNDTPIANQLQFSNESYDLISESKDFNKFSNFKGKKLDVFGISYNGQCNTKYIYGGVTATNEYLDKSRNIPINIWINGNHKTISTNKVSTNKKLVTAQEIDVKLRKYLQEEYNIYGHNGTKKGEEYGHKSKFYSGFNIGKVTFHLNNNDTFSYDLFYTGDDGLPKSFLKIYEDNKTVESEKFHLDVDISYKETI,3,2,0,0,1,1,0,0,4,2,0,0,SAUSA300_0800,NE1255,sek,enterotoxin K,NA,hypothetical protein,V17I|D40fs|C16G,SAB mortality and SAB persistence,NA,NA,NA,NA
988,MNQFRLEELCKQLRLPHLPLAVDNDSFETKEEWLMNLLENELTCREELKMARLYRQAKFPVRRTLDNYEWHDHIAIPNETTKDELISLSFIRQKENAVFVGTPGTGKTHLACALGQMATKVGIETRFWRVSDLVSELERQWKSNTLGAFKHRFDKVKLIILDEMGYVPFTKEGAELLFQLISDWYETKSIIVTSNLEFSQWNKVFIDTRLTAALVDRLIHHAHIISFTGESFRLKNALSKIK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,IS21 family transposase ISCth9,S231N,SAB persistence only,NA,NA,NA,NA
989,MVKMFLNLNSEQQHALDAAKQAFGPMLEGLVKYSIPITLVTFVLGLIIALFTALMRISTSKILRSISRVYVSIIRGTPMIVQLFIIFYGIPELGRLLTNDADNQWTLAPVVAAIIGLSLNVGAYASEIIRGGIISIPKGQTEAAYSIGMTYGQTIQCIILPQAIRVSIPALGNTFLSLIKDTSLLGFILVAEMFRKAQEVASTTYEYLTIYVLVALMYWVVCFIISIIQGIYESYIERGYRS,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2358,NE1774,-,ABC transporter permease,tcyB,L-cystine transport system permease protein TcyB,C157R,SAB mortality and SAB persistence,NA,NA,NA,NA
990,MKKNIMNKLVLSTALLLLGTTSTQLPKTPISFSSEAKAYNISENETNINELIKYYTQPHLSLSNKWLWQKPNGSIHATLQTWVWYSHIQVFGSESWGNINQLRNKYVDIFGTKDEDTVEGYWTYDETFTGGVTPAATSSDKPYRLFLKYSDKQQTIIGGHEFYKGNKPVLTLKELDFRIRQTLIKNKKLYNGEFNKGQIKITADGNNYSIDLSKKLKLTDTNRYVKNPKNAQIEVILEKSN,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1061,NE1194,-,superantigen-like protein,NA,Superantigen-like protein 13,S209T,Growth rate and cell death,+,3,+,0
991,MNNNITKKIILSTTLLLLGTASTQFPNTPINSSSEAKAYYINQNETNVNELTKYYSQKYLTFSNSTLWQKDNGTIHATLLQFSWYSHIQVYGPESWGNINQLRNKSVDIFGIKDQETIDSFALSQETFTGGVTPAATSNDKHYKLNVTYKDKAETFTGGFPVYEGNKPVLTLKELDFRIRQTLIKSKKVYNNSYNKGQIKITGADNNYTIDLSKRLPSTDANRYVKKPQNAKIEVILEKSN,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_1060,NE475,NA,putative exotoxin 4,NA,Superantigen-like protein 13,V189L,Cell death only,NA,NA,NA,NA
992,MTRKVFVVPDIHGEYDKLLRLMDKILDKRTNDDLIIFLGDYIDRGKQSNRVINYIFNLKSNDDNIITLLGNHDMAFWESMRSIETLDIYGVEWFARYCIETLEAYQIDTKPLKSFEEDNQMFYTEYFKKFVEEVKALKKTEEYRKFDILMCNSKLYHREGNTYLLILVAFIIKM,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,apaH,"Bis(5'-nucleosyl)-tetraphosphatase, symmetrical",N161fs,SAB mortality and SAB persistence,NA,NA,NA,NA
998,MNKNIVIKSMAALAILTSVTGINAAVVEETQQIANAEKNVTQVKDTNIFPYNGVVSFKDATGFVIGKNTIITNKHVSKDYKVGDRITAHPNGDKGNGGIYKIKSISDYPGDEDISVMNIEEQAVERGPKGFNFNENVQAFNFAKDAKVDDKIKVIGYPLPAQNSFKQFESTGTIKRIKDNILNFDAYIEPGNSGSPVLNSNNEVIGVVYGGIGKIGSEYNGAVYFTPQIKDFIQKHIEQ,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1756,NE1098,splC,serine protease SplC,splC,Serine protease SplC,G221D,SAB mortality and growth rate,NA,NA,NA,NA
999,MNKNIIIKSIAALTILTSITGVGTTVVDGIQQTAKAENSVKLITNTNVAPYSGVTWMGAGTGFVVGNHTIITNKHVTYHMKVGDEIKAHPNGFYNNGGGLYKVTKIVDYPGKEDIAVVQVEEKSTQPKGRKFKDFTSKFNIASEAKENEPISVIGYPNPNGNKLQMYESTGKVLSVNGNIVSSDAIIQPGSSGSPILNSKHEAIGVIYAGNKPSGESTRGFAVYFSPEIKKFIADNLDK,0,1,0,0,0,1,0,0,0,2,0,0,SAUSA300_1753,NE1764,splF,serine protease SplF,splF,Serine protease SplF,V26M|D28E,SAB persistence only,NA,NA,NA,NA
1000,MEHNNNINKKYKKFSRGSIIYLDFGINIGHEFSGRHFGIVLNKNDSPYNSLVTVVPLSSKNKKHYLPLQNIVFKTSLSILNKTVDNIEFDLDVINHVIFTVIEIINKNNLQNTLEQDTIDYLDDFAIKTRFPTEREVINKSKNIVESFNLYNDPKNFSALFNYLLIDVNDRKSNVNNLREVINKYKKFDKNTFACTQNVVTISKLRILKINAEDPSGRMKLDFDSMKLVDNEIKNKLIN,1,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,D117N|H6D,SAB mortality only,NA,NA,NA,NA
1001,MTVEWLAEQLKEHNIELTETQKQQFQTYYRLLVEWNEKMNLTSITDEHDVYLKHFYDSIAPSFYFDFNQPISICDVGAGAGFPSIPLKIMFPQLKVTIVDSLNKRIQFLNYLASELQLQDVSFIHDRAETFGKGVYRESYDVVTARAVARLSVLSELCLPLVKKGGQFVALKSSKGEEELEEAKFAISVLGGNVTETHTFELPEDAGERQMFIIDKKRQTPKKYPRKPGTPNKNPLLEK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2644,NE249,NA,glucose-inhibited division protein B,rsmG,Ribosomal RNA small subunit methyltransferase G,N234T,SAB mortality and SAB persistence,NA,NA,NA,NA
1002,MRIERVDDTTVKLFITYSDIEACGFSREDLWTNRKRGEEFFWSMMDEINEEEDFVVEGPLWIQVHAFEKGVEVTISKSKNEDMMNMSDDDATDQFDEQVQELLAQTLEGEDQLEELFEQRTKEKEAQGSKRQKSSARKNTRTIIVKFNDLEDVINYAYHSNPITTEFEDLLYMVDGTYYYAVYFDSHVDQEVINDSYSQLLEFAYPTDRTEVYLNDYAKIIMSHNVTAQVRRYFPETTE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0899,NE1315,-,adaptor protein,mecA_1,Adapter protein MecA,C23R,SAB mortality and SAB persistence,NA,NA,NA,NA
1003,MDKKELAKFIGNKIRYYRTKLNLTQDQLGEKLNTKKATISNYETGYRTPKQDDLFEIAHILNISIDDLFPTRNNKKNDITSIYSKLTPPRQKNVLNYANEQLDEQNKVTSIDEYKESKLVSYIACGATGAGIGEELYDDILHEEVFFKEDETPSNADFCILVNGDSMEPMLKQGTYAFIKKEDSIKDGTIALVVLDGVSLIKRVDICEDYINLVSLNPKYDDIKVASFSNIKVMGKVVL,1,1,0,2,1,1,0,1,1,1,0,1,NA,NA,NA,NA,lexA_3,LexA repressor,E113G,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1004,MRINDKILLENIEDYFNHKGLSPHLIDDIKEKVITDIKNSEKKDQDYIEYKRKSPAQIILMIQRNLFALQMNPVIFFIINFILISYLYDKQYVQFQAITGMSLFYCLVIFPMTIFVYLRVSQKNYLRSNKIEMIMGTIIAIISLLLIILQAFNITWGVIPITNFGHQFFFFIGIILVIAGIFYKRLEFSGIGLLFCQKTVDAMIHNPQSAQIFSLIIWILLVVLVIYFTIRLSSRTRL,0,1,0,1,0,1,0,1,0,1,0,1,SAUSA300_0603,NE1358,NA,conserved hypothetical protein,NA,hypothetical protein,F115V,SAB persistence and cell death,NA,NA,NA,NA
1009,MKILRYIGYLLLGGLVGGIIGGILGNFDGFGIENLTFATYNNVVVISIVATIIIILVEAIVLMNQRRALKYKQLVDKEVDIDATDQYELLANRYVLNGSILSILQTVIAFLVLLIFVVGHAAANAILFFLIPFFASAIFNTQFTLFNRRFDDRIPKIADKNYTEKRLEILDEGERHIELIALFKTYAINLSILILAIVVIGLYSITTGINQSFSLLLIIAIFIYNAFSYLLKRRRFY,1,0,0,1,1,0,0,1,1,0,0,1,SAUSA300_0351,NE156,NA,putative membrane protein,NA,hypothetical protein,S102R,SAB mortality and cell death,NA,NA,NA,NA
1014,MIINELKSCKLKFSKQALTFVPIIVPIIVTILFILFINWYLNVNLWNGRQISLFTASFNAITSLLISINVYQVINFEENIGHFNHILGKANRLNWLNASMIFTYTITAICILLASINLLWHSHDMKITLMFIGVSLFFNVIILLLLFIFSIFIKDVMAIVVGVLMFIFNVYFGLEVLGDHSWFYLPITYATRYVYMFIEGSIPVTLTLAIYIIITLLLAVLLFKGFNKWSGRTIKD,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1760,NE617,epiG,lantibiotic epidermin immunity protein F,NA,hypothetical protein,P26_V29del,SAB mortality only,NA,NA,NA,NA
1016,MTLLYEGKAKRIFSTNQENELRVEYKDEVTAGNGAKKDTMAGKGRLNNQITSIIFKYLQENGIESHFIKQLSETEQLVKPVKIIPLEVVVRNIASGSITKRLGFENGEVFREPLVEFFYKNDALNDPLITDDHVKLLNIASDEDIEILKSKALKINNVLKQLMDAMNLKLVDFKIEFGKIETGQILLADEISPDTCRIWDKATNANFDKDVYRNNTGSLIETYQIFLNKLEDLK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0968,NE950,NA,phosphoribosylaminoimidazole-succinocarboxamide synthase,purC,Phosphoribosylaminoimidazole-succinocarboxamide synthase,I180T,SAB persistence only,NA,NA,NA,NA
1017,MERNSTKKSSKDKILKAVNNFEEVCNSGKFKFKYLDDWLFTKSIIFKNETTLTNQKNFKVYPRGTIVYAKLGVNIGSEFSGNHFCVVLNKNDNKRNELITIVPLTSKDTKFSLKLQKNLILKALEKMKTDHKTLRFDLDRIKEMHARSTKVKNLNPAIEKELDEIENNYMQLAKIIERYERFVGKQTYAIPSQVITISKKRISTLNDYDPTGHISFNEETLKIIEDFMKANILS,3,1,0,3,1,1,0,1,2,2,0,2,NA,NA,NA,NA,NA,hypothetical protein,K117E|N57fs|K57fs,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1018,MTKIVLITGGNKGLGYASAEALKALGYKVYIGSRNDVRGQQASQKLGVHYVQLDVTSDYSVKNAYNMIAEKEGRLDILINNAGISGQFSTPSKLTPRDVEEVYQTNVFGIVRMMNTFVPLLEKSEQPVVVNVSSGLGSFGMVTNPETAESKVNSLAYCSSKSAVTMLTLQYAKGLPNMQINAADPGATNTDLVGDFSNNSKHVSEGIKPIIQLATIDADGPTGTFINGNGEMPW,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2516,NE1527,-,short chain dehydrogenase/reductase family oxidoreductase,cpnA,Cyclopentanol dehydrogenase,W234*,SAB mortality only,NA,NA,NA,NA
1020,MIELKHVTFGYNKKQMVLQDINITIPDGENVGILGESGCGKSTLASLVLGLFKPVKGEIYLSDNAVLPIFQHPLTSFNPDWTIETSLKEALYYYRCLTDNTAQDQLLLQHLSTFELNAQLLTKLPSEVSGGQLQRFNVMRSLLAQPRVLICDEITSNLDVIAEQNVINILKVQTITNLNHFIVISHDLSVLQRLVNRIIVLKDGMIVDDFAIEELFNVDRHPYTKELVQAFSY,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1273,NE1609,opp-2F,"oligopeptide permease, ATP-binding protein",nikE,Nickel import system ATP-binding protein NikE,V172A,SAB mortality and SAB persistence,NA,NA,NA,NA
1021,MKKTIMASSLAVALGVTGYAAGTGHQAHAAEVNVDQAHLVDLAHNHQDQLNAAPIKDGAYDIHFVKDGFQYNFTSNGTTWSWSYEAANSQTAGFSNVAGADYTTSYNQGSNVQSVSYNAQSSNSNVEAVSAPTYHNYSTSTTSSSVRLSNGNTAGATGSSAAQIMAQRTGVPASTWAAIIARESNGQVNAYNPSGASGLFQTMPGWGPTNTVDQQINAAVKAYKAQGLGAWGF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2506,NA,NA,NA,isaA,putative transglycosylase IsaA,S89G,SAB mortality and SAB persistence,NA,NA,NA,NA
1028,MTSLIIAEDQNMLRQAMVQLIKLHGDFEILADTDNGLDAMKLIEEYNPNVVILDIEMPGMTGLEVLAEIRKKHLNIKVIIVTTFKRPGYFEKAVVNDVDAYVLKERSIEELVKTINKVNNGEKEYSATLTTSFFVDKNPLTPKEQIVLREIGNGLSSKEISEKLFLTDGTVRNYTSVIIDKLFADNRFDAWKKANEKGWI,1,1,0,0,1,1,0,0,1,2,0,0,SAUSA300_1220,NE262,NA,"DNA-binding response regulator, LuxR family",desR,Transcriptional regulatory protein DesR,T130M|S59G,SAB mortality and SAB persistence,NA,NA,NA,NA
1033,MKSTAQLTKENNVKSLRLSNTDREIFENYMTYMRSDFRVNPHDTELIINRILKQLLSAEQHGLLALDFFNHDPKAHAIKELKAMPNETFKNIFKYIYQHIVLLIGIVSFLKGFLGFFMEKNGSNLYFVSFPFSVVVGFFIVFLFIWFSFKTIQLQCFNNSNWIWIFTYLAIILLIVGFFYVFFIPQSLLAFGPYIQVSNWVFIIFSFIVMPNGLRIERNISKKHSHTFL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0661,NE203,NA,conserved hypothetical protein,NA,hypothetical protein,N212I,SAB mortality only,NA,NA,NA,NA
1035,MGYKNILIDFDDTIVDFYDAEEWAFHYMANVFNHKATKDDFLTFKKINHQHWEAFQQNKLTKSEVLSERFVNYFKHHQMEVDGHRADVLFRNGLAEAKVKYFDQTLETIVELSKRHDLYIVTNGVTETQKRRLNQTPLHKYIKKIFISEETGYQKPNPEFFNYVFNDIGEDERQHSIIVGDSLTSDILGGINAGIATCWFNFRGFDHNPGIIPDYEINSWKQLNDIVR,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1069,NE1715,-,hypothetical protein,yfnB,Putative HAD-hydrolase YfnB,L1?,SAB mortality and SAB persistence,NA,NA,NA,NA
1037,MIGIIGAMEEEVTILKNKLTQLSEISVAHVKFYTGILKDREVVITQSGIGKVNAAISTTLLINKFKPDVIINTGSAGALDESLNVGDVLISDDVKYHDADATAFGYEYGQIPQMPVAFQSSKPLIEKVSQVVQQQQLTAKVGLIVSGDSFIGSVEQRQRIKKAFPNAMAVEMEATAIAQTCYQFNVPFVVVRAVSDLANGEAEMSFEAFLEKAAVSSSQTVEALVSQL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1558,NE714,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,R159K,SAB persistence only,NA,NA,NA,NA
1038,MRIFITSTNTDVGKTYVTKHLYHALKTRGHRVCIFKPFQTEERQDGTFPDLEVFKNECDLSYDITSLYTFKQPVSPHLAFKMADQIFLNKQRVLDKVKVLDKEFDFILVEGAGGIGVPIYEDTDDFYMTKDLINDCADCVISVLPSKLGAISDAIVHQDYVNQNVSVNNFLIMNRYTDSYIEKDNQMTIEKLTNKTVYTFEEHATYENFSEAFLKQLIGVKNELHTTT,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2373,NE777,bioD,dethiobiotin synthase,bioD,ATP-dependent dethiobiotin synthetase BioD,Q186*,SAB mortality only,NA,NA,NA,NA
1040,MKFTALAKATLALGILTTGTLTTEVHSGHAKQNQKSVNKHDKEALYRYYTGKTMEMKNISALKHGKNNLRFKFRGIKIQVLLPGNDKSKFQQRSYEGLDVFFVQEKRDKHDIFYTVGGVIQNNKTSGVVSAPILNISKEKGEDAFVKGYPYYIKKEKITLKELDYKLRKHLIEKYGLYKTISKDGRVKISLKDGSFYNLDLRSKLKFKYMGEFIESKQIKDIEVNLK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0404,NE59,NA,exotoxin,NA,Staphylococcal superantigen-like 10,F213V,SAB persistence only,NA,NA,NA,NA
1042,MKNILKVFNTTILALIIIIATFSNSANAADSGTLNYEVYKYNTNDTSIANDYFNKPAKYIKKNGKLYVQITVNHSHWITGMSIEGHKENIISKNTAKDERTSEFEVSKLNGKIDGKIDVYIDEKVNGKPFKYDHHYNITYKFNGPTDVVGANAPGKDDKNSASGSDKGSDGTTTGQSESNSSNKDKVENPQTNAGTPAYIYAIPVASLALLIAITLFVRKKSKGNVE,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1030,NE557,NA,iron transport associated domain protein,isdC,Iron-regulated surface determinant protein C,V149A,SAB mortality and growth rate,NA,NA,NA,NA
1043,MFLCKRQIDINARFGLPRIAFMSAVATIIMFLVSYEVMYFLSNTPLSDRHFLIFLLLVFMTYPLHKSIHLLFFLPYRKSFKVHKLTKRKWLIFYNTYVNQPVHKFYFCINLILPLIILSAMFVYLTISFPQYGHYFMFLLALNFGISITDLLYLKIIIFSNYGQYIEEHSTGINILKKLKIHIIYNKIIIARCYYLFLGYVIAYNQMYIDLVFLFSSISTPKPNALV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1789,NE1897,-,hypothetical protein,NA,hypothetical protein,L179fs,SAB mortality only,+,0,-,0
1047,MSFSFLFILTAGMVAAFNPCGIALLPSYISYLIGGETKDHSFRYAIFKGLGLGGAMTTGFLTIFVLAGLLIGGLGSALTGIFPILSLVMGILIALLGLGMLFGKHLPIKIGSFQVKPGKWSIYFYGIAYAVTSLGCTLPAFMLVVSASLNDNSVTAVIIKFIIYSLGMGIVVTAITMVSLISRQLVQKFLHNYMGSIQKIAAVVIFLSVLYMAYYWYFGSGGICTF,0,3,1,1,0,1,1,1,0,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,V209G,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
1048,MISLNNRLTTVSRFLKQGTIADIGSDHAYLPIYAIQNHLCECGIAGEVIQGPFQAAVKNVAANQLVYRIDVRLGDGLSVIQPEDVIDNITICGMGGPLIAKILKDGQDKLSQHPRLILQSNIQTENLRQTLQQLNYEIIDEIIMEEKGHIYEIVVAEYSTELIELSSDELKFGPKLLNNKNEYFIKKWQRELEALYHIKSKLNTEQHHQRLAQINDEIAVIERVL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1520,NA,NA,NA,trmK,tRNA (adenine(22)-N(1))-methyltransferase,Y67D,SAB mortality and SAB persistence,NA,NA,NA,NA
1050,MYQFLLRYKDFLTQWKLYIISAVVLIMVLIGFIFWRQDDYTSRNFENKDTALKQSTSENSSLSKLEDVQVKDGDNSKNKGPVYVDVKGAVKHPNVYKMTSKDRVVDLLDKAQLLDDADVSQINLSEKLTDQKMIFIPHKGQKNVEPQIGVNSVHVKNGNTNNTKVNLNTASVSELMSVPGVGQAKANAIVEYRNQQGAFQEIDDLKKSKRFWK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1549,NE832,-,ComE operon protein 1,comEA,ComE operon protein 1,S208fs,SAB persistence only,NA,NA,NA,NA
1052,MKLKNIAKASLALGILTTGMITTTAQPVKASTLEVRSQATQDLSEYYNRPFFEYTNQSGYKEEGKVTFTPNYQLIDVTLTGNEKQNFGEDISNVDIFVVRENSDRSGNTASIGGITKTNGSNYIDKVKDVNLIITKNIDSVTSTSTSSTYTINKEEISLKELDFKLRKHLIDKHNLYKTEPKDSKIRITMKDGGFYTFELNKKLQTHRMGDVIDGRNIEKIEVNL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0407,NE1409,NA,exotoxin,ssl5_2,Staphylococcal superantigen-like 5,G19E,SAB mortality only,NA,NA,NA,NA
1055,MVQCLVVDDDPRILNYIASHLQTEHIDAYTQPSGEAALKLLEKQRVDIAVVDIMMDGMDGFQLCNTLKNDYDIPVIMLTARDALSDKERAFISGTDDYVTKPFEVKELIFRIRAVLRRYNINSNSEMTIGNLTLNQSYLELQVSNKTMTLPNKEFQLLFMLAARPKQIFTREQIIEKIWGYDYEGDERTVDVHIKRLRQRLKKLNATLTIETVRGQGYKVENHV,2,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2308,NE1089,-,response regulator protein,hssR,Heme response regulator HssR,N69fs,SAB mortality only,NA,NA,NA,NA
1056,MINKNDIVADVVTDYPKAADIFRSVGIDFCCGGQVSIEAASLEKKNVDLNELLQRLNEVEQTNTLGSLNPKFLNVSSLIQYIQSAYHEPLREEFKNLTPYVTKLSKVHGPNHPYLVELKETYDTFKNGMLEHMQKEDDVDFPKLIKYEQGEVVDDINTVIDDLVSDHIATGQLLVKMSELTSSYEPPIEACGTWRLVYQRLKALEVLTHEHVHLENHVLFKKVS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0253,NE1857,scdA,cell wall biosynthesis protein ScdA,scdA,Iron-sulfur cluster repair protein ScdA,L65P,SAB mortality and SAB persistence,NA,NA,NA,NA
1058,MNNCLSCGAKLYENITIYNLFKKPNRLCDRCKENWDNIKLDIKARRCSRCLKHLNQNEAYCLDCKFLSAHFNLMEQLYCQFQYDGLMKEMIHQYKFLKDYYLCELLAHLIEIPQTTYDYIVPIPSSPPHDLSRTFNPVEAVLKAKGIRFDKILKMSNRPKQSHLTKKERLADENPFIIDTELDLNDKEILLVDDIYTTGLTIHRAGCKLYAKNIRKFKVFAFAR,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0735,NE1849,-,hypothetical protein,NA,hypothetical protein,A140S,SAB mortality only,NA,NA,NA,NA
1061,MESVLNNEKAIVVFSGGQDSTTCLFYAKKHFKEVELVTFNYGQRHDTEIEVAKQIAQDQGMKHHVLDMSLLSQLTPNALTRHDMEITNNEDGIPNTFVPARNLLFLSFAGALAYQIGAKHIITGVCETDFSGYPDCRDSFIKSMNVTLSLAMDKDFVIHTPLMWLNKAETWKLSDELEVLDYIRTKTLTCYNGIIGDGCGECPACHLRQRGLNQYLESKGAL,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_0697,NA,NA,NA,queC,7-cyano-7-deazaguanine synthase,R81Q|K29fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1062,MESTLELTKIKGVLQKNLKILIILPLLFLIISAIVTFFVLSPKYQANTQILVNQTKGDNPQFMAQEVQSNIQLVNTYKEIVKSPRILDEVSKDLNDKYSPSKLSSMLTITNQENTQLINIQVKSGHKQDSEKIANSFAKVTSKQIPKIMSVDNVSILSKADGTAVKVAPKTVVNLIGPLFLGLVVALIYIFFKVIFDKRIKDEEDVEKELGLPVLGSIQKFN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0152,NE302,Cap5A,capsular polysaccharide biosynthesis protein Cap5A,cap8A_2,Capsular polysaccharide type 8 biosynthesis protein cap8A,G12E,SAB mortality and SAB persistence,-,0,-,0
1065,MNTIESQFDKVAEDYDFVNELLNDYSFFVSNMSPKKGRALDIGCGSGLLVEKLASYYDEVVGIDISNQMLDLAKSKRQLTNTVYLNMNAEQLNFNEKFDFIVSRTTFHHLDDIASVIQQMKELLNEEGRIVILDNVSEVETPPTYVYKLGAIQEFLPHCFKFGIKNAIRIYNHNTSKSWLEHLASDKYLSEQNYYDLYEKLLPGCQFHKMGWAMGVVWTK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,COQ5_1|COQ5_2,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial",P142S,SAB mortality only,NA,NA,NA,NA
1067,MKRTDKYRDSYQYDNQNQNHRRQSEDASYRQQYAKGDPEEHPERYYNGRDYRREQILEEENEKSRRSKKWLYIIIAILLIIVAIFVTRALLNNDSDKVSNDPKVSQNYKKQVENQDGQINQQVDNAKENIKNNQKTDDIIKNLQNQIDNLKQQEQNKADSKLTQFYQDQINKLTEANNALKNNASQGKIESMLNDINTKFDSIKSKLESLFKDDNGGAN,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_2378,NE1010,-,hypothetical protein,NA,hypothetical protein,K69fs,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1069,MTNEQIKHMVDRFLNWKLPKTFNPDNGISYSRPNYHPNVDATPSGTNLFDAVQADAMVRHMLEGLPPVAETPSQPDREAVARAICKSKTCEGFLCCQWPGSMGRTNCPVKSGGYDDAADALLSLLSVQVDGEQKETHATKPSPSSTSATATETAVLDLLGPMLDAWDSLSNDEHVRISKIAPDFTLHLVAVRAAADSTNQPLPQTHAKTDAGLVSGARP,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,L121V,SAB mortality only,NA,NA,NA,NA
1073,MLKLYYKFNFATEPVFTMTNLETYFKNSQPLNEYIDGMKTNQDTVLSIYQSFELPEDDSRIKKIKEMNYSKVLVITEDWCGDAMMNLPILKHISEALNLEVRVFHRDDDTKLIDQYLTNGKSRAIPIFVFLNDQFEQETVWGPRANEVQKFVTDVRADKLPSKDHPDYADLEKETHLVISNRYKTDASFWKAVYNSILNKLENK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1909,NE1749,-,hypothetical protein,NA,hypothetical protein,A124T,SAB mortality and growth rate,NA,NA,NA,NA
1074,MVEQLNLYQRINKAKHSMEGFVKDTKGYQYSYVSGSQVLHKLNPELYKNGINITFKTAEPHFEQVTVIVKGKEKIEFLVSLNVHYTITNVDNPEEKIESSIFAIGQQDDPSKALGTALTYSERYFLMKFFGLPTDEDDADAKQKKERYTKPDAKAIGTLKEEIFKFSEFMQSLGKEVSVNDVHEILGINDIQSLSSAQITAIINKLNEWTKQAKGNE,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,V2A,SAB persistence only,NA,NA,NA,NA
1076,METIAIIYEYQKDISYLKNIINKMNENRAYNHIDSFITSEYRRKINDYNLYLDKFEEQFSQKFKINRTSIKERIIINLNKRRFK,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,Y139*,SAB persistence only,NA,NA,NA,NA
1078,MQQSDVISAAKKYMESIHQNDYTGHDIAHVYRVTALAKSIAENEGVNDTLVIELACLLHDTVDEKVVDANKQYVELKSFLSSLSLSTEDQEHILFIINNMSYRNGKNDHVTLSLEGQIVRDADRLDAIGAIGVARTFQFAGHFGEPMWTEHMSLDKINDDLVEQLPPSAIKHFFEKLLKLESLMHTDTAKMIAKERHDFMMMYLKQFFTEWNCHD,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_2045,NE253,NA,HD domain protein,yedJ,putative protein YedJ,V62I|I62V,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1081,MSQNTNHSYYHQNQHAQSISKVWLYFMYYWIIFGIGCYLGQFLPLSWRQPLSFGLLIIILATLVFERARRFGLIISHIYAVVIGLLSYATFTTYLQNLGPDIFYKNIALAIFAFIAFGIIGYFFVGDASSIGKYLFVTLITLIIASLIGIFLQNPIFYTIITVVSLLLFLLYTLYDFNRLKRGDYSPREMGFNLFINLLNIIKDILYLANMFRR,4,1,1,0,2,1,1,0,4,2,1,0,SAUSA300_0652,NE1797,-,hypothetical protein,NA,hypothetical protein,Q14R|E189G|T211M|L212F,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
1082,MTVFVMQLQSNLKSIEELISQSRWSYKKPRKVNYRYNQDKLMHRLGDILVQYGIQHDTGLLPHEWHYHISPRGKADIVQHNRDGQPIYVSLSYSYPYIVCVVDKEPVGIDIEKISQRLDWRTLVTCFSTNEAHQICSLNDFYQIWTQKESFTKLIGEGLIKGLDIYDMTQSHFYQSREVKFKQFIFDQFMVQVCFLGQAPWGYKKVSVFQLLSS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0182,NE964,-,4'-phosphopantetheinyl transferase superfamily protein,NA,hypothetical protein,K31T,SAB mortality and SAB persistence,NA,NA,NA,NA
1085,MLCETENINKNPKYRIIKYKDEYLMIDLVSTWLALFFPMINWLIPKKYVKISEKDFETLNIVKTAKINSFWPVAGSTVLFGVMLRRYSHLFIVKYEYSIVILICCIIILGIFLFFLYLNQKLKLQIYNENKNKSNKIIIFPTLKSLCLSIVLYIYLGGGSFFTIYMLLTIEVQNIILFITLFVIFLFFLFLNMCSLYDNKVHLLFKSNGIEKF,3,0,0,0,1,0,0,0,3,0,0,0,SAUSA300_0586,NE1093,-,hypothetical protein,NA,hypothetical protein,L203V|M8fs|I174N,SAB mortality only,NA,NA,NA,NA
1087,MFTPIVINLLNDVGSIFLVRVGNQLKVIEKVHYEDILESKIVRLFQAFIKDKMDQLFITSEHFAIDIDKLLFQLNLNVRYIKM,1,1,0,0,1,1,0,0,2,2,0,0,SAUSA300_1745,NE1525,-,hypothetical protein,NA,hypothetical protein,Ter84Eext*?|F56L,SAB mortality and SAB persistence,NA,NA,NA,NA
1089,MTQAQTETQIQKANQNQKVTLIQIATRIQTAIRTQTVTPIQIAIQNQTVSQIQIAIQNQTVTQNQTVTQIQTAIQTQTVSQIQTVSQIQTAIRTQIATPIQELHHQIMNKKHHQILKVK,1,1,0,0,1,1,0,0,2,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,E7A|I10V,SAB mortality and SAB persistence,NA,NA,NA,NA
1091,MTQNIITVKKEHIIENVISKSRFIAHIKPVQNEDEAKAFIAAIKKEHKDATHNCSAYTIGPEMNIQKANDDGEPTGTAGVPMLDILKKLDVHNACVVVTRYFGGIKLGGGGLIRAYSGAVRDVIYDIGRVELREAVPCIVTLNYDQTGKFEYELASTHFMLRNQTYTDKVSYYIDVVKSDYEAFINFLNQMTAGNFDLTEETPKQLPFDIPTE,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0732,NE205,NA,conserved hypothetical protein,NA,hypothetical protein,K45N,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1092,MEILLCEVRVVNKNPRYRIIKYKNDYLMIDLVSTWLVLFFPFINWLIPKKYVQISREDFDNLNIVKPVKNKALWPAIGSILLFGTMFRDKIYIPDSHLEKNCVIIICSVLLLSILVFYIYLIQKVKLSIYNDRSSN,2,1,0,0,1,1,0,0,3,1,0,0,SAUSA300_0581,NE621,NA,conserved hypothetical protein,NA,hypothetical protein,Ter137Gext*?|I122N|Ter99Eext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1093,MTNPNQRLEPFDETFQQPNIHRGKQRYGKKKRSLVSMIIQIIVVILTAIAGYSMWKQPIFNIVFTKESVDFDGIKNFNETIGKMHQLNINLGNINDLQQGIDRLILVFNGFFILCIVSLVITILTIVFNRTVLKVVNILVLTIMLVITLYFSYIIKALAQEIADVFKKYYLNVPPDQVITEADAIHNGIILLGCSIGLLVISLFFRNRMPRLK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2297,NE419,NA,conserved hypothetical protein,NA,hypothetical protein,Q25del,SAB mortality and SAB persistence,NA,NA,NA,NA
1096,MKLNNYSLKVKNKQLVDNCDLNFYLGQINHIVGKNGVGKSLLAKDFLLNNSGNIPKSISQNVTLISSSSNIPNDITKDFLLSLLKSKFENNRQTFDKIYNILNIEAIPSNILLKNLSDGQKQKLKLLSFLLEDHDLIILDEVTNALDKKTVNEIYEFLNDFIQSHQTKTIINITHNLSDLSALPGKYFIFKDLQIEEYQSKEEVINDYINL,1,1,0,1,1,1,0,1,1,1,0,2,SAUSA300_2465,NA,NA,NA,yydI,putative peptide export ATP-binding protein YydI,I111V,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1097,MLCESKVINKNPKYRVIKYGDEYLMIDLVSTWLTLFLPMINWLIPKKYVKISKKEFDDLNIVKPVKNKAFWPVAGSTILFGVTFRKYIPSLNIQLEKNMVIVICCAIFLGVLILFLFLNRKLRLEIYNNNSSKGKIILFPSLKNFCFTIFYYFLFGGLSIMALSMLLTLNPQNIIGFIGWLVMTAGFFLLNMSSIIDKKIYVLSKTNTVEK,2,1,1,1,1,1,1,1,2,1,1,1,SAUSA300_0587,NE1906,-,hypothetical protein,NA,hypothetical protein,A162V|S2I,all,NA,NA,NA,NA
1098,MKKVISLFVAILSVLIFTDNANAENNKPEGVNENSNLIPVRQPDANYPGPVSDIARVKKLDNLIDGTKDPDVIKQLKDDNEVPNNALKAKDSKIVSDCRHLLKHPDNLMDGTKDPNVINQLKNANGTSNNSAVNPSIKANDIHTKSNKQMAKQQSIHLDSKSKSVHKQQLKELPKTGVNNESNTAIMVLFIGLILLVVSLVTRFIKLNSHQ,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,L87V,SAB mortality only,NA,NA,NA,NA
1105,MSNQNYDYNKNEDGSKKKMSTTAKVVSIATVLLLLGGLVFAIFAYVDHSNKAKERMLNEQKQEQKEKRQKENAEKERKKKQQEEKEQNELDSQANQYQQLPQQNQYQYVPPQQQAPTKQRPAKEENDDKASKDESKDKDDKASQDKSDDNQKKTDDNKQPAQPKPQPQQPTPKPNNNQQNNQSNQQAKPQAPQQNSQSTTNKQNNANDK,3,1,1,1,1,1,1,1,2,1,1,1,SAUSA300_0754,NE616,NA,conserved hypothetical protein,NA,hypothetical protein,D127N|N127D|A116P,all,NA,NA,NA,NA
1106,MTIKVLFVDDHEMVRIGISSYLSTQSDIEVVGEGASGKETIAKAHELKPDLILMDLLMDDMDGVEATTQIKKDLPQIKVLMLTSFIEDKEVYRALDAGVDSYILKTTSAKDIADAVRKTSRGESVFEPEVLVKMRNRMKKRAELYEMLTEREMEILLLIAKGYSNQEIASASHITIKTVKTHVSNILSKLEVQDRTQAVIYAFQHNLIQ,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1865,NE554,vraR,DNA-binding response regulator,vraR,Response regulator protein VraR,T40A,SAB mortality and growth rate,NA,NA,NA,NA
1109,MLCESRVINQNPKYRIIKYNNEYFMVDLVSTWIAYFLPMINWFIPKKYAKISREEFESLNIVKPAKNNTFWPVAGFAVLLTTLTRKYIYLLNIHLEKEIVILTCCMILLGVFALFIYINSKLKLHIFDKNKSNNEKIILIPTFKNICLSLFAYILFGGLSTMALSMLVTSSPQNIIEFLALIGMTACFFLLNMSSVLDKKIHVILKTNK,2,1,0,0,1,1,0,0,2,3,0,0,NA,NA,NA,NA,NA,hypothetical protein,S120T|Ter117Yext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1110,MNLRGHENRLKFHAKYDVTPISHLKLLEGQKKDGEGGILTDSYYCFSYSLKGNSKKVLGTFNCGYHIAEDLLKLSNQDKLPLFNPFKVINEGNQLQGVTNKGNLNINRQRKQYNEVALQLSNAINLIIICYEDNIKEPLSTIKYETDKYYYSEPYDSKIKAVNTIIGNLFDKKLVEKISEINVNQKIRKFDFSLLTNKIKKYKIQNNSE,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,S208F,SAB mortality only,NA,NA,NA,NA
1111,MLFNIKVINKNPRYKVVQYNDEYLLIDLVSTWLVYFFPFINWFIPKRYAKLSEKELENLNVDKQNKNNIFWPVTGSSFLFVVILRKYVHTFEVQLDNKILISLCFIGFIGIAAFYIYLNKKLKLKIYDDNLDNENRVILVPTFKDGSFIVFT,1,2,0,0,1,1,0,0,1,3,0,0,SAUSA300_0580,NE1431,NA,conserved hypothetical protein,NA,hypothetical protein,Ter153Yext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1112,MKFKAIVAITLSLSLLTACGANQHKENSSKSNDTNKKTQQTDNTTQSNTEKQMTPQEAEDIVRNDYKARGVDEYQTLNYKTNLERSNEHEYYVEHLVRDAVGTPLKRCAIVNRHNGTIINIFDDMSEKDKEEFEAFKKRSPKYNPGMNNHDETDGESEDIQHHDIDNNKAIQNDIPDQKVDDKNDKNAVNKEEKHDNGANNSEETKVK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1742,NE1873,-,hypothetical protein,NA,hypothetical protein,D72N,SAB mortality and SAB persistence,NA,NA,NA,NA
1116,MANYDVLKLDGTKSGSIELSDAVFGIEPNNSVLFEAINLQRASLRQGTHAVKNRSAVSGGGRKPWKQKGTGRARQGTIRAPQWRGGGIVFGPTPRSYAYKMPKKMRRLALRSALSFKAQENGLTVVDAFNFEAPKTKEFKNVLSTLEQPKKVLVVTENEDVNVELSARNIPGVQVTTAQGLNVLDITNADSLVITEAAAKKVEEVLG,1,1,2,2,1,1,2,2,1,1,2,2,SAUSA300_2203,NA,NA,NA,rplD,50S ribosomal protein L4,G15S|K68_G69del|S15G,all,NA,NA,NA,NA
1117,MKATTIIGIAGGSGSGKTTVTNEIMKNLEGHSVALLAQDYYYKDQKHLTFDERLETNYDHPFAFDNDLLIENLKDLKNGKAVEVPTYDYASHTRSDITIDFKPKDVIIVEGIFALENKVLRDMMDVKIYVDTDADLRILRRLTRDTKERGRSMDSVINQYLSVVRPMHDQFIEPTKKYADIIIPEGGSNKVAIDIMTTKIQSLVSKQ,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1568,NE1414,udk,uridine kinase,udk,Uridine kinase,I138M,Growth rate and cell death,NA,NA,NA,NA
1118,MRELTKRQSEIYNYIKQVVQTKGYPPSVREIGEAVGLASSSTVHGHLSRLEEKGYIRRDPTKPRAIEIVSDQTNDNINMEETIHVPVIGKVTAGVPITAVENIEEYFPLPEHLTSTHNSDIFILNVVGDSMIEAGILDGDKVIVRSQTIAENGDIIVAMTEEDEATVKRFYKEKNRYRLQPENSTMEPIYLDNVAVIGKVIGLYREM,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1237,NA,NA,NA,lexA_1,LexA repressor,D120N,SAB mortality and SAB persistence,NA,NA,NA,NA
1119,MVESNDELKKELGRFLKSIRKQKGKTASEISKQMQYSQGHISGIENGVKSFPSNKLIESYLMNIKDTNEEYNFYVDEIAKITKNKVKLNKVSNVTNKMEIIDRMMDIPYSREFISFDDNNEKSFTIFNISINDLHFHLQDINNYKFYKCIRLKDNNKNNIDKILNNYFENKSVIIKENTKTLRDKNENWEQLVKLSDYIDDKLDKKN,1,0,0,0,1,0,0,0,3,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,N156D|K153T|C149G,SAB mortality only,NA,NA,NA,NA
1120,MLCESKIINKNPKYRIIKYNDEYLMIDIISTWISLFFPFINWFIPKRYVKISREEFENLNIVKPAKKNVFWPVAGISTLFAVTLRKYTHLLDTQLDRKLVIAICCITFIGILTFYVRLIKKSSLNIYNTKNKRSKIILIPTLKNFCLTLFSYAFFILWTVIFSYALLSMSYQNIIVYFAWITAIMGFFLVNIALIIDKNIHVILKN,1,1,0,0,1,1,0,0,1,2,0,0,SAUSA300_0583,NE1720,-,hypothetical protein,NA,hypothetical protein,S151R|L116V,SAB mortality and SAB persistence,NA,NA,NA,NA
1122,MKKWTNRLMTIAGVVLILVAAYLFAKPHIDNYLHDKDKDEKIEQYDKNVKEQASKDKKQQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATPEQLNRGVSFAEENESLDDQNISIAGHTFIDRPNYQFTNLKAAKKGSMVYFKVGNETRKYKITSIRDVKPTDVGVLDEQKGKDKQLTLITCDDYNEKTGVWEKRKIFVATEVK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2467,NE1787,srtA,sortase,srtA,Sortase A,I155M,SAB mortality only,NA,NA,NA,NA
1123,MFSKKKDKFMVQLEEMVFNLDRAAIEFGKMDFNTHLDLKAYSDNIKTYESHGDELVHQVITDLNQTFITPIEREDILSLCDAIDDVLDAIEETAAMFEMYSIEYTDEYMAEFVDNIQKAVAEMKLAVGLLVDKKLSHMRIHSINIKEFETNCDGILRQSIKHIFNSETDPITLIKIKDIYESMEEIADKCQIVANNLETIIMKNS,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0649,NE1915,NA,hypothetical protein,NA,hypothetical protein,L197F,SAB mortality only,NA,NA,NA,NA
1126,MSQWKRISLLIVFTLVFGIIAFFHESRLGKWIDNEVYEFVYSSESFITTSIMLGATKVGEVWAMLCISLLLVAYLMLKRHKIEALFFALTMALSGILNPALKNIFDRERPTLLRLIDITGFSFPSGHAMGSTAYFGSGIYLLNRLNQGNSKGILIGLCAAMILLISISRVYLGVHYPTDIIAGIIGGLFCIILSTLLLRNKLIN,2,0,2,1,1,0,1,1,2,0,2,1,SAUSA300_1310,NE577,NA,PAP2 family protein,NA,hypothetical protein,G156R|S125N|N125S,"SAB mortality, growth rate and cell death",+,2,-,0
1127,MNTENNKNQNQSAKNSERRGMLKGCGGCLIFFIILIILLSACSMMFSNNDNSTSNQSSKTQLTQKDEDKSENMPEEKSESETDKDLQSTEEVPANENTEKNQHEIDETTTKDQSDDEINTPNVAEDKSQDDLKDDLNEKQQPSDHHQSTQPKTSPSTETNKQQSFANCKQLRQVYPNGVTADHPAYRPHLDRDKDKRACEPDKY,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_1739,NE1811,-,hypothetical protein,NA,hypothetical protein,F31S,Cell death only,+,0,-,0
1129,MLRIAIAKGRLMDSLINYLDAIEFTTLSETLKNRERQLLLSVDNIECILVKGSDVPIYVEQGIADIGIVGSDILDERHYNVNNLLNMPFGACHFAVAAKPETTNYRKIATSYVHTAETYFKSKGIDVELIKLNGSVELACVVDMVDGIVDIVQTGTTLKANGLVEKQHISDINARLITNKTAYFKKSQLIEQFIRSLEVSIANA,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2612,NE103,NA,ATP phosphoribosyltransferase hisG,hisG,ATP phosphoribosyltransferase,T181A,SAB mortality and growth rate,NA,NA,NA,NA
1132,MANPIKIGIGGPVGAGKTQLIEKVVKRLSKEMSIGVITNDIYTKEDEKILVNSGVLPESRIIGVETGGCPHTAIREDASMNFAAIDELLERHDDIELIFIESGGDNLAATFSPELVDFSIYIIDVAQGEKIPRKGGQGMIKSDFFVINKTDLAPYVGASLEQMAEDTKVFRGKRPFTFTNLKTDEGLDEVIDWIERDTLLKGLS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2243,NE1113,ureG,urease accessory protein UreG,ureG,Urease accessory protein UreG,A153V,SAB mortality and SAB persistence,NA,NA,NA,NA
1133,MKKKGLTPEIVRNRVAKGWELSEAIDAPFGMKLNDYREIQITKALEREREMARQRRKEAELRRKKPHLFNVPQKHPRGRYACYLMENDIFPKVRV,2,1,0,0,1,1,0,0,2,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,E38K|P99fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1134,MHTFDAQSLTARENYKLLIGSIIPRPIAFVTTLNQDASVNAAPFSFLI,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_2593,NE1618,-,hypothetical protein,NA,hypothetical protein,L47fs,Growth rate and cell death,NA,NA,NA,NA
1135,MFKKYDSKNSIVLKSILSLGIIYGGTFGIYPKADASTQNSSSVQDKQLQKVEEVPNNSEKALVKKLYDRYSKDTINGKSNKSRNWVYSERPLNENQVRIHLEGTYTVAGRVYTPKRNITLNKEVVTLKELDHIIRFAHISYGLYMGEHLPKGNIVINTKDGGKYTLESHKELQKDRENVKINTADIKNVTFKLVKSVNDIEQV,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0370,NE1809,-,putative enterotoxin,selX,Enterotoxin-like toxin X,G103V,SAB persistence only,NA,NA,NA,NA
1137,MSHYYDEDPSVISNEQRIQYQLNHHKMDLITDNGVFSKDKVDYGSDVLVQTFLKAHPPGPSKRIADVGCGYGPIGLMIAKVSPHHSITMLDVNHRALALVEKNKKLNGIDNVIVKESDALSAVEDKSFDFILTNPPIRAGKETVHRIFEQALHRLDSNGELFVVIQKKQGMPSAKKRMNELFGNVEVVNKDKGYYILRSIKA,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_0526,NE1671,-,methyltransferase small subunit,rsmC,Ribosomal RNA small subunit methyltransferase C,M27I|T103fs,SAB mortality only,NA,NA,NA,NA
1138,MRFDINNLDIKKLNFRKGKNAIHLSLSGDKYQLLEDGKTINNNYFLDVYDKAINIFEDLFSPSDSINLVHVVYVYNEPYKKTNVIKKFTSLTIDELYYFKGYKKEKDDKIFCEEFSYKCSIKDIKYKKLLKAISNQDFKGLVPNINQNDNYSEIYIINNTKNLIYHLYDDRGLWLAFNNNEDYARYSEKYNDLISEFDNEDI,2,1,1,1,2,1,1,1,4,1,1,1,SAUSA300_2158,NA,NA,NA,NA,hypothetical protein,G101E|E107D|E116S|Y88F,all,NA,NA,NA,NA
1141,MTPFITYITRAHVSLHAFSFTEMIQIYVMIIFFIAFCFISPVMFYQLWAFIAPGLHNNERQFIYKYSFFSVLLFCAGVAFAFYVGFPMIIQFALKLSLTLKISPVIGFKAYLIELIRWLFTFGLLFQLPILFMGLAKFGLIDTTSLKHYRKYIYFACFVLASIIAPPDLTLNILFTLPLILLFEFSMFIVKFTCRGKPPTH,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_0347,NE426,tatC,Sec-independent protein translocase TatC,tatC2,Sec-independent protein translocase protein TatCy,F175L|K101N,SAB mortality only,NA,NA,NA,NA
1142,MARFRGSNWKKSRRLGISLSGTGKELEKRPYAPGQHGPNQRKKLSEYGLQLREKQKLRYLYGMTERQFRNTFDIAGKKFGVHGENFMILLASRLDAVVYSLGLARTRRQARQLVNHGHILVDGKRVDIPSYSVKPGQTISVREKSQKLNIIVESVEINNFVPEYLNFDADSLTGTFVRLPERSELPAEINEQLIVEYYSR,3,1,1,2,1,1,1,1,2,1,1,1,SAUSA300_1666,NA,NA,NA,rpsD,30S ribosomal protein S4,A96T|N115S|S115N,all,NA,NA,NA,NA
1149,MNLFYNPKYVGDIAFLQIEPVEGELNYNKKGNVVEITNEGNVVGYNIFEISKDITIEEKGHIKLTDELVNVFQKRISKAGFDYKLNADLSPKFVVGYVETKDKHPDADKLSVLNVNVGNDTLQIVCGAPNVEAGQKVVVAKVGAVMPSGMVIKDAELRGVASSGMICSMKELNLPNAPEEKVIMVLNDSYEIGQAFFE,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1688,NA,NA,NA,NA,hypothetical protein,V182G,SAB mortality and SAB persistence,NA,NA,NA,NA
1151,MKIGYARVSTGLQNLNLQEDRLNAYGCEKIFSDHISGSKSKRPGLDKAIEFARSGDTIVVWRLDRLGRNMEDLITLVNELNERGVSFHSLEENITMEKSSSTGQLLFHLFAAFAEFERNLILERSSAGRIAARARGRYGGRPEKLNQKDLNLLKTLYDNGTPIKTIAEQWQVSRTTIYRYLNKLEEKEDEKQGEVSN,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,hin,DNA-invertase hin,E97D,SAB persistence only,NA,NA,NA,NA
1154,MSELTAKQARFVNEYIRTLNVTQSAIKAGYNANSAHVTACRLLKKPHIKQYIQEQKDKIIDENVLTAKELLHVLTNAAVGDETETKEVVVKRGEYKENPQSGKVQLVYNEHVELIEVPIKPSDRLKARDMLGKYHKLFTDKHDINGNVPIFINIGEWDGGDEGLDKAVKDVSNDNPNHTVIVDDIPIEDYESIRFL,1,2,0,0,1,1,0,0,1,6,0,0,SAUSA300_1981,NE687,NA,phage terminase family protein,NA,hypothetical protein,I187L|D3E|Y135H|N147D|A167T|T174A,SAB mortality and SAB persistence,NA,NA,NA,NA
1156,MKEIVIASNNQGKINDFKVIFPDYHVIGISELIPDFDVEETGSTFEENAILKSEAAAKALNKTVIADDSGLEVFALNGEPGIYSARYAGENKSDEANIEKLLNKLGNTTDRRAQFVCVISMSGPDMETKVFKGTVSGEIADGKYGENGFGYDPIFYVPKLDKTMAQLSKEQKRQISHRRNAINLLQAFLEGDKNV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1050,NA,NA,NA,NA,dITP/XTP pyrophosphatase,R173G,SAB mortality only,NA,NA,NA,NA
1157,MTIDRRIRKSQVAMRNAFIELLHQHQLEEITVQQIADLADVNRSTFYTHYYDKYDLLEKLEDQQLEEIRDFIHDEKLNGAVKLSTDNIHQIMTVLIEMIEKDIAFYQLMFRMGKDSDIHEKLYDLIMCHLQRYKNENDQINGIPFSYFMSYVSGAGLSLIRHWVEDPNRIDKVDLIRHFNTIVNQGPATIIKNIQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2530,NE1216,-,TetR family transcriptional regulator,NA,hypothetical protein,D117N,SAB mortality and SAB persistence,NA,NA,NA,NA
1158,MGYLMSETFNQIKESFIEYLLFQYRFKSRIAVWVLNYIKVNEAKLANIHFVDTKINHHETLEIAEVGSHASAIQFTKRNIKLMNTNEIFDYIANHNCAFDIQIHFANVSKREQRLDDLIVAQLTESPSYQTYLHDLNSMAIDRHKHALLIYYLLHNIDLSLQMNEKQRFYQLTQILNTLKLVNKHNQFEDLADDN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1353,NE840,-,hypothetical protein,NA,hypothetical protein,Y151D,SAB mortality and SAB persistence,NA,NA,NA,NA
1160,MIIFILLTVFALFYIAMIASLFKSEGFSIIGLILDIVILTTLIFYYFVGASFVDNDLSNFLAFMNFGSFVYMYYAIKSLWVKPKLVNYIIAKEIGESKDVIEEQELDLQTSKIRGIYFFIIAIALLIITKLRMQPELQADAISMNPVFIFIGVIIILIWLVLDIYRKKKYGIFLFKTIVPLVVTTWIIIATIVLS,1,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,R166fs,SAB mortality only,NA,NA,NA,NA
1162,MLFSLFVEKEESQKLTYLKELGEDGEYKYVAKIDSKTSKLCHSLNGKIFKVKDMIPGVNAPPMHPWCRSTTVPHVGNWRDKFFKEREGKYQVEGCFIESGALNNKSDEYGIKRNRHAQIYYNSVRNRDKQIEISKIAKNTNINKDLIQRVYEHIFENKYLLESGFKQFDPDFYMAQSWQRLREGKNIKKMDIIM,1,0,1,0,1,0,1,0,4,0,4,0,SAUSA300_1209,NA,NA,NA,NA,hypothetical protein,M1?|S4*|V7T|KEES9NAEA,SAB mortality and growth rate,NA,NA,NA,NA
1163,MKVNDMKARLLNLEETFKKHESELTELDRAIGDGDHGVNMVRGFSSLKDKLDDSSMQSLFKSTGMALMSNVGGASGPLYGFSFVKMSAVTKDDMDNQDFITLIQAFAEAVESRGKVTLNEKTMYDVVARAAEKLKNGETLTFNDLQQLADNTKDMVATKGRAAYFGEESKGYIDPGAQSMVYILNALIGDEDNA,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0637,NA,NA,NA,dhaL,"PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL",G73D,SAB mortality only,NA,NA,NA,NA
1164,MIVYILINIAIVVLITGFNLYRHQMQHLSLSAMLLSITINDFINTFIIDKYNFITLCTITMFIIWTILQFYIDKKLKPVYITDQKFIAIILTIVVSLTQRVTDFSSTQSIYMSIPFLAPAIFIIGGIMLFISTFNSLDETAENNNKIKKLMIKGLIIINISFIVMMVLTPYWYLYLIVYLIFLLFLLWQKVYKF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0694,NE526,NA,putative membrane protein,NA,hypothetical protein,D41A,SAB mortality and SAB persistence,NA,NA,NA,NA
1172,MKALLIRNFKLRRYTLIIYVLLLTLYPFYIMLDSTKFFYLLQSFISPTILIIWILDAGHLFRLNRRLGGNDSYYFYMSLPVSKKQLLNANYITCIVLTLIGTLVISLYAYEADVIEPNSIYFSTAYAFVISNFLSIPIAFSQFTELRRVKVPYGIYVFTIIILVPFLFSIAIVLVNYFVLSQSSFPDLYSYI,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1912,NE1188,NA,putative membrane protein,NA,hypothetical protein,Ter193Lext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1178,MNRINRVTSILIQLQSKKIIPAKEIAQRFNISLRTVYRDIRTLEEAGIPIGSEAGKGYFLVEGFLLPPVMFTAAEVGALITAGKFLNCHGDESFIKDFDSAMYKIKSILKHGEKNYAQELENSINVYSTSGQKNTLADNVIAAIQTAICNKRVISIQYPASGGQEPESRMIEPISLGFYEQNWYLIGFAG,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,L65P,SAB mortality and cell death,NA,NA,NA,NA
1184,MYSQNIYVIRKGDMVIRPAFDDDDQRNGSEIIRFDKTRIQNPFKVQKIIERSCKFYGNTYLGKKAETNRITGISSKPPILLTPLFPTYFFPTHFDRQNENIWLNMHYIESIKELKNRKCKVTFINNESIILHVSYHSLWHQYNNSIFYYYMVDKQSRMISKNPDQPIDYNKATLNVFEALTRYSLFEDK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0928,NA,NA,NA,NA,hypothetical protein,F94S,SAB mortality only,NA,NA,NA,NA
1187,MLCENCQLNEAELKVKVTSKNKTEEKMVCQTCAEGHHPWNQANEQPEYQEHQDNIEEAFVVKQILQHLATKHGINFQEVAFKEEKRCPSCHMTLKDIAHVGKFGCANCYATFKDDIIDIVRRVQGGQFEHVGKTPHSSHKKIALKRKIEEKNEYLKKLIEIQDFEEAAIVRDEIKALKAESEVQHDDA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0508,NA,NA,NA,mcsA,Protein-arginine kinase activator protein,I55F,SAB mortality and SAB persistence,NA,NA,NA,NA
1188,MNTKFLGKTLVASALVLTTLGTGLHSSYLGLDTNKVVKTAKAEEKMTDGQLWKKVKDSLHDSDIILSNEYETINVTYLLSNGYSSSVSAPGNDDGGHLTQSIDFKGLKQIDLTKENVYDDFNKKLDAKNTWNSLTEKLKGFGLLQNGQKVSIYSSDSSSPVSGKVGEGVTSGGENTLTKRFINKITID,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_1759,NE1277,-,hypothetical protein,NA,hypothetical protein,F141L,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1189,MKRIAVYCGASKGHDLSYVQKAYDLGKYFAEQGYELVFGAGSIGIMGAIQDGVLDHGGKAIGVMPKMLDEHEITSQRLTELILVDSMHERKNKMAELADAFVMAPGGAGSLEEFFEMYSWAQIGIHEKPIAIYNINGFFNPLQTMIDHMIEEGFIDPKYRALAPLCDTKESLIESILNFKPLGTRSYD,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0666,NE1268,-,hypothetical protein,yvdD,LOG family protein YvdD,L16P,SAB mortality and SAB persistence,NA,NA,NA,NA
1191,MNKVEAIKFNDDIVKMYEALKIKSERDYLFFKLAIHSGLKVSELLTITVSQVKRLIEKCTLSEMCKAHFHSLIKIRLPETLSKELLQYIEDRSLSNEDVLFQSLRTNQVLSRQQAYRIIHQASIEAGIDNVGLTTLRKTFAYHAYQKGIPIPVIQKYLGHQPAIETLNFIGLENECEHSIYISLQL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0609,NA,NA,NA,xerD_2|xerD_1,Tyrosine recombinase XerD,P162S,SAB mortality and SAB persistence,NA,NA,NA,NA
1192,MKDKILGVAKELFIKNGYNATTTGEIVKLSESSKGNLYYHFKTKENLFLEILNIEESKWQEQWKKEQIKCKTNREKFYLYNELSLTTEYYYPLQNAIIEFYTEYYKTNSINENMNKLENKYIDAYHVIFKEGNLNGEWCINDVNAVSKIAANAVNGIVTFTHEQNINERIKLMNKFSQIFLNGLSK,1,1,0,0,1,1,0,0,3,5,0,0,NA,NA,NA,NA,qacR|qacR_2,HTH-type transcriptional regulator QacR,N113K|F91Y|Ter112Eext*?|I71K|Ter76Kext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1195,MKLKKDKRREAIRQQIDSNPFITDHELSDLFQVSIQTIRLDRTYLNIPELRKRIKLVAEKNYDQISSIEEQEFIGDLIQVNPNVKAQSILDITSDSVFHKTGIARGHVLFAQANSLCVALIKQPTVLTHESSIQFIEKVKLNDTVRAEAQVVNQTAKHYYVEVKSYVKHTLVFKGNFKMFYDKRG,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1121,NA,NA,NA,fapR,Transcription factor FapR,Q150R,SAB mortality and SAB persistence,NA,NA,NA,NA
1197,MISVNDFKTGLTISVDNAIWKVIDFQHVKPGKGSAFVRSKLRNLRTGAIQEKTFRAGEKVEPAMIENRRMQYLYADGDNHVFMDNESFEQTELSSDYLKEELNYLKEGMEVQIQTYEGETIGVELPKTVELTVTETEPGIKGDTATGATKSATVETGYTLNVPLFVNEGDVLIINTGDGSYISRG,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1490,NA,NA,NA,efp,Elongation factor P,G169D,SAB persistence only,NA,NA,NA,NA
1198,MKRLFDVVSSIYGLVVLSPILLITALLIKMESPGPAIFKQKRPTINNELFNIYKFRSMKIDTPNVATDLMDSTAYITKTGKIIRKTSIDELPQLLNVLKGEMSIVGPRPALYNQYELIEKRTKANVHTIRPGVTGLAQVMGRDDITDDQKVAYDHYYLTHQSMMLDMYIIYKTIKNIVTSEGVHH,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0164,NE803,cap5M,capsular polysaccharide biosynthesis protein Cap5M,epsL,putative sugar transferase EpsL,I82V,SAB mortality and SAB persistence,NA,NA,NA,NA
1199,MKINDNNDKNVEQNAVVDLKKVLEMAKSYDEIERYTLSNGEDIEFYPHFSRTKIKEIIEEYKGYLISEDKDDMKFMDMVSKDDVSLVLFWYFIAVKKFTHFGESMKRIKKVKSLAPYYNALLETGILEEICNDAFAYEELSKVTEMFAKEAAINVTANEFVNKYEDEIEVAREKFANTYLNKSED,1,2,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,I93L,SAB mortality and SAB persistence,NA,NA,NA,NA
1200,MLTMKDIIRDGHPTLRLKAAELELPLTKEEKETLIAMREFLVNSQDEEIAKRYGLRSGVGLAAPQINISKRMIAVLIPDDGSGKSYDYMLVNPKIVSHSVQEAYLPTGEGCLSVDDNVAGLVHRHNRITIKAKDIEGNDIQLRLKGYPAIVFQHEIDHLNGVMFYDHIDKDHPLQPHTDAVEV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0991,NA,NA,NA,def,Peptide deformylase,L17Q,SAB mortality and SAB persistence,NA,NA,NA,NA
1201,MIRQARPEDRFDIAKLVYMVWDDMELELVKHLPKDMVLDAIEKSCVDATYRTFYQHILVYEVENKVAGCIISYSGENELKYEKAWELLDLPEKIKQYGTPLPVKEAKDDEYYIETIATFAAYRGRGIATKLLTSLLESNTHVKWSLNCDINNEAALKLYKKVGFISDGQIELYKHMYHHLIVK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0943,NE730,NA,"acetyltransferase, GNAT family family",NA,hypothetical protein,A48G,SAB mortality only,NA,NA,NA,NA
1205,MGFKNNLTNKIGNSVFKIENVDGKGAMPTTIQELRERRQRAEAIVKRKSLMSSTMSVVPIPGLDFGVDLKLMKDIIEDVNKIYGLDHKQVNSLGDDVKERIMSAAAIQGSQFIGKRISNAFLKIVIRDVAKRTAAKQTKWFPVVGQAVSASISYYFMNKIGKDHIQKCENVIKNVM,0,0,1,1,0,0,1,1,0,0,2,1,SAUSA300_0982,NE1788,-,hypothetical protein,NA,hypothetical protein,T8_N9insSNLT,Growth rate and cell death,NA,NA,NA,NA
1206,MIYCETERLILRDWHEDDLLPFQKMNANYDVRKYFPSLLSYRRSELDMRTMDAVIKDYGIGLFAVEDKESHQWIGFIGLNYIPETSDYPFKELPLYEIGWRLLPEFWGKGLATEGAKATLKLAEEHQIYDVYSFTAEANKASQRVMEKISMTVYDHFELPNLSKYHLLKRQVRYYINLRK,3,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0665,NE630,NA,"acetyltransferase, GNAT family",NA,Acetyltransferase,S150G|D150G,SAB mortality and growth rate,NA,NA,NA,NA
1210,MDIIAICIAIFSFLLTALKYYLDYMKDSLNIDVIPTRSFNYLVDDKSSYNDITFINFTKFPISVIDVEFDIKNKVNEQKTFKPIRYKDKNYSIPFTLGPYESVECTFLLEEYPVIWEWDVTIKVTTNKRIYIKPVIIESRTEHRESEPQVTELTSANKVSALSNPKDGFLKKFLYHLKP,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,R129G,SAB mortality and SAB persistence,NA,NA,NA,NA
1212,MELQQAIANRRSVKKFKRDMHIDDALLYQAIEKAADAPNHGMREPWRVVHVPKDRLGDMSKDISKFAFPNELDKQQCHYDAVTKLGGMLLLILKTDPRQRQNDENYFAFGAYAQNLMLLLYEAGIGTCWKSPLYIYDPKVRKTLGIKKDEVLAGFLYLTDLEGDMPKAPRKNRNLITLY,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0788,NE1550,-,nitroreductase family protein,NA,hypothetical protein,A168T,Growth rate and cell death,NA,NA,NA,NA
1213,MITVLFGGSRPNGNTAQLTKFALQDLEYQWIDVTQHQFKPIRDVRHTAETITSYDDDYLPILDKILASDTIIFVSPVYWYSISAPLKAFIEHWSETLQDKRYPNFKAQMAEKDFRVILVGGDCPKIKAKPAITQMKYSLDFLGATLNGYIIGTAEKPGDIMKDNYALARATEWNSILQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0590,NE1402,-,hypothetical protein,ywqN,Putative NAD(P)H-dependent FMN-containing oxidoreductase YwqN,V74A,SAB mortality only,NA,NA,NA,NA
1214,MTLSDIKQGQGYIAKIESNSFVDGEGVRCSVYVSGCPFNCVGCYNKASQKFRYGEKYTDKILAEILDDCDHDYISGLSLLGGEPFCNLDITLNLVKAFRARFGNTKTIWVWTGFLYEYLANDCTERRELLSYIDVLVDGLFIQHLFKPDLPYKGSLNQRIIDVQQSLSHARMIEYIVS,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2550,NE1205,nrdG,"anaerobic ribonucleotide reductase, small subunit",NA,hypothetical protein,S4L,SAB mortality and growth rate,NA,NA,NA,NA
1215,MHNNNEFNKKLKDFIGSDKRMALVKGYVNEYKLTTVLRALNNSDYTKGTIHTRSIGNLKQIVDNRIIPKNITQNTIFKLSNLTLEVNLYERNTIYHGDFAIYYPVESALIIETDTPRLINHINNNPVQKIFIITTNDWSFNTLELEKIVDETIIYDLKQEDPKQYEILYKNKHGKLPY,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0390,NE632,NA,conserved hypothetical protein,NA,hypothetical protein,H173P,SAB persistence only,NA,NA,NA,NA
1217,MNNNILPAIRNIKDLEKLIKTDYKMCVLLDMHIGHIKSIMELLKQNHIECFMHIDLIKGLSHDEFASEFIIQQYKPKGIVSTKSKVIKKAKSLNTLTIFRVFIIDSQALKRSIDLIKKVEPDFVEVLPGVASKAIHHIQKETNTQVIAGGLINTIDEVNEAVKNGAKYVTTSYDKLW,1,1,0,1,1,1,0,1,1,1,0,1,SAUSA300_1190,NE307,glpP,glycerol uptake operon antiterminator regulatory protein,glpP,Glycerol uptake operon antiterminator regulatory protein,M52I,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1220,MRTLYYFLIGILLFYIDTAIGLLIPMHIGKFELVFVPHLTFMYILMMVVYRGFGVSLLLSIFLGVMTDVYFGSIYGVYLFGYILFLALIDRFFKIFYKDHSMLFIIILASTLLLEVYVALIYGMLGFIQFDIIHFVVFRLLPTLIMNFVLLIMLYPLIIKFLKKNKQ,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_1604,NE858,mreD,rod shape-determining protein MreD,NA,hypothetical protein,N165fs|F22L,SAB mortality only,+,0,-,2
1223,MGLVRKFFMPNSYVQSIFQIDLDKLVDKGVKGIITDLDNTLVGWDVKEPTERVKAWFKEANEKGITITIVSNNNESRVASFSQHLDIDFIFKARKPMGKAFDKAITKMNIRPDQTVVIGDQMLTDVFGGNRRGLYTIMVVPVKRTDGFITKFNRLIERRLLRHFSKKGYITWEEN,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_1557,NA,NA,NA,NA,hypothetical protein,M138I,all,NA,NA,NA,NA
1225,MKDLTMLLDELKDMSFFNKGDICLIGCSTSEVIGEKIGTVGSMEVAETIFNALDVVSKETGVTFAFQGCEHINRAITIEKSQYNPLTMEEVSVVPDVHAGGSLATYAFQHMKDPIVVEHITVPCGIDIGQTLIGMHIKHVCVPVRTSVKQVGQAIVTIATSRPKKIGGERAKYK,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_2068,NE361,NA,conserved hypothetical protein,NA,hypothetical protein,H139_C141delinsR,"SAB persistence, growth rate and cell death",-,2,-,0
1226,MLYLNKYKERVTSVRIQNRWVVFILFLICSFGVLIGLYQYRHTKTVDLSNLEINDIKLNEKFDKKGYEVNKKIKFDRFKFYNSKAHPDLTVKVREKDNIVKGIILVRDEKIHTNFDGGIGSPINNAIENLGFGYKRTKVGNDFSSVKYIDRDNHLKLNLLYQDLEIKRIEFFSK,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_1908,NE1894,-,hypothetical protein,NA,hypothetical protein,T12I,all,NA,NA,NA,NA
1227,MKKVVKYLISLILAIIIVLFVQTFVIVGHVIPNNDMSPTLNKGDRVIVNKIKVTFNQLNNGDIITYRRGNEIYTSRIIAKPGQSMAFRQGQLYRDDRPVDASYAKNRKIKDFSLRNFKELDGDIIPPNNFVVLNDQDNNKHDSRQFGLIDKKDIIGNVSLRYYPFSKWTVQFKS,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0867,NE535,spsA,signal peptidase IA,spsB_2,Signal peptidase IB,Q91R,SAB persistence only,NA,NA,NA,NA
1229,MSKILNTQLIGIFNRLEKQSLEIQMAAQCLIQAIGGEGYVYVKGYDDLQFFESFILHSDESLKSSRKLDAIKDFKEIDSTDRVLLFAPFYNDQVALDIQKLIDLDIDVVLISNKPKTDDFPDHLVHFIDLSTPRPIVYTEDYDKIVQPHAMALNYVYYDIYTQMIEMTRDLEL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2080,NE1870,NA,conserved hypothetical protein,NA,hypothetical protein,S61R,SAB mortality and SAB persistence,NA,NA,NA,NA
1230,MKKIYYIDFLETENNFFNVIYYRLEKHNNKIRLSKLERAFFSPFKADFLKYNFDVSIERIIKIKEFSTEEKAIKYIIKKHEYLKSKYFIKNDLSKFTNLNYIFSYEYVKDKAATHILKLLSYGVKYINYDFSQYQLNIMKEINKQLKDIYKYKICIKTEETENGQIKSTYTII,3,1,0,0,1,1,0,0,3,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,V108M|S138I|I35K,SAB mortality and SAB persistence,NA,NA,NA,NA
1233,MTKKVAIILANEFEDIEYSSPKEALENAGFNTVVIGDTANSEVVGKHGEKVTVDVGIAEAKPEDYDALLIPGGFSPDHLRGDTEGRYGTFAKYFTKNDVPTFAICHGPQILIDTDDLKGSTLTAVLNVRKDLSNAGAHVVDESVVVDNNIVTSRVPDDLDDFNREIVKQLQ,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1856,NA,NA,NA,NA,hypothetical protein,S120R,SAB mortality and SAB persistence,NA,NA,NA,NA
1234,MDSHLNHILSYWQGPPLEGAKTIISKYGYPQEATMSRLIWYNSGPWKRTIVYKDPVPHNFPTPHLDFLKQTIDYKVPVHLYDAIAAFDGSVYLDRTTGEASAKCHEEAMNFLSLNLLNDIVTGKRDVQGAKAFYAQTAEQFTKYHITSPYTEGFLFPMQYNTADLGVTYFK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,E18K,SAB mortality only,NA,NA,NA,NA
1237,MEKGNQGIKWSSLIMGVLLLMLAVVIFTFPIENFYAITWLIGLFVLINGVIQIVYRRKAKALVGGNQNWILFMGIVDILFGLTVIFNVGASSAFFIYMFAFWFIFSSIAGLFTFSGSGSLKLISVIFNLLGIVFGVILLFNPLMGIVFISTMIAIAFVFVGVIYVVDALA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2632,NE1542,-,hypothetical protein,NA,hypothetical protein,T83I,SAB mortality and SAB persistence,NA,NA,NA,NA
1242,MISHLIMATTKKKHQIATQIQIATQIQTAIQTATQTQIAIQIQTATQTQTATQTQIATQTQIATQIRIATQTQIAIQIQIAIRTQTVIQIQTQIATQILTAIQTQTVIQIQTATQTQIATQTQIATQTQIATQTRIAIQIQTAIRTQTTTQIQIAIQIQMQVNILRLNQ,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,T52I,SAB mortality only,NA,NA,NA,NA
1246,MKKLYTSYGTYGFLHQIKINNPTHQLFQFSASDTSVIFEETDGETVLKSPSIYEVIKEIGEFSEHHFYCAIFIPSTEDHAYQLEKKLISVDDNFRNFGGFKSYRLLRPAKGTTYKIYFGFADRHAYEDFKQSDAFNDHFSKDALSHYFGSSGQHSSYFERYLYPIKE,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1784,NE294,NA,signal transduction protein TRAP,traP,Signal transduction protein TRAP,N20H,SAB persistence only,NA,NA,NA,NA
1247,MKIISKYILTRFSKNGKHFDIPKEQRRVIPKFKNRRKMIVICFYSLLAILLILLLASFIKATRANNDSKEAVNKTNMIQKKYEDNANTVQYSPKLKLYADKFIDTYMNISKDSKELESREKELLKYFPSDYKKPDEKISDTERKLNSKEFYNFKRKDKQTIIQYIVN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1486,NE1059,-,hypothetical protein,NA,hypothetical protein,F153I,SAB mortality and SAB persistence,NA,NA,NA,NA
1248,MGEDLNEKRISFTAIMTVLLIGLTACGAESDTANESKVQDIQGNPVSLPNEKPTLIYFMATWCPSCIYNEEIFKEMHQLNPNDVQLITVSLDPNTDTKESLAKFKQDYGGDWPHVLKNGKEIADTYGVKQLEEIVLVNSENEVFYRSVRPSFDDLKEALTQIGVEL,1,2,0,0,1,1,0,0,1,2,0,0,NA,NA,NA,NA,resA,Thiol-disulfide oxidoreductase ResA,R9fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1249,MTFEEKLSQMYNEIANEISGMIPIEWEKVYTMAYIDDEGGEVFYYYTEPGSNELYYYTSVLNKYDISESEFMDSAYELYKQFQNLRNIFKKEGYEPWTSCEFDFTNEGKLKVSFDYID,1,1,0,0,1,1,0,0,1,2,0,0,NA,NA,NA,NA,essG_1|essG_5,Type VII secretion system protein EsaG,N106K|K109E,SAB mortality and SAB persistence,NA,NA,NA,NA
1250,MFKKLFGKGKEVQKDIAIYAPLTGEFVKIEDIPDPVFAQKMMGEGFGINPTEGEVVSPIAGRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFEVLVSSGDEVNVGDPLVRFNLEYINNNAKSVISPIIITNTDQAASINIYDENAVIKGETKVIDVTMN,1,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_1315,NA,NA,NA,crr,PTS system glucose-specific EIIA component,A77T,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1253,MQHLIKKHVLNGEFDLVRQLMSETDFMEFEEAYISSAHEVESMMFYTCILDMIKYEESSEMHDLAFLLLVYPLSEYEGALDSAYYHADASIKLTDGKEVKSLLQMLLLHAIPTPVISDKKAFDIAKQILKLDPNNNVARNVLKDTAKRMDNVVVDINELHQRNAR,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_0639,NA,NA,NA,NA,hypothetical protein,H160Q,SAB mortality and growth rate,NA,NA,NA,NA
1262,MTFEEKQSEMYNKIANEISGMIPVEWEKVYTIAYVNDRGGEVVFNYTKPGSDELNYYTNISRDYNVSEEIFDDLWMNLYYLFKNLRNLFKTEGHEPWTSCEFDFTRDGKLNVSFDYIDWINTEFDQLGRENYYMYKKIGVIPEMEYEMEEIKEIEQYIKSQES,1,2,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,essG_2|essG_4,Type VII secretion system protein EsaG,G93E,SAB mortality and SAB persistence,NA,NA,NA,NA
1264,MAQDRKKVLVLGAGYAGLQTVTKLQKAISTEEAEITLINKNEYHYEATWLHEASAGTLNYEDVLYPVESVLKKDKVNFVQAEVTKIDRDAKKVETNQGIYDFDILVVALGFVSETFGIEGMKDHAFQIENVITARDYHVISKTNLLTMQHQKKKMITIYLS,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,NADH dehydrogenase-like protein,D136fs,SAB persistence only,NA,NA,NA,NA
1268,MSLCEAESLCDSESQSESESLSESESLFESESLSESDSLSESESLSESESLSESESLSESESLSESDSLSEFESLSESESLSESESLSEPESLSEPESLSESESGSGSGLGSGSGVGSGSGSGLGSGSGVGSGSGSGSTGGPGVGSTGFTAESPSALPPP,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,Q15L,SAB mortality only,NA,NA,NA,NA
1269,MAPKTSKMPALTPHEKRLRNTECKLREALARLVKGLPTHPSLEKRSYRLTGATLAREARIGRNAIYTNHRAMIDELRRASDRKVVPEKLAAWEDKLAQQRSLIQVLRVEERRLVTENAVLLKRILEAETEVERQRRHNARLIAEHDRAVKPVPLARGPKP,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,G51V,SAB mortality only,NA,NA,NA,NA
1273,MSDYTKLTKSPKSALLYYYITNGLEFILSVAVYVIFYFIWLRFEWPHYLLYILLVLGALSTLKLFIKPLWQYHCRFYKVDQLSVQYRTSFFIYKEETSRIERLQYLSIKSNPISKVLNLYKVGFMTAGHTIYLPMMSHDDVKIIEERTMSNLRGVESDV,0,1,0,0,0,1,0,0,0,2,0,0,SAUSA300_2031,NE900,-,hypothetical protein,NA,hypothetical protein,I92fs,SAB persistence only,NA,NA,NA,NA
1274,MIQAYLGLGSNIGDRESQLNDAIKILNEYDGINVSNISPIYETAPVGYTEQPNFLNLCVEIQTTLTVLQLLECCLKTEECLHRIRKERWGPRTLDVDILLYGEEMIDLPKLSVPHPRMNERAFVLIPLNDIAANVVEPRSKLKVKDLVFVDDSVKRYK,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_0494,NA,NA,NA,folK,2-amino-4-hydroxy-6- hydroxymethyldihydropteridine pyrophosphokinase,I32V|V32I,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1275,MFKVRQATEKDVVQIRDVATKAWFNTYLNIYAATTVNHLLEASYNEHHLKKRLQEQLFLVVEEGNDIVGFANFIYGEELYLSAHYVKPESQHTGYGTALLNEGLSRFEDKFEGVYLEVDNKNEEAVAYYKEQGFTILRSYEPEMYGEKLDLALMYKAF,2,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_0591,NE1058,-,acetyltransferase,NA,hypothetical protein,A42V|V42A,SAB mortality and SAB persistence,NA,NA,NA,NA
1276,METIYDFVVETNKGVTYKLDAYKGDVMLIVNTASECGFTSQFEGLQSLYEKYKDQGFVILGFPCNQFGGQEPGSGEEAAQNCKLNYGVTFPMHQKIDVKGEHQLPLFRYLTAAQHGFFNEKIKWNFTKFLVDREGNVVKRFAPQKKPVQIEREIEKLL,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1197,NE1730,-,glutathione peroxidase,bsaA_2|bsaA_1,Glutathione peroxidase BsaA,P147T,SAB mortality only,NA,NA,NA,NA
1277,MGLLDIASIRSIERGFNYYQSECVINLKSFSETQHEAEVKGSGNKVYRCYIDMEHPRKSICNCPHADGRRVICKHMIALLFTASPEAANKHIIMLNEVEEDYQLRRNMWIDSLKEMINDMSEEELRDAYLNMLIEHGEMAELFGLDEEEEMFEDEFY,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1272,NA,NA,NA,NA,hypothetical protein,I93M,SAB mortality and SAB persistence,NA,NA,NA,NA
1283,MIYSITEIEARYAETDKMGVIYHGNYATWFEVARLDYISKLGFSYADMEKQGIISPVTDLNVNYKKSIFYPEKVKVKTWVEKYSRLRSVYKYEIFNEKGELATTGSTELICIKEDTFKPIRLDRYFPDWHEAYSKVQTLNNEGKTVEIMDGIDSL,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1247,NE1121,NA,conserved hypothetical protein,NA,"1,4-dihydroxy-2-naphthoyl-CoA hydrolase",I110T,Growth rate and cell death,+,1,+,0
1284,MNFKEIKELIEILDKSTLTEINIEDTKGKVTLKKEKETEIITPQISQMPVEAAAMPMPQAQSTDSNKTEAPKPTSDNHKTINAPMVGTFYKSPSPDEEAYVQVGDTVSNETTVCILEAMKLFNEIQAEISGEIVEILVEDGQMVEYGQPLFKVK,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_1476,NA,NA,NA,accB_1,Biotin carboxyl carrier protein of acetyl-CoA carboxylase,V134I,Growth rate and cell death,NA,NA,NA,NA
1285,MDMKREVILKLQQFIIERENADKRRQYKKENEELDLSLTQFHIIELIDNNDKVNNKFLSEMLNVSKPAITKSIKKLLAKDLVVESHNEFNKREVNCSLTQKGKKLSYIHDELHEKSVKKYEEVLKVFDDDEMAVIIEFLNRSIEELKKKMV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2452,NE281,NA,"transcriptional regulator, MarR family",NA,hypothetical protein,K149fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1286,MTTINPTNYTLLKKQAASLIEDEHHMIAILSNMSALLNDNLDQINWVGFYLLEQNELILGPFQGHPACVHIPIGKGVCGTAVSERRKQIVADVHQFEGHIACDANSKSEIVVPIFKDDKIIGVLDIDAPITDRFDDNDKEHLEAIVKIIEKQLA,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1665,NE1359,NA,conserved hypothetical protein,msrC,Free methionine-R-sulfoxide reductase,K87T,SAB mortality and SAB persistence,NA,NA,NA,NA
1287,MTTKTVFDVIDMGLGYLVNVYDTWKVEKVLDDYHKPFSNTIHWQFGHVLTIFESALAVAGKENIDLNIYRPLFGNGSSPDEWKDEVPSIETILESLQTLPERARNLTEDDLAIELKQPIVGCNNLEELLVLNAIHIPLHAGKIEEMSRILKNFK,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_2626,NE248,NA,conserved hypothetical protein,NA,hypothetical protein,K61N,SAB mortality only,NA,NA,NA,NA
1288,MGVPILPTISTTCIVISAILIVIGWRLIWKREINKHKNVMLAAAVFALTFFLIYASRTIFIGNTAFGGPASIKKYYTIFLFFHINLATIGGILGLVQIITAFKDKYNVHRKFGPFASVIWFCTAITGVAVYLLLYVLYPGGETTSLIKATFGH,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1017,NE1084,-,hypothetical protein,NA,hypothetical protein,V22A,SAB mortality and SAB persistence,NA,NA,NA,NA
1289,MLMNSVIALTFLTASSNNGGLNIDVQQEEEKRINNDLNQYDTTLFNKDSKAVNDAIVKQKKERQQQIKNDMFQNQASHSTRLNETKKVLFSKSNLEKTSESDKSPYIQNKQEKKIFPYILMSVGAFLTLGFVIFSIHKGRRTKNESARKSNI,1,1,1,1,1,1,1,1,1,1,1,1,SAUSA300_0280,NA,NA,NA,NA,hypothetical protein,T98I,all,NA,NA,NA,NA
1291,MNNDKLQRMVENLSEEKFGRTFRRCAYFNKRLRTTGGRYLLKSHDIEINPKQYEHYGEDAVVKIILHELCHYHLHIAGKGYQHKDQDFKRLSQQVGAPRFCNSIESYQQRANYEYYCTKCHAKYIRIRKVDTNRMRCGHCNGKLRMKRQLK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2020,NA,NA,NA,NA,Protein SprT-like protein,R24H,SAB mortality and growth rate,NA,NA,NA,NA
1297,MEERLNRVKQQLQQSSYKLTPQREATVRVLIENEKDHLSAEDVYLKVKDKAPEIGLATVYRTLELLAELKVVDKINFGDGVARFDLRKEGAKHFHHHLVCMECGRVDEIDEDLLPEVENRVENEFNFKILDHRLTFHGVCETCQAKGKG,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1448,NE99,NA,"transcriptional regulator, Fur family",fur,Ferric uptake regulation protein,V8I,SAB mortality only,NA,NA,NA,NA
1299,MHQHDFKVQTSWQGGRNNVGNVQGDILSENISIPASLGGVGIGTNPDEMLVSAASSCYIISLAATLERAKFTDISIEQQSIGTACLNNGKFSMSKIVHHPQIQIPSDQIAQLEKRLPKLITIADNNCMISNAVRNNVDIKIYPIIQAK,4,2,1,1,1,1,1,1,2,1,1,1,SAUSA300_1668,NE109,NA,OsmC/Ohr family protein,NA,hypothetical protein,I141T|M97V|V97M,all,NA,NA,NA,NA
1304,MNEQIIGSIYTLAGGVVLYSVKEIFRYFTDSNLQRKKINLEQIYPIYLDCFKKAKKMIGAYIIPTEQHEFLDFFDIEVFNNLDKQSKKAYENVIGFRQMINLSNRVKAMEDFKMSFNNEFSTNQIFLILLFLWKQLLLYMNIKKIYLI,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,F131L,SAB persistence only,NA,NA,NA,NA
1306,MSNQQDVVKELNQQVANWTVAYTKLHNFRWYVKGPNFFSLHVKFEELYNEASQYVDELAERILAVGGNPVGTLTECLEQSIVKEAAKGYSAEQMVEELSQDFTNISKQLENAIEIAGNAGDDVSEDMFIGMQTSVDKHNWMFKSYLS,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2092,NA,NA,NA,dps,General stress protein 20U,R29H,SAB mortality and SAB persistence,NA,NA,NA,NA
1308,MNIYDEYRSYVIEELDDCLTIQKNNDTAYYDVLEAINDLSNDTLCVLNHLYINEGQEETFEQKFLQRNKHLQNVDGFKALRFLRPRTAGRHYIIITLWENRQAFYHWQNSAEYKHTHKHRGTSKGADVKIINRELSYNIRIELADML,1,0,2,0,1,0,1,0,2,0,2,0,SAUSA300_2543,NE1005,-,hypothetical protein,isdG_1|isdG_2,Heme oxygenase (staphylobilin-producing),NA,SAB mortality and growth rate,NA,NA,NA,NA
1311,MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVATELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0672,NA,NA,NA,mgrA,HTH-type transcriptional regulator MgrA,A59V,SAB mortality and SAB persistence,NA,NA,NA,NA
1313,MILEFNIAVHVLAFLTKHHSEKFNSSSLAELTCLNPVQLRRVTTQLVDLKMINTIRGKDGGYLANDRSADVSLATLYKHFVLEKEHHTRLFTGDEGSHCQIARNIATTMSHYQQDEQNIIINFYKEKTIKDVIEDIQKEDLCHENI,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0577,NE713,NA,putative transcriptional regulator,NA,hypothetical protein,I2N,Growth rate and cell death,+,2,+,1
1315,MDINWKLRFKNKAVLTGLVGALLLFIKQVTDLFGLDLSTQLNQASAIIGAILTLLTGIGVITDPTSKGVSDSSIAQTYQAPRDNNKEEQQVTWKSSQDSSLTPELSTKAPKEYDTSQPFTDASNDVGFDVNEYHHGGGDNASKIN,1,1,0,2,1,1,0,1,1,1,0,1,NA,NA,NA,NA,NA,hypothetical protein,N84S,"SAB mortality, SAB persistence and cell death",NA,NA,NA,NA
1319,MFSKVNNQKMLEDCFYIRKKVFVEEQGVPEESEIDEYESESIHLIGYDNGQPVATARIRPINETTVKIERVAVMKSHRGQGMGRMLMQAVESLAKDEGFYVATMNAQCHAIPFYESLNFKMRGNIFLEEGIEHIEMTKS,2,3,0,0,1,1,0,0,1,1,0,0,SAUSA300_0956,NA,NA,NA,NA,Acetyltransferase,S139fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1326,MIKKIKDIIKLEVNYLNRIDKDNTDNDGIILKANNNVNLPNEDNEAYVEIIFTIRSVESNSWENEKNKKRILDDENDQNIIGKLRVNYKIICDFSTEREEKMRDALLEIIEPYFRKEVETLLSNMKLPNFILPYRFWENEDN,1,1,0,0,1,1,0,0,1,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,I54M|R80I,SAB mortality and SAB persistence,NA,NA,NA,NA
1329,MQKVVTKKEMTLPELIEWGFNNTKKVESKTFISETRLGTMERSSVQFSTDGHGVRIDEGVTDKDIFIVETEEVISENTVIPVLLQVYTNFTETNTYSEIYENTSIKEVLDDEVISLVKTFHLVKEDGEHILIWKNGKIIGE,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,S115L,SAB mortality only,NA,NA,NA,NA
1333,MKISTKGRYGLTLMISLAKKEGQGCISLKSIAEENNLSDLYLEQLVGPLRNAGLIRSVRGAKGGYQLRVPAEEISAGDIIRLLEGPITFVESIESEPPAQKQLWIRMRDAVRDVLDNTTLKYLAEYVDTSEDLDGYMFYI,2,1,0,0,2,1,0,0,2,1,0,0,SAUSA300_1583,NE1293,-,hypothetical protein,cymR,HTH-type transcriptional regulator CymR,P98L|I103L,SAB mortality and SAB persistence,NA,NA,NA,NA
1337,MEFTYSYLFRMISHEMKQKADQKLEQFDITNEQGHTLGYLYAHQQDGLTQNDIAKALQRTGPTVSNLLRNLERKKLIYRYVDAQDTRRKNIGLTTSGIKLVEAFTSIFDEMEQTLVSQLSEEENEQMKANLTKMLSSLQ,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0334,NE1781,-,MarR family transcriptional regulator,slyA_2,Transcriptional regulator SlyA,A83V,SAB mortality only,NA,NA,NA,NA
1338,MKILFVCTGNTCRSPLAESIAKEVMPNHQFESRGIFAVNNQGVSNYVEDLVEEHHLAETTLSQQFTEADLKADIILTMSYSHKELIEAHFGLQNHVFTLHEYVKEAGEVIDPYGGTKEMYVHTYEELVSLILKLKDIIC,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2069,NE1424,NA,conserved hypothetical protein,ptpB,Low molecular weight protein-tyrosine-phosphatase PtpB,A106V,SAB persistence only,NA,NA,NA,NA
1339,MIKIEKHDIKKLEEYIQHIDNYRRELKMREYELLESHEPDNAGASKSNLPGNPIERCAIKKFSDNRYNTLRNIVNGVDRLIDENDEDTLELLRFRYWDCPIGCYEWEDIAHYFGTSKTSILRRRNALIDKLAKYIGYV,2,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1944,NA,NA,NA,NA,hypothetical protein,N84S,SAB mortality only,NA,NA,NA,NA
1341,MPFTMKGYPEKWKEFEVIKRQKAIEIANAMLKEGYLEKDVVPIAAKKAKDWYRALSKEEIKALEEENFVQFHTATMEKTEVDSEYATTDNEEHIQEQSNQDKSYFDSESIGNQSGGVRQREPLMDGPHPKVVESFKDV,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2447,NA,NA,NA,NA,hypothetical protein,Ter139Ter,SAB mortality and SAB persistence,NA,NA,NA,NA
1347,MIKLTPKQEKFVLGLIEGKSQRKAYIDAGYSTKGKSDNYIDSRAFELSKNSAVLDRYEELRQEAAEQSKWTRQKAFEEYEWLKNVAKNDIEIEGVKKATADAFLASLDGMNRMTLGNEVLTNKKIETEIKMLEKKN,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N136fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1348,MIDILYKVHEVISQDRIIREHVNINNIKFNKYPNVKDTDVPFIVIDDIDDPIPTTYTDGDECAYSYIVQIDVFVKYNDEYNARIIRNKISNRIQKLLWSELKMGNVSNGKPKYIEEFKTYRSSRVYEGIFYKEEN,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,K112E,SAB mortality and SAB persistence,NA,NA,NA,NA
1349,MTEFFMEEVLIDDNMVFDIDNLKGFLNDTSSFGFIAKENNKIIGFAYCYTLLRPDGKTMFYLHSIGMLPNYQDKGYGSKLLSFIKEYSKEIGCSEMFLITDKGNPRACHVYEKLGGKNDYKDEIVYVYDYEKGDK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,F5del,SAB mortality and SAB persistence,NA,NA,NA,NA
1350,MGMKISELAKACDVNKETVRYYERKGLIAGPPRNESGYRIYSEETADRVRFIKRMKELDFSLKEIHLLFGVVDQDGERCKDMYAFTVQKTKEIERKVQGLLRIQRLLEELKEKCPDEKAMYTCPIIETLMGGPDK,0,2,0,0,0,1,0,0,0,3,0,0,NA,NA,NA,NA,merR1,Mercuric resistance operon regulatory protein,M120I|G99D|G2E,SAB persistence only,NA,NA,NA,NA
1354,MEIEIKFNEVFNAPMGSPRPRFRKTGRFVQTYMPTSYTKHKAYIQGQMPKLNLERALKIELDFYFPLLKSWSKKKKSEMVGQYKVTKPDIDNLIKTVLDACNGHVWKDDNQITEITSSKRYGIEPKIIIRIEEI,1,2,1,1,1,1,1,1,1,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,H40Q,all,NA,NA,NA,NA
1360,MKIKVKKEMRLDELIKWARENPELSKGKIFLAKVFSNGFFRFQRNTNTCSISSFIPIDTPFIVEVEEEITEDTVFDRLFEVYELQEGAYMSALHTSISINERLENTFFPTKAFYILNDGLTMTLIWKDGRLVE,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,F40V,SAB mortality and SAB persistence,NA,NA,NA,NA
1361,MKKVNNDTVFGILQLETLLGDINSIFSEIESEYKMSREEILILLTLWQKGSMTLKEMDRFVEVKPYKRTRTYNNLVELEWIYKERPVDDERTVIIHFNEKLQQEKVELLNFISDAIASRATAMQNSLNAIIAV,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_1708,NE386,rot,staphylococcal accessory regulator Rot,rot,HTH-type transcriptional regulator rot,I29M,all,NA,NA,NA,NA
1362,MKHVKENDLAHGEFGKWLEKVGLDKYQASRFIKVANEQSKLHSSANLGLKALYQIATIPVEHREEKQQTSSGEMKTPYEMTNKEREEFKRQLKQRDEENAQLQSQMEQAQRSEEIARKQYKYGLNNYIFTIKF,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,K5E,SAB persistence only,NA,NA,NA,NA
1370,MQNIKYLTEKQVIAINVKAIQELSPKEQVGVKVPEVLNATIEGVKQSFGGVELYETIERKAAFIYRNIAQKHAFFNANKRTAFTSMVIFLKLNKINFNCTQDEAVQFTLKVVEDKTLTLEDIADWIKRHCK,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,A104P,SAB mortality and cell death,NA,NA,NA,NA
1375,MKLTLMKFFVGGFTVLLSYIVSVTLPWKEFGGIFATFPAVFLVSMFITGMQYGDKVAVHVSRGAVFGMTGVLVCILVTWMMLHMTHMWLISIIVGFLSWFISAVCIFEAVEFIAQKRLEKHSWKAGKSNSK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2641,NE1755,-,hypothetical protein,NA,hypothetical protein,T14A,SAB mortality and SAB persistence,NA,NA,NA,NA
1376,MSSFTLAVNRTFTNAQGEREADFINIIVFKKQAENVNKYLSKGSLAGVDGRLQTRNYENKEGQRVYVTEVIADSIQFLEPKNSNDTQQDLYQQQVQQTRGQSQYSNNKPVKDNPFANANGPIEIDDNDLPF,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1958,NE824,-,single-strand binding protein,ssbA_3,Single-stranded DNA-binding protein A,S2fs,SAB mortality only,NA,NA,NA,NA
1379,MLNKIVIVGRLTKDAQIFEKEDRKIATFCVATHRNYKDENGEIVCDYLFCKAFGKLASNIEKYTNQGTLVGITGQMRSRKYDKDGQTHFVTELYVETIKFMSPKSQNNEILSDSILDIDSQNIDNLDLLEI,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2052,NE1679,-,single-stranded DNA- binding protein family,ssbA_2,Single-stranded DNA-binding protein A,L126H,SAB persistence only,NA,NA,NA,NA
1380,MYKNYNMTQLTLPIETSVRIPQNDNTRYVNEIVETISDSEFDEFICPNNKRIGFKRYAYRNDRYSFKRDFKLYECDDCSSCSLRHQCMKPNSKSNKKIMKNYNWEYFKAQINQKLSEPETKKSIVKEKLM,1,0,1,0,1,0,1,0,1,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,M1?,SAB mortality and growth rate,NA,NA,NA,NA
1392,MYLNQRIKFFLERVVRMMDENRSKGNRWGVWAFFGILLVPLLVPLLCCAGPILLVALGSTGIGALFAGATGNWWLTGIFAALAIVMIALILSKLLKNKYNSPEGNGKTKNKTDCCTPPESVDRKHETR,0,3,1,1,0,1,1,1,0,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,L11fs,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
1395,MSKFKKISASEFETLRFYQLPKFLFEDEYFSKMPTDAKVMYALLKDRFELSRLNNWVYSENNIYLLYTNKQLCSILNYAEPKIIKLKKELEKYNLIINERQGLNKPNKIYLLEPTYDKELINHQFKN,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,Y58D,SAB mortality only,NA,NA,NA,NA
1396,MANKQVEISMAEWDVMNIIWGKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKRYKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDILNDISKSN,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,blaI,Penicillinase repressor,S126fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1398,MLNRETLIARIEQELVQAEQAQHDHDFEKHMYAIHILTSLYASTSNTPHIGEQQMNRRIANHNQMPQSQITQPTHQVTAAEIEAMGGKVNTHSAHHHNKSYSQPSNQQQRLATDDDIGNGESIFDF,0,0,1,1,0,0,1,1,0,0,1,1,SAUSA300_0564,NE546,NA,conserved hypothetical protein,NA,hypothetical protein,T38K,Growth rate and cell death,+,4,+,0
1400,MNKKFLMIVIIILILILGGIFLKMKYDEKKYYDEQKERITIYMKYNVKGYKNISFANFKENPMDGYSISGYINNDKKLSFTAGIRSVDDFQFDTDISYTDELGRKFNKNPKSVSEIKKEQNTSNK,1,0,1,0,1,0,1,0,2,0,1,0,SAUSA300_1749,NE1639,-,hypothetical protein,NA,hypothetical protein,F5Y|I4K,SAB mortality and growth rate,NA,NA,NA,NA
1401,MIQSMWFNLHVQDLEKSAQFYKALGFKINRNPQMLDKMVGIQIGQTTVILIENKHFQNVSQQSLNTEPNEVMISLGVNTNEEVDQLVNKVKEVGGTVVQEPTVSQGFYGAMFKDLDGHHFNFLVC,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_2512,NA,NA,NA,NA,hypothetical protein,V93A,SAB mortality and growth rate,NA,NA,NA,NA
1405,MFISITLLIVPDLIRLSKTFLIESRDLTTVDFEFFSRDILDDFKGVDRNDIEIRQHRIILHKGEEMIEYKLINNKIIKVVNDRGNITMINNVTAFAANIYYKSIIKITITVKVGTNVQTKTIYV,1,3,1,0,1,2,1,0,3,5,1,0,SAUSA300_1500,NE322,NA,putative competence protein ComYC,NA,hypothetical protein,A96T|I106K|K110T,"SAB mortality, SAB persistence and growth rate",NA,NA,NA,NA
1408,MKRLIIGMLIIMMSIINYRCGNNQNENKYKSQINKVMKIQQETHKEMVKKSNEVNPEFNKDKVNTYVFNDGKLIIISYKLFKDKDQMFYATYEFKNDKIFYKRDIDPKTYVKEHQSDYKDIKVK,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,R19G,SAB mortality and SAB persistence,NA,NA,NA,NA
1409,MAKLKRNIIQLVEDPKANEIKLQTYLTPHFISFEIVYEAMDLIDDIEDENSTMKPREIADRLMDMVVKIYDNQFTVKDLKERMHAPDGMNALREQVIFITQGQQTEETRNFIQNMK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1932,NE244,NA,conserved hypothetical phage protein,NA,hypothetical protein,Y37_I43dup,SAB persistence only,NA,NA,NA,NA
1411,MIQQETRLKVADNSGAREVLTIKVLGGSGRKTANIGDVIVCTVKNATPGGVVKKGDVVKAVIVRTKSGVRRNDGSYIKFDENACVIIRDDKGPRGTRIFGPVARELREGNFMKIVSLAPEVL,2,2,0,0,1,1,0,0,2,1,0,0,SAUSA300_2194,NA,NA,NA,rplN,50S ribosomal protein L14,D37N|A38V|V38A,SAB mortality and SAB persistence,NA,NA,NA,NA
1417,MVKVTDYSNSKLGKVEIAPKVLSVIASIATSEVEGITGHFAELKETNLEKVSRKNLSRDLKIESKEDGIYIDVYCALKHGVNISKTANKIQTSIFNSISNMTAIEPKQINIHITQIVIEK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1474,NE1841,-,hypothetical protein,NA,hypothetical protein,K20E,SAB mortality and SAB persistence,NA,NA,NA,NA
1418,MKRFVATVLLLLVFISGCGNDKYVKEIDEAVKIQNQKQEQLAKKGNGDRVDHFERKDANIYVYDKDKIIILAYKSLSNDDEVHYYAYDFSDKRVSYKQDFDSRRYYQQHDADYHEENMTN,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2355,NE1213,-,putative lipoprotein,NA,hypothetical protein,S75P,SAB mortality and SAB persistence,NA,NA,NA,NA
1420,MNKNQLKSEILEYIKAHAGTSFVEIERVFEENNFDYKGDGAYTSGQHPNVVFWVGWNQEAFDVIAELKKDGHIEMDICEPIVYMVDGKGLDLPIVRSKNIKTDHWLPVTFTISKKETECV,0,0,1,1,0,0,1,1,0,0,1,1,NA,NA,NA,NA,NA,hypothetical protein,R27C,Growth rate and cell death,NA,NA,NA,NA
1424,MDKKTDIGLRIKSIRLAKGLNLREFGEEISKLTKEKKYISDSIVSRWEKGVSIPNAKRLKAIAEYGNVSINFLLYGNEISYEDIYQNIKSVNMKNNIQDKLIDFIFYYLHSCELITFYF,1,1,0,0,1,1,0,0,6,6,0,0,NA,NA,NA,NA,NA,hypothetical protein,FY106VN|LH109MP|C112S|LI114QN|F117Y|Ter120Kext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1426,MNDLKSKSNIKLMKRVLTTYELRKYLKKYFCLTLDNYLVLAYLDVFKNDEG,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2437,NE514,sarT,staphylococcal accessory regulator T,sarT_2,HTH-type transcriptional regulator SarT,Ter52Kext*?,SAB persistence only,NA,NA,NA,NA
1429,MTFEEKLSEMYNEIANEICGMIPVEWEKVCTIAYVNDRGGEVVFNYTKPGSDELNYYMNISRDYNVSEEIFDDLWMELYRSFKKLRNIFKEEGHEPWTSCEFDFTNEGKLKVSFDYID,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,essG_3,Type VII secretion system protein EsaG,C30Y,SAB mortality only,NA,NA,NA,NA
1431,MEAKAVARTIRIAPRKVRLVLDLIRGKNAAEAIAILKLTNKASSPVIEKVLMSALANAEHNYDMNTDELVVKEAYANEGPTLKRFRPRAQGRASAINKRTSHITIVVSDGKEEAKEA,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_2199,NA,NA,NA,rplV,50S ribosomal protein L22,A95_N97delinsGR,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
1432,MNSQELLAIAVDAIDNKKGEDTISLEMKGISDMTDYFVVTHGNNERQVQAIARAVKEVANEQNIEVKRMEGYNEARWILIDLADVVVHVFHKDERNYYNIEKLYQDAPLESYSQVA,3,2,2,1,1,1,1,1,1,1,1,1,SAUSA300_1551,NE712,NA,conserved hypothetical protein,rsfS,Ribosomal silencing factor RsfS,Ter117Yext*?,all,-,1,-,0
1435,MNLIPFIIILIFSCLWTAITNKYLPSETLDKKGQQDRYDERQRKMFIEILAKSFIWIVYCMLFTLVLKFTGLSPSIEGSWFSQYPEIFFIIVALFLMLFNYYTTNKKYTSKGLINEK,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,L113*,SAB mortality only,NA,NA,NA,NA
1436,MEQIDLFSIDKFKCNSEAKYYLNIIEGEWHPQDLNDSPLKFILSTSDDSDYICKYINTEHKQLTLYNKNNSSIVIEIFIPNDNKILLTIMNTEALGTSPRMTFIKHKS,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,D5E,SAB mortality only,NA,NA,NA,NA
1437,MINIGLTGWGDHYSLYEDLERQTDKLKTYAGHFPVVELDATYYAIQPERNILKWIKETPDTFEFVVKIHQALTLHADYKTFADTRQELFDQFKNMLEPLHTQKKISNGIGSISAMV,0,0,1,0,0,0,1,0,0,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,I105fs,Growth rate only,NA,NA,NA,NA
1438,MLEMISNGKMTMKLNNVKQNRHILFTNEYNNKKNNSSLLPSYTIIDSNESEKMTKKEFIDIPVLFDDEGNFRIKQVIDYKKIIGKSYVNGKYIETKLGKVHYSKTGFHVVPYIKKE,1,1,0,0,1,1,0,0,2,1,0,0,SAUSA300_1212,NA,NA,NA,NA,hypothetical protein,N20K|F25C,SAB mortality and SAB persistence,NA,NA,NA,NA
1445,MSDVSLKLSAKDIYEKDFEKTMARGYRREEVDAFLDDIIADYQKMADMNNEVVKLSEENHKLKKELEELRLRVATSRPQDNKSFSSNNTTTNTSSNNVDILKRISNLEKAVFGK,1,0,1,0,1,0,1,0,1,0,1,0,SAUSA300_1337,NE1357,-,hypothetical protein,gpsB,Cell cycle protein GpsB,D36Y,SAB mortality and growth rate,NA,NA,NA,NA
1447,MDKQQIKGFVCDYHERTRSDVLIDDDINTDEFFSIGDENSNEWMTDDNIDDHIVKNHLEMIVDRVANDKEFYIFDSLIQGRSFKDISNVLECSEQSVRLWYEALLDKIVEVIE,2,4,0,0,1,1,0,0,1,5,0,0,NA,NA,NA,NA,NA,hypothetical protein,A103T,SAB mortality and SAB persistence,NA,NA,NA,NA
1449,MIKKIFTKKHVFLVIEDENHNHSDAVFGKSILLSIYVGVNKKTNSKSGKFIYLDRSKRIVRQSDITKIESANENDVDFYNLLKKEKEIVYSKNIVYKYNLANYIIYYEVSTKE,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,Y96D,SAB mortality and SAB persistence,NA,NA,NA,NA
1458,MINETKYMRQQITNLIQIIDTIKYNTLKTDWNIQTHIYKFNQIVTNELNKFKGFETSYIINENQVSYYEIITLLNKRPLRQVDYGNKIQYLNFYHTELSNALFAIKFAH,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,K28M,SAB mortality and SAB persistence,NA,NA,NA,NA
1460,MKSIKKDIDKVYKEQNQMNKIASKVQNTIKTDIKQEDSNTHVYKNGKVIVIGIQLYKDREKMYYFAYEIKDGKAEINREIDPIKYMKDHKADYEDENVEVEKK,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,K103fs,SAB mortality and cell death,NA,NA,NA,NA
1463,MLDSYLFQLATNKEQITKKQFKTKLENIREVPEIPIRQVNDILEGYKNSELYVELIISILK,2,0,0,0,1,0,0,0,2,0,0,0,SAUSA300_0767,NE1574,-,hypothetical protein,NA,hypothetical protein,I57N|P106L,SAB mortality only,NA,NA,NA,NA
1465,MNETDEPQGSEHTHNRLNINQNSQSLMTFITSKLKSKLKQHIIIARGNKRIDYRLSYNFYTTYYDNVEIKKIDCEYTYAMAIAILIRHTMSFDNAHFFAQLRHPVL,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N2S,SAB mortality and SAB persistence,NA,NA,NA,NA
1466,MQSIKSNESFKSVINSDTPVIVKFEAGWCPDCRAMNLWIDPIVEQYNDYQWYTVNRDELEDVVVENEVMGIPSLLVFKNGDKIAHLHSANAKSPEQVESFLAETFK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0789,NE1803,-,putative thioredoxin,ydbP,Thioredoxin-like protein YdbP,N36D,SAB persistence only,NA,NA,NA,NA
1469,MRGGGNIQQMMKQMQKMQKKMAQEQEKLKEERIVGTAGGGMVAVTVTGHKEVVDVEIKEEAVDPDDIEMLQDLVLAATNEAMNKADELTQERLGKHTQGLNIPGM,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_0453,NA,NA,NA,NA,Nucleoid-associated protein,I7M,SAB mortality and SAB persistence,NA,NA,NA,NA
1474,MKYIKAQINQKLSEPETKKIYSHRKIYVEPVFGFMKAILGFTRMSVRGINKVKRELGFVLMALNIRKIAAQRAVHYKIHIKKADFYQIINRNQLFYIA,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,IS1182 family transposase ISSau3,Y86H,SAB mortality only,NA,NA,NA,NA
1477,MAKQKIRIRLKAYDHRVIDQSAEKIVETAKRSGADVSGPIPLPTEKSVYTIIRAVHKYKDSREQFEQRTHKRLIDIVNPTPKTVDALMGLNLPSGVDIEIKL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_2205,NA,NA,NA,rpsJ,30S ribosomal protein S10,Y58D,SAB persistence only,NA,NA,NA,NA
1479,MAENNQNSLVTKIATYGSFIAIASFVILFISIFLKFSFNIEFTATIMNICRYTLILGFILMSLPDVVDKNIKKIIFDAFIFIVFIFFLL,2,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,F81I|P62S,SAB mortality only,NA,NA,NA,NA
1480,MKNHTNIINILLVIVNSLTHFLTLNTSFFNNSASDFCFIIGAIFFLIGIFVAIYGMKRATYWLNLLILFTNIFYFPHFCVLLLLKYIGFKLFIYEGCVLLFI,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,P76L,SAB persistence only,NA,NA,NA,NA
1481,MVKPRQREYPTLKSSLNIIRETALIAISCVFWIYCLVVLLVYIGTIFEIHDESINTIRVALNIENTEILDIFETMGIFAIIIFVFLQLAY,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,icaD,"Poly-beta-1,6-N-acetyl-D-glucosamine synthesis protein IcaD",L86fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1487,MMTKDERIRFYKSKEWQTTRKRVLERDNYECQQCKRDSKLTTYDKSKRKSLDVDHILSLEHHPEFAHDLNNLETLCIKCHNKKEKRFIKKENKWKDEKW,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_1943,NE1792,-,phi77 ORF040-like protein,NA,hypothetical protein,S38G,SAB mortality only,NA,NA,NA,NA
1488,MSLNKEQRRITAEELQAHFEESTLSVQMIAGKLNVTT,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2514,NA,NA,NA,NA,hypothetical protein,Ter38Eext*?,SAB mortality and SAB persistence,NA,NA,NA,NA
1492,MTTFSEKEKIQLLADIVELQTENNNEIDVCNYLTDLFDKYDIKSEILKVNEHRANIVAEIGNGSPILALSGHMDVVDAGNQDNWSYPPFQLTQKDAKL,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1976,NE1222,-,succinyl-diaminopimelate desuccinylase,dapE_1,putative succinyl-diaminopimelate desuccinylase,Q93E,SAB mortality and SAB persistence,NA,NA,NA,NA
1494,MAEQDNAHHSEQIKTNLKSRLNRIEGQVRAINRMIEEDVYCDDVLTQIRATRSALNSVAIKLLEQHMKSCIMNKVNQGAQEEAMEELLVTFQKLIKD,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2043,NE1750,-,hypothetical protein,NA,hypothetical protein,A2T,SAB mortality and SAB persistence,NA,NA,NA,NA
1499,MLGHHLYNENKIRAILNNKKLPSYTILSIDLLNELLREKMSTGNLILSDERFDLKEIINFNQIIGKIHIENVYIETRKGKVHYSKTGAHIVPYIDK,2,1,1,2,1,1,1,1,1,1,1,1,SAUSA300_1210,NE608,NA,conserved hypothetical protein,NA,hypothetical protein,H68Y|Y68H,all,NA,NA,NA,NA
1500,MSNIIKTIGKGIGKGVGAAAYYSVATVGAAIGAIWETTGDRGLMRDALSDSSNQDLMEIYEIQKKDDGDYDTYIAAKSLLQERGFTYNHETNKWEK,1,1,1,1,1,1,1,1,1,1,1,1,NA,NA,NA,NA,NA,hypothetical protein,K6T,all,NA,NA,NA,NA
1504,MEKGIFNYDNANVLKLDTYQLNENIKVIDDIFKNYEQIEPTIEVENGNTKLKLNGYFIASIISPLNLNKLNNLYVEEEFYHTYNELIVKYTEVKE,2,2,0,0,1,1,0,0,2,2,0,0,SAUSA300_0938,NE1556,-,hypothetical protein,NA,hypothetical protein,Y19N|Y84N,SAB mortality and SAB persistence,NA,NA,NA,NA
1505,MVKFKVVRAFKDIEHNQHKYKVGELYPAEGYNNPRVELLTNQIKNKYDKVYIVPLDNLTKQELLELCESLQKKASSSMVKSEIVDLLNGEDNDD,2,2,0,0,1,1,0,0,2,1,0,0,SAUSA300_1937,NE1667,-,phi77 ORF045-like protein,NA,hypothetical protein,N57K|F75S,SAB mortality and SAB persistence,NA,NA,NA,NA
1514,MNKTDLINAVAEQADLTKKEAGSAVDAVFESIQNSLAKGEKVQLIGFGNFEVRERAARKGRNPQTGKEIDIQASKVPAFKAGKALKDAVK,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1362,NA,NA,NA,hup,DNA-binding protein HU,Q72P,SAB mortality and SAB persistence,NA,NA,NA,NA
1517,MKKVIKFISKIMNEESLFYKFSLFIVIAGVLVLSVMALDNINDLIRFLFNYEHLVMVSPIVALAIMFYSQAKYPLDKTIKYSDYAKKRM,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N42I,SAB persistence only,NA,NA,NA,NA
1519,MLHNHPGQSGFSEYDLFTFFKHPSIKSMTIVTNKGQVKFITKSNSFHGKIVSKFCAKYFTHINIINDSHIEKLLKKLYSINMIKYKVR,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,S45R,SAB persistence only,NA,NA,NA,NA
1524,MNEKHNIFNRFGRNTSIQTVAVKDTYFIEYRKGDEIKYFPIELATVVKALNIDLHDSDTVSNYENGPKFDIKKLNLYTGDMDQIGDE,2,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N65D,SAB mortality and SAB persistence,NA,NA,NA,NA
1525,MPKSILDIKNSIDCHVGNRIVLKANGGRKKTIKRSGILKETYPSVFIVELDQDKHNFERVSYTYTDVLTENVQVSFEEDNHHESIAH,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0471,NE1703,-,hypothetical protein,veg,Protein Veg,Y64C,SAB persistence only,NA,NA,NA,NA
1526,MNNILLNAINIVITTNFVIFNILITYNKDLDDLCWLLPGIIICGVILIVSFTIAMITKNWLSEILFFINIVLVLYYIYPIFYSFIG,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N16T,SAB persistence only,NA,NA,NA,NA
1527,MDILTLEGTEIYINSLGLQDQKLIYRTELKNEKEAAAKIEKYLNSNYLDHSKIVDHNYNDFKYLYIFTMFNGFNTLIGFKFSSVTI,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,F67V,SAB persistence only,NA,NA,NA,NA
1529,MVKFKVVRAFKDIEHNQHKYKVGELYPAEGYNNPRVELLTNQIKNKYDKVYIVPLDKLTKQELLELCESLQKKRLVQWLKVKSSTY,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,R74fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1534,MLILKIKEINDKSVTYTYFPNNDGNIKPGIIQMDIDSLEVINAEKSSLEKNTRDNYFIHAIDRIYINTSKGLFPESELVAWG,0,0,0,1,0,0,0,1,0,0,0,1,SAUSA300_1208,NE1852,-,hypothetical protein,NA,hypothetical protein,T17K,Cell death only,NA,NA,NA,NA
1535,MDINSEEYKQEVLIKDVVMLAARILLESGAEGTRVEDTMTRIAKNLVTVKVTALLQTLSSSLRYIRNRFLEYLELPLEIQT,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N45fs,SAB persistence only,NA,NA,NA,NA
1536,MTFNEYNYNNELILKLNKIEVQKNNEKISEVFKDYEILKPKIIFNGSNPYLALNHIIVAEIENYSSLETFSKIYVDEDYY,0,0,0,1,0,0,0,1,0,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,Ter81Yext*?,Cell death only,NA,NA,NA,NA
1537,MKVTDVRLRKIQTDGRMKALVSITLDEAFVIHDLRVIEGNSGLFVAMPSKRTPDGEFRDIAHPINSRYETRNSRCSDESI,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,spoVG,Putative septation protein SpoVG,R67fs,SAB mortality only,NA,NA,NA,NA
1540,MIATKKKPHIMPVWSIKNRALKVRDEDFEECDLITIEGSVFGEWLDELRDDHKAVAIDLKTGVVGTIVSVQKLSNELTF,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_2085,NE86,NA,conserved hypothetical protein,NA,hypothetical protein,V70A,SAB mortality and SAB persistence,NA,NA,NA,NA
1545,MKRTDKYRDSYQYDNQNQNHRRQSEDASYRQQYAKGDPEEHPERYYNGRDYRREQILEEENEKSRRSKNGYISLLPFS,0,2,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,N69fs,SAB persistence only,NA,NA,NA,NA
1550,MNYFRYKQFDKDVITVAVGYYLRYALSYRDISEILRERGIYVHHSTIYRWVQEYAPILYQIWKKKISKLIINGI,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,I66fs,SAB mortality only,NA,NA,NA,NA
1551,MNENSKTLYRDLVEEKIIPEIKEDGDSDLTIEEIDLIGSHLDKEIEDCAQIRKQTRKKELKDETVDAHLFLELF,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,Ter75Yext*?,SAB persistence only,NA,NA,NA,NA
1553,MAELTNGGVSLKMVSDMLWKRMKEFHQHGIYNDLTLDLEDASRRIAQILKYNDVKEVIDKDEFEEYFATGVKY,1,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,I58T,SAB mortality only,NA,NA,NA,NA
1555,MSYNNFLQMTTILESTAGDTWVEQVSNIIVQPIFTLILTCLTFLGFVYQLYSKKSMQLVLSPHYHYLFYFWDF,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,S55fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1557,MKYNTNVKHTTLEAFVTTVNDLGIELIINEALREVRKRQLIELIDDALVNKDEAAFNQYTAEYKNLEAFLGE,1,2,1,1,1,1,1,1,1,1,1,1,SAUSA300_0929,NA,NA,NA,NA,hypothetical protein,A47T,all,NA,NA,NA,NA
1562,MSINIDPEKFAELVIMSNPSKFEDAEDIAKESLKLYINAYRLAERYSTIATNCYDTAEVIKELKKTDLQLK,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1180,NE1413,NA,conserved hypothetical protein,NA,hypothetical protein,I15V,SAB persistence only,NA,NA,NA,NA
1565,MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYVILEYINFCIYDYNLNI,0,1,0,0,0,1,0,0,0,3,0,0,NA,NA,NA,NA,NA,hypothetical protein,YINF59NKKI|Y67*|L69*,SAB persistence only,NA,NA,NA,NA
1567,MNQFKEIYNTIDILLNDKSISYYRINQDTDVSYGGISELRSGKRKVNNLTLETAEKLYNYQKQLEIMIED,1,1,0,0,1,1,0,0,1,1,0,0,SAUSA300_1202,NA,NA,NA,NA,hypothetical protein,Y22N,SAB mortality and SAB persistence,NA,NA,NA,NA
1572,MNQTWKEVYQYLMHQPHIDVIKGIIAFSSNKKNNSELDELYSIYMNDDSITSIVHPDLIESIELIHNE,1,0,1,0,1,0,1,0,1,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,N33fs,SAB mortality and growth rate,NA,NA,NA,NA
1574,MTFYNFIMGFQNDNTPFGILAEHVSEDKAFPRLEERHQVIREYVMSNYTDHQLIETTNRAISLYMAN,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_0782,NA,NA,NA,NA,hypothetical protein,E42A,SAB persistence only,NA,NA,NA,NA
1575,MLHETWKERTPIKKVEVINTDAKKFTVSDMLTVGKQYDVINETEEYYQIIDNSGLVGGYNKTYFKEV,0,1,1,1,0,1,1,1,0,1,1,1,SAUSA300_1303,NA,NA,NA,NA,hypothetical protein,N60Y,"SAB persistence, growth rate and cell death",NA,NA,NA,NA
1576,MRNRLKELRARDGLNQTQLAKQAGVSRQTISLIERNNFMPSVLTAIKIARIFNETVETVFIIEEDEV,1,0,0,0,1,0,0,0,1,0,0,0,SAUSA300_0350,NA,NA,NA,NA,hypothetical protein,V67A,SAB mortality only,NA,NA,NA,NA
1579,MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEDGQAVEFEVVEGDRGPQAANVVKL,0,1,0,0,0,1,0,0,0,1,0,0,SAUSA300_1295,NA,NA,NA,cspA_1,Cold shock protein CspA,D43E,SAB persistence only,NA,NA,NA,NA
1581,MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYAILENKKICISH,2,1,0,0,2,1,0,0,2,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,D13fs|N50K,SAB mortality and SAB persistence,NA,NA,NA,NA
1585,MKFRELVKQSYEDLKNLTVTWYNVIALAIIVIVLSTVTTPIIGIPAGLLGGAYYLKRREEKGK,2,0,1,1,1,0,1,1,1,0,1,1,SAUSA300_2635,NE1082,-,hypothetical protein,NA,hypothetical protein,V31I|I31V,"SAB mortality, growth rate and cell death",NA,NA,NA,NA
1586,MMGCIILFFLAGPVILGVGNLVIGPIFNKQTPFRVQVRSFVVGSMIYLILATIGYFLLLQGKL,1,2,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,C4Y,SAB mortality and SAB persistence,NA,NA,NA,NA
1587,MDRLKYSLKVGILALLLFCTLNYLVPMQSNAFSIIIYSAIFAVLLMLLVYIFLGILKKLHETN,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,L59*,SAB mortality and SAB persistence,NA,NA,NA,NA
1589,MLLKPCPFCNGEARIRYSFKKALIECSNSKCKLQPSTFLYMDTDRVSKLVKAWNTRKYEGEN,1,2,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,P7L|L7P,SAB mortality and SAB persistence,NA,NA,NA,NA
1591,MKHQFSRNELAIGQQGLDLLKQQTVVILGVGGVGSFAAEALARTNIGHIILIDKEMMLILQM,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,E55fs,SAB mortality and SAB persistence,NA,NA,NA,NA
1592,MQQPIDILIMLTKEYLRLLEKRKEVQPNLSYSYERVSKARIQRAALMLRETMLDVENGRLK,3,0,0,0,1,0,0,0,1,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,Q42H,SAB mortality only,NA,NA,NA,NA
1598,MAKLQITLTRSVIGRPETQRKTVEALGLKKINSSVVVEDNPAIRGQINKVKHLVTVEEK,1,2,0,0,1,1,0,0,1,1,0,0,SAUSA300_2186,NA,NA,NA,rpmD,50S ribosomal protein L30,I31T,SAB mortality and SAB persistence,NA,NA,NA,NA
1599,MVVKEILRLLFLLAMYELGKYVTEQVYIMMTANDDVEAPSDFAKLSDQSDLMRAEVTE,1,0,0,0,1,0,0,0,2,0,0,0,NA,NA,NA,NA,NA,hypothetical protein,S49C|T57S,SAB mortality only,NA,NA,NA,NA
1618,MLQKFRIAKEKNKLKLKLLKHASYCLERSNNPELLRAVAELLKKVN,1,1,0,0,1,1,0,0,1,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,H21R,SAB mortality and SAB persistence,NA,NA,NA,NA
1624,MTRELRKKLTLYLNIATLILFIINLTRKNKLVFHFDKNYEPV,0,1,0,0,0,1,0,0,0,1,0,0,NA,NA,NA,NA,NA,hypothetical protein,V32F,SAB persistence only,NA,NA,NA,NA
1627,MNQTWKEVYQYLMHQPHIDVIKGIIAFSSNKKIIQN,1,0,0,1,1,0,0,1,1,0,0,1,NA,NA,NA,NA,NA,hypothetical protein,I33fs,SAB mortality and cell death,NA,NA,NA,NA
1629,MEDLKQSLKGLGWYDFFYSTYVSTIRVSAEL,1,0,1,0,1,0,1,0,1,0,1,0,NA,NA,NA,NA,NA,hypothetical protein,Y18fs,SAB mortality and growth rate,NA,NA,NA,NA
1631,MLKNGIENTNTDIGMIIIKSKNVTIIKFNK,0,1,0,0,0,1,0,0,0,2,0,0,NA,NA,NA,NA,NA,hypothetical protein,K19P|Ter31Yext*?,SAB persistence only,NA,NA,NA,NA
